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1 Introduction and Aims of the Project 
 
1.1 Relevance of Indoles and Indole as Privileged Structure 
 
     The indole framework is one of the most frequently found structural motifs in natural 
products and pharmaceutically active compounds.1 For instance, indole core is a key 
substructure in the amino acid tryptophan 1 (and is present in the multitude of molecules 
containing this amino acid). This bicycle is also very frequently found in physiologically 
active compounds, melatonin 2 and serotonin 3 being examples. The latter one is acting as a 
neurotransmitter in the central nervous system, regulating functions of the cardiovascular 
and gastrointestinal systems. It is also often found in hallucinogenic substances such as 
psilocin 4, as well as in many other naturally occurring molecules (Figure 1). 
 
Figure 1. Structures of naturally occurring indoles: tryptophan, melatonin and serotonin 
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Owing to the great structural diversity of biologically active indoles, literature even entitles it 
as the most important structural class in drug discovery. The indole ring systems have 
become an important structural components in many pharmaceutical agents, some examples 
being sertindole 5, which affects dopaminergic system and is used for the treatment of 
schizophrenia, or nonsteroidal anti-inflammatory drugs indomethacin 6 and ondansetron 7 
(Figure 2).2  
 
                                                 
1 For reviews see: (a) Saxton, J. E. The Chemistry of Heterocyclic Compounds; Wiley: New York, 1983; Vol. 
25, Part IV. (b) Feniuk, W.; Humphrey, P. P. A. Drug Dev. Res. 1992, 26, 235. (c) Somei, M.; Yamada, F. Nat. 
Prod. Rep. 2005, 22, 73-103. For examples of relevant natural products and potential medicinal agents, see: (d) 
Kinsman, A. C.; Kerr, M. A. J. Am. Chem. Soc. 2003, 125, 14120- 14125. (e) Rawson, D. J.; Dack, K. N.; 
Dickinson, R. P.; James, K. Biorg. Med. Chem. Lett. 2002, 12, 125-128. (f) Moloney, G. P.; Robertson, A. D.; 
Martin, G. R.; MacLennan, S., Mathews, N.; Dodsworth, S.; Sang, P. Y.; Knight, C.;  Glen, R. J. Med. Chem. 
1997, 40, 2347-2362. 
                                                                                                                                            
 
2 Insel, P. A., In Goodman & Gilman’s The Pharmacological Basis of Therapeutics 9th ed.; Ruddon, R. W., 
Ed.; McGraw-Hill: New York, 1996. 
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Figure 2. Structures of common pharmaceuticals containing the indole motif (R = ethyl imidazolidin-2-one) 
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Furthermore, chiral indole compounds mostly derived from the amino acid tryptophan are 
also used as catalysts. One example is the chiral Lewis acid 8 developed by Corey for 
stereoselective Diels-Alder reactions (Figure 3).3 Tryptophan itself is for instance used as 
organo-catalyst in Mannich and Mannich type reactions.4
 
Figure 3. Structure of Coreys’ oxazaborolidin catalyst 
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     Among indole derivatives, those with a tryptamine scaffold (3-aminoethyl indole) are 
particularly important compounds and many of these are known to be synthetic medicines 
and physiologically active substances (serotonin, melatonin, psilocin, etc.).5 Tryptamines and 
tryptamides are referred to as “privileged structures” owing to their binding ability to many 
different types of receptors with high affinity.6
                                                 
3 Corey, E. J.; Loh, T. P., J. Am. Chem. Soc. 1991, 113, 8966-8967. 
4 Ramasastry, S. S. V.; Zhang, H.; Fujie, T.; Barbas III, C. F., J. Am. Chem.Soc 2007, 129, 288-289. 
5 (a) Sakagami, H.; Ogasawara, K. Heterocycles 1999, 51, 1131-1135. (b) Shirota, O.; Hakamata, W.; Goda, Y. 
J. Nat. Prod. 2003, 66, 885-887.  
 16 
6 (a) Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; 
Verber, D. F.; Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. H.; Chen, T. B.; Kling, P. J.; Kunkel, K. 
A.; Springer, J. P.; Hirshfield, J. J. Med. Chem. 1988, 31, 2235. (b) Horton, D. A.; Bourne, G. T.; Smythe, M. 
L. Chem. Rev. 2003, 103, 893 and references therein. 
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Serotonin (5-hydroxy tryptamine, 5-HT, Figure 1, 3), is a biogenic amine neurotransmitter 
with diverse physiological actions in both the central and peripheral nervous systems, and 
operates through various distinct membrane receptors. Up to date fourteen different human 
serotonin (5-HT) receptors have been cloned and organized into seven distinct subclasses 
(5HT1- 5HT7).7 Among these subtypes, the 5HT1B and 5HT1D receptors have attracted 
considerable attention as putative targets for novel antimigraine drugs, leading to the 
development of 5HT1B/1D receptor selective agonist sumatriptan 9 (GR43175) which has 
been followed to the market by a series of other “triptans” such as naratriptan 10, 
zolmitriptan 11, rizatriptan and others (Figure 4).  
 
Figure 4. Recently marketed serotonin receptor agonists 
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However, neither sumatriptan nor number of related compounds in use distinguishes 
significantly between these two subtypes in their binding activities which is required in order 
to prevent side effects associated with commercial medicaments.  
     In the past few years, it was found that in addition to appropriate substituents at C5, more 
sophisticated amine moieties have to be attached with varying distances at C3 of indole core 
in order to achieve discrimination between subtypes of the serotonin receptor family.8 From 
a synthetic chemist’s point of view, these and additional features such as the occurrence of 
branching in the α and β-positions as well as stereochemical issues are important. Such 
branched tryptamines possessing pharmacologically interesting properties have recently been 
developed as well.9 Indole core is as well present as a substructure in a vast number of more 
                                                 
7 Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; 
Humphrey, P. P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine 
(serotonin). Pharmacol. Rev. 1994, 46, 157-203 
8 MacLeod, A. M.; Street, L. J.; Reeve, A. J.; Jelley, R. A.; Sternfeld, F.; Beer, M. S.; Stanton, J. A.; Watt, A. 
P.; Rathbone, D.; Matassa, V. G. J. Med. Chem. 1997, 22, 3501-3503. 
                                                                                                                                            
 
9 Nickelsen, T.; Samel, A.; Vejvoda, M.; Wenzel, J.; Smith, B.; Gerzer, R.; Chronobiol Int. 2002, 5, 915-936. 
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complex compounds, one of very important classes being tetrahydro ß-carbolines (THBC's, 
Figure 5).  
 
Figure 5. β-carboline and tetrahydro-β-carboline frameworks 
 
N
H
 ß-carboline
N
N
H
Tetrahydro ß-carboline
NH
 
 
This ring system is present in numerous natural and synthetic organic compounds, many of 
which display useful and interesting biological activities. The reported effects of this class of 
compounds comprise antineoplastic (tubulin binding),10 anticonvulsive, hypnotic and 
anxiolytic (benzodiazepine receptor ligands),11 antiviral,12 antiplasmodial activity13 and 
others. Some representative examples of biologically active natural products possessing 
THBC framework are depicted on Figure 6. Ajmaline 12 was isolated from Rauwolfia 
serpentina and exhibits important cardiovascular effect.14 Suaveoline 13 was isolated from 
the trunk bark of Rauwolfia suaveolens S. while fungal metabolite Fumitremorgin C 14 was 
isolated from Penicillium and Aspergillus genera and exhibits tremorgenic activity (Figure 
6).15
Figure 6. Naturally occurring tetrahydro-β-carbolines 
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10 (a) Takasu, K.; Shimogama, T.; Saiin, C.; Kim, H. S.; Wataya, Y.; Ihara, M. Bioorg. Med. Chem. Lett. 2004, 
14, 1689–1692; (b) Boursereau, Y.; Coldham, I. Bioorg. Med. Chem. Lett. 2004, 14, 5841–5844; (c) Wu, Y.; 
Zhao, M.; Wang, C.; Peng, S. Bioorg. Med. Chem. Lett. 2002, 12, 2331–2333. 
11 (a) Behforouz, M.; Merriman, R. L. US 5646150 A, 1997; (b) Seidelmann, D.; Huth, A.; Ottow, E.; Olesen, 
P. H.; Turner, J.; Hillman, M.; Cole, B.; DE 19514524 A1, 1996;  
12  Kawasaki, T.; Higuchi, K. Nat. Prod. Rep. 2005, 22, 761–793; 
13 Yu, J.; Wang, T.; Liu, X.; Deschamps, J.; Anderson, J. F.; Liao, X.; Cook, J. M. J. Org. Chem. 2003, 68, 
7565– 7581. 
14 Petter, A.; Engelmann, K. Arzneim. -Forsch. 1974, 24, 876. 
15 Cole, R. J.; Kirksey, J. W.; Dorner, J. W.; Wilson, D. M.; Johnson, J. C.; Johnson, A. N.; Bedell, D. M.; 
Springer, J. P.; Chexal, K. K., Clardy, J. C.; Cox, R. H. J.Agric. Food Chem. 1977, 25, 826. 
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Due to these important applications new methods for indole synthesis and functionalization 
continue to attract attention.16  
 
1.2  Syntheses of Indoles and Tetrahydro-β-Carbolines  
 
1.2.1 Syntheses of Indoles 
 
     Due to afore mentioned diversity of the indole ring systems, synthesis has always been a 
challenge. Key factors including starting material availability, functional group tolerance and 
substitution pattern often decide whether or not a particular synthetic method is suitable for a 
desired target. Furthermore, mild synthetic methods that provide rapid assembly of the 
indole ring and are atom economical are desirable. Miscellaneous elegant approaches were 
developed for the synthesis of indoles among which Fischer’s and the Larock’s method are 
the most commonly used for the preparation of functionalized indoles. Heteroannulation 
approach in the synthesis of indoles combining 2-haloanilines and 2-aminophenols with 
either terminal or internal alkynes has been achieved by a number of transition metal 
catalyzed processes.  In Larock’s method o-iodoanilines and disubstituted alkynes are used 
as substrates in the Pd catalyzed process to give 2,3-disubstituted indoles (Scheme 1).17
 
Scheme 1. The Larock indole synthesis 
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RsmallRlarge+
(1.5 - 2 eq.) N
R1
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Pd(0) or Pd(II) complexes (cat.)
Ligand (e.g. PPh3),
(n-Bu)4N+Cl- (1 eq.)
base (mostly K2CO3, 5 eq.)
 
Important features of this reaction are the wide variety of suitable disubstituted alkynes that 
can be used as coupling partners as well as the high regioselectivity of the reaction. 
However, alkyne coupling partner is required in excess (1.5-2 equiv) and for volatile alkynes 
multiple equivalents are needed to achieve high yields. Synthesis of additionally substituted 
                                                 
16  For recent reviews on the synthesis of indoles, see: (a) Gribble, G. W. J. Chem. Soc., Perkin Trans. 1 2000, 
1045-1075. (b) Gilchrist, T. L. J. Chem.Soc., Perkin Trans. 1 2001, 2491. (c) Cacchi, S.; Fabrizi, G. Chem. 
Rew. 2005, 105, 2873-2920. (d) Humphrey, G. R; Kuethe, J. T. Chem. Rev. 2006, 2875-2911 
                                                                                                                                            
 
17  (a) Larock, R. C.; Yum, E. K. J. Am. Chem. Soc. 1991, 113, 6689. (b) Larock, R. C.; Yum, E. K.; Refvik, M. 
D. J. Org. Chem. 1998, 63, 7652. 
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o-halo anilines may however require further steps and is not always easily achieved. 
Similarly, the alkyne unit may require laborious synthetic procedures.  
Fischer indole synthesis 18 is another important method developed as early as 1883 and up to 
date remained an extremely useful and important method for the synthesis of a variety of 
indole intermediates and biologically active compounds. Over 100 years after the initial 
discovery, the Fischer indole synthesis is still the most commonly employed method for the 
preparation of indoles.19 It can be regarded as the acid promoted cyclization of an 
arylhydrazone of aldehyde or ketone (Scheme 2).  
 
Scheme 2. Basic principle of The Fischer indole synthesis 
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In many cases, the indolization reaction is carried out by simply heating the ketone or 
aldehyde and the arylhydrazine with the appropriate acid or acid catalyst without isolation of 
the hydrazone intermediate. Wide range of functional groups around the aromatic ring is 
compatible with conditions of Fischer indolization. The degree of substitution of aryl 
hydrazines required for Fischer method is reduced by one as compared to the arylhalide 
required for a Larock synthesis of the same compound. However use of carbonyl compounds 
is often connected with side reactions such as aldol reaction or aldehyde oligomerization 
under the harsh conditions of the Fischer indole synthesis. It is therefore often required for 
these to be protected as acetals, aminals, enol ethers or bisulfite adducts. Use of masked 
aldehyde functionalities such as α-keto esters has been reported as well.5 However, methods 
that allow formation of aldehyde in situ in the presence of phenyl hydrazines have been 
developed recently. Hydrazone formation then prevents unwanted side reactions and 
indolization is readily carried out by the addition of the appropriate acid (vide infra). 
 
1.2.2 Syntheses of Tetrahydro-β-carbolines 
 
     Traditional strategies for the synthesis of functionalized variants of this “privileged” 
moiety have relied largely upon cyclocondensation of an appropriately substituted 
                                                 
18 Fischer, E. J. F., Chem. Ber. 1883, 16, 5. 
 20 
19 Sundberg, R. J., Best Synthetic Methods. Academic Press: London, 1996. 
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tryptophan or tryptamine derivatives with carbonyl compounds under aprotic or acidic 
conditions (Pictet-Spengler reaction).20 In general the Pictet-Spengler (PS) reaction 
comprises of an acid catalized cyclocondensation of the β-arylethyl amine derivatives with 
aldehydes or ketones involving iminium ion intermediates (Scheme 3).
 
Scheme 3. Classical Pictet-Spengler reaction 
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With the advent of asymmetric stereocontrol,21 the importance of this method for the 
synthesis of the tetrahydro-β-carboline core has rapidly increased culminating in 
enantioselective and diastereoselective preparations of this type of compound. Using a 
number of diastereoselective substrate-controlled Pictet-Spengler cyclizations lead to useful 
chiral building blocks for alkaloid syntheses.22 Recently, Jacobsen 23 and List 24 have 
independently reported examples of highly enantioselective catalytic Pictet-Spengler 
reactions providing ready access to a range of substituted tetrahydro-β-carbolines in high 
enantiomeric excesses. 
 
1.3 Aims of the Project 
 
     As already noted Fischer indole synthesis is one of the most important methods for the 
synthesis of indole containing molecules and its improvements has been an objective of 
numerous efforts of synthetic chemists during decades. One of the most recent 
                                                 
20 (a) Pictet, A.; Spengler, T. Ber. Dtsch. Chem. Ges. 1911, 44, 2030. (b) W. M. Whaley and T. R. 
Govindachari in Organic Reactions, Vol 6 Ed. R. Adams, Wiley, New York, 1951, p. 151 (c) Cox, E. D.; Cook, 
J. M.; Chem. Rev., 1995, 95, 1797-1842 and references cited therein. (d) Royer, J.; Bonin, M.; Micouin, L.; 
Chem. Rev. 2004, 104, 2311-2352. 
21 (a) Czerwinski, K. M.; Cook, J. M. Stereochemical Control of the Pictet-Spengler Reaction in the Natural 
Product Synthesis; Pearson, W., Ed.; JAI Press: Greenwich, CT, 1996; Vol 3, p. 217. 
22 (a) Cox, E. D.; Hamaker, L. K.; Li, J.; Yu, P.; Czerwinski, K. M.; Deng, L.; Bennett, D. W.; Cook, J. M. J. 
Org. Chem. 1997, 62, 44. (b) Waldmann, H.; Schmidt, G.; Henke, H.; Burkard, M. Angew. Chem., Int. Ed. 
Engl. 1995, 34, 2402. (c) Schmidt, G.; Waldmann, H.; Hanke, H.; Burkard, M. Chem.-Eur. J. 1996, 2, 1566. (d) 
Gremmen, C.; Willemse, B.; Wanner, M. J.; Koomen, G.-J. Org. Lett. 2000, 2, 1955 (e) Tsuji, R.; Nakagawa, 
M.; Nishida, A. Tetrahedron: Asymmetry 2003, 14, 177. 
23 Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558. 
                                                                                                                                            
 
24 Seayad, J.; Seayad, A. M.; List, B. J. Am. Chem. Soc. 2006, 128, 1086-1087. 
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improvements involves in situ formation of aldehyde component from the olefinic starting 
materials, using regioselective Rh catalyzed hydroformylation reaction. This process if 
performed in the presence of aromatic hydrazines allows one step synthesis of indoles from 
olefins (vide infra) in a reaction sequence known as tandem hydroformylation / Fischer 
indole synthesis. The aim of this work was to improve and extend synthetic pathways to 
chiral branched tryptamines, tryptamides, tryptophanes and their homologues using tandem 
hydroformylation / Fischer indole synthesis sequence (Scheme 4). 
 
Scheme 4. Tandem hydroformylation / Fischer indole synthesis sequence 
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     Due to their medicinal and pharmacological relevance desired structures shall be 
synthesised as enantiopure molecules if possible. Structures with varying distances between 
indole core and amine functionality are primary targets for the synthesis due to their 
biological relevance. Since multiple stereocenters are not generated during hydroformylation 
step, enantiopure starting materials should be synthesized via method that allows flexible 
access to both antipodes as well as introduction of diverse substituents and multiple 
stereocenters in one step. Optimization of reaction conditions with special regard to stability 
of the nitrogen protecting groups as well as preservation of chiral information especially in 
tryptophan derivatives possessing acidic α protons at chiral center would be an issue of 
special concern. 
     Next, application of olefins as the precursors of the electrophilic component in the Pictet-
Spengler reaction should be investigated. In situ hydroformylation of the olefin in the 
presence of indole nucleophiles (i.e. tryptamine, tryptophane, etc.) should yield in the 
tetrahydro-β-carboline structures (Scheme 5). The feasibility of tandem hydroformylation / 
Pictet-Spengler reaction for the synthesis of tetrahydro-β-carbolines shall be tested and 
optimized.  
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Scheme 5. Tandem hydroformylation/Pictet-Spengler reaction 
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The scope and limitations of this tandem reaction should be clarified; the tandem reaction 
shall be investigated starting with basic model olefins with respect to chemoselectivities and 
regioselectivities of all single steps involved in this sequence. Possible side reactions shall be 
minimized. Aprotic as well as protic conditions for this reaction are to be investigated.  
      Next, the tandem hydroformylation / Fischer indole synthesis sequence shall be applied 
for the synthesis of tetrahydro-β-carbolines. When using cyclic olefins in the tandem 
hydroformylation / Fischer indole synthesis sequence intermediate 3,3 spiroindoleninium 
cations are formed (vide infra), these species rearrange to give carbazole type molecules. If 
this cyclic olefin is containing nitrogen embedded in the ring tetrahydro-β-carbolines are 
obtained. This alternative and highly modular approach for the synthesis of biologically and 
pharmaceutically relevant tetrahydro-β-carbolines under hydroformylation conditions 
involving Fischer indole synthesis should be investigated. THBC structures possessing 
substituents that can not be introduced via classical approaches such as Pictet-Spengler 
reaction and those containing substituents in positions that are unavailable via those classical 
approaches are of special interest. Use of enantiopure substituted cyclic aminoolefins in the 
tandem hydroformylation / Fischer indole synthesis sequence shall grant access to 
enantiopure functionalized THBCs (Scheme 6).  
 
Scheme 6. Tandem hydroformylation / Fischer indole synthesis approach in the synthesis of tetrahydro-β-
carbolines 
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Enantiopure starting materials shall be synthesized via method that allows flexible variation 
of substituents R as well as access to both antipodes which consequently allows synthesis of 
both enantiomers of final molecule. The tandem reaction and its single steps shall be 
investigated starting with basic model cyclic aminoolefins with respect to stability of 
nitrogen protecting groups and different sources of aryl hydrazines. Furthermore, the tandem 
reaction shall be optimized with respect to chemoselectivity of the tandem reaction and 
regioselectivity of the hydroformylation and the indolization steps respectively. These 
optimized conditions shall be applied towards sophisticated substrates of possible 
pharmacological relevance considering all necessary biological valances (i.e. substitution 
pattern at the indole core as well as type of substituents with special regard on their 
electronic and steric properties).   
 
1.4   Hydroformylation in Tandem Sequences 
 
     Hydroformylation of the olefins represents highly efficient and atom economical, ''green'' 
method for the synthesis of the aldehydes required as the building blocks in many synthetic 
processes.  Subsequent reactions involving thus formed aldehyde comprise Fischer indole 
synthesis and Pictet-Spengler reaction as well as many other reactions.  In situ formation of 
aldehydes and their subsequent trapping by the suitable nucleophiles represents foundation 
for all tandem reactions performed under hydroformylation conditions. 
 
1.4.1 Rh Catalyzed Hydroformylation 
 
     Since O. Roelen  discovered hydroformylation (Oxo – Synthese) in 1937,25 by accident 
due to a breakdown of a high pressure reactor at the Ruhrchemie AG, this process has 
witnessed continual growth and the worldwide production capacity reached 6.6×106 tons in 
1995. This makes hydroformylation one of the most important industrial reactions. Formally, 
this chemical reaction involves the addition of a formyl group (CHO) and a hydrogen atom 
to a carbon-carbon double bond (Scheme 7). 
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Scheme 7. General scheme of hydroformylation reaction 
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     The first investigations toward rhodium catalyzed hydroformylation were carried out at 
the end of the 1950’s. The synthesis and the spectroscopic characterization of rhodium 
hydride complexes containing triphenylphosphine by Wilkinson et al.26 and their use in the 
hydrogenation and hydroformylation processes opened the way to the research on phosphine 
modified rhodium catalysts. Enormous amount of research done in this area led to catalyst 
systems with improved regioselectivity towards linear products as well as to enantioselective 
hydroformylations. 
     However, although aldehyde functionality offers a wide range of further transformations, 
only a few examples are reported in which hydroformylation is used in a multi-step synthesis 
of fine chemicals. Obviously, the homologization of the carbon skeleton by one carbon atom 
is not efficient enough and is only useful for simple steps at the very beginning of a 
synthesis. If the hydroformylation could be combined with methodologies for the 
derivatization of the aldehyde group to one step, the hydroformylation may become more 
attractive tool in the synthesis of more complex molecules. These combinations of multiple 
reactions proceeding consequtively in predictable manner are called tandem reactions. 
     The term “tandem reaction” refers to the synthetic strategies that involve sequential use of 
different reactions or catalysts with minimum workup, or change in conditions. Multiple 
catalysts and/or steps operating consecutively could circumvent the time and yield losses 
associated with the isolation and purification of intermediates in the multistep sequences. 
Tandem reactions constitute a significant challenge for synthetic chemists and give them a 
number of opportunities to improve chemical transformations. In the past few decades, a 
number of so called tandem reactions or sequential reactions under hydroformylation 
conditions have been reported.27
 
                                                 
26 Evans, D.; Osborn, J. A.; Wilkinson.G, J. Chem. Soc. 1968, (12), 3133. 
                                                                                                                                            
 
27 (a) Eilbracht, P; Bärfacker, L.; Buss, C.; Hollmann, C.; Kitsos-Rzychon, B. E.; Kranemann, C. L.; Rische, 
T.; Roggenbuck, R.; Schmidt, A.; Chem. Rev. 1999, 99, 3329-3366. (b) Schmidt, A.M.; Eilbracht, P; in 
Transition Metals for Organic Synthesis: Building Blocks and Fine Chemicals; (Beller, M.; Bolm, C., 2nd ed., 
Wiley-VCH, Weinheim, 2004, 57-111. 
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1.4.2 Tandem Hydroformylation / Aldol Reaction 
 
     Among all tandem hydroformylation sequences, the most attractive are those in which the 
aldehyde functionality is used for the formation of additional C-C bonds. Aldehydes 
generated in the hydroformylation reaction in the presence of silyl enol ethers, enamines or 
enolates undergo consecutive aldol reaction. Thus the unsaturated silyl enol ethers such as 16 
are undergoing selective hydroformylation at the monosubstituted double bond followed by 
a intramolecular Mukaiyama type aldol addition  to give the silylated aldol adducts 17 in 
good yields and with complete transfer of the silyl fragment to the carbinol oxygen (Scheme 
8).28
Scheme 8. Mukaiyama type aldol addition under hydroformylation conditions 
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     The tandem enolboration / hydroformylation / aldol addition is another example of the 
aldol reaction under hydroformylation conditions. This cascade reaction allows regio- and 
diastereoselective construction of carbocycles bearing highly-functionalised quaternary 
carbon centers.29 Both intra- and intermolecular aldol reactions following hydroformylation 
are reported. Recently, enantioselective organocatalyzed aldol reactions under 
hydroformylation conditions were reported.30
 
1.4.3 Tandem Hydroformylation / Wittig Reaction 
 
     Consecutive hydroformylation / Wittig reaction is one of the last reported consecutive 
reactions involving hydroformylation.31 The reaction is limited to stabilized ylides, because 
non stabilized ylides are too basic and induce rhodium inactivation. Under hydroformylation 
conditions and in the presence of Ph3P=CHCOR, compound 18 leads to the oxo derivative 
19. The process involves a sequence of reactions that includes initial hydroformylation to 
give the aldehyde 20 in a stereoselective way, Wittig olefination to give the trans conjugated 
                                                 
28 Hollmann, C.; Eilbracht, P. Tetrahedron Lett. 1999, 40, 4313. 
29 (a) Keränen M.D.; Eilbracht P.; Org. Biomol. Chem. 2004, 2, 1688-1690. (b) Keränen M. D.;  Kot, K.; 
Hollmann, C.; Eilbracht P.; Org. Biomol. Chem. 2004, 2, 3379-3384. 
30 Chercheja, S.; Eilbracht, P. Adv Synth. Cat. 2007, 349, 1897-1905 
31 Breit, B.; Zahn, S. K. Angew. Chem. Int. Ed. 1999, 38, 969. 
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alkene 21 and hydrogenation (Scheme 9). Disubstituted ylides (i.e. PPh3=C(Me)COR) do not 
undergo hydrogenation and in consequence α, β-unsaturated ketones or esters are obtained. 
Ylides including the ester function provide low yields. The stereoselectivity of the process is 
determined by the chelating (directing) group o-DPPB, and stereochemistries all- syn, anti-
syn, and all -anti can be obtained. 
 
Scheme 9. Tandem hydroformylation / Wittig reaction 
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1.4.4 Indole Syntheses under Hydroformylation Conditions  
 
     Until recently, only a few examples were described in which the hydroformylation has 
been used to generate aldehydes required for the indole syntheses. Hydroformylation of 
styrene type anilines 23, derived from a Heck reaction of o-halo anilines 22, gives 
tryptamines in fair yields. Here, the olefinic bond of 23 is regioselectively hydroformylated, 
and the resulting aldehyde condenses intramolecularly with the amine to give 3-substituted 
indole 24 (Scheme 10).32  
 
Scheme 10. Tandem hydroformylation / enamine formation in the synthesis of tryptamines 
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32 Dong, Y.; Busacca, C. A.; J. Org. Chem. 1997, 62, 6464-6465. 
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In 2000, Sheldon et al. have published the synthesis of melatonin 26 via regioselective 
hydroformylation of N-allyl acetamide 25 followed by Fischer indole synthesis (Scheme 
11).33
Scheme 11. Scheldon synthesis of melatonin 
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     In 2001, Köhling demonstrated that, both, the hydroformylation and the Fischer 
indolization can be combined to a new tandem reaction.34 The general reaction pathway 
involves hydroformylation to generate the aldehyde in situ from an olefin. Presence of an 
aryl hydrazine allows formation of the hydrazone intermediate which undergoes Fischer 
indolization catalyzed by in situ present BrØnsted acid yielding the desired indole (Scheme 
12). 
 
Scheme 12. Tandem hydroformylation / Fischer indole synthesis approach 
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Eilbracht and Schmidt were able to perform tandem hydroformylation / Fischer indole 
synthesis sequence in water. Using the water soluble TPPTS as ligand, it was possible to 
                                                 
33 Verspui, G.; Elbertse, G.; Sheldon, F. A.; Hacking, M. A. P. J.; Sheldon, R. A.; Chem. Commun. 2000, 1363. 
 28 
34 (a) Köhling, P.; Diploma Thesis 2001, University of Dortmund. (b) Köhling, P.; Schmidt, A. M.; Eilbracht, 
P. Org. Lett. 2003, 5, 3213-6. 
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perform the whole reaction sequence in aqueous sulphuric acid. The antimigraine drug 
candidate LY334370 28 was prepared in one pot synthesis sequence in excellent yield.35 The 
use of α-Boc protected aryl hydrazine 27 increased the selectivity of the reaction and 
allowed introduction of substituents at the phenyl ring of the indole moiety (Scheme 13).  
  
Scheme 13. One pot synthesis of LY 334 370 
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     The hydroformylation / Fischer indole synthesis might be especially interesting from a 
large scale preparative viewpoint. Low catalyst loadings and environmentally harmless 
solvents can be used, which accompanied with good yields makes promising perspective for 
industrial use. 
     Standard hydroformylation / Fischer indolization reactions do not create chiral 
information. In order to obtain chiral tryptamines and tryptamides, enantiopure amino olefins 
have to be used. These in turn, are easily obtained via transition metal catalyzed asymmetric 
allylic substitutions. In the next chapter short overview on Ir catalyzed allylic substitution 
reactions is given. These were broadly used throughout work described in this thesis.  
 
1.4.5 Tetrahydro-β-carboline Syntheses under Hydroformylation Conditions  
 
     Hydroformylation have only scarcely been used for the synthesis of aldehydes required 
for the preparation of tetrahydro-β-carbolines via Pictet-Spengler reaction. Tandem 
hydroformylation / Pictet-Spengler reaction have been used by Taddei et al. for the synthesis 
of tetrahydro-β-carbolines on the solid phase.36
     Tandem hydroformylation / Fischer indolization besides its role in the preparation of 
indoles has been applied for the synthesis of tetrahydro-β-carboline as well. Cyclic 
                                                 
35 Schmidt, A. M.; Eilbracht, P. J. Org. Chem. 2005, 70, 5528-5535. 
                                                                                                                                            
 
36 Dessole, G.; Marchetti, M.; Taddei, M. J. Comb. Chem. 2003, 5, 198-200  
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aminoolefin 29 was hydroformylated in the presence of phenylhydrazine. After subsequent 
acidic indolization intermediate spiroindoleninium cation 30 undergoes rearrangement to 
give tetrahydro-β-carboline structure 31 in excellent yield (Scheme 14).37 The product of 
formal retro Mannich reaction was obtained exclusively. 
 
Scheme 14. Tandem hydroformylation / Fischer indolization in the synthesis of the tetrahydro-β-carboline 31 
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However, when carbocyclic and cyclic silyl olefins 32 were used in this sequence γ-
carbolines 34 were obtained i.e. exclusive rearrangement of β carbon of intermediate 
spiroindoleninium cations 33 has occurred (Scheme 15).37  
 
Scheme 15. Use of carbocyclic and silyl olefins in the synthesis of carbazoles 
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It is noteworthy to mention that when 6, 7 or 8 membered carbocyclic olefins were used in 
this sequence, intermediate spiroindoleninium structures were trapped by hydrogenation 
under applied hydroformylation conditions.37 It was possible to control outcome of the 
reaction to some extent by control of partial pressures of CO and H2. Higher partial pressures 
of H2 favored reduction of intermediate spiroindoleninium cation. However, when 5 
membered cycloolefins were used as substrates it was observed that spiroindolenines could 
not be trapped by simply increasing partial pressure of H2 as in case of higher olefins. 
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37 Linnepe (nee Kohling), P.; Schmidt, A. M.; Eilbracht, P.; Org. Biomol. Chem. 2006, 4, 302-13. 
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1.4.6 Tandem Hydroformylation / Reductive Amination 
 
     Another important group of tandem reactions under hydroformylation conditions that are 
performed in the presence of heteroatom nucleophiles (amines) are reductive aminations, so 
called ‘’hydroaminomethylation’’ reactions. The hydroaminomethylation of alkenes was 
originally discovered by Reppe 38 and consists of the hydroformylation of an alkene, 
followed by reaction of the intermediate aldehyde with a primary or secondary amine to 
form an imine or enamine, and a final hydrogenation to give a secondary or tertiary amine. 
For example the hydroformylation of terminal diarylethenes 35 in the presence of amines 36 
grants direct access to pharmacologically active 3,3-diarylpropylamines 37 (Scheme 16).39 
Rhodium catalyzed the hydroformylation of the olefin as well as the hydrogenation of the 
enamine 39 which is obtained from the condensation of the aldehyde 38 with the secondary 
amine.  
 
Scheme 16. Hydroamionomethylation reaction 
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Besides intermolecular processes these reactions are occurring intramolecularly as well. 
Unsaturated amines or amides 40 under hydroformylation conditions undergo intramolecular 
ring closure. The catalytic cycle of the hydroformylation offers two reaction pathways of the 
metal acyl intermediate 41 leading to lactams 42 on one hand or cyclic amines 43 on the 
                                                 
38 Reppe, W.; Vetter, H. Liebigs Ann. Chem. 1953, 582, 133. 
39 Rische, T.; Eilbracht, P.; Tetrahedron 1999, 55, 1915-1920. 
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other (Scheme 17). The generation of the lactams 42 proceeds via cleavage of the rhodium-
acyl species 41 by the nitrogen atom, which presumably is precoordinated to the metal. 
Cyclic amines of type 43 are obtained from unsaturated amines if the metal acyl intermediate  
as an alternative undergoes hydrogenolysis by reaction with hydrogen. The aldehyde thus 
generated is following the hydroaminomethylation sequence to give 43. The 
chemoselectivities of these reactions are controllable to some extent by the ratio of syngas 
and/or the chosen catalyst and ligand.40
 
Scheme 17. Intramolecular hydroaminomethylation reaction 
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40 For example see: (a) Ojima, I.; Zhang, Z. J. Org. Chem. 1988, 53, 4422. (b) Zhou, J.-Q.; Alper, H. J. Org. 
Chem. 1992, 57, 3328. (c) Busacca, C. A.; Dong, Y. Tetrahedron Lett. 1996, 37, 3947. (d) Bergmann, D. J.; 
Campi, E. N.; Jackson, W. R.; McCubbin, Q. J.; Patti, A. F. Tetrahedron 1997, 53, 17449.   
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1.5 Transition Metal Catalyzed Allylic Substitutions 
 
     As already noted, starting materials required for the synthesis of the tryptamines with 
varying lengths of side chains, containing multiple stereocenters (see Figure 7), can 
successfully be prepared via transition metal catalyzed allylic substitution reactions. This 
methodology was used as well for the preparation of precursors required for the synthesis of 
tetrahydro-β-carbolines via tandem hydroformylation / Fischer indole synthesis (see Scheme 
6). 
 
Figure 7. Examples of desired starting materials and final structures available through combination of Ir 
catalyzed allylic substitution with tandem hydroformylation / Fischer indole synthesis 
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Due to their wide use in this thesis, asymmetric allylic substitutions will be shortly 
overviewed in this chapter. Allylic substitutions are one of the most important transition 
metal catalyzed reactions for C-C and C-Heteroatom bond formation.41 Pd catalyzed allylic 
alkylation of sodium dimethylmalonate was introduced for the first time in 1965 by Tsuji,42 
followed by the first enantioselective version by Trost in 1977.43 Allylic alkylations with 
dialkylmalonates as well as with other nucleophiles have been intensively studied and good 
yields and high enantioselectivities can now be obtained via proper combination of a 
transition metal and a chiral ligand. 44-49 Over the past few years research has been focused 
on finding the catalyst which favors the formation of branched chiral products 46 in the 
                                                 
41 Recent reviews: (a) Trost, B. M. Chem. Pharm. Bull. 2002, 50, 1. (b) Trost, B. M.; Lee, C. B. In Catalytic 
Asymmetric Synthesis II; Ojima, I., Ed.; Wiley-VCH: Weinheim, Germany, 2000; p 593.  
42 J. Tsuji, H. Takahashi, M. Morikawa, Tetrahedron Lett. 1965, 6, 4387-4388. 
                                                                                                                                            
 
43 B. M. Trost, P. E. J. Stege, J. Am. Chem. Soc. 1977, 99, 1649-1651. 
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substitution reactions of the allylic substrates 44 or 45. Simple cinnamyl substrates do not 
lead to chiral products 46 with palladium catalysts because substitution occurs at the less 
substituted allylic terminus (Scheme 18).
 
Scheme 18. Possible products of transition metal catalyzed allylic substitution reaction 
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Unlike the palladium catalyst,44 some transition metals such as platinum,45 rhodium,46 
ruthenium,47 molybdenum,48 tungsten,49 and iridium promote the allylic alkylation at the 
more substituted terminus of the allylic substrate. However with Mo or W based catalysts 
only substrates with R = aryl are giving high levels of both regio- and enantioselectivity 
towards branched product, while the substitutions catalyzed by Ru or Rh are suitable for use 
with chiral branched allylic alcohol derivatives of type 45.  
 
1.5.1 Iridium Catalyzed Allylic Substitution Reactions 
 
     The first studies towards iridium catalyzed allylic substitution were conducted by 
Takeuchi in 1997.50 He used allylic carbonates and acetates as substrates and sodium 
dimethylmalonate as nucleophile. Catalytic amounts of [Ir(cod)Cl]2 and triphenylphosphite 
catalyzed the allylic substitution (Scheme 19). Branched to linear ratios of up to 99/1 were 
                                                 
44 (a) Nakoji, M.; Kanayama, T.; Okino, T.; Takemoto, Y. Org. Lett. 2001, 3, 3329. (b) You, S.-L.; Hou, X.-L.; 
Dai, L.-X.; Cao, B.-X.; Sun, J. Chem. Commun. 2000, 1933. (c) Trost, B. M.; Ariza, X. J. Am. Chem. Soc. 
1999, 121, 10727. (d) Kuwano, R.: Ito, Y J. Am. Chem. Soc. 1999, 121, 3236.  
45 A. J. Blacker, M. L. Clarke, M. S. Loft, M. F. Mahon, M. E. Humphries, J. M. J. Williams, Chem. Eur. J. 
2000, 6, 353-360 
46 T. Hayashi, A. Okada, T. Suzuka, M. Kawatsura, Org. Lett. 2003, 1713-1715. 
47 B. M. Trost, P. L. Fraisse, Z. T. Ball, Angew. Chem. 2002, 114, 1101-1103. 
48 (a) Lloyd-Jones, G. C.; Pfaltz, A. Angew. Chem. Int. Ed. Engl. 1995, 34, 462. (b) R. Pretot, G. C. Lloyd-
Jones, A. Pfalz, Pure Appl. Chem. 1998, 70, 1035-1040. (c) Trost, B. M.; Dogra, K. J. Am. Chem. Soc. 2002, 
124, 7256. (d) O. Belda, C. Moberg, Acc. Chem. Res. 2004, 37, 159-167. 
49 R. Pretot, G. C. Lloyd-Jones, A. Pfalz, Pure Appl. Chem. 1998, 70, 1035-1040. 
 34 
50 R. Takeuchi, M. Kashio, Angew. Chem. 1997, 109, 268-270. 
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reached. Especially promising were the short reaction times and very good yields of the 
reactions. Takeuchi noted that in case of enantiopure substrates of type 45 and soft 
nucleophiles retention of configuration is observed.  
 
Scheme 19. First Iridium catalyzed allylic substitution reactions 
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     The first enantioselective iridium catalyzed allylic alkylation was published in the same 
year by Helmchen.51 As ligands, chiral phosphinooxazolines 48 with differently substituted 
aryl moieties were used. It was found that electron withdrawing substituents furnished good 
yields, high enantioselectivities and regioselectivities towards branched product, although 
their steric demands had to be small. Ligand 48b was therefore found to be most suitable 
(Scheme 20). 
 
Scheme 20. First enantioselective allylic alkylation reaction 
 
R1 OAc R1
∗ +
R1
2 mol% [Ir(cod)Cl]2
4 mol% L*
branched linear
Ph or 4-MeOPh
NaCH(CO2Me)2
THF, rt, 24h
MeO2C CO2Me CO2MeMeO2C
R1 =
Ar2P
O
N
L* =
a: Ar = Ph
b: Ar = 4-CF3C6H4
c: Ar = 3,5-(CF3)2C6H3
48
R1 = Ph                  L* = 30 %ee
91 %ee
84 %ee
72 %ee
95 %ee
62 %ee
92 : 8
95 : 5
89 : 11
99 : 1
99 : 1
93 : 7
61 %   
99 %   
95 %   
89 %   
98 %   
71 %
a
b
c
a
b
c
R1 = 4-(MeO)Ph     L* =
 
 
                                                 
                                                                                                                                            
 
51 J.P. Janssen, G. Helmchen, Tetrahedron Lett. 1997, 38, 8025-8026. 
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     In 2001 Takeuchi et al.52 performed the first Ir catalyzed allylic amination and obtained 
branched allylic amines in excellent regioselectivities. Here, regioselective allylic amination 
of allylic carbonates and acetates has been achieved with a Ir/P(OPh)3 catalyst. 
Phosphoramidite ligand L1 originally developed by Feringa for the copper catalyzed 1,4-
additions of dialkylzinc reagents,53  was introduced in 2002 by Hartwig et al. to a iridium 
catalyzed allylic aminations, good to very good yields and excellent enantioselectivities were 
obtained with all tested substrates (Scheme 21).54  
 
Scheme 21. First enantioselective Ir catalyzed allylic amination 
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These results prompted several research groups to start investigations towards mechanistic 
aspects of this catalytic system. It was discovered that simple stirring of [Ir(cod)Cl]2 with 
ligand L1 gives the square planar complex 49, which is however catalytically not active in 
allylic substitution reactions (Scheme 22).55 Nevertheless, the addition of a sufficiently basic 
amine leads to the cyclometalation of the phosphoramidite ligand at the methyl group of the 
amino substituent. Subsequent elimination of hydrochloric acid and coordination of a second 
phosphoramidite ligand generates a trigonal bipyramidal structure 50. Dissociation of the 
second monodentate phosphoramidite ligand then generates the active catalyst 51. Reactions 
using this activated catalyst proceeded significantly faster and allowed lower catalyst 
loadings to be used.56 In subsequent studies Hartwig developed procedures for preforming of 
the active catalyst using DABCO or propylamine as additives. At room temperature, the 
                                                 
52 Takeuchi, R.; Ue, N.; Tanabe, K.; Yamashita, K.; Shiga, N.; J. Am. Chem. Soc. 2001, 123, 9525-9534. 
53  (a) de Vries, A. H. M. ; Meetsma, A.; Feringa, B. L. Angew. Chem. Int. Ed. Engl. 1996, 35, 2374-6 (b) 
Feringa, B. L.; Pineschi, M.; Arnold, L. A.; Imbos, R.; de Vries, A. H. M. Angew. Chem. Int. Ed. Engl. 1997, 
36, 2620-3. 
54 Ohmura, T.; Hartwig, J. F., J. Am. Chem. Soc.  2002, 124, 15164-15165. 
55 Bartels, B.; Garcia-Yebra, C.; Rominger, F.; Helmchen, G. Eur. J. Inorg. Chem. 2002, 10, 2569.  
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56 Kiener, C. A.; Shu, C. T.; Incarvito, C.; Hartwig, J. F., J. Am. Chem. Soc. 2003, 125, 14272-14273. 
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required cyclometalation of complex 49 requires hours, therefore reactions without 
activation of the catalyst prior to addition of the reagents occur with an induction period and 
without full concentration of the active catalyst. 
 
Scheme 22. Formation of the active catalyst 
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Eventhough yields and selectivities appeared to be similar when using a non-preformed 
catalyst system, Hartwig could show that due to the long induction period the reaction rates 
were significantly lower. The reaction of benzylamine with the carbonate derived from (E)-
2-hexen-1-ol without activation of the catalyst required 10 h to proceed to completion, while 
the reaction with initial activation with propylamine occurred within 2 h.57 Mainly all 
assumptions about the mechanism of the Ir catalyzed allylic aminations were based on Pd 
catalyzed allylations. Pd-catalyzed allylic substitution reactions occur by oxidative addition 
of an allylic ester, followed by attack of the nucleophile on the allyl intermediate.58 The 
identity of each species on the palladium-catalyzed reaction pathway has been determined, 
and the rates of individual steps of the catalytic cycle have been measured. The connection 
                                                 
57 Leitner, A.; Shu, C. T.; Hartwig, J. F.,. Org. Lett. 2005, 7, 1093-1096. 
                                                                                                                                            
 
58 (a) Trost, B. M. J. Org. Chem. 2004, 69, 5813. (b) Trost, B. M.; Lee, C. In Catalytic Asymmetric Synthesis, 
2nd ed.; Ojima, I., Ed.; Wiley-VCH: Weinheim, Germany, 2000; p 593. 
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between the mechanisms of iridium- and palladium-catalyzed processes has been made 
recently. Hartwig and Markovic were able to isolate resting state of the catalyst 53.59 The 
kinetic data on the catalytic process lead to the unexpected conclusion that reaction of the 
Ir(I) species with the allylic esters is endergonic and reversible (Scheme 23).  
 
Scheme 23. Mechanism of Ir catalyzed allylic substitution reaction 
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Proposed catalytic cycle resembles one accepted for the Pd catalyzed allylation reactions. 
     In 2004 Alexakis et al.60 introduced even more efficient class of phosphoramidite type 
ligands: ortho substituted ligands (Figure 8), with these ligands higher selectivities and 
shorter reaction times were achieved.  
 
 
 
 
 
 
                                                 
59 Markovic, D.; Hartwig,  J. F., J. Am. Chem. Soc. 2007, 129, 11680-11681 
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60 (a) K. Tissot-Croset, D. Polet, A. Alexakis, Angew. Chem. 2004, 116, 2480-2482. (b) A. Alexakis, D. Polet, 
Org. Lett. 2004, 6, 3529-3532. (c) K. Tissot-Croset, D. Polet, S. Gille, C. Hawner, A. Alexakis, Synthesis 2004, 
15, 2586-2590. 
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Figure 8. Ligands from the Alexakis study 
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It was initially thought that orthomethoxy group on the phenyl ring has a role in coordinating 
to metal center and therefore influencing on selectivity and rate of reaction. However, proofs 
for this could not be observed, additionally it was found that ligands possessing ortho methyl 
groups such as L4 and L5 are even better in terms of rate and selectivity of the reaction 
(Scheme 24).61 It is now accepted that the substituents on phenyl ring enhance the 
dissociation of ligand L from complex 50 making formation of active complex easier. 
 
Scheme 24. Application of ortho substituted ligands in Ir catalyzed allylic substitution reaction 
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     In 2005 Hartwig et al. showed that phosphoramidite ligands with single resolved 
stereocenter are equally efficient as their precedents with two stereocenters (Scheme 25).62
 
 
                                                 
61 D. Polet, A. Alexakis, Org. Lett. 2005, 7, 1621-1624. 
                                                                                                                                            
 
62 Leitner, A.; Shekhar, S.; Pouy, M. J.; Hartwig, J. F., J. Am. Chem. Soc. 2005, 127, 15506-15514. 
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Scheme 25. Ligands with single resolved stereocenter in Ir catalyzed allylic amination reaction 
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Due to the excellent regioselectivities towards branched products which makes Ir 
complementary method to palladium catalyzed allylic aminations and due to excellent 
enantioselectivities this method has witnessed considerable research efforts directed towards 
extension of scope of reaction as well as attempts towards application in the synthesis of 
more complex molecules. Reactions of ketone enolates 63 and enamines 64 as nucleophiles 
with allylic carbonates proceeded in excellent yields and enantioselectivities. In addition 
various O-alkylating agents such as phenolates can be used for allylic etherifications 65 as 
well as aryl zinc reagents for allylic arylations.66
     Since allylic esters are typically prepared from allylic alcohols, the use of allylic alcohols 
in asymmetric allylic substitution would streamline synthetic sequences and would be more 
atom economic. The poor leaving group ability of a hydroxyl group causes the substitution 
of allylic alcohols typically to require high temperatures, neat conditions or an activator. 
However, in the presence of Ti, Ta or Nb alkoxides in stoichiometric amounts allylic 
aminations proceed in good yields and high regio- and enantio-selectivities. In the presence 
of catalytic amounts of BPh3 reactions with aromatic anilines proceed in same manner 
(Scheme 26).67
 
                                                 
63 Graening, T.; Hartwig, J. F., J. Am. Chem. Soc., 2005, 127, 17192-3.  
64 Weix, D.J.; Hartwig, J. F., J. Am. Chem. Soc., 2007, 129, 7720-1. 
65 (a) Lopez, F.; Ohmura, T.; Hartwig, J. F., J. Am. Chem. Soc., 2003, 125, 3426; (b) Leitner, A.; Shu, C.; 
Hartwig, J. F., Org. Lett., 2005, 7, 1093-6. 
66 Alexakis, A.; Polet D.; El Hajjaji, S.; Rathgeb, G. Org. Lett. 2007, 9, 3393-5. 
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Scheme 26. Ir catalyzed allylic aminations with allylic alcohols 
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     Ir catalyzed intramolecular allylic substitution, as well as combination of intermolecular 
Ir catalyzed allylic substitution with ring closing metathesis reaction has allowed asymmetric 
syntheses of various carbo-68 and hetero-cycles.69 A combination of Ir catalyzed allylic 
substitutions with ring closing metathesis (RCM) has been recently applied for the 
preparation of some biologically active compounds like (S)-nicotine 69d or prostaglandin 
analogue TEI-9826.68b Similarly, 2,5-disubstituted-2,5-dihydropyrroles 55 were prepared by 
Helmchen`s group in excellent regio- and diastereoselectivities (Scheme 27).69fThe primary 
amine 54 was synthesized via Ir catalyzed allylic amination with N, N-diacylamines  as 
ammonia equivalents followed by subsequent deprotection of acyl moieties. 
 
Scheme 27. Synthesis of 2,5-disubstituted dihydropyroles via combination of allylic amination and RCM 
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68 (a) Streiff,S.; Welter, C.; Schelweis, M.; Lipowsky, G.; Miller, N.; Helmchen, G. Chem. Commun.,  2005, 
2957-9; (b) Schelwies, M.; Dubon P.; Helmchen G., Angew. Chem. Int. ed., 2006,  45, 2466-9.   
                                                                                                                                            
 
69 (a) Welter, C.; Koch, O.; Lipowsky G.; Helmchen, G.; Chem. Commun., 2004, 896; (b) Shu, C.; Hartwig, J. 
F. Angew. Chem., Int. Ed., 2004, 43, 4794. (c) G. Lipowsky, N. Miller and G. Helmchen, Angew. Chem. Int. 
Ed., 2004, 43, 4595. (d) Welter, C.; Moreno, R. M; Streiff, S.; Helmchen, G.,   Org. Biomol. Chem. 2005,  3,  
3266-8.  (e) Welter, C.; Dahnz, A.; Brunner, B.; Streiff, S.; Dubon, P.; Helmchen, G. Org. Lett. 2005, 7, 1239. 
(f) Weihofen R.; Tverskoy O.; Helmchen G., Angew. Chem. Int. Ed., 2006, 45, 5546. (g) Bohrsch, V.; Blechert, 
S. Chem. Commun., 2006, 1968. (h), Dahnz, A.; Dubon P.; Schelwies. M.; Weihofen R.; Helmchen G., Chem. 
Comm. 2007, 675-91. (i) Weihofen R.; Dahnz A.; Tverskoy O.; Helmchen G., Chem. Comm. 2005,  28,  3541-
3. 
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1.5.2 Ir Catalyzed Allylic Alkylations with Unsymmetric Nucleophiles 
 
   Iridium catalyzed allylic alkylation using symmetric nucleophiles (e.g. dimethylmalonates) 
has been studied by several research groups and a variety of substrates can be alkylated with 
enantiomeric excesses that are quite generally higher than 90% ee (vide supra). However, the 
use of unsymmetrical nucleophiles is a far more challenging task since not only regio- and 
enantioselectivity have to be controlled, but also diastereoselectivity has to be taken into 
account in order to obtain desired stereoisomers 57 or 58 in excess (Scheme 28).  
 
Scheme 28. Possible products in transition metal catalyzed allylic alkylation with unsymmetric nucleophiles 
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Linear product 56 and branched 57 and 58 can be selectively obtained depending on the 
transition metal applied. 
     In 2003 Takemoto et al. published an elegant approach towards β-substituted α-amino 
acids using iridium catalyzed allylic alkylation as key step.70 Iridium catalyzed allylic 
alkylation favoured the branched diastereomeric products 61 and 62. Diastereoselectivity 
was influenced by the type of base and counter cation used. Both diastereomers were 
synthesized in excess depending on reaction conditions and with high enantioselectivities 
using t-butyl glycinate 60 and ligand 63 (Scheme 29).  
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Scheme 29. Diastereoselective allylic alkylation of benzophenone glycinate 
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     The stereochemical course of the reaction can be explained as follows (Scheme 30). 
Initially, two π-allyl complexes 64 and 65 (σ-allyl complexes could not be excluded) would 
be formed predominantly by attack of the iridium(I)-ligand 63 complex on the allylic 
substrate 59. However, the complex 65 should be disfavored due to the steric interaction 
between the ethylthio group of the ligand and the phenyl group of 59. Therefore, the 
nucleophilic attack of the enolate of 60 at the allylic carbon trans to the phosphorus atom 
would give the chiral products 61 and 62 with high enantioselectivity. Different behavior of 
the bases might be attributed to the geometry of the enolate of 60.  
 
Scheme 30. Stereochemical course of reaction 
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Namely, it was assumed that the use of KOH as a base would give the E-enolate 66 
predominantly, but, in contrast, the Z-enolate 67 would be formed with use of LiN(SiMe3)2 
as a base.71 Length of the linker to sulphide group proved to be crucial for good 
enantioselectivities of reaction, since six membered transition state was assumed to be 
essential for high enantioselectivities. Ligands possessing longer chains or bulkier groups 
than ethyl on the other side of chain gave lower ee´s. 
Additionally Takemoto was able to make several interesting observations. The substitution 
pattern of the chiral ligand did not influence the diastereoselectivity of reaction at all. The 
use of chiral phase transfer catalyst, which should influence the enolate geometry of the 
nucleophile, also failed to improve the ratio of 61/62. In contrast the type of ester moiety had 
drastic influence on the diastereoselectivity. When using the corresponding methyl ester of 
57 diastereoselectivies were significantly lower, albeit the enantioselectivity of the reaction 
was not affected. Therefore stereodifferentiation of the enantiotopic faces of the allyl-metal 
complex coordinated by chiral ligand 63 is highly independent of the nucleophiles 
employed.  
 
 
 
 
 
                                                 
71 Lipkowitz, K. B.; Cavanaugh, M. W.; Baker, B.; O’Donnell, M. J. J. Org. Chem. 1991, 56, 5181. 
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2 Syntheses of Tryptamines, Tryptophanes and Homologues 
 
     Schmidt and Eilbracht have recently reported on the synthesis of various branched 
tryptamine and tryptamide analogues involving tandem hydroformylation / Fischer indole 
synthesis sequence.35, 72 This convergent method allowed introduction of various substituents 
in all pharmacologically relevant positions of the indole core. We wanted to concentrate on 
the side chains of these molecules i.e. formally, substituents in position 3. We used tandem 
hydroformylation / Fischer indolization strategy for the preparation of enantiopure 
tryptamines, tryptophanes and their homologues with different complexities and lengths of 
side chain which is as already mentioned (vide supra) very important issue in regard to 
biological activity of these types of molecules. Required olefinic starting materials are 
synthesized via efficient enantioselective Ir catalyzed substitution reactions (Scheme 31). 
 
Scheme 31. Envisaged synthetic pathway for the synthesis of tryptamine analogues 
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2.1 Synthesis of Enantiopure Tertiary Tryptamines and Tryptamides 
 
     Most of the known β-branched tryptamines are tryptophan derivatives and can be 
synthesized starting from this essential amino acid. Therefore, not surprisingly, only a few 
examples of β-branched tryptamines are reported with substituents not possessing the 
oxidation level of carboxylic group or with substituents not obtainable from carboxylic 
group of tryptophane. Powerful method for the synthesis of this type of indole molecules is 
tandem hydroformylation / Fischer indole synthesis sequence. The chiral branched allylic 
amines required are synthesized via Ir catalyzed allylic amination of allylic carbonates. After 
hydroformylation in the presence of the phenyl hydrazines and subsequent indolization 
tryptamines and tryptamides bearing substituents other than those obtainable from 
tryptophan carboxylic group could be prepared (Scheme 32). 
 
Scheme 32. Envisaged reaction pathway for the synthesis of branched tryptamines and tryptamides 
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2.1.1 Synthesis of Allylic Amines via Ir Catalyzed Allylic Amination Reaction 
 
     Although vast number of approaches is available for the enantioselective synthesis of 
allylic and homoallylic amines, in the last couple of years Ir catalyzed allylic aminations 
emerged as one of the most powerful and most convenient methods for their synthesis. With 
this methodology, a large number of different allylic amines is accessible. Our reactions 
were run using conditions previously described,73 i.e. the catalyst was prepared by in situ 
activation of [Ir(cod)Cl]2  and ligands L1 or L3 with the propyl amine, in dry THF. In the 
test reaction of cinnamyl carbonate 68a and benzylamine, ligand L1 (Table 1, Entry 1) gave 
product 70a in 56% yield and 90% ee, while ligand L3 gave product 70a in 76% yield and 
94% ee, proving to be the ligand of choice for this reaction (Table 1, Entry 2). 
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Table 1. Ir catalyzed allylic aminations of various allylic carbonates 68, with amines 69 
 
R1= Ph (68a) 
R1= 2-MeOC6H4 (68b)   
R1= 4-MeOC6H4 (68c)         
R1= 2-furyl (68d)                  
R1= 3-pyridyl (68e)
R1= n-C2H5 (68f)
R1= n-C3H7 (68g)
R1 OCO2Me  +  R2R3NH R1
NR2R3
R1 NR2R3
[Ir(COD)Cl]2
(R´O)2PNR"2
68 69 70 major 71 minor
+
Methoda
O
O
P N
O
O
P N
R=H, (Ra,RC,RC)-L1
R=OMe, (Ra,RC,RC)-L3
(Sa,SC,SC)-ent-L3
R OMe
 
 
entry R1 Amine, 69 ligand 
Time 
 (h) 
70/71b Yieldc ,  
 70 (%) 
eed 
% 
1 Ph (68a) benzylamine L1 1.5 90/10 58 (70a) 90 (R) 
2 Ph (68a) benzylamine L3 0.25 92/8 76 (70a) 94 (R) 
3 Ph (68a) benzylamine entL3 0.5 96/4 75 (70a) 97 (S) 
4 Ph (68a) cyclohexylamine L3 46 94/6 74 (70b) 97 
5  Ph (68a) morpholine L3 16 95/5 82 (70c) 94 
6 Ph (68a) phthalimide L3 12 98/2 66 (70d) 98 (R) 
7 Ph (68a) pyrrolidine L3 0.5 95/5 73 (70e) 98 
8 2-MeOPh (68b) diethylamine L3 18 96/4 62 (70f) 91 
9 4-MeOPh (68c) piperidine L3 46 91/9 91 (70g) 94 
10 2-furyl (68d) morpholine L3 20 95/5 81 (70h) nde 
11 3-Purydyl (68e) piperidine L3 0.5 96/4 85 (70i) 99 
12 Et (68f) benzylamine L3 5 91/9 62 (70j) 98 
13 nPr (68g) benzylamine L3 2 89/11 60 (70k) 94 
14 nPr (68g) aniline L3 46 95/5 77 (70l) 91 
a Method A: In THF at 50 °C, The ratio of 68: 69:[Ir(cod)Cl]2: L3 = 100:150:1:2, b Ratio determined by 
1H-NMR of crude reaction mixture, c Yield of isolated product after column chromatography,  d 
Determined by chiral HPLC, e Not Determined 
 
Reactions with all other substrates were run with ligand L3 and good yields and excellent 
enantioselectivities were obtained in all cases with allylic carbonates bearing sp3 as well as 
sp2 substituents (Table 1). Ent-L3 gave comparable yield and enantioselectivity as L3 but 
product 70a with opposite configuration at chiral center was obtained (Table 1, Entry 3). Not 
only amines are good nucleophiles for this reaction, phthalimide as well gave product 70d in 
66% yield  and 98% ee in reaction with cinnamyl carbonate  68a (Table 1, Entry 6). Various 
other carbonates and amines were combined demonstrating the versatility of this approach 
for the synthesis of starting materials for tandem hydroformylation / Fischer indole 
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synthesis. Absolute configurations of 70a and 70d were determined by comparison of optical 
rotation data of isolated compounds with literature values of known compounds. 
     Phenyl, substituted phenyl as well as alkyl rests present in starting carbonates 68a-g are 
generating substituents in the β position of the final tryptamine molecule, as already 
mentioned introducing these substituents by other methods is extremely difficult. Aromatic 
pyridyl and furyl substituents can be introduced in the tryptophane molecule starting from 
carboxylic group but this requires multiple steps and is associated with serious drawbacks. 
     It is already mentioned that under hydroformylation conditions primary and secondary 
amines are undergoing intramolecular ´´hydroaminomethylation´´ reaction.40 Schmidt 
observed that under hydroformylation conditions allylic amides 72 are completely 
consumed, but aldehydes 73 and 74 were only detected as the minor product (Scheme 33).74 
Instead, 2-hydroxy pyrrolidines 75 are formed in nearly quantitative yield. Consequently, by 
use of protected secondary allylic amines, this consecutive reaction can be suppressed and 
the n-aldehydes can be obtained with high yields and selectivities. Jackson et al. found a 
similar behavior.75
  
Scheme 33. Intramolecular cyclization of secondary allylic amines under hydroformylation conditions 
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cond.: 1eq. 72, 0.3mol% Rh(acac)(CO)2, 1.5mol% XANTPHOS,
10bar CO, 10bar H2, THF, 20h, 70°C.
H
N
R
R= Ac, Boc, Ts
O
H
N
R
O
H
N
R+
n-aldehyd iso-aldehyd
N
R
OH
quant.
72 73 74
75
 
 
Due to these observations secondary allylic amines obtained from the amination reaction of 
carbonates with primary amines had to be protected. Substrates 70a, b and 70j-l (Table 2) 
were protected with acetyl group and in all cases good yields of acetylation products were 
                                                 
74 Schmidt A. M. Dissertation , 2005, University of Dortmund 
75 (a) Teoh, E.; Campi, E. M.; Jackson, W. R.; Chem. Commun. 2002, 978-979. b) Teoh, E.; Campi, E. M.; 
Jackson, W. R. N.; Robinson, A. J. New J. Chem. 2003, 27, 387-394. 
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obtained. Acetyl group is stable under hydroformylation conditions and is desirable in the 
potentially bioactive molecules as it is increasing lipophilicity of the parent molecules.  
 
Table 2. Protection of primary amines prior to hydroformylation 
 
R1
NH
R2
R1
N
R2
O
70 a,b, j-l 76 a-f
AcCl, Et3N, THF
0 °C to r.t., 24h
 
 
substrate entry 
label R1 R2
Yielda 
% 
1 70a Ph Bn 88 (R) (76a) 
2 70a Ph Bn 85 (S) (76b) 
3 70b Ph Cy 92 (76c) 
4 70j Et Bn 75 (76d) 
5 70k nPr Bn 78 (76e) 
6 70l nPr Ph 76 (76f) 
aYield of isolated product after column 
chromatography 
 
 
2.1.2 N-selective Hydroformylation of Allylic Amines and Amides 
 
     Having tertiary allylic amines in hands, attention was turned towards optimization of 
hydroformylation of the chosen substrates. Hydroformylation of tertiary allylic amines 
however can be associated with some serious side reactions such as rhodium catalysts 
promoted isomerisation of allylic amines to enamines at mild temperatures,76 the enamines 
formed are easily hydrogenated under hydroformylation conditions in a sequence known as 
hydroaminomethylation. It is also well known that the hydrogenation activity of rhodium 
catalysts is increased in the presence of catalytic amounts of tertiary amines.77 In using 
amino olefins, the tertiary amines, as part of the substrate, are present in high excess relative 
to the catalyst. Furthermore, tertiary amines acting as bases can induce aldol condensation 
reactions of the aldehydes as a side-reaction. However all these possible side reactions are 
avoided when hydroformylation of olefins is performed in the presence of phenyl 
hydrazines.34 Hydrazines are trapping the aldehyde formed and protecting it from possible 
                                                 
76 Tani, K.; Yamagata, T.; Akutagawa, S.; Kumobayashi, H.; Taketomi, T.; J. Am. Chem. Soc. 1984, 106, 5208-
5217. 
                                                                                                                                            
 
77 (a) Kaneda, K.; Yasumura, M.; Hiraki, M.; Imanaka, T.; Teransihi, S. Chem. Lett. 1981, 1763. (b) Kaneda, 
K.; Imanaka, T.; Teranishi, S. Chem. Lett. 1983, 1465. 
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side reactions. The role of phenyl hydrazines is therefore dual as they are building blocks for 
the final molecule but at the same time they are acting as protecting group for the aldehyde 
moiety.  
     For our desired indole structures it is crucial to have n-aldehydes in highest possible 
percent in reaction mixture. Iso-aldehydes are giving another type of indole structures, 
namely 2,3 disubstituted indoles. These structures if present might be hampering isolation of 
desired product from the reaction mixture. It is well known that ligand free hydroformylation 
of terminal disubstituted olefins regioselectively gives n-aldehydes, however, ligand free 
hydroformylation of monosubstituted olefins leads to a mixtures of n- and iso-aldehydes. N-
selectivity is increased by the use of bidentate ligands such as the biphosphite BIPHEPHOS 
77 or the biphosphine XANTPHOS, 78 (Figure 9).  
 
Figure 9. Ligands for n-selective hydroformylations 
 
OMeMeO
But O tBuO
P
O
OPO
O
XANTPHOSBIPHEPHOS
O
PPh2PPh2
77 78
 
 
Both ligands lead to high n-selectivities if simple olefins like 1-hexene or 1-octene are used. 
With functionalized olefins however, the n-selectivity decreases dramatically. The nature of 
the protecting group strongly affects n/iso selectivity. Additionally N-donor groups attached 
to the olefin may compete with ligand for the catalyst, altering its activity. It has been 
established previously that XANTPHOS is giving best n/iso selectivities in tandem 
hydroformylation / Fischer indolization sequence. Ratios of Rh / XANTPHOS of 1/10 were 
sufficient to achieve high selectivities towards the desired n-aldehydes.35 To test the 
influence of the protecting group and substrate structure on the n/iso-selectivity, several 
protected allylic amines are hydroformylated with a Rh(acac)(CO)2 / XANTPHOS system in 
1:10 ratio (Table 3). Here lower carbon monoxide partial pressures were chosen to ensure 
that carbon monoxide does not displace XANTPHOS from the catalytically active rhodium 
complex.  
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Table 3. Optimization of hydroformylation of allylic amines, amides and imides 
 
79 80
Ph
NAcBn
76a/79/80 70e/79/8070d/79/80
Ph
N
Ph
N OO
R
N
R1 R2
R
N
R1 R2
O
cond. +
n:iso
R
N
R1 R2
O
 
 
entry substrate [Rh] : 
XANTPHOS 
CO/H2
bar 
Time 
/ d 
Temp 
/ °C 
Solvent Conv.a 
/ % 
Ratioa 
79:80 
1 76a 1 : 10 10/10 2 80 THF 45 95/5 
2 76a 1 : 10 10/10 3 80 THF 80 98/2 
3 76a 1 : 10 10/10 3 90 THF 100 98/2 
4 70e 1 : 10 10/10 3 90 THF 100 100:0 
5 70e 1 : 10 50/10 3 80 DCM 100 95:5 
6 70d 1 : 10 10/10 3 90 THF >95 96:4 
7 70d 1 : 10 10/10 3 80 DCM 100 93:7 
conditions: 1equiv substrate, 1 mol% Rh(acac)(CO)2, 10 mol% XANTPHOS , CO/H2 (see table), 
THF, Time and temperature (see table);  a Determined by 1H-NMR of the crude reaction mixture.  
 
Among the compounds tested, three different types can be recognized (Table 3). Those 
containing two carbonyl groups are known to give lower n/iso ratios.72 Here a 
precoordination of the catalyst is more probable than in substrates with only one carbonyl 
group. The allylic acetamide 76a was hydroformylated under conditions involving 1 mol% 
Rh(acac)(CO)2, 10 mol% XANTPHOS, 10/10bar CO/H2, at 80°C in THF, however after 2 
days of reaction only 45% of substrate was converted to aldehyde although in high n/iso 
ratio of 95/5 (Table 3, Entry 1), after 3 days 80% conversion of substrate was achieved 
maintaining high ratio of n/iso products (Table 3, Entry 2). In order to achieve full 
conversion 76a was submitted to the same reaction conditions with increased temperature to 
90 °C which after 3 days yielded in full conversion of aldehyde and in 98/2 ratio of n/iso 
isomers (Table 3, Entry 3). Under same conditions tertiary amine 70e (Table 3, Entry 4) is 
fully converted to n-aldehyde exclusively. Allylic phthalimide 70d under the same 
conditions was converted more than 95% and gave as well high n/iso-selectivity of 96/4 
(Table 3, Entry 5). Reactions run in DCM appeared to be faster, yielding in full conversions 
at lower temperatures (compare Entries 4 and 5, Table 3) or in shorter reaction times 
(compare entries 6 and 7, Table 3). In no case significant amounts of side reaction products 
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were observed. Even in absence of phenylhydrazine hydroformylation gave aldehydes 
exclusively in high n/iso ratios. Due to the somewhat higher selectivity towards n-products 
when hydroformylation is performed in THF, although at the expense of longer reaction 
times all tandem reactions were performed in THF as a solvent (see below). It is known that 
subsequent acid promoted indolizations are giving highest yields in THF,74 this as well 
contributed to the selection of THF as a solvent of choice for our reaction sequence. 
 
2.1.3 Tandem Reaction towards Synthesis of β-branched Tertiary Tryptamines 
and Tryptamides 
 
     Since hydroformylation of olefins is not affected by the presence of aryl hydrazines it can 
be expected that optimized conditions for hydroformylation can be transferred to the tandem 
sequence without negative effects on yield or selectivity or reaction. Tertiary amines 
obtained were submitted to optimized hydroformylation conditions in the presence of aryl 
hydrazines. Reaction conditions involved 1 mol% Rh(acac)(CO)2, 10 mol% XANTPHOS, 
10 bar CO and 10 bar H2  gas pressure at 90 °C. Indolization was subsequently performed in 
4w% H2SO4 (Table 4). This protocol involving tandem hydroformylation / hydrazone 
formation with subsequent indolization in the presence of acid was proven to be superior to 
the protocol where BrØnsted acid (mainly PTSA) is added directly in reaction vessel during 
hydroformylation.34  
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Table 4. Tandem hydroformylation / Fischer indolization in the synthesis of tryptamines and tryptamides 
 
N
R2 R3
R1 N
H
N
R1
R2
R3
812. indolization
70c-i
76a-f
1. CO/H2, 10:10 bar,
    Rh(acac)(CO)2 1mol%
    XANTPHOS 10 mol%,
    PhNHNH2
    THF, 90 °C, 3d
 
 
entry olefin product Yield,
a 
 ee%b entry olefin product Yield
c 
1 
76a, 
R1 = Ph, 
R2 = Ac, 
R3 = Bn 
N
H
N
Ph
Ac Bn
 
62%, (R) 
92%ee 
((+)-81a) 
8 
70d, 
R1 = Ph, 
R2 = R3=
phthaloyl 
N
H
Ph
NPht
 
67%, (R) 
((+)-81h) 
2 
76b, 
R1 = Ph, 
R2 = Ac, 
R3 = Bn 
 
N
H
N
Ph
Ac Bn
 
65%, (S) 
97%ee 
((-)-81b) 
9 
70e, 
R1 = Ph, 
R2 = R3=
pyrrole 
N
H
N
Ph
 
47%, 
98%ee 
((-)-81i) 
3 
76c, 
R1 = Ph, 
R2 = Ac, 
R3 = Cy 
N
H
N
Ph
Ac Cy
 
45%, 
((+)-81c) 10 
70f, 
R1 = 
2-MeOPh, 
R2 = R3= 
Et 
HN N
MeO
 
33%, 
((-)-81j) 
4 
76d, 
R1 = Et, 
R2 = Ac, 
R3 = Bn 
N
H
N
Ac Bn
Et
 
59% 
(81d) 11 
70g, 
R1 = 
4-MeOPh 
R2 = R= 
piperidine 
HN N
OMe
 
50%, 
((-)-81k) 
5 
76e, 
R1 = nPr, 
R2 = Ac, 
R3 = Bn 
N
H
N
nPr
Ac Bn
 
76%, 
91%ee 
((+)81e) 
12 
70h, 
R1 =2-furyl, 
R2 = R= 
morpholine 
 
HN
N
O
O
 
56% 
(81l) 
6 
76f, 
R1 = nPr, 
R2 = Ac, 
R3 = Ph 
N
H
N
Ac Ph
Prn
 
66%, 
((-)-81f) 13 
70i, 
R1 = 3-pyr, 
R2 = R3=
piperidine 
 
N
H
N
N  
41% 
(81m) c 
7 
70c, 
R1 = Ph, 
R2 = R3 = 
Morphol
ine 
N
H
N
Ph
O  
52%, 
97%ee 
((-)-81g) 
 
 
 
 
All indolizations are performed in 4w% H2SO4 under reflux for 2h unless otherwise stated.a Isolated yield after 
column chromatography; b Determined by chiral HPLC columns; cIndolization performed in toluene with 4eq of  
ZnCl2
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While allylic amination proceeds with high ee's, the stereocenter may epimerize during a 
tandem hydroformylation / Fischer indolization via reversible double bond isomerisation 
catalyzed either by the transition metal catalyst or the acid. The tryptamines and tryptamides 
81 obtained from enantiomerically pure allylic amines and amides, however, reveal complete 
retention of enantiopurity (Table 4, Entries 1, 2, 5 and 7). In all cases hydroformylation led 
to the complete conversion of olefin into aldehyde, subsequent indolizations in 4w% H2SO4 
gave moderate to good yields in all cases except in entry 13 where protic acid led to the 
precipitation of the pyridinium salts of the hydrazone formed. In this case indolization in the 
presence of aprotic acid i.e. 4eq of ZnCl2 in refluxing toluene for 12h gave 41% yield of the 
product 81m.  Allylic amides in general gave slightly higher yields of products probably due 
to the lowered basicity of the nitrogen  present in side chain of tryptamides (Nb), which 
eased isolation of the product and prevented tailing on SiO2 columns (Table 4, Entries 1-6, 
8). On the contrary amines with alkyl groups on the Nb nitrogen were isolated in lower 
yields due to the higher basicity which during chromatography induced increased tailing and 
stacking on the columns of SiO2. Absolute configurations, where available, were determined 
by ascribing absolute configurations of starting material to final tryptamine molecule. 
     In summary, combination of iridium catalyzed enantioselective allylic amination and 
tandem hydroformylation / Fischer indole synthesis, in contrast to other methods reported, 
gives fast access to β-branched tryptamines which can not be derived from tryptophan and 
allows ready access to a new class of tryptamine derivatives for biological screenings. 
 
2.2   Synthesis of β-branched Homotryptophanes 
 
2.2.1 Ir Catalyzed Allylic Substitutions of Benzophenone Glycinates 
 
     Using the same protocol with branched homoallylic amines, branched homotryptophanes 
were synthesized. For the synthesis of homoallylic amines Ir catalyzed allylic alkylation of 
allylic carbonates 68 with benzophenone glycinate 82 was envisaged. These allyl glycinates 
(83+84) after hydroformylation in presence of the phenyl hydrazines and indolization should 
yield in homotryptophane structures 85 (Scheme 34). 
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Scheme 34. Envisaged reaction pathway for the synthesis of homotryptophanes 
 
R1
N
H
NH2
CO2Et
NEtO2C
R1
Ph
Ph
N CO2Et
Ph
PhR1 OCO2Me
1 2
3
R1 = alkyl, aryl
R1 = alkyl, aryl
Ir, Ligand
Rh, CO/H2
PhNHNH2,
H+
68
82
83+84 85
*
*
 
 
As already mentioned, iridium catalyzed allylic substitutions of symmetric nuclephiles (e.g. 
sodium dimethylmalonate) and 3-substituted allylic alcohol derivatives are very well 
established reactions. On the contrary, Ir catalyzed allylic alkylations of benzophenone 
glycinate 82 are only scarce in the literature. Benzophenone glycinates have some 
advantageous properties for our purposes: benzophenone group is stable under 
hydroformylation conditions but under conditions of subsequent indolization which include 
reflux for 2h in 4 w% H2SO4, this group is cleaved allowing synthesis of primary β-branched 
tryptophanes (Scheme 34). Test substrate 68a in the presence of ligands L1 and L3 was 
submitted to various reaction conditions which are known to give different stereochemical 
outcomes, yields and selectivities were then compared (Table 5). 
  
Table 5. Ir catalyzed allylic substitution of 82 and 68a under various reaction conditions 
 
Ph OCO2Me
Ph N CO2Et
Ph
N
Ph
CO2Et
Ph
Ph N
Ph
CO2Et
Ph
Ph
[Ir(COD)Cl]2
L3, THF
82
83a
+
84a68a  
 
yield, %a Ratiob ee, %c entry ligand, reaction conditions 
reaction 
time 83a + 84a 83a : 84a 83a 84a 
1 L3, 0.2 equiv DABCO, THF, 50°C 16h 87 62:38 97 95 
2 L1, LiN(SiMe3)2, THF, -78°C to rt 3h 80 70:30 65 62 
3 L3, LiN(SiMe3)2, THF, -78°C to rt 3h 84 75:25 87 nd 
4 L3, solid KOH, THF, rt 5h 65 40/60 91 nd 
5 ‘’cyclometalated’’ catalyst 50 7d / / / / 
a Yield of isolated product after column chromatography; b Determined by isolation after column 
chromatography; c Determined by HPLC on chiral column. 
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     First, standard established protocol for the allylic aminations using 20 mol% DABCO for 
preactivation of the catalyst in the presence of ligand L3 was applied (Table 5, Entry 1). 
Under these conditions after 16 hours complete conversion was achieved and the products 
were isolated in 87 % overall yield. Both, syn and anti stereoisomers were separately isolated 
in approximately 3/2 ratio in favour of syn isomer 83a. Both isomers showed excellent ee 
values of 97% and 95 %ee respectively. In contrast to the method used by Takemoto which 
required 10 mol% of metal catalyst and 20 mol% of ligand 63, here, only 2 mol% of catalyst 
and 4 mol% of ligand L3 had to be used to achieve reasonable reaction times. Preforming of 
the enolate at -78 °C using LHMDS as a base and adding preformed enolate to the mixture 
of catalyst, ligand and carbonate gave 80% and 84 % yield of products respectively for 
ligands L1 and L3. Approximately 4/1 ratio of syn/anti, was observed in both cases. As 
expected ligand L3 gave higher ee´s of products 83a and 84a than ligand L1 (Table 5, 
entries 2 and 3). Complete conversion of starting material was observed after 3h, but 
surprisingly in this case ee values were lower as compared to salt free conditions (Table 5, 
Entry 1). Preforming of the enolate with KOH at room temperature and adding preformed 
enolate to the mixture of catalyst, ligand L3 and carbonate gave approximately 2/3 ratio of 
syn/anti products with good enantioselectivity of 83a (Table 5, Entry 4). Under these 
conditions products were isolated in 65% overall yield which is somewhat lower value as 
compared to other tested conditions. 
     These results are in accordance with Takemoto’s observation that diastereoselectivity is 
controlled by the geometry of enolate formed and not by the chiral ligand, i.e. reaction 
performed under kinetic control (small counterion, low temperature) is favouring the 
formation of Z enolate and syn product while thermodynamic control (bigger counterion, 
room temperature) is favouring the formation of E enolate and anti product. However, in no 
case high stereoselectivities were observed, they ranged from 4/1 in favour of syn isomer 
(Table 5, Entry 3) to 2/3 in favour of anti isomer (Table 5, Entry 4). These poor 
regioselectivities can most probably be ascribed to the stericaly undemanding ester group 
applied. 
     However, even base free allylic substitutions are well known for palladium catalyzed 
allylic substitutions using carbonates as substrates.78 The general mechanism involves 
coordination of the carbonate to the metal center and subsequent loss of CO2. Dissociation of 
the metal bound alkoxide will then normally provide a sufficiently basic species, which will 
                                                 
78 Tsuji, J.; Minami, I. Acc. Chem. Res. 1987, 20, (4), 140-145. 
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act as base during the reaction. Interestingly, when the active   ´´cyclometalated´´ catalyst 50 
obtained by activation with excess propylamine,71 was applied for alkylation reaction 
without additional base no conversion was observed even after several days of reaction time. 
Apparently unlike our initial thoughts the use of DABCO in substoichiometric amounts is 
crucial for success of this procedure. Besides its role in catalyst activation DABCO is most 
probably taking part in deprotonation of 82 making it sufficiently nucleophilic for alkylation 
reactions. Enantioselectivities obtained in test reactions were very promising, and showed 
high potential of phosphoramidite type ligands in the Ir catalyzed allylic substitution 
reactions. Despite somewhat longer reaction times when using salt free conditions (i.e. 
DABCO as a base) due to the best enantioselectivities of both diastereoisomers and due to 
the lack of higher diastereodifferentiation with other methods, these conditions were chosen 
to be used with various allylic carbonates 68b-f (Table 6).  
 
Table 6. Ir- Catalyzed Allylic Substitution of 79 with Various Substrates 67b-f 
 
R1 OCO2Me
Ph N CO2Et
Ph
N
R1
CO2Et
Ph
Ph N
R1
CO2Et
Ph
Ph
[Ir(cod)Cl]2, THF
Conditions*
82
83 b-f, h
+
84 b-f, h68 b-f, h  
 
entry substrate Conditions,a yield, %b Ratioc ee, %d 
 R1 ligand 83 + 84 83 : 84 83 84 
1 2-MeOPh (68b) A, L3 82  70/30 91 (83b) nd (84b) 
2 4-MeOPh 68c) A, L3 97 56:44 94 (83c) 91 (84c) 
3 4-MeOPh (68c) B, L1 55 62:38 67 (83c) 62 (84c) 
4 2-furyl (68d) A, L3 69 60:40 95 (83d) 94 (84d) 
5 3-purydyl (68e) A, L3 72 65:35 92 (83e) nd (84e) 
6 n-C2H5 (68f) A, L3 65 75:25 nd (83f) nd (84f) 
7 H (68h) A, L3 28 (83h) / /  / 
a Method A: In THF at 50 °C, The ratio of 68: 82: DABCO: [Ir(cod)Cl]2: (Ra ,Rc, Rc)-L3 was 
100: 100: 20: 2:4. Method B: In THF at 0 °C The ratio of 68: 82: LiN(SiMe3)2: [Ir(cod)Cl]2: L1 
was 150: 100: 150: 2: 4; b Yield of isolated product after column chromatography;  c  Determined 
by isolation of both isomers; d Determined by HPLC on chiral column. 
 
All tested substrates gave good yields and excellent enantioselectivities. Syn isomer was 
obtained in excess in all cases, although with poor diastereoselectivities. Substrates 68c-e 
possessing p-MeO-Ph, furyl or pyridyl groups reapectively, yielded in approximately 60/40 
ratios of syn/anti isomers (Table 6, Entries 2, 4 and 5), substrate 68b possessing o-MeO-Ph 
group, however, gave slightly higher ratio of syn isomer of 70/30 (Table 6, Entry 1), 
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surprisingly substrate 68f possessing Et group gave 75/25 ratio of syn/anti diastereoisomers 
with good enantiomeric excess of syn isomer, ee of anti isomer was not determined (Table 6, 
Entry 6). p-MeO-cinnamyl carbonate 68c was submitted to conditions which involved 
preforming the enolate with LiHMDS in presence of ligand L1 yielding in 55% overall yield 
of products with low enantioselectivity (Table 6, Entry 2) once more proving the superiority 
of ligand L3 and salt free conditions (Table 6, Entry 3). In reaction of 68h with 82 only one 
stereocenter is formed, product was isolated in rather poor yield of 28 %, which can be partly 
ascribed to higher volatility of allylcarbonate (Table 6, Entry 7). 
     Absolute configuration of isolated diastereoisomers was determined by transforming 
ethyl ester 83a into methyl ester and by comparing optical rotation data of 86a with literature 
data.70 Absolute configuration was determined to be as shown on scheme 35. Absolute 
configurations of other substrates can be ascribed by analogy. 
 
Scheme 35. Determination of absolute configuration 
 
N
Ph
CO2Et
Ph
Ph N
Ph
CO2Me
Ph
Ph
1%K2CO3,
 MeOH, 1h
83a 86a
(R)
(S)
 
 
     In an attempt to introduce nitrogen protecting group that is stable under the acidic 
indolization conditions and that would yield in tertiary tryptophanes which are as well 
interesting compounds from medicinal point of view, ethyl glycinate was protected with the 
phthaloyl group to give compound 87. Phthaloyl group is stable under acidic indolization 
conditions. However, standard procedure used for alkylations with benzophenone protected 
glycine 82 proved unsuccessful with Pht protected glycine ethyl ester 87. Preforming of the 
enolate with LiHMDS and adding it to the solution of the carbonate and catalyst led to the 
intensive coloration of the reaction mixture but even after prolonged reaction times no 
product could be observed, this was as well the case when the salt free conditions using 
DABCO as a base were applied (Scheme 36). 
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Scheme 36. Attempted Ir catalyzed allylic alkylation with phthaloyl protected ethylglycinate 
 
Ph OCO2Me
PhtN CO2Et
PhtN
R
CO2Et PhtN
R
CO2EtConditions
87 +
Conditions: (a) 2 mol-% [Ir(cod)Cl]2, 4 mol-% L3, 20 mol-% DABCO, THF, 50°C, 48 h 
(b) 2 mol-% [Ir(cod)Cl]2, 4 mol-% L3, then 87 1 eq, LiHMDS, -78 ° C
X
68a
 
 
2.2.2 Hydroformylation and Indolization of Allyl Benzophenone Glycinates 
 
 
     Since it proved difficult to separate sufficient amounts of diastereoisomers for indole 
synthesis reaction, diastereomeric mixture of allyl glycinates 83a+84a containing 62/38 ratio 
of these two was submitted to same conditions used for the synthesis of branched 
tryptamines and tryptamides involving 1 mol% Rh(acac)(CO)2, 10 mol% XANTPHOS, in 
THF at 90 °C for 3 days. After 3 days the olefin was hydroformylated with only 45 % 
conversion, which resulted in 22% yield of desired indole after indolization. In order to 
achieve full conversion of the olefin, reaction time was prolonged to 5 days leaving other 
variables the same and each step of the sequence was separately performed and examined. 
After 5 days of hydroformylation full conversion of olefin was observed, with a ratio of n/iso 
aldehyde of 95/5 as determined by 1H-NMR of crude reaction mixture. To a solution of 
aldehyde 1 equiv phenyl hydrazine was added and after 2 h of reaction full conversion 
towards hydrazone 88 was achieved, subsequent indolization with 4 w % H2SO4 yielded in 
satisfactory 57 % of indole 85a (Scheme 37). This test reaction showed that aldehyde 
hydroformylation is the key step for obtaining good yields and once full conversion of 
aldehyde is achieved remaining steps are proceeding without any major influences on the 
overall yield of the reaction. Ratio of isomers in the indole mixture was the same as in the 
starting material, approximately 60/40 implying that even at reflux temperatures in diluted 
H2SO4 racemization can not be observed. 
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Scheme 37. Stepwise optimization of reaction conditions 
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With these newly established conditions substrates 83a+84a and 83f+84f were submitted to 
tandem sequence yielding in primary β-branched homotryptophanes. Products were isolated 
in moderate yields as mixtures of diastereoisomers (Scheme 38). It is noteworthy to mention 
that substrate 83a+84a gave slightly higher yield in tandem process than when every step 
was performed separately. 
 
Scheme 38. Synthesis of branched homotryptamines from homoallylic amines 
 
N
R1
CO2Et
Ph
Ph
R1
N
H
H2N COOEt
83a+84a   R1 = Ph
*
85a  R1 = Ph  61%
85b  R1 = Et   46%
1) 1 mol % Rh(acac)(CO)2
    10 mol % XANTPHOS
    1 equiv Phenylhydrazin
    10 bar CO, 10 bar H2
    THF, 5 d, 90 °C*
83f +84f    R1 = Et
80+81
2) 4 w % H2SO4, 3h, 80°C
 
 
Attempted hydroformylation / hydrazone formation reactions with subsequent indolization 
with Lewis acids, which should preserve benzophenone group of 83a+84a, and in turn yield 
in tertiary tryptophane 89 were unsuccessful, after 24 hours of reflux with 4 equiv of ZnCl2 
in toluene79 only starting hydrazone was quantitatively recovered. Attempted indolization 
                                                 
79 Ahmed, M.; Jackstell, R.; Seayad, A.M.; Klein, H.; Beller, M.; Tetrahedron Lett. 2004, 45, 869-873 
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with BF3 was unsuccessful as well, hydrazone was completely recovered even after 
prolonged reaction times (Scheme 39). 
 
Scheme 39. Lewis acid promoted indolizations 
 
N
Ph
CO2Et
Ph
Ph Ph
N
H
N COOEt
* 2) indolization conditions*
*
83a+84a
1) 1 mol-% Rh(acac)(CO)2
    10 mol-% XANTPHOS
    10 bar CO, 10 bar H2
    THF, 5 d, 90°C
    PhNHNH2 X
Ph
Ph
indolization conditions: a) 4eq ZnCl2, toluene, reflux 24h
 b) 2 eq BF3*Et2O, THF, rt then reflux 12h
89
 
 
     In summary, we have shown that Ir catalyzed alkylation reactions in combination with 
tandem hydroformylation / Fischer indolization are representing a powerful strategy for the 
synthesis of branched homotryptophanes. Starting materials were obtained in high 
enantiomeric purities however their separation on large scale was not successful. In order to 
make this procedure more synthetically useful it would be necessary to use single 
enantiopure diastereoisomers in this sequence in order to get access to enantiopure 
homotryptophane derivatives. 
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2.3 Synthesis of Longer Chain Tryptophanes 
 
2.3.1 Ir Catalyzed Allylic Alkylation of Cyanoacetates  
 
     Ir catalyzed allylic alkylation of allylic carbonates 68 with cyanoacetates 90 was applied 
in the synthesis of required starting materials 91. Nitrile group of cyanoacetates is planed to 
be used as masked amine functionality. These substrates after hydroformylation, indolization 
and selective reduction of nitrile moiety should yield in primary tryptophane homologues 93 
(Scheme 40). 
 
Scheme 40. Envisaged pathway for the synthesis of longer chain tryptophanes 
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NC
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92 93
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1
2
34
 
 
As noted by Takemoto albeit influencing diastereoselectivity the ester functionality does not 
affect the enantioselectivity of the reaction.70 Therefore stereodifferentiation of the 
enantiotopic faces of the allyl-metal complex coordinated by chiral ligands should be highly 
independent of the nucleophiles employed. Based on this rationale it was expected that 
similar enantioselectivities will be obtained with the cyanoacetate nucleophiles as with 
benzophenone protected glycinates. Since there are no precedents for the Ir catalyzed allylic 
alkylations with cyanoacetates as nucleophiles in the literature, optimisation of reaction 
conditions was required. We focused on allylic alkylations using t-butyl cyanoacetate as 
nucleophile hoping that the sterically more demanding t-butyl group of 90a would both 
increase diastereodifferentiation and ease the separation of diastereomers (Table 7). Allylic 
carbonate 68a was chosen as test substrate. 
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Table 7. Ir catalyzed allylic substitution of  90a and 68a under various reaction conditions 
 
 
CO2tBuNC
Ph OCOOMe NC OtBu
O
2 mol-% [Ir(cod)Cl]2
4 mol-% L3
Conditions: table 7
90a 91a68a  
 
entry Base, conditions Reaxn.time dra Yield, %b 91a 
1 LiHMDS, THF, -78°C to rt 3h 62/38 65 
2 solid KOH, THF, rt 16h 43/57 62 
3 solid NaOH, THF, rt 6h 45/55 60 
4 DABCO, THF, 50 °C 18h 57/43 76 
5 ‘‘cyclometalated’’ catalyst 50 5 days 52/48 42 
a Diastereomeric ratio determined by NMR of crude reaction mixture, b Yield of isolated 
product after column chromatography 
 
 
                                                                                                                                            
 
Salt free conditions involving use of 20 mol% of DABCO as well as kinetic and 
thermodynamic conditions for enolate formation were tested (Table 7), in all cases products 
were obtained but stereoselectivities were rather poor considering the fact that bulky ester 
group was used, only approximately 1/1 ratios of diastereoisomers were observed in all 
cases. Nevertheless ratio depended on the applied base so that Li base and kinetic conditions 
(Table 7, Entry 1) gave opposite diastreoisomer from KOH or NaOH under thermodynamic 
conditions (Table 7, Entries 2 and 3). In all cases yields were moderate ranging from 42-
76%. One reason for poor diastereoselectivities could be low steric demand of the nitrile 
group, which results in unselective enolate formation. In the case of benzophenone glycinate 
large benzhydrylidene group should favour the E enolate to a larger extent when a sterically 
demanding counter cation is used. Similarly selective formation of the Z enolate might be 
hampered by the fact, that the nitrile moiety is unable to sufficiently coordinate the small 
lithium ion. Another reason for the loss of stereochemical information might be due to 
racemization under the reaction conditions. Methylene protons of cyanoacetates are more 
acidic than those of benzophenone glycinates, abstraction of the methylene proton and 
subsequent reprotonation would presumably produce a 50:50 mixture of both 
diastereoisomers.  This observation was supported by the fact that under base free conditions 
using previously activated catalyst 50 (by the propyl amine activation method) on the 
contrary to the benzophenone glycinates, reaction proceeds with moderate yield (Table 7, 
Entry 5) although after longer reaction time of 5 days. This result is showing that most 
probably the methoxide released is sufficiently basic to deprotonate substrate and make it 
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more nucleophilic. Unfortunately we were not able to separate diastereoisomers of the 
obtained products and consequently we could not determine ee values of syn and anti 
isomers.  
     We next focused on the allylic alkylations of various carbonates with cyanoacetates 90a 
and 90b as nucleophiles using DABCO as a base which although somewhat slower 
compared to other bases gave best yields in test reactions. Several reactions were set up first 
utilizing 90b as nucleophile (Table 8, entries 1-5). The diastereoselectivities determined and 
yields are summarized in table 8. All reactions gave approximately 1/1 ratios of 
stereoisomers in moderate to good yields. 
 
Table 8. Ir catalyzed allylic alkylation of 90a and 90b with 68  
 
R1 OCOOMe NC OR2
O
CO2R2
R
NC
conditions: table 8
90a R2 = tBu
90b R2 = Me 91
68
*
*
 
 
entry R. R1 methoda Time (h) 
dr. 
ratiob 
Yield,c 
%, (91) 
1 Ph Me A 16 50:50 65 (91b) 
2 4-MeO-Ph Me A 12 50:50 70 (91c) 
3 2-furyl Me A 3 55:45 47 (91d) 
4 3-purydyl Me A 45 50:50 50 (91e) 
5 H Me A 48 / 27 (91f) 
6 H tBu A 48 / 47 (91g) 
7 2-MeO-Ph tBu A 20 70/30 70 (91h) 
8 2-MeO-Ph tBu B 6d 68/32 35 (91h) 
9 3-purydyl tBu A 48 52/48 60 (91i) 
a Method  A:  In THF at 50 °C. The ratio of 68: 90: DABCO: [Ir(cod)Cl]2: (Ra, 
Rc, Rc)-L3 was 100: 100: 20: 2: 4, THF, 50 °C; Method  B: The ratio of 68: 90: 
50 : was 100: 100: 4, THF, 50 °C b Determined by 1H-NMR of crude reaction 
mixture; c Yield of isolated product after column chromatography 
 
 
     We next turned attention on the cyanoacetate 90a, (Table 8, entries 6-9) The reactions 
with this nucleophile  however showed that the benzhydrylidene protecting group and its 
steric demand seem to be vital for obtaining significant diastereomeric induction. Due to its 
sp hybridisation and the resulting shape the nitrile group is especially small and it might be 
unsuitable for this kind of diastereoselective reaction. 
However, all compounds were obtained in moderate to good yields showing the viability of 
this approach. Diastereomeric ratios were determined by 1H-NMR of crude reaction 
mixtures. Disappointingly regardless of substrate used, only slightly improved 
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diastereoselectivities were observed as compared to methyl ester. In the reaction with the 
orthomethoxy substituted cinnamyl carbonate 68b (Table 8, Entry 7) slightly improved 
diastereoselectivity of 70/30 was observed. To test if DABCO is responsible for this result 
the preformed catalyst 50 and no external base was used. Here, the same diastereoselectivity 
was observed, albeit in this case the reaction rate and yield were lower (Table 8, Entry 8). 
Obviously DABCO is not solely controlling the diastereoselectivity, instead a substrate 
controlled diastereoselectivity might be apparent. Most probably due to the steric 
compression caused by the methoxy substitutent of the substrate one of the isomeric enolates 
(E or Z) of 90a is reacting faster with 68b. Enolate reacting faster is removed from E/Z 
equilibrium hence causing shifting of the reaction further in the same direction i.e. higher 
preference towards formation of one of the two possible diastereoisomers is observed. Since 
diastereoisomers could not be separated in any case we decided to use mixtures of 
diastereoisomers for hydroformylation / Fischer indole reactions and try to separate both 
diastereomers in later stages of the synthesis. 
 
2.3.2 Hydroformylation and Indolization of Allyl Cyanoacetates 
 
     Hydroformylation of the homoallylic nitriles 91 proved to be difficult and initial test 
reactions using standard conditions for hydroformylation of homoallylic amines (1 mol% 
Rh(acac)(CO)2, 10 mol% XANTPHOS, 1eq PHNHNH2, 10/10 bar pressure of CO/H2, 90 
°C, THF, 5d, followed by indolization with 4 wt% H2SO4) on the allylic cycanoacetate 91a 
did not yield the desired indole. Therefore we tested all steps of the reaction separately. 
Performing the reaction in the absence of phenylhydrazine with the same substrate under the 
same conditions revealed that only 20% of olefin was converted under these conditions, 
therefore we increased temperature to 110 °C since longer reaction times than 5 days are to 
the authors experience highly inconvenient and impractical. After 5 days complete 
conversion of olefin 91a was observed. Hydrazone formation was then carried out under 
atmospheric pressure at room temperature. After indolization under standard conditions the 
desired indole 91a was isolated in 39 % yield. This test experiment once more demonstrated 
that conversion of the olefin is the decisive factor for the success of reaction. After the new 
conditions were established other substrates were submitted to these conditions, Table 9 
summarizes the synthesized indoles, which were all obtained as mixtures of diastereomers. 
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Table 9. Syntheses of idoles from homoallylnitriles  
 
NC
OR2
O
R1 N
H
R1
NC COOR2
1 mol% Rh(acac)(CO)2
10 mol% XANTPHOS
1 eq. Phenylhydrazin
10 bar CO, 10 bar H2
THF, 5 d, 110°C
1)
2) H2SO4, 3h, 80°C
9291  
 
entry R1 R2 Yield %,a 92 
1 Ph Me 39 (92a) 
2 4-MeO-Ph Me 66 (92b) 
3 Ph tBu 60 (92c) 
4 2-MeO-Ph tBu 37 (92d) 
5 H tBu 57  (92e) 
aYield of isolated product after column 
chromatography. 
 
 
 
 
 
 
 
 
 
It is noteworthy to mention that hydroformylation conditions as well as subsequent acidic 
indolization conditions did not influence the diastereomeric ratios of obtained products 
which were the same as in the starting materials. In general products are obtained moderate 
to good yields, however separation of diastereomers would be necessary in order to increase 
the synthetic use of this pathway.  
 
2.3.3 Reduction of Nitrile Group  
 
     For the reduction of nitrile group few different conditions were tested including LiAlH4 in 
THF and Pd/C under H2 atmosphere but in all cases inseparable mixtures of products were 
observed. Catalytic hydrogenation however, using Raney-Co as a catalyst in stoichiometric 
amount under 40 bar pressure of H2 selectively reduced nitrile functionality and furnished 
quantitative yield of desired products (Scheme 41).  
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Scheme 41. Reduction of nitrile functionality in indoles 92c and 92e 
 
R1
N
H
COOR2H2N
N
H
R1
NC COOR2
Raney-Co
40 bar H2
MeOH/H2O
80 °C, 5h
92c                                                    93a, R1 = Ph, R2 = Me quantitative
92e                                                    93b, R1 = H, R2 = tBu  90%  
 
2.3.4 Double Alkylation of Allyl Methylcarbonate and Synthesis of Bisindole 95 
 
     Notably, in allylic alkylations with allyl carbonate (Table 8, Entries 5 and 6) double 
alkylation was observed when performing the reaction with DABCO as a catalyst. 
Compounds 94a and 94b were isolated in an addition to the monoalkylation products 91f 
and 91g (Scheme 42). Tert-butylcyanoacetate 90a gave almost doubled yield of desired 
monoalkylation product compared to methylcyanoacetate 90b but both gave similar yield of 
double alkylation product 94. No reaction conditions that entirely favour double alkylation 
product have been developed, although it seems that higher temperature and excess of base 
are shifting the reaction towards the bisubstituted product. For all other carbonates no double 
alkylation could be observed. 
 
Scheme 42. Conditions for double alkylation of cyanoacetates 
 
O OMe
O
NC
OR
O
NC
OR
O
2 mol % [Ir(cod)Cl]2
4 mol% L3, 
20 mol% DABCO
THF, 50°C
R = Me, 91f (27%)               94a (21%)       
R = tBu, 91g (47%)              94b (20%)
1.2 eq. 90a or 90b
+
68h
 
 
Double alkylation product 94b was converted into bisindole 95 in the reaction with the 2 
equivalents of phenylhydrazine (Scheme 43). Bisindole was obtained in very good yield of 
68%. 
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Scheme 43. Synthesis of bisindole 95 from the double alkylation product 94b 
 
N
H
NC CO2
tBu
NH
NC
OtBu
O
N
H
NH2
94b
95
68%
conditions
 
                                       Conditions: 1 mol-% Rh(acac)(CO)2, 10 mol-% Xantphos, 
                                       2 equiv Phenylhydrazin,10 bar CO, 10 bar H2, THF, 5 d, 100°C 
                                       then H2SO4, 2h, 80°C. 
 
     In summary, this convergent, one-pot strategy allowed synthesis of various functionalized 
indoles. Combination of Ir catalyzed allylic substitutions and tandem hydroformylation / 
Fischer indole synthesis sequence gave completely new insight in the synthesis of 
tryptamines, tryptophanes and homologues. Variabilities of the possible reactants are high, 
which allows flexible determination of the substitution pattern in final products.  
Regioselectivity of the tandem reaction was effectively controlled with the use of the 
biphosphine ligand XANTPHOS. Finally we have given several examples for the application 
of this tandem sequence demonstrating that this approach may be valuable for the synthesis 
of substance libraries with high diversity. 
 
2.3.5 Allyl Glycinates in the Synthesis of Pipecolic Acid Derivatives 
 
     Compounds 83+84 obtained from Ir catalyzed allylic alkylation reactions with 
benzophenone glycinates can be used as starting materials for the synthesis of pipecolic acid 
derivatives 97. Reaction sequence involves deprotection of 83+84 and subsequent 
hydroformylation of amine 96 which after intramolecular hydroaminomethylation reaction 
should yield in pipecolic acid derivatives 97 (Scheme 44). 
 
Scheme 44. Retrosynthetic pathway for the synthesis of pipecolic acid derivatives 97 
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H
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While deprotection of substrates 83+84 to give 96a-c proceeded in good yields, subsequent 
hydroformylation in presence of 1 mol%  Rh catalyst and 10 mol% of ligand XANTPHOS at 
80 °C in THF for 3 days gave inseparable mixtures of products in all cases (Scheme 45). 
  
Scheme 45. Deprotection and hydroformylation of allyl glycines 
 
N
H
R
EtO2CN
R
CO2Et
Ph
Ph H2N
R
CO2Et
X
NH2OH*HCl
THF/H2O(1/1)
2h
a: H                    66%                
b: Ph                  56%
c: p-MeOPh        69%
R =
CO/H2, 50/10 
THF, 3 d, 80°C
1 mol% Rh(acac)(CO)2
10 mol% XANTPHOS
96a-c83+84 97
 
 
     Further optimizations of reaction conditions in regard of applied catalyst, ligand, solvent 
and pressures of CO/H2 should be done in order to selectively obtain desired structures. 
Protection of primary amino group in form of carbamate as performed by Ojima et al.80  in 
their synthesis of pipecolic acid derivatives via hydroformylation intramolecular cyclization 
sequence, would be one of the solutions to minimize side reactions and obtain high yields of 
desired products.
                                                 
                                                                                                                                            
 
80 (a) Ojima, I.; Tzamarioudaki, M.; Eguchi, M. J. Org. Chem. 1995, 60, 7078; (b) Ojima, I.; Vidal, E. S. J. 
Org. Chem. 1998, 63, 7999. 
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     Although classical Pictet-Spengler (PS) reaction is well established as a method of choice 
for construction of tetrahydro-β-carboline (THBC) frameworks, original strategy has been 
modified over the past decades, allowing N-acyl, N-sulfinyl and N-sulfonyl β-
arylethylamines to be used as nucleophilic components.81 On the other hand, masked 
ketones, aldehydes and aldehyde equivalents such as acetals, ketals, enol ethers, thioortho 
esters, oxazines and oxazolidines82  as well as acetylene sulfoxides, enamines, azalactones, 
and perhydro-1,3-heterocycles83 have been applied as electrophilic components. Olefins, 
however have rarely been used as precursors of electrophilic component in the Pictet-
Spengler reaction. 
 
3.1 Tandem Reaction under Aprotic Conditions 
 
     Possibility of combining Rh catalyzed olefin hydroformylation reaction and the PS 
reaction into a tandem reaction sequence, involving olefins as precursors of electrophilic 
component was explored by Taddei et al. They used this sequence for solid phase synthesis 
of carbolines.36 However, completely new set of reaction conditions had to be developed in 
order to achieve application of this reaction sequence in solution. While the 
hydroformylation reaction in the presence of rhodium catalyst would be used to synthesize 
the aldehyde in situ from an olefin 99, reducing functional group transformations to a 
minimum, the presence of β-arylethyl amine 98 (and a BrØnsted acid
 70 
                                                 
81 (a) Orazi, O. O.; Corral, R. A.; Giaccio, H. J. Chem. Soc., Perkin Trans. 1 1986, 1977-1982.  (b) Zinczuk, J.; 
Sorokin, I. H. Orazi, O. O.; Corral, R. A. J. Heterocycl. Chem. 1992, 29, 859-866.  (c) Ito, K.; Tanaka, H. 
Chem. Pharm. Bull. 1977, 25, 1732-1739.  (d) Lukanov, L. K.; Venkov, N. M. Synthesis 1987, 204-206.  (e) 
Wee, A. G. H.; Yu, Q. J. Org. Chem. 2001, 66, 8935-8943.  (f) Gremmen, C.; Wanner, M. J.; Koomen, G.-J. 
Tetrahedron Lett. 2001, 42, 8885-8888.  (g) Gremmen, C.; Willemse, B.; Wanner, M. J.; Koomen, G.-J. Org. 
Lett. 2000, 2, 1955-1958.  
82 (a) Cho, S.-D.; Song, S.-Y.; Hur, E.-J.; Chen, M.; Joo, W.-H.; Falk, J. R.; Yoon, Y.-J.; Shin, D.-S. 
Tetrahedron Lett. 2001, 42, 6251-6253.  (b) Comins, D. L.; Thakker, P. M.; Baevski, M. F.; Badawi, M. M. 
Tetrahedron 1997, 53, 16327-16340. (c) Singh, K.; Deb, P. K. Heterocycles, 1999, 51, 1509. (d) Singh, K.; 
Deb, P. K. Tetrahedron Lett.  2000, 41, 4977. 
83 (a) Lee, A. W. M.; Chan, W. H. Chiral Acetylenic Sulfoxides and Related Compounds in Organic Synthesis. 
In Topics in Current Chemistry; Springer-Verlag: New York, 1997; Vol. 190, pp 103-129. (b) Singh, K.; Deb, 
P. K. Heterocycles 1999, 51 1509-1512.  (c) Singh, K.; Deb, P. K. Tetrahedron Lett. 2000, 41, 4977-4980. (d) 
Vohra, R.; MacLean, D. B. Tetrahedron Lett. 1993, 34, 7673-7676. (e) Audia, J. A.; Droste, J. J.; Nissen, J. S.; 
Murdoch, G. R.; Evard, D. A. J. Org. Chem. 1996, 61, 7937-7939. (f) Ezquerra, J.; Lamas, C.; Pastor, A.; 
Alvarez, P.; Vaquero, J. J.; Prowse, W. C. Tetrahedron 1996, 37, 5813-5816. 
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allows direct conversion to a Schiff base 100 which then subsequently cyclizes to form 
tetrahydro-β-carboline ring system 101 (Scheme 46).  
 
Scheme 46. Tandem hydroformylation / Pictet Spengler reaction 
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This methodology allows introduction of various substituents at C1 without the need of 
costly aldehyde components, high concentrations of aldehyde component in the mixture are 
avoided due to the slow hydroformylation step, causing that competitive aldehyde self-
condensation reaction which may result in low yields is avoided.84 Thus some of the primary 
limitations of the conventional Pictet-Spengler reaction are overcome. To achieve high 
yields of desired product high chemoselectivities would be required in each step of tandem 
process. Therefore, it is important that all individual steps work as selectively as possible and 
all reagents and reactants required as well as all intermediates are compatible and do not 
affect each other. Hydroformylations of olefins in the presence of amines are yielding in 
different products, primary and secondary amines are condensing with the aldehydes 
followed by hydrogenation of the resulting imines or enamines to amines in an overall 
hydroaminomethylation. It is also known that the rhodium acyl species are partially 
undergoing nucleophilic addition of the amine to form the amide, instead of hydrogenolysis 
to form the aldehyde.85 Hence, a tandem synthesis of tetrahydro-β-carbolines under 
hydroformylation conditions according to the above described limitations has to consist of 
efficient hydroformylation step leading exclusively to aldehyde. This without isolation or 
side reactions must condense under the same reaction conditions with β-arylethyl amine to 
form imine so that reduction and self condensation of aldehydes are avoided. Intermediate 
imine must cyclize fast in order to avoid reduction which leads to hydroaminomethylation 
product. 
                                                 
84 Ungemach, F.; DiPiero, M.; Weber, R.; Cook, J. M. J. Org. Chem. 1981, 46, 164. 
85  Wittmann, K.; Wisniewski, W.; Mynott, R.; Leitner, W.; Kranemann, C.L.; Rische, T.; Eilbracht, P.; 
Kluwer, S.; Ernsting, J.M.; Elsevier, C.J.; Chem. Eur. J.; 2001; 7, 4584-4589.  
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     Since hydroformylation of terminal olefins usually results in a mixture of linear and 
branched aldehydes, disubstituted terminal olefins like 1,1' diphenylethylene or cyclic 
olefins are preferably investigated. The former undergo regioselective hydroformylation to 
form linear aldehydes and make use of n-directing ligands obsolete, and the latter are 
symmetric compounds and may yield in only one aldehyde structure. To prevent 
hydrogenation of the starting olefin, and/or intermediate Schiff base high carbon monoxide 
partial pressures are chosen in order to support the rate determining carbon monoxide 
insertion. 
     It is well known that tryptophan methylester undergoes Pictet-Spengler reaction with 
aldehydes in aprotic conditions,20c the conversion of later and cyclopentene as electrophile 
precursor under hydroformylation conditions was chosen as a model reaction. Cyclopentene 
is a cheap and readily available olefin, hydroformylation of cyclopentene is well known and 
described, conditions usually include temperatures of 40-80 °C and pressures of 40-80 bar of 
syngas for 1-3 days depending on tandem sequence involved, in the presence of 0.5-1 mol% 
of rhodium catalyst.30, 37 
     When cyclopentene was mixed with (S)-tryptophan methylester in toluene, which is  most 
commonly used as solvent in conventional PS reactions and is also very convenient solvent 
for hydroformylation reactions, and submitted to the hydroformylation in the presence of 1 
mol % of Rh(acac)(CO)2 at 80 °C and at 30/10 bar of CO/H2 pressure two different products 
were isolated (Table 10, Entry 1). Surprisingly no Pictet-Spengler product was observed, 
only byproducts 105 and 106 were isolated, which arouse from mono and double 
hydroaminomethylation reactions respectively. Obviously, reduction of intermediate Schiff 
base 109 is faster than electrophilic attack of imine to aromatic ring of indole, (Scheme 47, 
pathways b and d). Same products were isolated in reaction with cyclohexene (Table 10, 
Entry 2) although this olefin requires higher temperature for reaction to proceed as compared 
to cyclopentene. Apparently, in toluene only reduction products were obtained. On the 
contrary, when reaction was performed in more polar solvents such as CH2Cl2, THF or 
MeOH, we were able to isolate the Pictet-Spengler products 103, cis and 104, trans in all 
cases. When mixture of cyclopentene and (S)-tryptophan methylester 102 was 
hydroformylated in CH2Cl2, 103 and 104 were isolated in relative ratios of approximately 
1/1 and overall yield of 73 % accompanied with four additional byproducts 105, 106, 107 
and 108 (Table 10, entry 6), even in this case reduction of intermediate Schiff bases 
represents significant problem, formation of two new byproducts 107, and 108 is observed in 
addition to 105 and 106 which were observed before. 
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Table 10. Tandem hydroformylation / Pictet-Spengler reaction under aprotic conditions 
 
N
H
NH2
CO2Me
N
H
HN
CO2Me
N
H
N
CO2Me
N
H
NH
CO2Me
N
H
N
CO2Me
N
H
NH
CO2Me
N
H
N
CO2Me
CO/H2
1 mol%
Rh(acac)(CO)2 
solvent, t°C
+ +
+
s
s s
r
+ +
n
nn
n n
n
103 104
105 106 108
99
n
+
nn
107
102
1eq
 
 
Yield,(%) b 
entry Conda Solvent Olefin 99 (n) 
Yield b (%) 
103+104  
Ratioc 
103/104 105 106 107 108 
1 A Toluene 1 / / 65 10 / / 
2 D Toluene 2 / / 60 12 / / 
3 A THF 1 45 49/51 / / / / 
4 C THF 1 52 47/53 10 / / / 
5 A MeOH 1 15 50/50 48 / / / 
6 A CH2Cl2 1 73 48/52 3 7 4 / 
7 B CH2Cl2 1 79 48/52 1 5 3 / 
8 C CH2Cl2 1 72 51/49 / 6 5 / 
9 D CH2Cl2 2 63 45/55 / 11 5 5 
10 B CH2Cl2 3 71 44/56 22 / / / 
11 B CH2Cl2 4 / / 43 / / / 
a Conditions A: 1 mol% of Rh(acac)(CO)2  30 bar CO, 10 bar H2, 80 °C, 3d; Method B: 1 mol% of 
Rh(acac)(CO)2  50 bar CO, 10 bar H2, 80 °C, 3d. Method C: 1 mol% of Rh(acac)(CO)2  70 bar CO, 
10 bar H2, 80 °C, 3d, D: 1 mol% of [Rh(COD)Cl]2  50 bar CO, 10 bar H2, 120 °C, 3d. b Yield of 
isolated product after column chromatography; c ratio based on isolated products after column 
chromatography. 
 
Formation of 106 and 107 can be explained as depicted (Scheme 47, pathways c and d), 
monoalkylated tryptophan methylester 105 reacts with another molecule of aldehyde giving 
Schiff base 110 which undergoes hydrogenation yielding in 106 or cyclization giving 107. 
While it is clear for 106 that it arises from 105, 107 can be formed in the 
hydroaminomethylation sequence starting from 104 as well. To test which of this pathways 
is actually occurring control experiments were set. Pure 103, 104 and 105 were 
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independently submitted to the hydroformylation conditions in the presence of cyclopentene 
and only 105 yielded in 47 % of 107 accompanied with dihydroaminomethylation product 
106 in 22 % yield. Compounds 103 and 104 gave no product of hydroaminomethylation 
presumably due to high steric hindrance of piperidine ring nitrogen (Nb). Based on these 
observation direct formation of 107 from 103 or 104 can be ruled out.  
 
Scheme 47. Tandem hydroformylation / Pictet-Spengler reaction and formation of side products 
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     It is noteworthy to mention that 107 is isolated exclusively as trans isomer. The 
formation of  the trans isomer in this case is kinetically and thermodynamically favored, and 
can be explained by a Felkin-Ahn –like attack of the E-iminium from the face oposite to the 
ester group (Figure 10).20c Cook et al. have shown that if Nb nitrogen of tryptophan esters is 
monoprotected with stericaly demanding Bn or Cbz groups and as such submitted to 
conventional PS reaction trans adducts will be formed exclusively. Apparently 
methylcyclopentyl group of 105 creates enough sterical congestion so that iminium attack is 
following Felkin-Ahn rule and hence yields exclusively in trans isomer of 107 when reacted 
with second molecule of aldehyde.  
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Figure 10. Felkin-Ahn model for rationalization of stereochemical outcame of Pictet-Spengler reaction 
 
N
H
N
R1
CO2R3
R1
X  
 
     Byproduct 108 was only observed when CH2Cl2 was used as solvent and CH2 fragment 
which inserts between iminium carbon and indole position 1 originates most probably from 
the solvent. Same reactants in THF under the same conditions gave rise only to Pictet-
Spengler products in 45 % yield (Table 10, entry 3). Lower yield compared to the CH2Cl2  is 
due to the incomplete conversion of 80% in this case. Prolonged reaction time of 4 days 
allowed full conversion of olefin and increased yield of  103 and 104 to some extent but also 
yielded in reduction product 105 (Table 10, Entry 4).  
     It is known that aldehydes can undergo nucleophilic attack by the alcohols to yield 
acetals. Since acetals are used as protected aldehydes in PS reaction, the use of alcohols as 
solvents in the hydroformylation step is an option and would support the principle of low 
stationary aldehyde concentrations.86 To our surprise when we attempted this reaction in 
MeOH only 15 % overall yield of Pictet-Spengler adducts were isolated accompanied with 
105 as a main product in 48 % yield, (Table 10, Entry 5). Up to now it was  obvious that 
polarity of solvent plays a crucial role in distribution of products in this reaction, while in 
unpolar solvent, such as toluene, reduction of intermediate Schiff base is favoured, in more 
polar solvents that  stabilize  cationic intermediate and promote electrophilic attack, rate of 
cyclization is  by far higher than that of reduction. 
     Best yields of 103 and 104 were obtained in CH2Cl2, thus this solvent was chosen for 
further optimization of reaction conditions. In order to lower the extent of reduction, carbon 
monoxide pressure and CO/H2 ratio was increased to 50/10 and 70/10 bar (Table 10, Entries 
7 and 8 respectively) while 50/10 ratio gave 79 % yield of 103 and 104 and lower yields of 
                                                 
86 (a) B. Cornils, J. Mol. Catal. A: Chem., 1999, 143, 1–10; (b) M. Beller, B. Cornils, C. D. Frohning and C. W. 
Kohlpaintner, J. Mol. Catal. A: Chem., 1995, 104, 17–85; (c) B. Cornils, W. A. Herrmann and C.W. 
Kohlpaintner, Angew. Chem., Int. Ed. Engl., 1994, 33, 2144; (d) Rhodium Catalyzed Hydroformylation, ed. P. 
W. N. M. van Leeuwen and C. Claver, Kluwer Academic  Publishers, Dordrecht, 2000. 
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byproducts, ratio of 70/10 gave lower yields of Pictet-Spengler adducts, therefore operating 
pressure of 50 bar CO and 10 bar H2 was chosen. Few different substrates were reacted 
under these conditions and results are summarized in (Table 10, Entries 9-11). In the reaction 
of cycloheptene under the same conditions (Table 10, Entry 10) 103 and 104 are obtained in 
lower yields than in case of 1 or 2 carbons smaller carbocycles. Surprisingly when 
cycooctene was reacted no Pictet-Spengler products were observed, main product was that of 
mono hydroaminomethylation reaction 105 obtained in 43 % yield (Table 10, Entry 11).         
Trend from cyclopentene to cycooctene can be observed: yield of Pictet-Spengler products 
lowers until finally reaches zero. This is most probably connected with steric hindrance of 
formed aldehydes i.e. higher sterical hindrance lowers the rate of cyclization and hence 
reduction becomes more competitive reaction exclusively yielding in 
hydroaminomethylation product. This trend can be observed as well when trans stilbene 111 
and 1,1' diphenylethylene 112 are reacted with 102 (Scheme 48). Former having one Ph 
group in α position and one in ß position gives lower yield of PS product 113 accompanied 
with mono hydroaminomethylated by-product 114, while later having two Ph groups in ß 
position of aldehyde due to lower steric compression gives Pictet-Spengler product 115 in 
higher yield as a mixture of inseparable diastereoisomers accompanied by-product 116 as 
well, however in lower yield as compared to trans stilbene.  
 
Scheme 48. Tandem hydroformylation / Pictet-Spengler reaction of noncyclic olefins 
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3.2 Tandem Hydroformylation / Pictet-Spengler Reaction under Protic 
Conditions 
 
     These optimized conditions were applied in the Pictet-Spengler reaction of tryptamine. 
PS reactions of tryptamine often require harsher conditions than their tryptophan 
counterparts, this is due to the absence of the inductively electron-withdrawing carbonyl 
group in tryptophan and thus lower pKa values of tryptamine based Schiff bases.20c 
Tryptamine imines are significantly less reactive towards electrophilic attack, and hence the 
presence of Brønsted acid is required in order for reaction to procede.20 Brønsted acids such 
as sulphuric acid (1equiv), trifluoroacetic acid (TFA) (1equiv), p-toluenesulphonic acid 
(pTsOH) (1equiv), and camphorsulphonic acid (CSA) (1equiv) (Table 11, Entries 1-4) were 
tested in reaction of tryptamine 98 and cyclopentene under optimized conditions, Lewis 
acids ZnCl2 and BF3 (Table 11, Entries 5 and 6) were tested as well. All reactions were 
carried out at the identical conditions for 72 hours and yields of product 101a were 
determined by isolation. Best results are obtained with CSA, while p-TsOH gave lower 
yields of desired product while sulphuric and trifluoroacetic acid gave mainly mixtures of 
byproducts. Lewis acids gave no product at all (Table 11). 
 
Table 11. Testing different acids in tandem hydroformylation / Pictet-Spengler reaction of tryptamine 
 
N
H
NH2
N
H
NH
+
CO/H2, Rh catalyst
acid, CH2Cl2
98 101a  
 
entry acid T (°C) t (h) Yield (%)a 
1 H2SO4 80 72 / 
2 TFA 80 72 38 
3 pTSOH 80 72 55 
4 CSA 80 72 65 
5 ZnCl2 100 72 / 
6 BF3 100 72 / 
a Yield of isolated product after column 
chromatography 
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     Conditions optimized for tryptophan methylester, with addition of 1equiv of CSA were 
applied in the reaction of tryptamine with selected olefins (Table 12). Although in these 
reactions formation of byproducts of similar structure as in aprotic version was observed, 
their isolation proved to be very difficult. It was possible to separate main product from 
byproducts in each case but not to separate byproducts from each other. Only in the case of 
protected methallylic amines (Table 12, Entries 7, 8) product of elimination of N residue 117 
was isolated (Scheme 49). Surprisingly and in the contrary to the aprotic conditions Pictet-
Spengler product from cyclooctene was isolated in fair yield (Table 12, Entry 4).  
 
Table 12. Tandem hydroformylation / Pictet-Spengler reaction of tryptamine and selected olefins under protic 
conditions 
 
N
H
NH2
R2R1
R3
N
H
NH
R3
R2
R1
+
50/10 bar CO/H2
Rh(acac)(CO)2
CSA, CH2Cl2
98 99 101  
 
Entry Substrate T (°C) t (h) 
Alkene 
Conversion (%)b 
Yieldc 
(%), 101 
1 
 
80 72 >99 65 (101a) 
2 
 
110 80 >95 46 (101b) 
3 
 
80 68 >99 68 (101c) 
4 
 
80 72 >99 59 (101d) 
5 
Ph Ph  
110 72 >95 64 (101e) 
6 Ph Ph  110 72 >99 49 (101f) 
7 N(Et)Ts  110 72 >99 74 (101g) 
8 NPht  110 72 >99 82 (101h) 
9 OBn  110 72 >99 51 (101i) 
a Reactions were conducted at room temperature on a 1 mmol scale in 
THF(10ml) with a relative mol ratio of tryptamine/olefin/catalyst of 100/100/1; 
1 mol% of Rh(acac)(CO)2, 1equiv CSA, 50 bar CO, 10 bar H2, CH2Cl2; b 
Determined by analysis of 1H spectra of crude reaction mixture; c Yield of 
isolated product after column chromatography 
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All other substrates gave moderate to good yields in presence of 1 equiv of 
camphorsulphonic acid. 1,1 disubstituted substrates as well as hindered internal olefins such 
as stilbene (Table 12, Entry 5) are requiring harsher conditions for hydroformylation, 
therefore temperature of 110 °C for 3 days was applied. Temperature of 80° C in the 
hydroformylation of 1,1 diphenylethylene gave only  20 % conversion of olefin and product 
in the 8 % yield.  Same substrate at 110 °C after 3 days was almost quantitatively consumed 
and yielded product in quite fair yield of 64 % (Table 12, Entry 5). Cyclohexene and 
methallylic amines require harsher conditions as well, temperatures of 110°C were applied in 
order to achieve full conversion of olefin (Table 12, Entries 2 and 7-9). Yields of products 
varied from moderate 46% for cyclohexane to very good 74% and 82 % for methallylic 
amines respectively (Table 12, Entries 7 and 8). Methallylic alcohol (Table 12, Entry 9) 
required harsher conditions for hydroformylation as well, product was isolated in moderate 
51% yield. 
 
Scheme 49. Byproduct isolated after tandem hydroformylation / Pictet-Spengler reaction with tertiary 
methallylic amines 
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3.3 Witkop-Winterfeldt Oxidation of Tetrahydro-β-carbolines 
 
     In the early 1950s Witkop described in a series of papers that oxidation of indoles with a 
variety of oxidation reagents leads to the formation of quinolones.  The mechanism of this 
reaction involves the oxidative cleavage of the 2,3-double bond of the indole moiety (Witkop 
oxidation) followed by a Camps cyclization forming the quinolone ring.  Winterfeldt 
identified conditions which allowed a one pot Witkop oxidation / Camps cyclization 
sequence and applied this strategy for the synthesis of pyrrolo[2,3-c]quinolones starting from 
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1,2,3,4-tetrahydro-β-carbolines.87 In general γ-quinolones are representing a class of 
biologically active molecules.88
We used synthesized THBCs as substrates for Witkop-Winterfeldt oxidation. Prior to 
oxidation, Nb nitrogen atoms of tetrahydro-β-carbolines 101a and 101e were protected with 
benzyl group to give 118 and 120 and than were submitted to standard Witkop-Winterfeldt 
conditions to yield γ-quinolones 119 and 121 in fair yields (Scheme 50). 
 
Scheme 50. Witkop-Winterfeldt oxidation of THBCs 
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     Benzyl protected 118 was as well  submitted to ozonolyzis reaction, this should result in 
the oxidative cleavage of 2,3 double bond of indole core without subsequent Camps 
cyclization  and yield in macrocyclic structure 122. However, depending on the method of 
reduction of intermediate ozonide, γ-quinolone 119 may also be expected (Scheme 51). 
Nevertheless, ozonolyzis gave no desired products. Mixture of inseparable compounds was 
observed. Further optimizations of reaction conditions should be done in order to obtain 
macrocyclic structure 122 as main product. 
 
Scheme 51. Ozonolyzis of 118 
 
                                                 
87 (a) Witkop, B; J. Am. Chem. Soc. 1951, 73, 2641; (b) Winterfeldt, E. Liebigs Ann. Chem. 1971, 745, 23-30. 
(c) Warneke, J.; Winterfeldt, E. Chem. Ber. 1972, 105, 2120-2125; (d) Boch, M.; Korth T.; Nelke, J. M.; Pike, 
D.; Radunz, H.; Winterfeldt, E. Chem. Ber. 1972, 105, 2126-2142. 
88 For instance see: (a) Sui, Z.; Guan, J.; Macielag, M. J.; Jiang, W.; Zhang, S.; Qiu, Y.; Kraft, P.; 
Bhattacharjee, S.; John, T. M.; Haynes-Johnson, D.; Clancy, J. J. Med. Chem. 2002, 45, 4094-4096.(b) Jiang, 
W.; Guan, J.; Macielag, M. J.; Zhang, S.; Qiu, Y.; Kraft, P.; Bhattacharjee, S.; John, T. M.; Haynes-Johnson, 
D.; Lundeen, S.; Sui, Z.  J.  Med. Chem.  2005,  48,  2126-2133.  
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      When phenethyl amine 123 was used as nucleophile in tandem hydroformylation / Pictet-
Spengler reaction under the optimized conditions gave only hydroaminomethylation 
products 124 and 125 in reactions with cyclopentene and 1,1 diphenylethylene (Scheme 52). 
This is most probably due to the lower nucleophilicity of phenyl ring compared to indole 
nucleus causing that reduction of intermediate iminium ion is faster in this case than 
cyclization to form tetrahydroisoquinoline structures. 
 
Scheme 52. Attempted tandem hydroformylation / Pictet-Spengler reaction with phenethylamine 
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     In conclusion we have demonstrated that this reaction sequence can be applied in the 
synthesis of various THBCs involving both aprotic and protic conditions, problem with 
formation of reduction byproducts still remains. However, yields of tetrahydro-β-carbolines 
are synthetically useful in most of the cases. Tandem hydroformylation / Pictet-Spengler 
reaction allowed syntheses of tetrahydro-β-carbolines starting exclusively from cyclic- and 
1,1-disubstituted terminal olefins but proved inapplicable when more sensitive substrates 
were applied, this hampered preparations of more complex carboline structures. Due to this 
drawbacks alternative method for the synthesis of tetrahydro-β-carbolines involving tandem 
hydroformylation / Fischer indole synthesis was thoroughly investigated. This convenient 
method for the synthesis of the indole core containing molecules should allow introduction 
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of various substituents that are unavailable via tandem hydroformylation / Pictet-Spengler 
reaction and allow placing of substituents in positions unavailable via classical approaches.  
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4 Tetrahydro-β-carbolines via Tandem Hydroformylation / Fischer 
Indole Synthesis  
 
     Despite the wide scope of the Pictet-Spengler condensation and its continuous 
development, it turns out to be less applicable when 3- or 4-substituted THBC systems are 
targeted. In these cases syntheses of appropriate α or β substituted tryptamine precursors are 
required, which can be very laborious and time-demanding process especially when 
enantiomerically pure molecules are desired.  
     Lately, for the synthesis of enantiopure 4- substituted THBCs attention has been focused 
on the asymmetric functionalization of the indole core, involving Pd-catalyzed 
intramolecular allylic alkylations of 2-indolyl carbonates or acetates,89 or intramolecular 
Lewis acid catalyzed Friedel-Crafts type functionalisations of indoles.90 While these 
examples take advantage of the relatively nucleophilic 3-position of the indole nucleus to 
add electrophiles via both Lewis acid and transition metal catalyzed intramolecular 
alkylations, there are comparatively few methods for the synthesis of enantiopure 3-
functionalized THBCs. Most of the known 3-substituted THBCs are tryptophan derivatives 
and are synthesized via Pictet-Spengler reaction starting from this essential amino acid. 
Therefore, not surprisingly, only a few examples of 3-substituted tetrahydro-β-carbolines are 
reported with substituents not possessing the oxidation level of carboxylic group or with 
substituents not obtainable via number of simple functional group transformations of 
carboxylic group of tryptophan. Lack of the versatile methods for the synthesis of THBCs 
having particular kind of substituents in positions which are not easily accessible by PS 
reaction has prompted us to test possibility of synthesizing these molecules via tandem 
hydroformylation / Fischer indole synthesis sequence. Recently use of carbo- or hetero-
cyclic olefins in tandem hydroformylation / Fischer indole synthesis sequence yielding 
carbazoles, β-sila carbazoles and β-carboline has been reported.37 If performing this reaction 
with substituted N-containing heterocyclic olefins 126 formations of substituted carbolines 
127 should be expected (Scheme 53).  
                                                                                                                                            
 
                                                 
89 For Lewis acid catalyzed procedures, see: (a) Agnusdei, M.; Bandini, M.; Melloni, A.; Umani-Ronchi, A. J. 
Org. Chem. 2003, 68, 7126. (b) Angeli, M.; Bandini, M.; Garelli, A.; Piccinelli, F.; Tommasi, S.; Umani-
Ronchi, A. Org. Biomol. Chem. 2006, 4, 3291. 
90 For transition-metal-catalyzed procedures, see: (a) Bandini, M.; Melloni, A.; Umani-Ronchi, A. Org. Lett. 
2004, 6, 3199. (b) Bandini, M.; Melloni, A.; Piccinelli, F.; Sinisi, R.; Tommasi, S.; Umani-Ronchi, A. J. Am. 
Chem. Soc. 2006, 128, 1424. 
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Scheme 53. Envisaged reaction pathway for the synthesis of tetrahydro-ß-carbolines 
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     We envisaged use of this strategy for the synthesis of enantiopure substituted carboline 
derivatives starting from enantiopure 2-substituted 2,5 dihydropyrroles 128 (Scheme 54). 
These substrates are possessing two available positions for the hydroformylation, and can 
yield in two regioisomeric aldehydes, which condense with aromatic hydrazine giving 
hydrazones 129 and 130. In the presence of acid each of the two hydrazones formed 
undergoes [3, 3] sigmatropic rearrangement to give two pairs of diastereoisomeric cationic 
spiroindoleninium intermediates 131 and 132. Two rearrangement pathways of these species 
are possible and four different carbolines can be expected depending on the preference of 
rearrangement. However, we assumed that only retro Mannich type products 133 and 135 
(highlighted, Scheme 54) will be formed exclusively due to the higher stability of 
carbocation in α position to nitrogen and hence its higher preference towards migration.37 
Spiroindoleninium intermediates 131 and 132 are believed to be involved as intermediates in 
Pictet-Spengler reaction as well, they are formed after endo attack of position 3 of indole to 
iminium ion. It is noteworthy to mention that preference of migration in Pictet-Spengler 
reaction is directed towards β and not γ carbolines such as 134 and 136. This was in 
accordance with our expectations for the rearrangement of 131 and 132 in our envisaged 
sequence. Retention of chiral information during rearrangement was expected as well 
(Scheme 54). 
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Scheme 54. Tandem hydroformylation / Fischer indole synthesis sequence in the synthesis of THBCs 
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4.1  Synthesis of Enantiopure 2-Substituted 2,5 Dihydropyrroles 
 
     2-substituted 2,5-dihydropyrroles were synthesized via Ir catalyzed allylic amination / 
ring closing metathesis strategy (Table 13). Since under hydroformylation conditions 
primary and secondary amines are undergoing hydroaminomethylation reaction use of N-
protected starting materials is required. Electron withdrawing protecting groups were 
required in order to ease ring closing metathesis reaction. 
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Table 13. Enantioselective synthesis of 2-substituted 2,5-dihydropyrroles 
 
R
R
NPG
ClPG, Et3N, 
DMAP, THF
NPG
R
128
* Grubbs I
DCM
R OCO2Me
H2N
R
HN
[Ir(cod)Cl]2
L3, DABCO,
50 °C, THF
68
137
139
N
H
+
138
*
*
 
 
entry R. Ligad Time (h)b 137/138
c Yield, 
137, (%)d 
ee 
% PG 
Yield, 
139 (%)d 
Yield, 
128 (%)d 
Eoc 139a (87) 128a (92) 1 Ph L3 20 95/5 137a (76) 96 
Ts 139b (86) 128b (95) 
2 o-MeO-Ph L3 24 96/4 137b (48) nd Ts 139c (81) 128c (89) 
3 p-MeOPh L3 18 95/5 137c (74) 95 Ts 139d (91) 128d (93) 
4 p-Cl-Ph L3 24 93/7 137d (78) 91 Ts 139e (92) 128e (90) 
5 p-CF3-Ph L3 48 92/8 137e (75) nd Ts 139f (88) 128f (91) 
6 Eta L3 24 94/6 137f e 98 Ts 139g (68) 128g (85) 
7 nPra L3 24 95/5 137ge 97 Ts 139h (70) 128h (94) 
a Tosilated in situ due to high volatility; b Reaction time; c Branched to linear ratio determined by 1H 
NMR spectroscopy; d Yield of isolated product; e Not isolated, protected in situ;   
 
Ir catalyzed reactions were run using previously optimized procedure for the allylic 
aminations i.e. the catalyst was prepared by in situ activation of [Ir(cod)Cl]2  and ligand L3 
with the base DABCO, in dry THF. Good yields and enantioselectivities were obtained with 
all tested allylic carbonates bearing sp3 as well as sp2 substituents, possessing electron 
withdrawing and electron donating groups (Table 13). Amines bearing an aliphatic group R 
(Table 13, Entries 6 and 7) had to be protected in situ due to high volatility. Prior to ring 
closing metathesis reaction all amines were protected with Ts or Eoc groups (Table 13). 
These reactions proceeded in good yields in all cases. After protection tertiary amines were 
submitted to metathesis reaction using Grubbs I catalyst, all desired products were isolated in 
excellent yields after 24 h.  
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4.2  Synthesis of 3,4 Dehydro 2-Substituted Piperidines  
 
     Six membered 2-substituted 3,4 dehydropiperidine 143 was synthesized via allylic 
amination / ring closing metathesis sequence using homoallylamine in amination step instead 
of allyl amine. Allylic aminations with homoallylic amine proceeded in good yields and in 
high enantioselectivities with various allylic carbonates (Table 14). 
 
Table 14. Allylic amination of allylic carbonates with homoallylic amine 
 
R OCO2Me R
HN
[Ir(cod)Cl]2
L3, DABCO,
50 °C, THF
68 140H2N
R N
H+
141  
 
entry R ligand Time (h)a 
140/141,b 
b/l 
Yield, 
140 (%)c 
Ee, 
%d 
1 Ph L3 48 96/4 140a (74) 96 
2 p-MeOPh L3 48 95/5 140b (78) nde 
3 2-Furyl  L3 4 94/6 140c (70) 94 
4 3-Purydyl L3 24 97/3 140d (81) 97 
a Reaction time; b Branched to linear ratio determined by1H NMR 
spectroscopy; c Yield of isolated product after column 
chromatography; d Determined by HPLC on chiral column; e not 
determined 
 
Amine 140b was protected with Eoc group to give 142 and submited to ring closing 
metathesis reaction to give 143 in 95% yield (Scheme 55). 
 
Scheme 55. Synthesis of 3,4 dehydropiperidine 143 
 
N
ClCO2Et, THF
HN
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DCM
MeO
0°C to rt
O
EtO
MeO
N
EtO
O
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These six membered substrates are possible precursors for interesting, new type of carboline 
molecules possesing 7 membered ring attached to indole core. 
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With required starting materials in hands, we could start the investigation on the distribution 
of reaction products in the tandem sequence. First, reaction conditions had to be optimized. 
 
4.3 Optimization of Reaction Conditions Towards Synthesis of   THBCs 
 
     Stepwise procedure involving tandem hydroformylation / hydrazone formation using 1 
mol% Rh(acac)(CO)2 under 50/10 bar CO/H2 pressure in THF at 100 °C for 3 days with 
subsequent indolization in 4 w % H2SO4 have been applied for the test reaction with 
substrate 128b. Here, higher partial pressures of CO were chosen in order to prevent possible 
hydrogenation of intermediate spiroindolinenium species.37 Unmodified Rh catalyst which 
was expected to unselectively hydroformylate both available positions of substrate, yielded 
in only two THBC products 133a and 135a, out of four possible, in good yield of 87% and 
ratio of 1/1.3 in favour of 135a (Scheme 56). 1-substituted carboline 133a was isolated as 
racemate while 3-substituted 135a retained enantiopurity of the substrate. 
 
Scheme 56. Tandem hydroformylation/Fischer indole synthesis in the synthesis of functionalized THBCs 
 
N
H
NTs
Ph N
H
NTs
Ph
+
1. CO/H2, 50:10 bar,
    THF 100 °C, 3d
    Rh(acac)(CO)2 1mol%
    Ligand 5 mol%
    PHNHNH2
2. 4w% H2SO4
    THF, reflux, 2h
(R)-4a 5a (R)-6a
NTs
Ph
98% ee 0% ee 96-97% ee
R
R
 
     Both products originated from the rearrangement 91 of carbons situated between pyrrole N 
atom and quaternary center of spiroindolenine intermediates 131 and 132 i.e. the products of 
formal retro Mannich reaction / Pictet-Spengler cyclization were obtained exclusively, no 
rearrangement of β carbon was observed as was the case with carbocyclic and cyclic silyl 
olefins yielding in γ-carboline structures (see Scheme 15).  
     Since rearrangement showed high selectivity towards retro Mannich type products i.e. 
main product is ß not γ carboline, and since decisive factor whether 1- or 3-substituted 
THBC would be formed is hydroformylation step (Scheme 57), it was necessary to  
 
                                                 
91 For previous work considering this type of rearangemet see: (a) Benito, Y.; Temporano. F.; Rodriguez, J. G., 
J. Heterocyclic Chem, 1985, 22, 1207. (b) Benito, Y.; Canoira, L.; Martinez-Lopez, N.; Temporano. F.; 
Rodriguez, J. G., J. Heterocyclic Chem, 1987, 24, 623 (c) Li, C.; Chan, K.; Heimamm, A. C.; Danishefsky, S. J. 
Angew. Chem. Int. Ed. Engl. 2007, 46, 1444-7. 
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Scheme 57. Dependence of product distribution on hydroformylated position of substrate 
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regioselectively hydroformylate olefin in order to shift distribution of reaction products 
towards desired 3-substituted THBCs. This was achieved via modifications of rhodium 
catalyst with various phosphine and phosphite ligands (Table 15). Reaction with 
monophosphine ligand PPh3 modified catalyst (Table 15, Entry 1), gave good yield of 85 % 
and ratio of products of 1/2.7 in favour of 135a. Rh catalyst modified with diphosphine 
ligands such as DPPF and BINAP, (Table 15, Entries 2 and 4) yielded in no aldehyde at all, 
while DPPB (Table 15, Entry 3) gave 30% conversion of olefin and only 22 % yield of 
products. 
 
Table 15. Testing of ligands in tandem hydroformylation / THBC synthesis 
 
NTs
Ph
N
H
NTs
Ph N
H
NTs
Ph
+
1. CO/H2, 50:10 bar,
    THF 100 °C, 3d
    Rh(acac)(CO)2 1mol%
    Ligand 5 mol%
    PhNHNH2
2. 4w% H2SO4
    THF, reflux, 2h
128b 133a 135a  
 
yield, %b Ratioc ee, %d entry Ligand Olefin conv., %a 133a + 135a 133a : 135a 133a 135a 
1 PPh3 full 85 1:2.7 0 96 
2 DPPF 0 / / / / 
3 DPPB 30 22 1:1.3 nd nd 
4 BINAP 0 / / / / 
5 XANTPHOS full 37 1: 5.2 0 95 
6 P(OPh)3 full 72 1:1.6 0 95 
7 BIPHEPHOS full 81 1:1.4 0 96 
a Determined by 1H-NMR of crude reaction mixture b Isolated yield after column 
chromatography; c based on isolated product; d Determined by HPLC on chiral 
column. 
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     Bulky diphosphine ligand XANTPHOS (Table 15, Entry 5) commonly used for n 
selective hydroformylations of terminal olefins gave the best ratio of 133a/135a stating 1/5.2 
but in poor yield of 37 %. Phosphite ligand P(OPh)3 (Table 15, Entry 6) provided moderate 
yield and had low influence on regioselectivity of hydroformylation, bulky diphosphite 
ligand BIPHEPHOS (Table 15, Entry 7) which is as well used for n selective 
hydroformylations of terminal olefins had almost no effect on regioselectivity with ratio of 
1/1.4 in favour of 133a and yield of 81 %. In summary PPh3 appeared to be the best 
compromise between yield and selectivity of hydroformylation step and hence this ligand 
was chosen for further reactions. In all cases 1-substituted THBC 133a was isolated as 
racemate while 3-substituted 135a retained enantio purity of starting material. Possible 
explanations for this behaviour are offered in the next chapter. 
     Piperidine 143 was as well submited to these standard conditions for tandem 
hydroformylation / Fischer indol synthesis, however mixture of inseparable products was 
obtained. Complex mixture of products can actualy be expected based on mechanistic 
considerations of rearrangement pathways of intermediate spiroindoleninium cations 144 
and 145 (Scheme 58). It is clear that 144 will have preference towards exclusive formation 
of 146, while 145 may give 147 and 148 with approximately same probability since there is 
no driving force for selective rearrangement of this spiroindoleninium specie towards one of 
the possible products.  
 
Scheme 58. Possible products in tandem hydroformylation / Fischer indolization of piperidine 133 
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As already mentioned when 6, 7 or 8 membered cyclic olefins are used, intermediate 
spiroindolenine structures can as well be trapped by hydrogenation under hydroformylation 
conditions.37 This further complicates possible outcome of the reaction with 
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dehydropiperidines of type 143, although degree of reduction can be controlled to some 
extent by control of partial pressures of CO and H2.  
Due to the all mentioned drawbacks of envisaged protocol when using six membered cyclic 
olefins further optimizations of reaction conditions would be necessary in order to obtain 
desired products exclusively. Since it proved difficult to isolate products of rearrangement in 
these cases further investigation was focused to five membered systems exclusively. 
 
4.4 Mechanistic Insight 
 
     Few ambiguities exist about the mechanism by which spiroindoleninium cation 
undergoes transformation to carboline molecule, nevertheless, few possible explanations are 
offered that seem to be viable. Possible rearrangement pathways of enantiopure 
spiroindoleninium cation 149 are shown on scheme 59. The first proposed mechanistic 
pathway involves Wagner-Meerwein's like 1,2 shift which proceeds in a suprafacial 
fashion92 leading to the preservation of stereochemical information in the final molecule 
giving 151.  The second mechanistic pathway proposed by Danishevsky 91c involves retro 
Mannich reaction of 149 to give 150 followed by subsequent Pictet-Spengler cyclization of 
150 proceeding via attack of position 2 of indole core to iminium ion. This pathway 
therefore results in racemization due to the free rotation in the ring opened intermediate 150, 
allowing statistical distribution of final product and hence yielding in 151rac (Scheme 59).  
 
Scheme 59. Possible reaction pathways of indoleninium intermediate 
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92 For instance see: Starling, S. M.; Vonwiller, S. C.; Reek, J. N. H. J. Org. Chem. 1998, 63, 2262. 
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Some reports, however, are suggesting that attack on the iminium ion of 150 would 
presumably occur from position 3 of indole core (Scheme 60).93 This makes Danyshefsky 
pathway obsolete, and as well causes racemization of 149 due to the equilibrium between 
149 and 150 that is established in that case. Racemization of 149 then subsequently leads to 
the racemization of 151. 
 
Scheme 60. Attack from position 3 of indole core on iminium ion and intramolecular trapping of formed 
spiroindoleninium cation in the total synthesis of aspidophytine93c 
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     As 1-substituted THBC is isolated as racemate which complies with involvement of retro 
Mannich pathway, it can be assumed based on the discussion presented above that this 
pathway takes part in the rearrangement sequence and not Wagner-Meerwein’s 1,2 shift.  
However, that would most probably be premature conclusion since there is another factor 
that has to be taken into consideration, and that is acid catalyzed racemization of 1-
substituted THBCs. Racemization of 1-substituted THBCs under acidic conditions is well 
documented and presumably occurs via C1-Nb bond scission (Scheme 61).20c This means 
that even if Wagner-Meerwein’s 1,2 shift is occurring, final carboline would be isolated as 
racemate since acidic conditions were used in the course of rearrangement. Therefore at this 
                                                 
93 (a) van Maarseveen, J. H.; Scheeren, H. W.; Kruse, C. G. Tetrahedron 1993, 49, 2325. (b) Nyerges, M.; 
Rudas, M.; Bitter, I.; To¨ke, L.; Szantay, C. J., Jr. Tetrahedron 1997, 53, 3269. (c) He, F.; Bo, Y.; Altom, J. D.; 
Corey, E. J. J. Am. Chem. Soc. 1999, 121, 6771. (d) Turet, L.; Marko, I. E.; Tinant, B.; Declercq, J.-P.; 
Touillaux, R. Tetrahedron Lett. 2002, 43, 6591. (e) Amat M.; Santos M. M. M.; Gomez, A. M.; Jokic, D. ; 
Molins, E.; Bosch, J. Org. Lett.,  9, 2007, 2907-10.  
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point we can not say with certainty that retro Mannich pathway is responsible for 
racemization. 
 
Scheme 61. Mechanism of the acid induced racemization of chiral 1-substituted THBCs 
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     To sort out the possibility of acid catalyzed racemization, stepwise procedure involving 
thermally induced indolization was attempted but unfortunately gave no product (Table 16, 
Entry 2). Lewis acid catalyzed indolization gave desired products in significantly lower 
yields but again 1-substituted THBC was isolated as racemate (Table 16, Entry 3).  
 
Table 16. Testing of different indolization conditions in tandem hydroformylation / THBC synthesis 
 
NTs
Ph
N
H
NTs
Ph N
H
NTs
Ph
+
1. CO/H2, 50:10 bar,
    THF 100 °C, 3d
    Rh(acac)(CO)2 1mol%
    Ligand 5 mol%
    PhNHNH2
2. indolization methodb
128b 133a 135a  
 
yield, %c Ratiod ee, %e entry Ligand Olefin conv., %a 
Indoliz. 
Methodb 133a + 135a 133a : 135a 133a 135a 
1 / full A 87 1:1.3 0 97 
2 / full B / / / / 
3 / full C 35 1:1.3 0 96 
4 / 65 D 32 1:1.2 0 97 
a Determined by 1H-NMR of crude reaction mixture; b Method A: 4 w % H2SO4, THF, 60 °C; 
method B: ethylenglycol, 180 °C, 24h; method C: 4eq ZnCl2, toluol, 120 °C, method D: tandem 
reaction with 1eq PTSA; c Isolated yield after column chromatography; d Based on isolated 
product; e Determined by HPLC on chiral column. 
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     Stability of product towards racemization in acidic conditions can be tested independently 
if enantiopure 1-substituted THBC is submitted to conditions used for indolization, but 
unfortunately we were not able to separate enantiomers of 1-substituted THBCs on 
preparative scale. It is noteworthy to mention that when reaction was performed in the 
presence of 1 eq PTSA added in reaction mixture i.e. one step procedure is performed, 
comparable results to stepwise procedure were obtained in terms of ee´s of isolated products 
although yield was drastically lowered (Table 16, Entry 4). In order to finally make 
discrimination between retro Mannich pathway and 1,2-shift, crossover experiment with 
internal, symmetric allylic amines 152 and 153 was performed (Scheme 62). It is known that 
acyclic internal olefins are undergoing to the same type of rearrangement as cyclic ones.37 
These substrates should clearly have the same preference towards formation of Mannich type 
products, however, they have additional possibility of forming crossover products. 
 
Scheme 62. Crossover experiment with internal allylic amines 
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These substrates were submitted to the same reaction conditions as cyclic aminoolefin 128b. 
A crossover experiment indicated that the rearrangement occurs intramolecularly, no 
crossover products were observed in the crude reaction mixture, meaning that retro Mannich 
pathway is not favored. Although due to general difficulties in analysis of the crude mixtures 
after hydroformylation / indolization procedures, these experiments should be performed 
with more different substrates in order to establish conclusions with more certainty. 
Nevertheless, now it can be speculated with a little more certainty that the reaction occurs 
via 1, 2 shift and that most probably racemization is post rearrangement event i.e. acid 
present in the mixture as indolization promotor causes racemization of the 1-substituted 
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tetrahydro-β-carboline. 3-substituted carboline is obtained from the intermediate whose 
stereocenter is not influenced by any of the possible reaction pathways therefore it stays 
intact. 
 
 4.5 Synthesis of Various Substituted THBCs 
 
     Next, attention was turned to the scope of the reaction (Table 17). Several pyrroles 
containing various alkyl or aromatic substituents were tested in optimized conditions in the 
presence of unsubstituted phenyl hydrazine (Table 17, Entries 1-8). In all cases 3-substituted 
THBC was the main product. Pyrroles containing both electron donating and electron 
withdrawing aromatic substituents were tested. The regioselectivities of products ranged 
from 1/1.4 to 1/5.5 in favor of 135. Tosyl protected pyrrole 128a gave better yields of 
products under applied conditions than its Eoc protected counterpart 128b (Table 17, Entries 
1 and 2), hence Ts protected substrates were used in further reactions. Electron donating 
substituents on the substrate are shifting regioselectivity towards 3-substituted product 
giving 1/5.2 - 5.5 ratios in favor of 135 (Table 17, Entries 3 and 4) while electron 
withdrawing one gave 1/1.4 ratio in favor of 135 (Table 17, Entry 6).  
 
Table 17. Synthesis of THBCs from substrates 109 
 
N
H
N PG
N
H
N
R
1.Rh(acac)(CO)2
   CO/H2=50/10
   PPh3, THF
   100 °C, 3d
NPG
R
128
2.4w% H2SO4
PG
R
133 135
++
H
N
NH2
R1 R1
R1
 
 
Olefin yield, %a Ratiob ee, %c Entry R PG R1 133 + 135 133 : 135 133 135 
1 Ph (128a) Ts H 85 1:2.7 0 97 
2 Ph (128b) Eoc H 63 1:2.1 0 98 
3 o-MeO-Ph (128c) Ts H 71 1:5.2 0 95 
4 p-MeO-Ph (128d) Ts H 76 1:5.5 0 96 
5 p-Cl-Ph (128e) Ts H 74 1:2.4 0 ndd 
6 p-CF3-Ph (128f) Ts H 58 1:1.4 0 ndd 
7 Et (128g) Ts H 65 1:3.3 0 94 
8 nPr (128h) Ts H 69 1:3.6 0 93 
a Isolated yield after column chromatography; b Determined by isolation; c Determined 
by HPLC on chiral column, d Ratio not determined; 
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Substrates 128g and 128h having alkyl substituents Et and Pr gave 65 and 69 % yield of 
products respectively and ratios of 133/135 of 1: 3.3 and 1:3.6 (Table 17, Entries 7 and 8). 3-
substituted product retained enantiopurity of starting material in all cases while 1-substituted 
product was obtained as racemate, in all cases as well.  
     Recently, Buchwald et al. have demonstrated that benzhydrylidene protected aryl 
hydrazines 154 undergo high yielding Fischer indolization in the presence of carbonyl 
compounds under acidic conditions.94 Benzhydrylidene protected aryl hydrazines can be 
prepared either via protection of phenylhydrazines with benzophenone group or via Pd 
mediated amination of aryl halides (Scheme 63). 
 
Scheme 63. Routes towards synthesis of benzhydrylidene protected phenyl hydrazines 
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Feasibility of these substrates was tested in our tandem sequence. Variously substituted 
phenylhydrazones 154 can be used which consequently allows introduction of various 
substitutents in the indole part of the molecule (Table 18). 
 
Table 18. Synthesis of tetrahydro-β-carbolines from benzophenone protected phenyl hydrazones 
 
H
N
N Ph
Ph
R1
N
H
N Ts
N
H
N
Ph
NTs
Ph
128b
Ts
Ph
133 135
++
R1 R1
   Rh(acac)(CO)2
   CO/H2=50/10
   PTSA 1eq
   PPh3, THF
   100 °C, 3d
154  
 
 Olefin  yield, %a Ratiob ee, %c 
Entry R PG R1 133 + 135 133 : 135 133 135 
9 Ph Ts o-Me 45  nde / 95 (135i) 
10 Ph Ts p-Cl 41  1:4.4 0 (133j) 95 (135j) 
11 Ph Ts p-MeO 46  nde / ndd (135k) 
a Isolated yield after column chromatography; b Determined by isolation; cDetermined by HPLC 
on chiral column, dRatio not determined, only product 135 was isolated; 
 
                                                 
94  (a) Wagaw, S.; Yang, B. H.; Buchwald, S. L.; J. Am. Chem. Soc. 1998, 120, 6621-6622.(b) Wagaw, S.; 
Yang, B. H.; Buchwald, S. L. J. Am. Chem. Soc. 1998, 121, 10251-10263. 
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     Since the benzhydrylidene group is stable under hydroformylation conditions, here the 
reaction has to be conducted in the presence of Brønsted acid added to reaction mixture. 
Acid present cleaves protecting group during the course of reaction thus releasing free 
hydrazine for condensation with aldehyde. Hence, reactions were run with 1eq of PTSA 
added in reaction mixture. Tandem reaction with benzhydrylidene protected hydrazines gave 
lower yields under the same reaction conditions than its stepwise counterpart with 
unprotected hydrazines. Same migration tendency was observed as with unprotected 
hydrazines. Presence of substituents in the indole part of the molecule is important from the 
biological point of view, for instance 5-MeO substituent is present in many bioactive THBCs 
while presence of 5-Cl substituent allows further derivatizations of indole core via coupling 
reactions. 
     In 2004, Cho et al. have applied α-Boc aryl hydrazines 155 in Fischer indolization and 
obtained indoles with very high purity.95 α-Boc aryl hydrazines, were synthesized using 
Buchwald´s optimized conditions of the copper(I) catalyzed N-arylation of amides (Goldberg 
reaction, Scheme 64).96  
 
Scheme 64. Synthesis of t-Boc protected phenyl hydrazines via Goldberg Reaction 
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Substrate 156 obtained via Goldberg reaction was tested in the tandem hydroformylation / 
Fischer indole synthesis in the reaction with 128b (Scheme 65). Here, the reaction was 
conducted in a stepwise manner with subsequent addition of acid. Boc group is stable under 
hydroformylation conditions, and primary amine functionality is free for condensation with 
phenyl hydrazines, therefore α-Boc protected aryl hydrazones can be obtained in quantitative 
yields. After acidic indolization product 157 was obtained in moderate yield of 38%. 
Apparently, benzhydrylidene or α-Boc protected hydrazines are giving lower yields in this 
reaction sequence. However presence of heterocyclic moieties in the position 5 of the indole 
core is very important and was found to be crucial for biological activities in various kinds of 
biological assays.1 
                                                 
95 Lim, Y.-K.; Cho, C.-G.; Tetrahedron Lett. 2004, 45, 1857-1859. 
                                                                                                                                            
 
96 Wolter, M.; Klapars, A.; Buchwald, S.; Org. Lett. 2001, 3 , 3803-3805. 
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Scheme 65. Application of α-Boc protected aryl hydrazines in tandem sequence 
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     Highly convergent approach for the synthesis of 157 is illustrated in scheme 66. 
Presinthesized functionalized building blocks are assembled in last step, making this method 
highly desirable for the combinatorial library syntheses. 
 
Scheme 66. Retrosynthetic pathway for the synthesis of 157 
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4.6 Synthesis of 1,3 Disubstituted Tetrahydro-β-Carboline 165 
 
     In order to synthesize 1,3-disubstituted tetrahydro-β-carbolines 159 it was necessary to 
synthesize 2,5-disubstituted pyrroles 158 (Scheme 67). 
 
Scheme 67. Envisaged retrosynthetic pathway for the synthesis of 1,3-disubstituted tetrahydro-β-carbolines 
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This was achieved by modified procedure of Helmchen et al.69c Ir catalyzed allylic 
amination of cinnamyl carbonate 68a with phtalimide in the presence of ligand L3 gave 
allylimide 160 in 66% yield and 98% ee as R enantiomer (Scheme 68). After deprotection of 
160, primary amine 161 was obtained in 90% yield. This amine was further mono protected 
with Ts group to give 162. Alternative method for the synthesis of 162 would involve direct 
amination with TsNH2, however due to the low acidity of protons attached to the 
sulphonamido group of TsNH2 this substrate was not successfully used in amination 
reactions so far. If appropriate conditions for aminations with TsNH2 can be found, synthesis 
of 162 can then be achieved in one step. Aminations with p-nosylamide are however, known 
and they proceed in high yields and enantioselectivities.69i Unfortunately nitro group of p-
NsNH2 is not compatible with hydroformylation conditions since anilines are obtained due 
to the reduction reaction under harsh hydroformylation conditions.97
 
 
 
 
 
 
 
 
 
 
                                                 
                                                                                                                                            
 
97 Rische, T.; Dissertation 1999, University  of Dortmund. 
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Scheme 68. Synthesis of 2,5 disubstituted dihydropyrroles via Ir catalyzed allylic amination / ring closing 
metathesis sequence 
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Allylic amine 162 was used as nucleophile for next Ir catalyzed amination reaction with 
cinnamyl carbonate 68a in the presence of ligand L3 to yield 163 as a 90/10 trans/cis 
mixture of diastereomers (Scheme 69). After separation of diastereomers and ring closing 
metathesis pyrrole 164 was isolated in 89 % yield as single diastereoisomer possessing R, R 
configuration at stereo centers (Scheme 68). It is noteworthy to mention that 162 was 
converted into Li anion to promote reaction since salt free conditions using DABCO 
activation of catalyst gave no product. Unprotected pyrrole that is obtained by Helmchen 
procedure (Scheme 29) could not be used under hydroformylation conditions since it can 
undergo intermolecular hydroaminomethylation reaction and since protection of such pyrrole 
is prevented by steric hindrance of bulky Ph groups. Pyrrole 164 was submitted to standard 
reaction conditions in a stepwise manner in the presence of phenylhydrazine to give 165 in 
71 % yield and in excellent ee of 98%. Symmetric pyrrole 164 circumvents problems with 
regioselectivity of hydroformylation, so that single carboline product is obtained. This 
methodology can be used for synthesis of variously substituted substrates of type 164 either 
with same or different substituents in positions 2 and 5 of pyrrole ring granting access to 
various interesting THBC structures. 
     In summary, this convergent, one-pot strategy offers a convenient approach towards 
functionalized THBCs. Modularity and variability of the reactants are high, highly 
functionalized building blocks are assembled in a last synthetic step allowing simultaneous 
 
             4 Tetrahydro-β-carbolineS VIA TANDEM HYDROFORMYLATION / FISCHER INDOLE SYNTHESIS 
 
variations and flexible determination of the substitution pattern in final products. Reaction 
sequence depends on two factors,  the regioselective hydroformylation to yield desired 
aldehyde and the selective migration of one of the two available substituents. For both 
factors clear tendencies were observed. 
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5 Summary and Outlook 
 
5.1 Summary 
 
     Tandem hydroformylation / Fischer indole synthesis in combination with enantioselective 
Ir catalyzed allylic substitution reactions proved to be powerful method for the preparation 
of tryptamines, tryptophanes and their homologues. Starting with appropriate substrates it 
was possible to introduce side chains of varying complexities and lengths in position 3 of the 
desired indole structures. 
     Using amines as nucleophiles in the enantioselective Ir catalyzed allylic amination 
reaction simple chiral allylic amines were synthesized in high yields and with excellent 
enantioselectivities. These after hydroformylation / Fischer Indolization sequence granted 
access to various tryptamines and tryptamides (Scheme 69).  In using chiral allylic amines, 
no epimerization due to double bond migration either by the rhodium catalyst or by the acid 
is observed, giving full retention of absolute configuration 
 
Scheme 69. Access to chiral tryptamines and tryptamides 
 
NO O
R
R
N
H
N
O
O
67%, 98% ee
[Rh], CO/H2
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98% ee  
 
When benzophenone glycinates were used as substrates in the enantioselective Ir catalyzed 
allylic substitution reactions with allyl carbonates, allyl glycine derivatives were obtained. 
These are suitable substrates for the synthesis of homotryptophane framework containing 
molecules. Using phosphoramidite ligands for the first time with this nucleophile high yields 
and enantioselectivities of final products were achieved (Scheme 70). Low catalyst and 
ligand loadings and mild reaction conditions were accompanied with reasonable reaction 
times, good yields and excellent ee values in all cases. All this makes phosphoramidite 
ligands the ligands of choice for this reaction.
 102 
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Scheme 70. Enentioselective synthesis of allyl glycinates 
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     Allylated benzophenone glycinates were synthesized as starting materials for the 
hydroformylation / Fischer indolization sequence. They allowed access to primary 
homotryptophane derivatives in good yields. Deprotection of benzophenone group is taking 
place in parallel with indolization under acidic conditions (Scheme 71). 
 
Scheme 71. Synthesis of primary homotryptophane derivatives 
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     Finally in order to achieve further homologization of the carbon chain at position 3 of 
indole core, cyanoaceates were used as substrates for Ir catalyzed allylic substitution 
reaction. Here, nitrile group is used as masked amino functionality. Alkylations of allylic 
carbonates with cyanoacetates proceeded in good yields (Scheme 72).  
 
Scheme 72. Synthesis of allylated cyanoacetates 
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     Synthesized cyanoacetates were submitted to tandem hydroformylation / Fischer indole 
synthesis sequence to give indoles in moderate yields. After reduction of nitrile functionality 
primary amine moiety was obtained to give tryptophane homologues with four carbons in 
side chain (Scheme 73). 
 
Scheme 73. Synthesis of longer chin tryptophane analogues 
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     In summary, tandem hydroformylation / Fischer indole synthesis sequence proved to be 
very efficient tool for the syntheses of various types of functionalized indoles, from simple 
tryptamines to complex tryptophane homologues bearing multiple stereocenters.  
     Scope of tandem processes that can be performed under hydroformylation conditions has 
been expanded to the tandem hydroformylation / Pictet-Spengler reactions. Importance of 
this approach lies in the fact that it allows fast and convenient access to pharmacologically 
important annulated indole systems known as tetrahydro-β-carbolines. Tandem 
hydroformylation / Pictet-Spengler reaction was performed in the solution for the first time. 
Reactions run under aprotic conditions using tryptophane methyl ester as a nucleophilic 
component and carbocyclic olefins as aldehyde precursors allowed access to cis and trans 
THBCs in good yields and ratios of approximately 1 : 1 in all cases (Scheme 74). 
 
Scheme 74. Tandem hydroformylation / Pictet-Spengler reaction under aprotic conditions 
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     This reaction under protic conditions i.e. in the presence of Brønsted acid and tryptamine 
as a nucleophilic component and various carbocyclic, methallylic amines and methallylic 
alcohols as precursors of electrophilic component under optimized conditions proceeded in 
good yields although with detectable formation of byproducts that lowered the yield of 
reaction and that could not be completely suppressed (Scheme 75). 
 
Scheme 75. Tandem hydroformylation / Pictet-Spengler reaction under protic conditions 
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     Tandem hydroformylation / Pictet-Spengler reaction allowed syntheses of tetrahydro-β-
carbolines starting from symmetric cyclic- and 1,1' disubstituted terminal olefins but proved 
impotent when more sensitive substrates like terminal olefins bearing stereocenters were 
applied, this hampered the preparations of more complex carboline structures. Due to this 
drawback, alternative method for the synthesis of tetrahydro-β-carbolines involving tandem 
hydroformylation / Fischer indole synthesis has been investigated. This powerful 
methodology has been applied for the synthesis of tetrahydro-β-carbolines possessing 
substituents that were not available via tandem hydroformylation / Pictet-Spengler reaction. 
These substituents were as well quite generally introduced in positions that are unavailable 
via classical approaches. Use of enantiopure 2-substituted 2,5 dihydropyrroles (previously 
synthesized via allylic amination / ring closing metathesis approach) in the hydroformylation 
/ Fischer indole synthesis sequence yielded in the tetrahydro-β-carboline structures in good 
yields and moderate selectivities (Scheme 76). 
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Scheme 76. Synthesis of tetrahydro-β-carbolines via tandem hydroformylation / Fischer indole synthesis 
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     Here, 3-substituted products retained enentiopurity of substrate while 1-substituted were 
isolated as racemates in all cases. Distribution of 1- and 3-substituted products depended 
solely on the regioselectivity of hydroformylation step which was controlled to some extent 
with phosphine ligand modified Rh catalysts. 
     Use of benzophenone protected phenylhydrazones allowed introduction of substituents in 
the positions 5-7 of indole core. Here reactions were run with the BrØnsted acid present in 
the reaction mixture. This allowed deprotection of benzophenone group in situ and its 
subsequent condensation with aldehyde formed in the hydroformylation step from olefin. 
Here, 3-substituted THBCs were obtained in excess as in the case when unprotected 
hydrazines were used, although yields were lower with these hydrazones (Scheme 77).  
p-MeO group present in position 5 of indole core has important medicinal repercussions, 
while presence of halogenide in this position allows further derivatizations of these 
molecules via cross coupling techniques. 
 
Scheme 77. Use of benzophenone protected hydrazones in the synthesis of tetrahydro-β-carbolines 
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     Use of α-Boc protected hydrazines synthesized via Goldberg reaction proved beneficial 
for introduction of more sophisticated moieties in the position 5 of the indole core, e.g. 
heterocyclic triazole unit was introduced with help of these hydrazines (Scheme 78). Use of 
these hydrazines however resulted in lower yields of final products. 
 
Scheme 78. Use of α-Boc protected hydrazines in the synthesis of THBCs via tandem hydroformylation / 
Fischer indole synthesis sequence 
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Using 2,5 disubstituted pyrrole as a substrate for tandem hydroformylation / Fischer 
indolization allowed preparation of 1,3-disubstituted tetrahydro-β-carboline in high 
enantiopurity  (Scheme 79). 
 
Scheme 79. Synthesis of 1,3 disubstituted tetrahydro-β-carbolines 
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     In summary, efficient modular synthesis of functionalized enantiopure THBCs starting 
from enantiopure cyclic aminoolefins has been achieved. Good yields of final products and 
moderate to good regioselectivities of hydroformylation were achieved. 
 
 
 
 
 
5.2 Outlook 
 
     Based on the results presented in this thesis various options may be possible for further 
extension of the scope of tandem hydroformylation / Fischer indole synthesis sequence in the 
preparation of the tetrahydro-β-carbolines. This protocol may also be used for the synthesis 
of tetracyclic systems 168 and 171 (Scheme 80) via intramolecular trapping of the 
spiroindolenine intermediates 167 and 170 either with carbon or oxygen nucleophiles present 
in the starting pyrroles. This approach has been used by Corey in total synthesis of the 
Aspidophytine (see Scheme 60). However problem of selectivity of hydroformylation would 
still be present. 
 
Scheme 80. Possible approach to tetracyclic indoline structures involving trapping of intermediate 
spiroindolinenium cation 
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     To avoid problems with regioselectivity of hydroformylation and in order to get access to 
pentacyclic annulated indolines, substrates 172 and 175 can be used, after initial 
hydroformylation, intramolecular trapping of spiroindolenine carbocations 173 and 176 
would give access to rather complex structures 174 and 177 (Scheme 81). 
 
 
 
 
 
Scheme 81. Tandem hydroformylation / Fischer indolization in the synthesis of pentacyclic indoline systems 
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     Tandem hydroformylation / Fischer indolization approach for the synthesis of THBCs 
can be transferred to the solid phase making this highly convergent method even more 
attractive for the combinatorial libraries syntheses. Sulphonated polystyrene resins have 
already been used in the syntheses of indoles under hydroformylation conditions on solid 
phase (Scheme 82).70 
 
Scheme 82. Tandem hydroformylation / Fischer indolization on solid phase 
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cond.: a) 1equiv 178, 10equiv. 179, 5equiv PTSA, 20mol% Rh(acac)(CO)2, 
50bar CO, 10bar H2 , THF, 80°C, 44h. b) 1equiv. 180, 10equiv Libiphenylide 
                             (1M in THF), 0°C, 2h. 
 
Few alternative approaches for the synthesis of the tetrahydro-β-carbolines on solid phase 
under hydroformylation conditions would be possible. Attaching enantiopure amines to the 
resin would give 182, after ring closing metathesis on the solid phase and subsequent 
hydroformylation / indolization sequence 184 would be obtained, which after cleavage can 
yield in THBCs, alternatively, Winterfeldt oxidation of 184 on solid phase would be an 
option for access to γ-quinolones (Scheme 83). 
 
Scheme 83. Prospectives in solid phase approaches towards indoles and THBCs 
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      An alternative approach might include allylic amination on solid phase starting from 186 
or attaching of already preformed amines to the resin both options giving 187, subsequent 
hydroformylation / indolization sequence would yield in indoles 188. These can be cleaved 
or submitted to Pictet-Spengler reaction under hydroformylation conditions to yield in the 
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1,3 disubstituted THBCs 184. 187 can be as well submitted to another allylic amination 
which leads to the synthesis of 184 by the set of reactions already described above. These 
highly diversified approaches can give access to the vast number of THBC structures that are 
not available by other methods. 
     Enantiopure tertiary tryptamides 81, obtained from tandem hydroformylation / Fischer 
indole synthesis of allylic amides after deprotection can be submitted to the acyl Pictet-
Spengler reaction to give stereo defined 1,3 disubstituted THBCs 189. Pictet-Spengler 
reaction can be used for the further derivatizations of the tryptophane homologues 93 as 
well, granting access to the indole structures 190 hardly obtainable by other methods 
possessing annulated 7 or 8 membered rings (Scheme 84). Here an option of submitting 
starting materials to Pictet-Spengler reaction under hydroformylation conditions would lead 
to further diversification of reaction pathways and to the increase in substance library 
diversity. 
Scheme 84. Pictet-Spengler reaction of tryptamides and tryptophane homologues 
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6 Experimental Section 
 
6.1 General Methods 
 
      1H-NMR and 13C-NMR spectra were measured on a Bruker Advance DRX 400 
spectrometer or a Bruker Advance DRX 500 spectrometer using CDCl3 as solvent with 
CHCl3 as internal standard. Chemical shifts (δ) are given in parts per million (ppm) and 
coupling constants are given in Hertz (Hz).The proton spectra are reported as follows δ/ppm 
(multiplicity, number of protons, coupling constant J/Hz). Two dimensional spectra (COSY, 
HSQC, HMBC) were used where appropriate to aid the assignments in 1H and 13C spectra. 
High resolution mass analyses were performed on a Jeol JMS-SX 102A. IR spectra were 
measured on a Nicolet Impact 400D FT-IR spectrometer. IR spectra were recorded as films 
on NACl or KBr plates or for solids pressed with KBr. The peak intensities are defined as 
very strong (vs), strong (s), medium (m) or weak (w). Optical rotations were measured on a 
Perkin-Elmer 341 polarimeter in a 10 cm cell in the stated solvent ; [α]D values are given in 
10-1deg.cm2g-1 (concentration c given as g/100 mL).  Enantiomeric excesses were 
determined by analytical HPLC, Hewlet-Packard 1050 series chromatograph using a 
CHIRALCELL OD-H (250x4.6 mm), CHIRALCELL OJ-H (250x4.6 mm) and 
CHIRALPAK AD (250x4.6 mm) columns as noted. Column chromatography was carried 
out on 70–230 mesh silica gel (Macherey– Nagel; silicagel 60) using Cyclohexane/EA, 
Cyclohexane/MTBE or CH2Cl2/MeOH as eluents.  
 
6.2 Materials 
 
     All Ir catalyzed reactions were conducted using standard Schlenk techniques. THF was 
distilled from sodium-benzophenone ketyl under nitrogen, CH2Cl2 was distilled from CaH2 
under nitrogen. All other solvents were purchased and used as received. [Ir(cod)Cl]2,98 O,O'-
(R)-(1,1'-Dinaphthyl-2,2'-diyl)-N,N'-di-(R,R)-1 phenylethylphosphoramidite [(Ra,RC,RC)-
L1], [(Ra,RC,RC)-L3],  [(Sa,SC,SC)-entL3],99 were prepared according to published 
procedures. Rh(acac)(CO)2 was purchased.  Allylic carbonates (68a – 68f) were synthesized 
                                                 
98 Herde, J. L.; Lambert, J. C.; Senoff, C. V. Inorg. Synth. 1974, 15, 18. 
99 Alexakis, A.; Rosset, S.; Allamand, J.; March, S.; Guillen, F.; Benhaim, C. Synlett 2001, 1375. 
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by the reaction of corresponding allylic alcohols with methyl chloroformate in the presence 
of pyridine. (E)-4-methoxycinnamyl alcohol, (E)-2-methoxycinnamyl alcohol, and (E)-3-(2-
furanyl)-2-propen-1-ol were prepared by the NaBH4/CeCl3 reduction of corresponding 
aldehydes. (E)-4-chlorocinnamyl alcohol,100 (E)-4-trifluoromethylcinnamyl alcohol,100 (E)-3-
(pyridin-3-yl)prop-2-en-1-ol 101 were prepared according to published procedure. (E)-
cinnamyl alcohol, (E)-2-hexen-1-ol, (E)-2-penten-1-ol, 2-methoxycinnamaldehyde, (E)-3-(2-
furyl)acrolein, (Aldrich Chemicals Co.), (E)-4-methoxycinnamaldehyde (TCI),  (Alfa Aesar) 
were purchased and used without further purification. 
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100 Lehmann, J.; Lloyd-Jones, G. C. Tetrahedron 1995, 51, 8863-8874. 
101 Welter, C.; Moreno, R. M; Streiff, S.; Helmchen, G.,   Org. Biomol. Chem. 2005,  3,  3266-8. 
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6.3 Experiments in Chapter 2 
 
General Procedure for iridium catalysed allylic aminations 
 
Catalyst activation with propylamine. 
[Ir(cod)Cl]2 (0.04 mmol) and phosphoramidite ligand (L1 or L3) (0.08 mmol.) were diluted 
in 0,3 ml of dry THF and 0.3 ml propylamine and the mixture was stirred under argon stream 
at 50 °C for 20 min. After this time all volatiles were evaporated. The yellow solid was 
diluted in 4ml of dry THF to generate a stock solution of the activated catalyst. Amine (1.2 
mmol) was added to 1 ml of the stock solution of the catalyst (1 mol% catalyst). Carbonate 
(1 mmol) was added via syringe and the reaction was stirred at room temperature until the 
carbonate was fully converted (TLC analysis). The volatile materials were evaporated and 
the ratio of regioisomers (branched to linear b/l) was determined by 1H – NMR of the crude 
mixture. The crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate or cyclohexane/MTBE) to give the desired product. 
 
Benzyl-(1-phenyl-allyl)-amine (Table 1, Entry 1), (70a) 
 The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(6.7 mg, 0.01 mmol) ligand L1 (9 mg, 0.02 mmol), cinnamyl methyl 
carbonate (192 mg, 1 mmol.) and benzylamine (214 mg, 2 mmol). The 
reaction was conducted at room temperature for 1.5 h. 1H NMR analysis of 
the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 
90/10. The mixture was purified by column chromatography on silica gel 
(cyclohexane/MTBE = 4/1) to give the title compound (129 mg, 58 %) as yellowish oil. 
HPLC analysis indicated that the enantiomeric excess of the product was 90 % [Diacel 
Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 99.6/0.4; flow rate = 1 
ml/min; detection wavelength = 254 nm; TR = 13.4 (-), 17.5 (+) min]. (R) 
configuration,[ ]20Dα = -2.5 (c = 0.84, CHCl3); (Table 1, Entry 2), (70a) The general
HN
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procedure for allylic aminations was followed with [Ir(cod)Cl]2 (6.7 mg, 0.01 mmol), ligand 
L3 (11.4 mg, 0.02 mmol), cinnamyl methyl carbonate (192 mg, 1 mmol.) and benzylamine 
(214 mg, 2 mmol). The reaction was conducted at room temperature for 0.25 h. 1H NMR 
analysis of the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 92/8. The 
mixture was purified by column chromatography on silica gel (cyclohexane/MTBE = 4/1) to 
give the title compound (170 mg, 76 %) as yellowish oil. HPLC analysis indicated that the 
enantiomeric excess of the product was 94 % [Diacel Chiralcel OD-H (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 99.6/0.4; flow rate = 1 ml/min; detection wavelength = 254 nm; 
TR = 13.4 (-), 17.5 (+) min]. (R) configuration,[ ]20Dα = -2.6 (c = 1.100, CHCl3); (Table 1, 
Entry 3), (70a) The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(6.7 mg, 0.01 mmol), ligand entL3 (11.4 mg, 0.02 mmol), cinnamyl methyl carbonate (192 
mg, 1 mmol.) and benzylamine (214 mg, 2 mmol). The reaction was conducted at room 
temperature for 0.5 h. 1H NMR analysis of the crude reaction mixture indicated the ratio of 
regioisomers (b/l) to be 96/4. The mixture was purified by column chromatography on silica 
gel (cyclohexane/MTBE = 4/1) to give the title compound (168 mg, 75 %) as yellowish oil. 
HPLC analysis indicated that the enantiomeric excess of the product was 97 % [Diacel 
Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 99.6/0.4; flow rate = 1 
ml/min; detection wavelength = 254 nm; TR = 13.4 (-), 17.5 (+) min]. (S) configuration, 
[ ]20Dα = +2.8 (c = 1.35, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.40-7.20 (m, 10H), 5.95 
(ddd, 1H, J = 7.3 Hz, J = 10.1 Hz, J = 17.2 Hz), 5.22 (d, 1H, J = 17.1 Hz), 5.12 (d, 1H, J = 
10.2 Hz), 4.22 (d, 1H, J = 7.1 Hz), 3.73 (d, 2H, J = 3.1 Hz), 1.85 (bs, 1H). 13C-NMR (CDCl3, 
100 MHz) δ ppm 142.9,141,1, 140.8, 128.5, 128.3, 128.2, 127.3, 127.2, 126.9, 115.2, 65.0, 
51.2; Analytical data fits with literature.102
 
N-(1-phenylallyl)cyclohexanamine  (Table 1, Entry 4), (70b) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(13 mg, 0.02 mmol), ligand L3 (23 mg, 0.04 mmol), cinnamyl methyl 
carbonate (384 mg, 2 mmol) and cyclohexylamine (218 mg, 2.4 mmol). The 
reaction was conducted at room temperature for 46 h. 1H NMR analysis of 
the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 94/6. The mixture 
was purified by column chromatography on silica gel (cyclohexane/MTBE = 6/1) to give the 
NH
                                                 
102 T. Ohmura, J.F. Hartwig, J. Am. Chem. Soc. 2002, 124, 15164-15165. 
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title compound (319 mg, 74 %) as yellowish oil. HPLC analysis indicated that the 
enantiomeric excess of the product was 97% [Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 98/2; flow rate = 0.3 mL/min; detection wavelength = 215 nm; TR = 
14.6 (+), 15.3 (-) min]. [ ]20Dα = -14.3 (c = 0.700, CHCl3); 1H NMR (400 MHz, CDCl3)  δ ppm 
7.32 (d, J = 4.33 Hz, 1H), 7.25-7.20 (m, 1H), 5.92 (ddd, J = 17.18, 10.12, 7.13 Hz, 1H), 
5.15 (d, J = 17.10 Hz, 1H), 5.07 (d, J = 10.10 Hz, 1H), 4.38 (d, J = 7.11 Hz, 1H), 2.35-2.45 
(m, 1H), 1.94 (d, J = 12.79 Hz, 1H), 1.84 (d, J = 12.69 Hz, 1H), 1.64-1.74 (m, 2H), 1.52-
1.61 (m, 1H), 1.32 (br, 1H), 1.11 (m, 5H); 13C NMR (101 MHz, CDCl3) δ ppm 143.4 (C), 
141.6 (CH), 128.4 (CH), 127.2 (CH), 126.9 (CH), 114.5 (CH2), 62.3 (CH), 53.4 (CH), 34.0 
(CH2), 33.7 (CH2), 26.2 (CH2), 25.1 (CH2), 25.05 (CH2); HRMS: m/z (FAB) calc for 
C15H21N (M+) 215.1675, found 215.1634; IR(film): ν [cm-1] = 3061(w), 3025(w), 2925(s), 
2851(s), 1450(s), 1115(m), 700(s); 
 
4-(1-phenylallyl)morpholine (Table 1, Entry 5), (70c) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol), cinnamyl methyl 
carbonate (180 mg, 0.93 mmol) and morpholine (105 mg, 1.2 mmol). The 
reaction was conducted at room temperature for 16 h. 1H NMR analysis of 
the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 95/5. The mixture 
was purified by column chromatography on silica gel (cyclohexane/MTBE = 6/1) to give the 
title compound (155 mg, 82 %) as colourless oil. HPLC analysis indicated that the 
enantiomeric excess of the product was 94% [Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 98.4/1.6; flow rate = 1 mL/min; detection wavelength = 215 nm; TR = 
6.7 (+), 7.5 (-) min]. [ ]20Dα = -94 (c = 1.022, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 
7.34-7.27 (m, 4H), 7.24-7.20 (m, 1H), 5.89 (ddd, 1H, J = 9.5 Hz, J = 9.5 Hz, J = 17.3 Hz), 
5.22 (d, 1H, J = 17.0 Hz), 5.09 (dd, 1H, J = 1.1 Hz, J = 10. 1Hz), 3.67 (t, 4H, J = 4.6 Hz), 
3.60 (d, 1H, J = 8.8 Hz), 2.46 (bs, 2H), 2.34-2.28 (m, 2H); 13C NMR (101 MHz, CDCl3 ) δ 
ppm 147.6 (s, 1C), 140.1 (s, 1C), 129.1 (s, 1C), 117.0 (s, 1C), 114.9 (s, 1C), 113.2 (s, 1C), 
55.6 (s, 1C), 38.0 (s, 1C), 19.1 (s, 1C), 13.9 (s, 1C). Analytical data fits with literature.102 
N
O
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2-((R)-1-phenylallyl)isoindoline-1,3-dione (Table 1, Entry 6), (70d) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(13 mg, 0.02 mmol), ligand L3 (23 mg, 0.04 mmol), cinnamyl methyl 
carbonate (384 mg, 2 mmol) and phthalimide (441 mg, 3 mmol). The 
reaction was conducted at room temperature for 12 h. 1H NMR analysis of 
the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 
98/2. The mixture was purified by column chromatography on silica gel 
(cyclohexane/MTBE = 6/1) to give the title compound (347 mg, 66 %) as yellowish oil. 
HPLC analysis indicated that the enantiomeric excess of the product was 98% [Diacel 
Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 7.7 (+), 8.8 (-) min]. 1H-NMR (CDCl3, 400 MHz) δ 
ppm 7.82 (dd, 1H, J = 3.0 Hz, J = 5.4 Hz) , 7.68 (dd, 1H, J = 3.0 Hz, J = 5.4 Hz), 7.46 (d, 
1H, J = 7.5 Hz), 7.34 (dd, 1H, J = 7.4 Hz, J = 7.4 Hz), 7.27 (dd, 1H, J = 7.2 Hz, J = 7.2 Hz), 
6.67 (ddd, 1H, J = 7.6 Hz, J = 10 Hz, J = 17.2 Hz), 5.98 (d, 1H, J = 7.6 Hz), 5.39 (d, 1H, J = 
10.2 Hz,), 5.36 (d, 1H, J = 17.1 Hz); 13C NMR (101 MHz, CDCl3 δ ppm 167.6, 138.4, 134.0, 
133.9, 131.8, 128.4, 127.7, 127.6, 123.2, 119.0, 56.7; Analytical data fits with literature.103
N OO
R
 
1-(1-phenylallyl)pyrrolidine (Table 1, Entry 7), (70e) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(7 mg, 0.01 mmol), ligand L3 (12 mg, 0.02 mmol), cinnamyl methyl 
carbonate (192 mg, 1 mmol) and pyrrolidine (86 mg, 1.2 mmol). The 
reaction was conducted at room temperature for 0.5 h. 1H NMR analysis of 
the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 95/5. The mixture 
was purified by column chromatography on silica gel (cyclohexane/MTBE = 4/1) to give the 
title compound (136 mg, 73 %) as colourless oil. HPLC analysis indicated that the 
enantiomeric excess of the product was 98 % [Diacel Chiralcel OD-H (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 99.6/0.4; flow rate = 0.4 mL/min; detection wavelength = 215 
nm; TR = 13.0 (-), 15.2 (+) min]. [ ]20Dα = -1.1 (c = 1.000, CHCl3); 1H-NMR (CDCl3, 400 
MHz) δ ppm 7.35-7.27 (m, 4H), 7.24-7.19 (m, 1H), 6.02 (ddd, 1H, J = 9.0 Hz, J = 9.8 Hz, J 
= 17.1 Hz), 5.19 (d, 1H, J = 17.0 Hz), 4.99 (dd, 1H, J = 1.2 Hz, J = 10.1 Hz), 3.57 (d, 1H, J 
= 8.6 Hz), 2.52-2.46 (m, 2H), 2.39-2.33 (m, 2H), 1.78-1.71 (m, 4H); 13C NMR (101 MHz, 
N
                                                 
103 Weihofen R.; Tverskoy O.; Helmchen G., Angew. Chem. Int. Ed., 2006, 45, 5546. 
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CDCl3 ) δ ppm 143.2 (s, 1C), 141.5 (s, 1C), 128.4 (s, 1C), 127.6 (s, 1C), 127.0 (s, 1C), 114.8 
(s, 1C), 75.2 (s, 1C), 52.9 (s, 1C), 23.3 (s, 1C). Analytical data fits with literature.102 
 
N,N-diethyl-1-(2-methoxyphenyl)prop-2-en-1-amine (Table 1, Entry 8), (70f) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(11 mg, 0.015 mmol), ligand L3 (17 mg, 0.030 mmol, 0.02 equiv.), (E)-3-(2-
methoxyphenyl)allyl methyl carbonate (335 mg, 1.5 mmol) and diethylamine 
(79 mg, 1.8 mmol). The reaction was conducted at room temperature for 18 h. 1H NMR 
analysis of the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 96/4. The 
mixture was purified by column chromatography on silica gel (cyclohexane/ethylacetate = 
3/1) to give the title compound (205 mg, 62 %) as yellowish oil. HPLC analysis indicated 
that the enantiomeric excess of the product was 91% [Diacel Chiralcel OD-H (0.46 cm x 25 
cm, 5 µm); heptane/2-propanol = 99.6/0.4; flow rate = 1 mL/min; detection wavelength = 
215 nm; TR = 7.2 (-), 8.0 (+) min]. [ ]20Dα = -73.0 (c = 1.004, CHCl3); 1H NMR (400 MHz, 
CDCl3)  δ ppm  7.47 (dd, J = 7.57, 1.39 Hz, 1H),  7.23-7.16 (m, 1H), 6.95 (t, J = 7.40, 7.40 
Hz, 1H), 6.86 (d, J = 8.19 Hz, 1H), 5.91 (ddd, J = 17.38, 9.82, 8.76 Hz, 1H), 5.22 (dd, J = 
17.04, 0.90 Hz, 1H), 4.99 (dd, J = 10.04, 1.59 Hz, 1H), 4.67 (d, J = 8.50 Hz, 1H), 3.82 (s, 
3H), 2.68-2.53 (m, 4H), 0.97 (t, J = 7.08, 7.08 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ ppm 
157.1 (C), 140.8 (CH), 131.0 (C), 128.5 (CH), 127.4 (CH), 120.6 (CH), 114.5 (CH2), 110.8 
(CH), 61.1 (CH), 55.5 (CH), 42.6 (2xCH2), 10.8 (2xCH3); HRMS: m/z (FAB) calc for 
C14H21NO (M+) 219.1623, found 219.1621. IR(film): ν [cm-1] = 3076 (w), 2968 (s), 2943 (s), 
2871(m), 2834 (m), 1488 (s), 1464 (s), 1239 (s), 754 (s). 
 
OMe
N
N-1-(1-(4-methoxyphenyl)allyl)piperidine  (Table 1, Entry 9), (70g) 
was followed with The general procedure for allylic aminations 
[Ir(cod)Cl]2 (26 mg, 0.04 mmol), ligand L3 (45 mg, 0.08 mmol), (E)-
3-(4-methoxyphenyl)allyl methyl carbonate (888 mg, 4 mmol.) and 
piperidine (374 mg, 4.4 mmol). The reaction was conducted at room 
1H NMR analysis of the crude reaction mixture indicated the ratio of 
regioisomers (b/l) to be 91/9. The mixture was purified by column chromatography on silica 
gel (cyclohexane/ethylacetate/triethylamine = 3/1/0.01) to give the title compound (863 mg, 
91 %) as yellowish solid. HPLC analysis indicated that the enantiomeric excess of the 
N
MeO
temperature for 46 h. 
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product was 94% [Diacel Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 
99.6/0.4; flow rate = 0.5 mL/min; detection wavelength = 230 nm; TR = 16.1 (-), 17.8 (+) 
min]. [ ]20Dα = -102.5 (c = 1.012, CHCl3); 1H NMR (400 MHz, CDCl3 ) δ ppm 1.37-1.45 (m, 
2H), 1.50-1.59 (m, 4H), 2.33-2.20 (m, 2H), 2.36-2.48 (m, 2H), 3.61 (d, J = 8.59 Hz, 1H), 
3.79 (s, 3H), 5.06 (d, J = 10.09 Hz, 1H), 5.15 (d, J = 17.40 Hz, 1H) 5.94 (ddd, J = 17.40, 
10.09, 8.59 Hz, 1H), 6.85 (d, J = 8.60 Hz, 2H), 7.24 (d, J = 8.60 Hz, 2H);  13C NMR (100 
MHz, CDCl3) δ ppm 158.6 (C), 140.73 (CH), 134.5 (C), 129.07 (2xCH), 115.64 (CH2), 
113.84 (2xCH), 74.8 (CH), 55.3 (CH3), 52.6 (2xCH2), 26.3 (2xCH2), 24.8 (CH2);  HRMS: 
m/z (FAB) calc for C14H21NO (M+) 231.1623, found 231.1625; IR(KBr): ν [cm-1] = 2963 (s), 
2934 (s), 2851 (m), 2783 (s), 2744 (m), 1609 (m), 1510 (s), 1253 (s), 834 (s), 803 (s). 
 
4-(1-Furan-2-yl-allyl)-morpholine (Table 1, Entry 10), (70h) 
s followed with [Ir(cod)Cl]2 
NMR analysis 
The general procedure for allylic aminations wa
 120 
(13.5 mg, 0.02 mmol), ligand L3 (23 mg, 0.04 mmol), (E)- 3-Furan-2-yl-
prop-2-en-1-ol methyl carbonate (365 mg, 2 mmol.) and morpholine (350 
mg, 4 mmol). The reaction was conducted at room temperature for 20 h. 1H 
of the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 
95/5. The mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 9/1) to give the title compound (313 mg, 81 %) as yellowish oil. 
Enantiomers could not be separated on any of available columns. [ ]20Dα = -54.5 (c = 0.915, 
CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.37 (s, 1H), 6.30 (m, 1H), 6.18 (d, 1H, 
J=3.0Hz), 6.00 (ddd, 1H, J=8.5Hz, J=10.0Hz, J=18.0Hz), 5.25 (m, 2H), 3.89 (d, 1H, 
J=8.2Hz),3.69 (t, 4H, J=4.7Hz), 2.50 (m, 2H) ppm 2.35 (m, 2H); 13C-NMR (CDCl3, 100 
MHz) δ ppm  135.4, 118.7, 110.1, 108.2, 67.4, 67.2, 51.2; HRMS: m/z (FAB) calc for 
C11H15NO2 (M+) 193.1103, found  193.1077; IR(film): ν [cm-1] = 3106 (w), 3080 (w), 2955 
(s), 2863 (s), 2810 (s), 1641 (w), 1497 (m), 1457 (m), 1310 (m), 1122 (vs), 1004 (vs), 925 
(s). 
O
N
O
 
3-(1-Piperidin-1-yl-allyl)-py  (Table 1, Entry 11), (70i) 
[Ir(cod)Cl]2 
ridine
The general procedure for allylic aminations was followed with 
N
N (13.5 mg, 0.02 mmol), ligand L3 (23 mg, 0.04 mmol), (E)- 3-Pyridin-3-yl-
prop-2-en-1-ol methyl carbonate (396 mg, 2 mmol.) and piperidine (340 
mg, 4 mmol). The reaction was conducted at room temperature for 0.5 h. 1H 
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NMR analysis of the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 
96/4. The mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 1/1) to give the title compound (345 mg, 85 %) as colourless oil. 
HPLC analysis indicated that the enantiomeric excess of the product was 99 % [Diacel 
Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 ml/min; 
detection wavelength = 254 nm; TR = 6.9 (-), 8.0 (+) min]. [ ]20Dα = -65 (c = 1.060, CHCl3); 
1H-NMR (CDCl3, 400 MHz) δ ppm 8.52 (s, 1H), 8.44 (d, 1H, J = 4.6 Hz), 7.64 (d, 1H, J = 
7.8 Hz), 7.21 (dd, 1H, J = 4.8 Hz, J = 7.8 Hz), 5.92-5.83 (m, 1H), 5.18 (d, 1H, J = 17.1 Hz), 
5.11 (d, 1H, J = 10.1 Hz), 3.71 (d, 1H, J = 8.6 Hz), 2.41-2.22 (m, 4H), 1.55-1.49 (m, 4H), 
1.41-1.36 (m, 2H); 13C-NMR (CDCl3, 100 MHz) δ ppm 149.7, 148.3, 139.0, 137.6, 135.3, 
123.3, 116.9, 72.6, 52.2, 26.1, 24.5; HRMS: m/z (ESI) calc for C13H19N2 (M+H+) 
203.15428, found 203.15425; IR(film): ν [cm-1] = 3461 (m), 2942 (vs), 2843 (vs), 2784 (vs), 
2751 (vs), 2357 (w), 1845 (w), 1653 (m), 1574 (vs), 1418 (vs), 1313 (s), 1109 (vs), 991 (vs), 
925 (vs). 
 
Benzyl-(1-ethyl-allyl)-amine (Table 1, Entry 12), (70j) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(13.5 mg, 0.02 mmol), ligand L3 (23 mg, 0.04 mmol), (E)- Pent-2-en-1-ol 
methyl carbonate (290 mg, 2 mmol.) and benzylamine (430 mg, 4 mmol). The 
reaction was conducted at room temperature for 5 h. 1H NMR analysis of the 
crude reaction mixture indicated the ratio of regioisomers (b/l) to be 91/9. The mixture was 
purified by column chromatography on silica gel (cyclohexane/ethylacetate = 5/1) to give 
the title compound (218 mg, 62 %) as colourless oil. HPLC analysis indicated that the 
enantiomeric excess of the product was 98 % [Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 99/1; flow rate = 1 ml/min; detection wavelength = 254 nm; TR = 7.8 
(-), 8.6 (+) min]. [ ]20Dα = -2.5 (c = 1.040, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.32-
7.28 (m, 4H), 7.25-7.20 (m, 1H), 5.60 (ddd, 1H, J = 8.3 Hz, J = 10.2 Hz, J = 17.3 Hz), 5.16-
5.07 (m, 2H), 3.82 (d, 1H, J = 13.2 Hz), 3.64 (d, 1H, J = 13.2 Hz), 2.93 (dd, 1H, J = 7.9 Hz, 
J = 13.5 Hz), 1.59-1.39 (m, 3H), 0.87 (t, 3H, J = 7.5 Hz); 13C-NMR (CDCl3, 100 MHz) δ 
ppm 141.0, 140.7, 128.3, 128.1, 126.8, 116.3, 62.8, 51.21, 28.4, 10.3; HRMS: m/z (FAB) 
calc for C13H19N (M+) 189.1517, found 189.1525; IR(film): ν [cm-1] = 3060 (m), 2962 (m), 
2935 (m), 1451 (s), 1390 (m), 1102 (s), 912 (vs), 708 (vs). 
HN
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Benzyl-(1-propyl-allyl)-amine (Table 1, Entry 13), (70k) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(6.7 mg, 0.01 mmol), ligand L3 (11.4 mg, 0.02 mmol), (E)- Hex-2-en-1-ol 
methyl carbonate (145 mg, 1 mmol.) and benzylamine (214 mg, 2 mmol). 
The reaction was conducted at room temperature for 2 h. 1H NMR analysis 
of the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 
89/11. The mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 4/1) to give the title compound (114 mg, 60 %) as colourless oil. 
HPLC analysis indicated that the enantiomeric excess of the product was 94% [Diacel 
Chiralcel OJ (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 99/1; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 7.2 (-), 8.1 (+) min]. [ ]20Dα = -1.0 (c = 1.072, CHCl3); 
1H-NMR (CDCl3, 400 MHz) δ ppm 7.32-7.28 (m, 4H), 7.25-7.20 (m, 1H), 5.61 (ddd, 1H, J = 
8.3 Hz, J = 10.2 Hz, J = 17.2 Hz), 5.15-5.06 (m, 2H), 3.82 (d, 1H, J = 13.1 Hz), 3.63 (d, 1H, 
J = 13.2 Hz), 3.01 (dd, 1H, J = 7.7 Hz, J = 13.7 Hz), 1.48-1.22 (m, 5H), 0.88 (t, 1H, J = 7.2 
Hz). 13C-NMR (CDCl3, 100 MHz) δ ppm 141.4, 140.7, 128.3, 128.1, 126.7, 115.9, 60.9, 
51.2, 37.9, 19.1, 14.0; Analytical data fits with literature.102 
HN
 
N-(hex-1-en-3-yl)aniline (Table 1, Entry 14), (70l) 
The general procedure for allylic amination was followed with [Ir(cod)Cl]2 
(28 mg, 0.04 mmol), ligand L3 (45 mg, 0.02 mmol), (E)-hex-2-enyl methyl 
carbonate (318 mg, 2 mmol) and aniline (204 mg, 2.2 mmol). The reaction 
was conducted at room temperature for 46 h. 1H NMR analysis of the crude reaction mixture 
indicated the ratio of regioisomers (b/l) to be 95/5. The mixture was purified by column 
chromatography on silica gel (cyclohexane/MTBE = 20/1) to give the title compound (271 
mg, 77 %) as colourless oil. HPLC analysis indicated that the enantiomeric excess of the 
product was 91% [Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 
99.6/0.4; flow rate = 1 mL/min; detection wavelength = 215 nm; TR = 7.2 (-), 8.0 (+) min]. 
[ ]20Dα = -7.044 (c = 0.530, CHCl3); 1H NMR (400 MHz, CDCl3)  δ ppm 7.15 (t, J = 7.89, 7.89 
Hz, 2H), 6.67 (t, J = 7.30, 7.30 Hz, 1H), 6.60 (d, J = 7.77 Hz, 2H), 5.74 (ddd, J = 16.75, 
10.28, 6.19 Hz, 1H), 5.21 (d, J = 17.21 Hz, 1H), 5.11 (d, J = 10.29 Hz, 1H), 3.81 (q, J = 
6.44, 6.42, 6.42 Hz, 1H), 3.70 (bs, 1H), 1.63-1.53 (m, 2H), 1.50-1.38 (m, 2H), 0.95 (t, J = 
7.26, 7.26 Hz, 3H); 13C NMR (101 MHz, CDCl3 ) δ ppm 147.6 (C), 140.1 (CH), 129.1 (CH), 
NH
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117.0 (CH), 114.9 (CH2), 113.2 (CH), 55.6 (CH), 38.0 (CH2), 19.1 (CH2), 14.0 (CH3); 
Analytical data fits with literature.104
 
General Procedure for Acetylation of the Secondary Amines: 
 
To a stirred solution of amine (1 equiv.) in 10 ml of dry CH2Cl2 was added DMAP (0.05 
equiv.) and dry triethylamine (3 equiv.) and the mixture was degassed under argon 
atmosphere using an ultrasound bath. Reaction mixture was cooled down to 0 °C and 
acetylchloride (2 equiv.) was added dropwise via syringe. The mixture was allowed to stir at 
room temperature until amine was fully converted as determined by TLC. After completion 
of the reaction solvent was evaporated and 10 ml of diethylether were added. The formed 
suspension was filtered through sintered glass filter, and the volatiles removed in vacuo. The 
crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate or cyclohexane/MTBE) to give the desired product. 
 
N-benzyl-N-(1-phenylallyl)acetamide (Table 2, Entry 1), (76a), (R-(-)). 
The general procedure was followed with N-benzyl-1-phenylprop-2-en-1-
amine (447 mg, 2.0 mmol), DMAP (12 mg, 0.1 mmol), triethylamine (607 
mg, 0.79 ml, 6.0 mmol) and acetylchloride (314 mg, 0.285 ml, 4.0 mmol) in 
10 ml of CH2Cl2. The crude reaction mixture was purified by column 
chromatography on silica gel (cyclohexane/MTBE = 4/1) to give the title compound (467 
mg, 88 %) as viscous colourless oil.  [ ]20Dα = -44.6 (c = 1.60, CHCl3); (Table 2, Entry 2), 
(76b), (S-(+)). The general procedure was followed with N-benzyl-1-phenylprop-2-en-1-
amine (447 mg, 2.0 mmol), DMAP (12 mg, 0.1 mmol), triethylamine (607 mg, 0.79 ml, 6.0 
mmol) and acetylchloride (314 mg, 0.285 ml, 4.0 mmol) in 10 ml of CH2Cl2. The crude 
reaction mixture was purified by column chromatography on silica gel (cyclohexane/MTBE 
= 4/1) to give the title compound (452 mg, 85 %) as viscous colourless oil. [ ]20Dα =+46.2 (c = 
1.12, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.37-7.18 (m, 8 H), 7.05 (d, 2 H, J = 7.0 
Hz), 6.48,5.54, (2d, 1 H, J = 4.6 Hz, J = 6.8 Hz), 6.01 (ddd, 1H, J = 6.9 Hz, J = 10.3 Hz, J = 
17.3 Hz), 5.33-5.11 (m, 2 H), 4.75-4.35 (m, 2 H), 2.23, 2.07 (s, 3 H); 13C-NMR (CDCl3, 100 
MHz) δ ppm 171.8 (s, C), 139.2 (s, C), 137.9 (s, C), 135.2, 135.0 (d, CH), 128.7, 128.6, 
N
Bn
O
                                                 
104 Leitner, A.; Shu, C. T.; Hartwig, J. F.Org. Lett. 2005, 7, (6), 1093-1096. 
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128.1, 127.9, 127.7, 127.6, 127.1, 126.7, 126.1  (10d, CH), 119.2, 118.8 (t, CH2), 64.7, 60.1 
(d, CH), 49.4, 47.5 (t, CH2), 22.6, 22.5,(q, CH3); HRMS: m/z (ESI) calc for C18H20NO 
(M+H+) 266.15394, found  266.15400; IR(film): ν [cm-1] = 3060 (m), 3021 (m), 2929 (m), 
1943 (w), 1818 (w), 1648 (vs), 1497 (s), 1418 (vs), 1260 (m), 1188 (m), 918 (m).  
 
N-cyclohexyl-N-(1-phenylallyl)acetamide (Table 2, Entry 3), (76c) 
The general procedure was followed with N-(1-phenylallyl)cyclohexanamine 
(193mg, 0.896mmol), DMAP (5 mg, 0.041 mmol), triethylamine (145 mg, 
2.79 mmol) and acetylchloride (145 mg, 1.86 mmol) in 10 ml of CH2Cl2. 
The crude reaction mixture was purified by column chromatography on silica 
gel (cyclohexane/MTBE = 2/1) to give the title compound (213 mg, 92 %) as viscous 
yellowish oil. 1H NMR (400 MHz, CDCl3 ) δ ppm 7.42-7.14 (m, 10H), 6.62-6.45 (m, 1H), 
6.34-6.14 (m, 1H), 5.44 (d, 1H, J = 10.05 Hz), 5.39-5.15 (m, 4H), 5.03 (bs, 1H), 4.10 (bs, 
1H), 3.61 (t, 1H, J = 11.1 Hz,), 2.17 (s, 1H), 1.99-1.44 (m, 18H), 1.86 (s, 3H), 1.68 (s, 3H), 
1.40-1.00 (m, 6H); 13C NMR (101 MHz, CDCl3) δ ppm 171.1, 169.3, 140.5, 140.1, 137.5, 
136.1, 128.4, 127.9, 127.2, 126.8, 126.5, 126.3, 118.7, 117.3, 60.9, 60.6, 59.2, 55.3, 32.5, 
32.0, 31.0, 30.4, 26.1, 26.0, 24.7, 23.4; HRMS: m/z (FAB) calc for C17H23NO (M+) 
257.1780, found  257.1787; IR(film): ν [cm-1] = 3028 (w), 2929 (s), 2853 (s), 1644 (s), 1449 
(s), 1427 (s), 699 (s); 
N
O
 
N-Benzyl-N-(1-ethyl-allyl)-acetamide  (Table 2, Entry 4), (76d) 
The general procedure was followed with N-benzylpent-1-en-3-amine (315 mg, 
1.80 mmol), DMAP (11 mg, 0.089 mmol), triethylamine (547 mg, 0.72 ml, 5.4 
mmol) and acetylchloride (283 mg, 0.26 ml, 3.6 mmol) in 10 ml of CH2Cl2. 
The crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/MTBE = 4/1) to give the title compound (293 mg, 75 %) as viscous colourless 
oil. [ ]20Dα = -48.7  (c = 1.634  CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.30 (t, 1H, J = 
7.3 Hz), 7.26-7.15 (m, 4H), 5.73 (dddd, 1H, J = 6.4 Hz, J = 10.4 Hz, J = 16.7 Hz, J = 23.4 
Hz), 5.17-5.06 (m, 2H), 4.95 (dd, 1H, J = 7.1 Hz, J = 14.3 Hz), 4.68 (d, 1H, J = 15.4 Hz), 
4.43 (s, 1H), 4.31 (d, 1H, J = 15.4 Hz), 4.12 (dd, 1H, J = 6.6 Hz, J = 12.9 Hz), 2.20, 2.00 (s, 
3H), 1.58 ( p, 2H, J = 7.3 Hz), 0.81 (dt, 3H, J = 7.3 Hz, J = 24.8 Hz). 13C-NMR (CDCl3, 100 
MHz) δ ppm 171.6, 139.2, 138.1, 136.6, 136.4, 128.6, 128.1, 127.6, 127.1, 126.6, 126.1, 
117.6, 116.6, 62.8, 58.3, 48.4, 45.4, 25.6, 24.6, 22.5, 22.3, 11.0, 10.9; HRMS: m/z (FAB) 
N
Bn
O
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calc for C14H20NO (M+) 218.15394, found  218.15381; IR(film): ν [cm-1] = 2968 (s), 2929 
(m), 2876 (m), 1753 (m), 1641 (vs), 1457 (s), 1411 (s), 1254 (w), 1208 (m), 925 (s), 728 (s). 
 
N-benzyl-N-(hex-1-en-3-yl)acetamide (Table 2, Entry 5), (76e) 
The general procedure was followed with N-benzylhex-1-en-3-amine (294 
mg, 1.55 mmol), DMAP (9.5 mg, 0.078 mmol), triethylamine (471 mg, 0.62 
ml, 4.65 mmol) and acetylchloride (243 mg, 0.22 ml, 3.10 mmol) in 10 ml of 
CH2Cl2. The crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/MTBE = 4/1) to give the title compound (280 mg, 78 %) as colourless oil. 
[ ]20Dα = -41.5 (c = 0.836, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.33 (t, 2H, J = 7.5 
Hz), 7.26 (d, 2H, J = 7.9Hz), 7.20 (d, 1H, J = 7.9 Hz), 5.73 (dddd, 1H, J = 6.3 Hz, J = 10.4 
Hz, J = 16.8 Hz, J = 27.6 Hz), 5.18-5.01 (m, 2.5H), 4.72 (d, 0.5 H, J = 15.4 Hz), 4.43 (d, 1H, 
J = 1.7 Hz), 4.28 (d, 0.5H, J = 15.4 Hz), 4.24-4.20 (m, 0.5H), 2.20, 2.00 (s, 3H),1.58-1.50 
(m, 2H), 1.32-1.12 (m, 2H), 0.84, 0.73 (t, 1H, J = 7.3 Hz); 13C-NMR (CDCl3, 100 MHz) δ 
ppm 171.6 (s, C), 139.2,138.1 (s, C), 136.9, 136.7 (d, CH), 128.6, 128.2, 127.6, 127.1, 126.7, 
126.1 (6d, CH), 117.4, 116.5 (t, CH2), 60.9, 56.6 (d, CH), 48.5, 45.5 (t, CH2), 34.6, 33.7 (t, 
CH2), 22.5, 22.3 (q, CH3), 19.6 (t, CH2), 13.9, 13.6 (q, CH3); HRMS: m/z (ESI) calc for 
C15H22NO (M+H+) 232.16959, found  232.16945; IR(film): ν [cm-1] = 2955 (s), 2922 (s), 
2870 (m), 1955 (w), 1648 (vs), 1420 (m), 1200 (w), 978 (m). 
N
Bn
O
 
N-Phenyl-N-(1-propyl-allyl)-acetamide (Table 2, Entry 6), (76f) 
The general procedure was followed with N-(hex-1-en-3-yl)aniline (203 mg, 
1.16 mmol), DMAP (7 mg, 0.058 mmol), triethylamine (352 mg, 0.46 ml, 
3.48 mmol) and acetylchloride (180 mg, 0.163 ml, 2.30 mmol) in 10 ml of 
CH2Cl2. The crude reaction mixture was purified by column chromatography 
on silica gel (cyclohexane/MTBE = 4/1) to give the title compound (192 mg, 76 %) as 
viscous colourless oil. [ ]20Dα = -12.7 (c = 0.937, CHCl3); 1H NMR (400 MHz, CDCl3)  δ ppm 
7.42-7.30 (m, 3H), 7.08 (d, J = 6.82 Hz, 2H), 5.66-5.52 (m, 1H), 5.22-5.12 (m, 2H), 5.08 (d, 
J = 10.26 Hz, 1H), 1.73 (s, 3H), 1.57-1.42 (m, 1H), 1.41-1.27 (m, 3H), 0.88 (t, J = 7.00 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ ppm 170.0 (C), 139.9 (C), 137.2 (CH), 129.9 (CH), 
129.1 (CH), 128.0 (CH), 117.4 (CH2), 57.3 (CH), 34.2 (CH2), 23.3 (CH3), 19.5 (CH2), 13.8 
(CH3); HRMS: m/z (ESI) calc for C14H20NO (M+H+) 218.15394, found  218.15381; 
N
O
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IR(film): ν [cm-1] = 3063 (w), 2958 (s), 2931 (s), 2872 (s), 1660 (s), 1594 (s), 1494 (s), 1382 
(s), 1313 (s), 702 (s);  
 
General procedure for hydroformylation / Fischer indole synthesis reactions with 
subsequent addition of bronsted acid. General procedure A 
 
In a thick walled sample vial containing PTFE septum Rhodium(I)(acac)(CO)2 (0.01 equiv.), 
XANTPHOS (0.1 equiv.), phenylhydrazine (1 equiv.) and olefin (1 equiv.) were dissolved in 
dry THF (5 mL). The vial was placed in a pressure vessel, flushed with argon and 
pressurized with 10 bar H2 and 10 bar CO. The reaction mixture was stirred for 5 days at  80 
°C. A 4 wt. % solution of H2SO4 in THF (5 mL) was slowly added and the resulting mixture 
was refluxed for 3 hours. Reaction was quenched with ammonia solution (30% in water) and 
the aqueous phase was extracted with 4x10 mL  DCM. The combined organic layers were 
washed with brine, dried over MgSO4, filtered and volatiles were removed in vacuo. The 
crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate or cyclohexane/MTBE) to give the desired product. 
 
General procedure for hydroformylation / Fischer indole synthesis reactions with 
subsequent addition of Lewis acid. General procedure B 
 
In a thick walled sample vial containing PTFE septum olefin (1 equiv.), phenylhydrazine (1 
equiv.), Rhodium(I)(acac)(CO)2 (0.01 equiv.) and XANTPHOS (0.1 equiv.) were dissolved 
in dry THF (5 mL). The vial was placed in a pressure vessel, flushed with argon and 
pressurized with 10 bar H2 and 10 bar CO. The reaction mixture was stirred for 5 days at 80 
°C. After completion of the reaction volatiles were removed in vacuo, residue was dissolved 
in toluol (10 mL) and ZnCl2 (4 eq) was added and the resulting mixture was refluxed for 12 
hours. Reaction mixture was diluted with water and the aqueous phase was extracted with 
4x10 mL DCM. The combined organic layers were washed with brine, dried over MgSO4, 
filtered and volatiles were removed in vacuo. The crude reaction mixture was purified by 
column chromatography on silica gel (cyclohexane/ethylacetate or cyclohexane/MTBE) to 
give the desired product.  
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N-Benzyl-N-[2-(1H-indol-3-yl)-1-phenyl-ethyl]-acetamide (Table 3, Entry 1), (81a), (R-
(+))  
The general procedure A was followed with N-Benzyl-N-(1-phenyl-
allyl)-acetamide (335 mg, 1.26 mmol), phenylhydrazine (136 mg, 1.26 
mmol), Rh(acac)(CO)2 (4.5 mg, 0.013 mmol) and XANTPHOS (73 
mg, 0.13 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 1/1/0.1) to give 
(288 mg, 62 % yield) of the title compound as yellowish oil. HPLC analysis indicated that 
the enantiomeric excess of the product was 92 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 90/10; flow rate = 2 ml/min; detection wavelength = 254 nm; TR 
= 11.3 (+), 14.2 (-) min]. [ ]20Dα = + 2.1 (c = 1.800, CHCl3); (Table 3, Entry 2), (81b), (S-(-)) 
The general procedure A was followed with N-Benzyl-N-(1-phenyl-allyl)-acetamide (265 
mg, 1.0 mmol), phenylhydrazine (109 mg, 1.26 mmol), Rh(acac)(CO)2 (4 mg, 0.01 mmol) 
and XANTPHOS (60 mg, 0.1 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 1/1/0.1) to give 
(240 mg, 65 % yield) of the title compound as yellowish oil. HPLC analysis indicated that 
the enantiomeric excess of the product was 97 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 90/10; flow rate = 2 ml/min; detection wavelength = 254 nm; TR 
= 11.2 (+), 14.3 (-) min]. [ ]20Dα = - 2.0 (c = 1.800, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ 
ppm  8.25, 8.16 (2 bs, 1 H, NH) , 7.85-7.07 (m, 13 H, 13 x CH), 6.91 (d, 1 H, J = 4.5 Hz, 
CH), 6.97, 6.47 (2 s, 1 H, CH), 6.36, 5.38 (dd, t, 1H, J = 4.9 Hz, J = 9.3 Hz, J = 7.8 Hz, CH), 
4.45, 4.29 (2 d, 1 H, J = 17.6 Hz, CHH), 4.73, 4.21 (2 d, 1 H, J = 15.0 Hz, J = 14.9 Hz, 
CHH), 3.48-3.31 (m, 2 H, CH2), 2.02, 1.82, (2 s, 3 H, CH3); 13C-NMR (CDCl3, 100 MHz) δ 
ppm 172.1 (s, C), 142.4 (s, C), 139.9 (s, C), 137.9 (s, C), 131.8, 131.7, 128.8, 128.6, 128.5, 
128.1, 127.7, 127.4 (2 d, CH), 127.3, 127.1, 126.8, 126.3 (s, C), 122.6, 122.2, 122.0, 119.7, 
119.4, 118.8, 118.1 (2 d, CH), 112.5 (s, C), 111.6, 111.1 (2 d, CH), 62.0, 57.1 (2 d, CH), 
49.0, 45.9 (2 t, CH2), 27.8, 27.1 (2 t, CH2), 23.0, 22.2 (2 q, CH3); HRMS: m/z (FAB) calc 
for C25H25N2O (M+H+) 369.1967, found 369.2004; IR(film): ν [cm-1] = 3419 (w), 3273 (m), 
3029 (w), 2925 (w), 1630 (s), 1495 (m), 1455 (m), 1421 (m), 1360 (w), 1336 (w), 1028 (w), 
981 (w), 743 (s), 699 (s), 542 (w); 
N
H
N
Ph
Ac Bn
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N-(2-(1H-indol-3-yl)-1-phenylethyl)-N-cyclohexylacetamide, (Table 3, Entry 3), (81c) 
The general procedure A was followed with N-cyclohexyl-N-(1-
phenylallyl)acetamide (100 mg, 0.39 mmol), phenylhydrazine (42 
mg, 0.39 mmol), Rh(acac)(CO)2 (1 mg, 0.004 mmol) and 
038 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE = 1/2) to give (64 mg, 45 % 
yield) of the title compound as yellow oil.
XANTPHOS (22 mg, 0.
[ ]20Dα = +46.4 (c = 0.507, CHCl3); 1H NMR (400 
MHz, CDCl3 ) δ ppm 8.49 (s, 1H), 8.23 (s, 1H), 7.71 (d, 1H, J = 7.36 Hz), 7.58 (d, 1H, J = 
7.73 Hz), 7.49 (d, 2H, J = 7.43 Hz), 7.44 (d, 2H, J = 7.29 Hz), 7.41-7.24 (m, 8H), 7.24-7.09 
(m, 4H), 6.94 (d, 2H, J = 23.79 Hz), 5.20 (dd, 1H, J = 7.79 Hz, J = 5.35 Hz), 3.81 (dd, 1H, J 
= 11.52 Hz, J = 6.95 Hz), 3.70-3.54 (m, 2H), 3.31 (dd, 2H, J = 14.79 Hz, J = 8.77 Hz), 2.18 
(s, 3H), 1.78 (s, 3H), 1.70-1.43 (m, 10H), 1.41-1.00 (m, 6H), 1.00-0.70 (m, 4H); 13C NMR 
(126 MHz, CDCl3)  δ ppm 170.9, 170.8 (2xC), 139.8 (2xC), 136.1 (2xC), 128.3 (CH), 128.1 
(CH), 128.0 (CH), 127.9 (CH), 127.7 (CH), 127.2 (C), 126.6 (CH), 123.0, 122.9 (2xCH), 
122.0 (CH), 121.6 (CH), 119.4 (CH), 119.1 (CH), 118.5 (CH), 118.0 (CH), 111.6 (C), 111.5 
(CH), 111.2 (CH), 56.6 (CH),32.2 (CH2), 30.4 (CH2), 29.2 (CH2), 26.7 (CH2), 26.4 (CH2), 
26.3 (CH2), 26.1 (CH2), 25.3 (CH2), 25.2 (CH2), 24.2 (CH3), 23.9 (CH3); HRMS: m/z 
(HPLC-ESI) calc for C24H29N2O (M+H+) 361.2274, found 361.2268; IR(film): ν [cm-1] = 
3279 (s), 3058 (s), 2930 (s), 2853 (s), 1719 (m), 1633 (s), 1494 (s), 1454 (s), 1380 (s), 1366 
(s), 1316 (s), 909 (s), 738 (s), 699 (s), 646 (m); 
N
H
N
Ph
Ac
 
N-Benzyl-N-[1-(1H-indol-3-ylmethyl)-propyl]-acetamide, (Table 3, Entry 4), (81d)  
The general procedure A was followed with N-Benzyl-N-(1-ethyl-
allyl)-acetamide   (245 mg, 1.13 mmol), phenylhydrazine (122 mg, 
1.13 mmol), Rh(acac)(CO)2  (4.7 mg, 0.011 mmol) and XANTPHOS 
(65.4 mg, 0.113 mmol). The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/ethylacetate/triethylamine = 1/1/0.1) to give (214 
mg, 59 % yield) of the title compound as brownish oil. [ ]20Dα = -54.4 (c = 1.02, CHCl3); 1H-
NMR (CDCl3, 400 MHz) δ ppm  8.77, 8.69 (2 bs, 1H), 7.53, 7.47 (2 d, 1H, J = 7.8 Hz), 7.38-
7.04 (m, 8H), 6.99, 6.66 (2 s, 1H), 4.71, 4.55 (2 d, 1H, J = 15.4 Hz), 4.33 (dd, 1H, J = 17.4 
Hz, J = 43.0 Hz), 4.02 -3.95, 3.07-3.02 (2 m, 1H), 2.95-2.85 (m, 2H), 2.05,1.81 (2 s, 1H), 
1.70-1.59 (m, 2H), 0.92-0.80 (m, 3H); 13C NMR (100 MHz, CDCl3 ) δ ppm 172.2 (s, C), 
139.3 (s, C), 137.8, 136.1 (2s, C), 127.5, 126.9 (2s, C), 128.5, 128.2, 127.9, 127.1, 126.7, 
N
H
N
Ac Bn
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126.3, 122.9, 122.4, 121.7, 121.5, 119.2, 118.9, 118.5, 117.8 (14d, 7xCH), 112.6, 111.4 (2s, 
C), 111.5, 111.1 (2d, CH), 61.8 (d, CH), 43.9 (t, CH2), 29.4, 28.4 (2t, CH2), 26.4, 25.2 (2 t, 
CH2), 22.9, 22.0 (2q, CH3), 11.4, 11.3 (2q, CH3); HRMS: m/z (ESI) calc for C21H25N2O 
(M+H+) 321.19614, found  321.19619; IR(film): ν [cm-1] =3412 (m) , 3280 (bs), 2955 (s), 
2925 (s), 2860 (s), 1580 (s), 1495 (m), 1440 (m), 1333 (m), 1305 (m), 1240 (m), 1160 (w), 
1106 (m), 974 (m), 742 (s). 
 
N-Benzyl-N-[1-(1H-indol-3-ylmethyl)-butyl]-acetamide, (Table 3, Entry 5), (81e)  
The general procedure A was followed with N-Benzyl-N-(1-propyl-
allyl)-acetamide (405 mg, 1.75 mmol), phenylhydrazine (190 mg, 1.75 
mmol), Rh(acac)(CO)2 (6.3 mg, 0.017 mmol) and XANTPHOS (101 
mg, 0.17 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 1/1/0.1) to give 
(445 mg, 76 % yield) of the title compound as yellow oil. HPLC analysis indicated that the 
enantiomeric excess of the product was 91 % [Diacel Chiralcel OD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 95/5; flow rate = 1.5 ml/min; detection wavelength = 254 nm; TR 
= 17.0 (-), 19.5 (+) min]. [ ]20Dα = + 26.2 (c = 0.992, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ 
ppm 8.69, 8.61 (2 bs, 1H, NH),  7.53, 7.46 (2d, 1H, J = 7.8 Hz, CH),  7.40-7.04 (m, 8H, 8 x 
CH), 7.02, 6.67 (2 d, 1H, J = 1.8 Hz, J = 2.1 Hz, CH), 4.79, 4.47 (2 d, 1H, J = 15.3 Hz, 
CHH), 4.38, 4.32 (2d, 1H, J = 17.4 Hz, CHH), 4.10-4.02, 3.08-3.01 (m, 1H, CH), 2.94-2.84 
(m, 2H, CH2), 2.04, 1.77 (2 s, 3H, CH3), 1.61-1.51 (m, 2H, CH2), 1.32-1.20 (m, 2H, CH2), 
0.81, 0.74 (2 t, 3H, J = 7.3 Hz, CH3); 13C-NMR (CDCl3, 100 MHz) δ ppm 172.2 (s, C), 
139.7 (s, C), 136.3, 128.7, 128.4, 128.2 (s, C), 127.8, 127.3, 126.9, 126.5, 123.0 (s, C), 
122.5, 122.2, 121.9, 119.6, 119.3, 118.9 (d, CH), 118.1 (d, CH), 113.0 (s, C), 111.6, 111.2 (2 
d, CH), 60.1 (d, CH), 46.0 (t, CH2), 35.9, 34.7 (2 t, CH2), 29.8, 28.9 (2 t, CH2), 23.2, 22.2 
(2 q, CH3), 20.3, 20.1, (2 t, CH2), 14.1, 13.9 (2 q, CH3); HRMS: m/z (FAB) calc for 
C22H27N2O (M+H+) 335.2123, found 335.2129; IR(film): ν [cm-1] = 3412 (m) , 3296 (bs), 
2955 (s), 2925 (s), 2870 (s), 1560 (s), 1495 (m), 1456 (m), 1340 (m), 1299 (m), 1237 (m), 
1162 (w), 1106 (m), 974 (m), 879 (w), 742 (s). 
N
H
N
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N-(1-(1H-indol-3-yl)pentan-2-yl)-N-phenylacetamide, (Table 3, Entry 6), (81f) 
The general procedure A was followed with N-(hex-1-en-3-yl)-N-
phenylacetamide (100 mg, 0.46 mmol), phenylhydrazine (50 mg, 0.46 
mmol), Rh(acac)(CO)2 (1.5 mg, 0.006 mmol) and XANTPHOS (32 
mg, 0.055 mmol). The crude reaction mixture was purified by column chromatography on 
silica gel (cyclohexane/MTBE = 1/1) to give (99 mg, 66 % yield) of the title compound as 
brown oil.[ ]20Dα = -47.2 (c = 0.46, CHCl3); 1H NMR (500 MHz, CDCl3 ) δ ppm 8.27 (bs, 1H), 
7.52 (d, 1H, J = 7.89 Hz), 7.50-7.28 (m, 5H), 7.23-7.17 (m, 2H), 7.08-7.12 (m, 1H), 5.33 (s, 
1H), 2.87 (dd, 1H, J = 15.44 Hz, J = 9.11 Hz), 2.73 (dd, 1H, J = 15.53 Hz, J = 5.91 Hz), 
1.74 (s, 3H), 1.59-1.44 (m, 4H), 0.93 (t, 3H, J = 7.05 Hz); 13C NMR (125 MHz, CDCl3 ) δ 
ppm 171.1 (C), 139.5 (C), 136.2 (C), 129.2 (CH), 129.0 (CH), 128.1 (CH), 127.6 (C), 122.2 
(CH), 121.8 (CH), 119.2 (CH), 118.7 (CH), 113.2 (C), 111.0 (CH), 60.5 (CH), 35.2 (CH2), 
29.1 (CH2), 23.7 (CH3), 20.0 (CH2), 14.0 (CH3); HRMS: m/z (ESI) calc for C21H25N2O 
(M+H+) 321.1961, found 321.1962; IR(film): ν [cm-1] = 3291 (s), 2957(s), 2928(s), 2870 
(m), 1633 (s), 1593 (s), 1494 (s), 1394 (s), 740 (s), 703 (s). 
N
H
N
Ac Ph
Prn
 
4-(2-(1H-indol-3-yl)-1-phenylethyl)morpholine, (Table 3, Entry 7), (81g)  
The general procedure A was followed with 4-(1-
phenylallyl)morpholine (150 mg, 0.738 mmol), phenylhydrazine (80 
mg, 0.738 mmol), Rh(acac)(CO)2 (1.92 mg, 0.007 mmol) and 
XANTPHOS (43 mg, 0.07 mmol). The crude reaction mixture was 
purified by flash column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 
1/1/0.1) to give (119 mg, 52 % yield) of the title compound as yellowish oil. HPLC analysis 
indicated that the enantiomeric excess of the product was 97 % [Diacel Chiralcel OD (0.46 
cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 2 ml/min; detection wavelength 
= 254 nm; TR = 16.2 (+), 18.2 (-) min]. [ ]20Dα = -41.6 (c = 1.35, CHCl3); 1H NMR (400 
MHz, CDCl3 ) δ  7.88 (bs, 1H), 7.55 (d, 1H, J = 7.9 Hz), 7.14-7.34 (m, 7H), 7.10 (t, 1H, J = 
7.4 Hz), 6.56 (d, 1H, J = 2.5 Hz), 3.74 (t, 4H, J = 4.6 Hz,), 3.64 (dd, 1H, J = 4.8 Hz, J = 9.6 
Hz), 2.51-2.55 (m, 2H), 3.50 (dd, 1H, J = 4.5 Hz, J = 14.4 Hz), 3.08 (dd,1H , J = 9.6 Hz, J = 
14.3 Hz,), 2.61-2.66 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ  140.8 (C). 136.0 (C), 128.9 
(CH), 128.0 (CH), 127.8 (C), 127.1 (CH), 122.7 (CH), 121.8 (CH), 119.2 (CH), 118.7 (CH), 
113.2 (C), 111.1 (CH), 71.0 (CH), 67.5 (CH2), 51.5 (CH2), 28.6 (CH2); HRMS: m/z (FAB) 
calc for C20H23N2O (M+H+) 307.1810, found 307.1805; IR(film): ν [cm-1] = 3396 (m), 3012 
N
H
N
Ph
O
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(m), 3027 (w), 2954 (s), 2853 (s), 2810 (s), 1599 (s), 1500 (s), 1452 (s), 1272 (m), 1116 (s), 
1068 (m), 876 (m), 742 (s), 703 (s). 
 
2-(2-(1H-indol-3-yl)-1-phenylethyl)isoindoline-1,3-dione, (Table 3, Entry 8), (81h) 
The general procedure A was followed with phthalimide (300 mg, 2 
mmol), phenylhydrazine (220 mg, 2 mmol), Rh(acac)(CO)2 (5.2 mg, 
0.02 mmol) and Xanthphos (120 mg, 0.2 mmol). The crude reaction 
mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate/ = 2/1) to give (491 mg, 67 % yield) of the title compound as 
yellowish oil. [ ]20Dα = +112.5 (c = 0.810, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 8.05 
(s, 1H), 7.72-7.63 (m, 4H), 7.54 (dd, 2H, J = 3.1 Hz, J = 5.3 Hz), 7.37 (t, 2H, J = 7.4 Hz), 
7.31 (d, 1H, J = 7.2 Hz), 7.23 (d, 1H, J = 7.1 Hz), 7.16-7.08 (m, 2H), 6.92 (s, 1H), 5.85 (dd, 
1H, J = 6.0 Hz, J = 10.4 Hz), 4.19 (dd, 1H, J = 10.5 Hz, J = 14.9 Hz), 3.70 (dd, 1H, J = 6.0 
Hz, J = 14.9 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 168.3, 139.6, 136.0, 133.7, 131.6, 
128.5, 128.0, 127.8, 127.2, 122.9, 122.4, 121.8, 119.3, 118.5, 112.0, 111.0, 54.9, 27.1; 
HRMS: m/z (ESI) calc for C24H19N2O2 (M+H+) 367.1410, found 367.14410; IR(film): ν [cm-
1] = 3441 (w), 3054 (w), 2929 (w), 1757 (w), 1707 (vs), 1615 (m), 1398 (s), 1352 (s), 1319 
(m), 1102 (m), 715 (s). 
N
H
Ph
NPht
 
3-(2-phenyl-2-(pyrrolidin-1-yl)ethyl)-1H-indole, (Table 3, Entry 9), (81i) 
The general procedure A was followed with 1-(1-
phenylallyl)pyrrolidine (100 mg, 0.533 mmol), phenylhydrazine (58 
mg, 0.533 mmol), Rh(acac)(CO)2 (1.55 mg, 0.006 mmol) and 
XANTPHOS (36 mg, 0.062 mmol). The crude reaction mixture was 
purified by flash column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 
1/1/0.1) to give (73 mg, 47 % yield) of the title compound as brown oil. HPLC analysis 
indicated that the enantiomeric excess of the product was 98 % [Diacel Chiralcel OD (0.46 
cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 2 ml/min; detection wavelength 
= 254 nm; TR = 7.1 (-), 9.2 (+) min]. [ ]20Dα  = -112.9 (c = 1.00, CHCl3); 1H NMR (400 MHz, 
CDCl3 ) δ ppm 7.98 (bs, 1H), 7.54 (d, 1H, J = 7.9 Hz), 7.27 (d, 1H, J = 7.8 Hz) , 7.07-7.21 
(m, 6 H), 6.40 (d, 1H, J = 2.1 Hz), 4.48 (dd, J = 3.9 Hz, J = 10.4 Hz, 1 H), 3.58 (dd, J = 3.6 
Hz, J = 13.8 Hz, 1 H), 3.11 (dd, 1H, J = 10.5 Hz, J = 14.0 Hz,), 2.77-2.79 (m, 2 H), 2.54-
N
H
N
Ph
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2.57 (m, 2 H), 1.79-1.85 (m, 4 H); 13C NMR (101 MHz, CDCl3)  δ ppm 143.1 (s, C), 136.0 
(s, C), 128.5 (2 d, CH), 128.0 (2 d, CH), 127.8 (s, C), 127.1 (d, CH), 122.9 (d, CH), 121.7 (d, 
CH), 119.2 (d, CH), 118.9 (d, CH), 112.9 (s, C), 111.0 (d, CH), 71.8 (d, CH), 53.3 (2 t, 
CH2), 32.0 (t, CH2), 23.4 (2 t, CH2); HRMS: m/z (FAB) calc for C20H23N2 (M+H+) 
291.1861, found 291.1846; IR(film): ν [cm-1] = 3478 (m), 3424 (m), 2969 (m), 2794 (m), 
1731 (m), 1492 (m), 1455 (s), 1372 (m), 1046 (m), 915 (w), 889 (w), 702 (s). 
 
N,N-diethyl-2-(1H-indol-3-yl)-1-(2-methoxyphenyl)ethanamine, (Table 3, Entry 10), 
(81j)  
The general procedure A was followed with N,N-diethyl-1-(2-
methoxyphenyl)prop-2-en-1-amine (150 mg, 0.68 mmol), phenyl 
hydrazine (74 mg, 0.68 mmol), Rh(acac)(CO)2 (1.78 mg, 0.0068 
mmol) and XANTPHOS (40 mg, 0.068 mmol, 0.1 equiv.). The 
crude reaction mixture was purified by column chromatography on silica gel 
(DCM/MeOH/triethylamine = 10/1/0.1) to give (74 mg, 33 % yield) of the title compound as 
brown solid. [ ]20Dα = -20.45 (c = 1.700, CHCl3); 1H NMR (400 MHz, CDCl3) δ ppm, 7.79 
(bs, 1H), 7.61 (d, 1H, J = 7.66 Hz), 7.45 (d, 1H, J = 7.33 Hz), 7.25 (d, 1H, J = 6.49 Hz), 
7.19-7.03 (m, 1H), 6.92 (t, 1H, J = 7.41Hz), 6.74 (d, 1H, J = 8.13 Hz), 6.67 (s, 1H), 4.77 
(dd, 1H, J = 9.52 Hz, J = 5.33 Hz), 3.48 (s, 1H), 3.38 (dd, 1H, J = 14.52 Hz, J = 5.19 Hz), 
3.14 (dd, 1H, J = 14.47 Hz, J = 9.65 Hz), 2.79 (qd, 1H, J = 14.18, J = 7.14 Hz, J = 7.13 
Hz), 2.50 (qd, 1H, J = 13.49 Hz, J = 6.79 Hz, J = 6.79 Hz), 1.06 (t, 1H, J = 7.05 Hz); 13C 
NMR (100 MHz, CDCl3 ) δ ppm 158.1 (C), 135.8 (C), 128.5 (CH), 128.0 (CH), 127.4 (CH), 
122.1 (CH), 121.4 (CH), 120.1 (CH), 118.8 (2xCH), 114.0 (C) 110.7 (2xCH), 55.8 (CH), 
55.3 (CH3), 43.4 (CH2), 28.5 (CH2), 12.8 (CH3); HRMS: m/z (FAB) calc for C21H26N2O 
(M+H+) 322.2045, found 323.2098; IR(film): ν [cm-1] = 3450 (s), 2975 (s), 1615 (s), 1510 
(s), 1410 (s), 1255 (s), 1178 (s), 1035 (s), 747 (s); 
HN N
MeO
 
3-(2-(4-methoxyphenyl)-2-(piperidin-1-yl)ethyl)-1H-indole, (Table 3, Entry 11), (81k) 
The general procedure A was followed with N-1-(1-(4-
Methoxyphenyl) allyl) piperidin (150 mg, 0.64 mmol), 
Phenylhydrazin (70 mg, 0.64 mmol), Rh(acac)(CO)2 (1.71 
mg, 0.006 mmol) and XANTPHOS (37 mg, 0.06 mmol). 
The crude reaction mixture was purified by column chromatography on silica gel 
HN N
N OMe
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(cyclohexane/MTBE = 1/1) to give (116 mg, 50 % yield) of the title compound as white 
solid. [ ]20Dα = -25.45 (c = 1.700, CHCl3); 1H NMR (500 MHz, CDCl3 ) δ ppm 7.81 (bs, 1H), 
7.60 (d, 1H, J = 7.61 Hz), 7.32-7.24 (m, 1H), 7.18-7.05 (m, 4H), 6.79 (d, 2H, J = 8.43 Hz), 
6.62 (s, 1H), 3.77 (s, 3H), 3.77-3.75 (m, 1H), 3.46 (dd, 1H, J = 15.34, J = 5.16 Hz), 3.24-
3.14 (m, 1H), 2.50 (bs, 4H), 1.61 (bs, 4H), 1.39 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 
ppm 159.2 (C), 135.8 (C), 129.8 (2xCH), 129.8 (C), 128.0 (CH), 127.7 (C), 122.5 (CH), 
121.3 (CH), 118.7 (CH), 113.4 (C), 112.9 (2xCH), 110.9 (CH), 69.9 (CH), 55.5 (CH3), 51.3 
(CH2), 29.6 (CH2), 28.2 (CH2), 26.3 (2xCH2), 24.6 (CH2); HRMS: m/z (ESI) calc for 
C22H27N2O (M+H+) 335.2118, found 335.2118; IR(KBr): ν [cm-1] = 3444 (s), 2956 (s), 1609 
(s), 1515 (s), 1457 (s), 1403 (s), 1255 (s), 1181 (s), 1027 (s), 747 (s); 
 
3-(2-Furan-2-yl-2-morpholin-4-yl-ethyl)-1H-indole, (Table 3, Entry 12), (81l) 
The general procedure A was followed with 4-(1-Furan-2-yl-allyl)-
morpholine (315 mg, 1.63 mmol), phenylhydrazine (176 mg, 1.63 
mmol), Rh(acac)(CO)2 (5.8 mg, 0.016 mmol) and XANTPHOS (94 
mg, 0.16 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 1/1/0.1) to give 
(270 mg, 56 % yield) of the title compound as brown oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 
7.98 (s, 1H), 7.56 (d, 1H, J = 7.8 Hz), 7.37 (s, 1H), 7.28 (d, 1H, J = 8.0 Hz), 7.12 (dt, 2H, J = 
7.2 Hz, J = 25.3 Hz), 6.76 (s, 1H), 6.24 (dd, 1H, J = 2.0 Hz, J = 2.7 Hz), 6.04 (d, 1H, J = 3.1 
Hz), 3.85 (t, 1H, J = 7.4 Hz), 3.73 (m, 4H), 3.31 (d, 2H, J = 7.4 Hz), 2.57 (dtd, 2H, J = 4.9 
Hz, J = 10.9 Hz, J = 15.6 Hz); 13C-NMR (CDCl3, 100 MHz) δ 153.6, 141.7, 136.0, 127.7, 
122.4, 121.9, 119.3, 118.7, 113.1, 111.2, 109.9, 108.9, 67.4, 63.7, 50.5, 26.4; HRMS: m/z 
(ESI) calc for C18H21N2O2 (M+H+) 297.15975, found  297.15973; IR(film): ν [cm-1] = 3410 
(s), 2925 (s), 1615 (s), 1515 (s), 1457 (m), 1395 (s), 1245 (s), 1181 (s), 910 (s), 747 (s); 
HN
N
O
O
 
3-(2-Piperidin-1-yl-2-pyridin-3-yl-ethyl)-1H-indole, (Table 3, Entry 13), (81m) 
The general procedure B was followed with 3-(1-Piperidin-1-yl-
allyl)-pyridine (264 mg, 1.30 mmol), phenylhydrazine (141 mg, 
1.30 mmol), Rh(acac)(CO)2 (4.7 mg, 0.013 mmol) and XANTPHOS 
(75 mg, 0.13 mmol). The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexane/MTBE/triethylamine = 1/1/0.1) to 
N
H
N
N
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give (162 mg, 41 % yield) of the title compound as brown solid. [ ]20Dα = -42.6 (c = 1.21, 
CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm  8.40-8.35 (m, 2H), 7.88 (bs, 1H), 7.55-7.48 (m, 
2H), 7.26 (d, 1H, J = 8.1 Hz), 7.15-7.10 (m, 2H), 7.06 (t, 1H, J = 7.3 Hz), 6.63 (d, 1H, J = 
1.5 Hz), 3.77 (dd, 1H, J = 4.3 Hz, J = 9.5 Hz), 3.47 (dd, 1H, J = 3.0 Hz, J = 14.0 Hz), 3.14 
(dd, 1H, J = 10.3 Hz, J = 14.0 Hz), 2.48 (bs, 4H), 1.70-1.55 (m, 4H), 1.42-1.36 (m, 2H); 13C-
NMR (CDCl3, 100 MHz) δ ppm 150.2, 148.2, 136.0, 135.9, 134.5, 127.4, 122.9, 122.5, 
121.8, 119.1, 118.5, 112.6, 111.0, 68.3, 51.4, 27.9, 26.1, 24.45; HRMS: m/z (ESI) calc for 
C20H24N3 (M+H+) 306.19647, found  306.19616; IR(film): ν [cm-1] = 3467 (w), 3165 (m), 
2922 (vs), 2843 (s), 1720 (s), 1615 (s), 1589 (s), 1464 (vs), 1365 (m), 1249 (s), 1088 (s), 741 
(vs). 
 
General Procedures for iridium catalyzed Allylic Alkylations.  
 
Catalyst activation with DABCO. General procedure A 
In a schlenck tube [Ir(cod)Cl]2 (0.02 equiv.), phosphoramidite ligand L3 (0.04 equiv.) and 
DABCO (0.2 equiv.) were dissolved in dry THF (1 ml/mmol) and stirred under argon 
atmosphere at 50 °C for 2 hours. Carbonate (1 equiv.) was added in one portion and the 
mixture was stirred for another 20 minutes. Nucleofile (Cyanoacetate) was added and the 
mixture was stirred at 50 °C until TLC showed full conversion. The reaction was quenched 
with saturated   NH4Cl solution and the aqueous layer was extracted with CH2Cl2. Collected 
organic extracts were dried over MgSO4, filtered and volatiles were evaporated in vacuo. 
The ratio of diastereoisomers (sin/anti) was determined by 1H – NMR of the crude reaction 
mixture. The crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate or cyclohexane/MTBE) to give the desired product. 
 
Catalyst activation with propylamine. General procedure B 
[Ir(cod)Cl]2 (0.08 mmol) and phosphoramidite ligand L3 (0.16 mmol.) were diluted in 1 ml 
of dry THF, 0.3 ml propylamine were added and the mixture was stirred under argon stream 
at 50 °C for 20 min. After this time all volatiles were evaporated. The yellow solid was 
diluted in 4ml of dry THF to generate a stock solution of the activated catalyst. Amine (1.2 
mmol) was added to 1 ml of the stock solution of the catalyst (2 mol% catalyst). Carbonate 
(1 mmol) was added in one portion and the reaction was stirred at room temperature until 
TLC showed full conversion. The volatile materials were evaporated and the ratio of 
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diastereoisomers (sin/anti) was determined by 1H – NMR of the crude reaction mixture. The 
crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate or cyclohexane/MTBE) to give the desired product. 
 
LiHMDS as a base. General procedure C 
[Ir(cod)Cl]2 (0.02 mmol, 0.02 equiv.), phosphoramidite ligand L3 (0.04 mmol, 0.04 equiv.) 
and carbonate (1 mmol, 1 equiv.) were dissolved in dry THF (1mL) and stirred under argon 
atmosphere at r.t. for 15 minutes.  In a separate flask solution of cyanoacetate or 
benzophenone protected glycine ethyl ester (1.1 mmol, 1.1 equiv.) in dry THF (2 mL) was 
cooled to -78°C. LiHMDS (1.1 mmol, 1.1 equiv.) was added dropwise via syringe and 
solution was stirred for 30 minutes at  -78°C. The solution containing lithium enolate was 
added dropwise to a solution containing carbonate and catalyst cooled to -78 °C. The 
reaction mixture was allowed to warm up to room temperature and was stirred until TLC 
showed full conversion. Reaction mixture was quenched with 20 mL of sat. NH4Cl solution, 
extracted with CH2Cl2 (4x10mL), washed with brine, dried over MgSO4, filtered and 
evaporated. The crude reaction mixture was purified by flash column chromatography on 
silica gel (cyclohexane/MTBE) to give the desired product. 
 
KOH or NaOH as a base. General procedure D 
 [Ir(cod)Cl]2 (0.02 mmol, 0.02 equiv.), and phosphoramidite ligand L3 (0.04 mmol, 0.08 
equiv.) were dissolved in 1 mL of dry THF and stirred under argon atmosphere at r.t. for 15 
min.. In a separate flask cyanoacetate or benzophenone protected glycine ethyl ester (1.1 
mmol, 1.1 equiv.), KOH (1.1 mmol, 1.1 equiv.) or NaOH (1.1 mmol, 1.1 equiv.) and 
Bu4NHSO4 (0.1 mmol, 0.1 equiv.) were suspended in dry THF and stirred vigorously for 30 
minutes at 0 °C. The solution containing the catalyst was cooled to 0 °C and carbonate (1 
mmol, 1 equiv.) was added dropwise via syringe, suspension containing the enolate was 
subsequently added and the reaction mixture was allowed to warm to room temperature. The 
reaction was conducted at r.t until TLC showed full conversion. Reaction mixture was 
quenched with 20 mL of sat. NH4Cl solution, extracted with CH2Cl2 (4x10mL), washed with 
brine dried over MgSO4, filtered and evaporated. The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexane/MTBE) to give the desired product. 
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(2S,3R)-ethyl 2-(diphenylmethyleneamino)-3-phenylpent-4-enoate (83a), 
(2R,3R)-ethyl 2-(diphenylmethyleneamino)-3-phenylpent-4-enoate (84a). 
(Table 5, Entry 1) The general procedure A was followed with cinnamyl methylcarbonate 
(96 mg, 0.5 mmol), N-(Diphenylmethylene)glycin ethyl ester (150 mg, 0.55 mmol), 
[Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol) and DABCO (12 mg, 0.1 
mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 16 hours. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate =25/1) to give (103 mg, 54 % yield) of the 83a and (63 mg, 33 % 
yield) of the 84a. 83a: [ ]20Dα = -175.4 (c = 0.960, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 97 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection wavelength = 254 nm; TR 
= 5 min. (-), 5.9  min (+)]; 84a: [ ]20Dα = +168.7 (c = 1.230, CHCl3); HPLC analysis indicated 
that the enantiomeric excess of the product was 95 % [Diacel Chiralcel AD (0.46 cm x 25 
cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection wavelength = 254 
nm; TR = 4.8 (-), 7.1 (+) min].  
(Table 5, Entry 2) The general procedure C was followed with cinnamyl methylcarbonate 
(96 mg, 0.5 mmol), N-(Diphenylmethylene)glycin ethyl ester (150 mg, 0.55 mmol), 
[Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L1 (11 mg, 0.02 mmol) and LiHMDS (0.5 ml, 1M 
solution in THF) in dry THF (3 mL). The reaction was conducted at r.t. for 3h. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate =25/1) to give (107 mg, 56 % yield) of the 83a and (46 mg, 24 % 
yield) of the 84a. 83a: [ ]20Dα = -89.6 (c = 0.742, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 65 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection wavelength = 254 nm; TR 
= 5.0 (-), 5.9 min (+)]. 84a:[ ]20Dα = +119.6 (c = 0.945, CHCl3); HPLC analysis indicated that 
the enantiomeric excess of the product was 62 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection wavelength = 254 nm; TR 
= 4.7 (-), 7.1 min (+)].  
(Table 5, Entry 3) By a similar procedure as above in the presence of ligand L3 cinnamyl 
methylcarbonate (96 mg, 0.5 mmol) was transformed into (121 mg, 63 % yield) of the 83a 
and  (40 mg, 21 % yield) of the 84a. The reaction was conducted at r.t. for 3h. 83a: [ ]20Dα = -
172.4 (c = 0.560, CHCl3); HPLC analysis indicated that the enantiomeric excess of the 
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product was 87 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 
95/5; flow rate = 1 mL/min; detection wavelength = 254 nm; TR = 5.0 (-), 5.9  min (+)]. 
84a: ee not determined.  
 (Table 5, Entry 4) The general procedure D was followed with cinnamyl methylcarbonate 
(96 mg, 0.5 mmol), N-(Diphenylmethylene)glycin ethyl ester (150 mg, 0.55 mmol), 
[Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol) and DABCO (12 mg, 0.1 
mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 5 hours. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate =25/1) to give (50 mg, 26 % yield) of the 83a and (75 mg, 39 % 
yield) of the 84a. 83a: [ ]20Dα = -170.5 (c = 0.89, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 91 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection wavelength = 254 nm; TR 
= 5.0 (-), 5.8 (+) min]. 84a: ee not determined. 
83a: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.64 (d, 2H, J = 7.2 Hz), 7.42-
7.30 (m, 6H), 7.24-7.10 (m, 5H), 6.79 (d, 2H, J = 6.2 Hz), 6.32 (ddd, 
1H, J = 8.9 Hz, J = 13.5 Hz, J = 16.9 Hz), 5.22-5.16 (m, 2H), 4.35 (d, 
1H, J = 6.0 Hz), 4.17-4.02 (m, 3H), 1.12 (t, 3H, J = 7.1 Hz); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 171.1, 170.8, 140.9, 139.5, 137.4, 136.2, 130.3, 128.9, 128.5, 
128.4, 128.2, 127.9, 127.7, 126.6, 117.4, 70.6, 60.8, 53.7, 14.1; HRMS: m/z (ESI) calc for 
C26H26NO2 (M+H+) 384.19581, found  384.19616; IR(film): ν [cm-1] = 3054 (m), 2981 (s), 
2922 (vs), 2850 (s), 1963 (w), 1878 (w), 1733 (vs), 1615 (s), 1444 (s), 1240 (s), 1024 (s), 
703 (s).  
N CO2Et
Ph
Ph
84a: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.43 (d, 2H, J = 7.3 Hz), 7.39-
7.29 (m, 4H), 7.26-7.07 (m, 7H), 6.71 (d, 2H, J = 3.8 Hz), 5.97 (ddd, 
1H, J = 8.9 Hz, J = 10.1 Hz, J = 17.3 Hz), 5.11 (d, 1H, J = 17.1 Hz), 
5.05 (d, 1H, J = 10.2 Hz), 4.33 (d, 1H, J = 9.1 Hz), 4.22-4.08 (m, 3H), 
1.23 (t, 3H, J = 7.1 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 171.1, 170.9, 140.3, 139.6, 
137.5, 135.9, 130.1, 128.9, 128.9, 128.6, 128.2, 128.2, 128.0, 127.8, 126.6, 116.9, 70.9, 60.9, 
54.1, 14.2; HRMS: m/z (ESI) calc for C26H26NO2 (M+H+) 384.19581, found  384.19630; 
IR(film): ν [cm-1] = 3050 (m), 2985 (s), 2922 (vs), 2850 (s), 1960 (w), 1876 (w), 1730 (vs), 
1615 (s), 1448 (s), 1240 (s), 1120 (s), 1024 (s), 703 (s). 
N CO2Et
Ph
Ph
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(2S,3R)-ethyl 2-(diphenylmethyleneamino)-3-(2-methoxyphenyl)pent-4-enoate, (83b), 
(2R,3R)-ethyl 2-(diphenylmethyleneamino)-3-(2-methoxyphenyl)pent-4-enoate, (84b), 
(Table 6, Entry 1). 
The general procedure A was followed with (E)-3-(2-methoxyphenyl)allyl methyl carbonate 
(111 mg, 0.5 mmol), N-(Diphenylmethylene)glycin ethyl ester (150 mg, 0.55 mmol), 
[Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol) and DABCO (12 mg, 0.1 
mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 48 hours. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate =20/1) to give (118 mg, 57 % yield) of the 83b and (52 mg, 25 % 
yield) of the 84b.  
83b: [ ]20Dα = -170.5 (c = 0.89, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 91 % [Diacel Chiralcel AD 
(0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 98/2; flow rate = 1 
mL/min; detection wavelength = 254 nm; TR = 7.6 (-), 8.3 (+) min]. 1H-NMR (CDCl3, 400 
MHz) δ ppm 7.58 (d, 2H, J = 7.2 Hz), 7.37-7.25 (m, 6H), 7.12 (t, 2H, J = 7.9 Hz), 6.79 (t, 
1H, J = 7.3 Hz), 6.71-6.65 (m, 3H), 6.42 (dt, 1H, J = 9.6Hz, J = 17.3 Hz), 5.22 (d, 1H, J = 
17.3 Hz), 5.17 (dd, 1H, J = 1.1 Hz, J = 10.2 Hz), 4.54 (d, 1H, J = 5.5 Hz), 4.47 (dd, 1H, J = 
5.6 Hz, J = 8.7 Hz), 4.17-4.00 (m, 2H), 3.50 (s, 3H), 1.13 (t, 3H, J = 7.1 Hz); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 171.3, 170.8, 156.7, 139.6, 136.7, 136.4, 130.1, 129.6, 129.2, 
128.8, 128.1, 127.9, 127.9, 127.5, 120.1, 117.5, 110.3, 67.8, 60.6, 54.9, 47.6, 14.1; HRMS: 
m/z (ESI) calc for C27H28NO3 (M+H+) 414.20637, found  414.20594; IR(film): ν [cm-1] = 
3073 (m), 2968 (s), 2929 (s), 2830 (m), 2265 (m), 1746 (vs), 1661 (s), 1635 (vs), 1490 (vs), 
1457 (s), 1420 (s), 1326 (m), 1286 (m), 1155 (m), 1024 (m), 912 (s), 754 (vs), 689 (vs). 
N CO2Et
Ph
Ph
OMe
84b: [ ]20Dα = -136.5 (c = 1.15, CHCl3); ee not determined; 1H-NMR 
(CDCl3, 400 MHz) δ ppm 7.41-7.33 (m, 5H), 7.29 (t, 1H, J = 7.3 Hz), 
7.21 (t, 2H, J = 7.5 Hz), 7.13-7.05 (m, 2H,), 6.85-6.77 (m, 2H), 6.69 (d, 
1H, J = 8.1 Hz), 6.11 (dt, 1H, J = 9.8Hz, J = 18.3 Hz), 5.13 (d, 1H, J = 
17.1 Hz), 5.01 (d, 1H, J = 10.1 Hz), 4.62 (d, 1H, J = 9.4 Hz), 4.44 (t, 1H, J = 9.0 Hz), 4.27-
4.10 (m, 2H), 3.56 (s, 3H), 1.25 (t, 3H, J = 7.2 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 
171.5, 170.4, 157.0, 140.1, 137.0, 136.0, 130.2, 129.9, 128.9, 128.5, 128.5, 127.9, 127.7, 
127.6, 120.2, 116.7, 110.3, 69.3, 60.7, 54.8, 49.9, 14.2; HRMS: m/z (ESI) calc for 
C27H28NO3 (M+H+) 414.20637, found  414.20602; IR(film): ν [cm-1] = 3070 (m), 2954 (s), 
N CO2Et
Ph
Ph
OMe
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2929 (s), 2834 (m), 2265 (m), 1743 (vs), 1640 (vs), 1485 (vs), 1420 (s), 1320 (m), 1241 (m), 
1155 (m), 1024 (m), 912 (s), 754 (vs), 696 (vs). 
 
(2S,3R)-ethyl 2-(diphenylmethyleneamino)-3-(4-methoxyphenyl)pent-4-enoate, (83c), 
(2R,3R)-ethyl 2-(diphenylmethyleneamino)-3-(4-methoxyphenyl)pent-4-enoate, (84c), 
(Table 6, Entry 2) The general procedure A was followed with  (E)-3-(4-
methoxyphenyl)allyl methyl carbonate (111 mg, 0.5 mmol), N-(Diphenylmethylene)glycin 
ethyl ester (150 mg, 0.55 mmol), [Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 
mmol) and DABCO (12 mg, 0.1 mmol) in dry THF (3 mL). The reaction was conducted at 
50 °C for 48 hours. The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/Ethylacetate =20/1) to give (110 mg, 54 % yield) 
of the 83c and (89 mg, 43 % yield) of the 84c. 83c: [ ]20Dα = -145.2 (c = 0.515, CHCl3); HPLC 
analysis indicated that the enantiomeric excess of the product was 94 % [Diacel Chiralcel 
AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 6.1 (-), 7.9 min (+)]; 84c: [ ]20Dα = +84.3 (c = 0.865, CHCl3); 
HPLC analysis indicated that the enantiomeric excess of the product was 91 % [Diacel 
Chiralcel AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 6.2 (-), 7.9 (+) min].  
(Table 6, Entry 3) The general procedure C was followed with (E)-3-(4-
methoxyphenyl)allyl methyl carbonate (96 mg, 0.5 mmol), N-(Diphenylmethylene)glycin 
ethyl ester (150 mg, 0.55 mmol), [Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L1 (11 mg, 0.02 
mmol) and LiHMDS (0.5 ml, 1M solution in THF) in dry THF (3 mL). The reaction was 
conducted at r.t. for 3h. The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/Ethylacetate =20/1) to give (74 mg, 36 % yield) 
of the 83c and (39 mg, 19 % yield) of the 84c. 83c: [ ]20Dα = -93.7 (c = 1.10, CHCl3); HPLC 
analysis indicated that the enantiomeric excess of the product was 67 % [Diacel Chiralcel 
AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 6.1 (-), 7.9 min (+)]; 84c: [ ]20Dα = +46.2 (c = 0.645, CHCl3); 
HPLC analysis indicated that the enantiomeric excess of the product was 62 % [Diacel 
Chiralcel AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 6.2 (-), 7.9 (+) min].  
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83c: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.61 (d, 2H, J = 7.3 Hz), 
7.40-7.27 (m, 6H), 7.01 (d, 2H, J = 8.6 Hz), 6.81 (d, 2H, J = 6.0 
Hz), 6.73 (d, 1H, J = 8.6 Hz), 6.28-6.17 (m, 1H), 5.16-5.08 (m, 2H), 
4.28 (d, 1H, J = 6.2 Hz), 4.10-3.99 (m, 3H), 3.73 (s, 3H), 1.10 (t, 
3H, J = 7.1 Hz), 13C-NMR (CDCl3, 100 MHz) δ ppm 171.0, 170.9, 158.2, 137.7, 136.3, 
132.9, 130.3, 129.5, 128.9, 128.4, 128.3, 127.9, 127.8, 117.0, 113.6, 70.8, 60.8, 55.2, 52.8, 
14.1; HRMS: m/z (ESI) calc for C27H28NO3 (M+H+) 414.20637, found  414.20568; IR(film): 
ν [cm-1] = 3050 (s), 2975 (s), 2929 (s), 1920 (w), 1872 (w), 1740 (vs), 1621 (vs), 1510 (vs), 
1444 (s),  1240 (s), 1120 (s), 1030 (s), 918 (s), 695 (m);  
N CO2Et
Ph
Ph
MeO
84c: 1H-NMR (CDCl3, 400 MHz) δ ppm  7.45 (d, 1H, J = 7.3 Hz), 
7.40-7.29 (m, 4H), 7.26-7.21 (m, 2H), 7.03 (d, 2H, J = 8.6 Hz), 
6.78-6.71 (m, 4H), 5.93 (ddd, 1H, J = 8.6 Hz, J = 10.1 Hz, J = 17.3 
Hz), 5.08 (d, 1H, J = 17.1 Hz), 5.02 (d, 1H, J = 10.3 Hz), 4.29 (d, 
1H, J = 8.9 Hz), 4.20-4.03 (m, 3H), 3.74 (s, 3H), 1.23 (t, 3H, J = 7.1 Hz); 13C-NMR (CDCl3, 
100 MHz) δ ppm 171.7, 171.1, 158.2, 137.8, 136.0, 132.4, 130.1, 129.8, 128.9, 128.5, 128.2, 
128.0, 127.8, 116.5, 113.5, 70.9, 60.8, 55.2, 53.2, 14.2; HRMS: m/z (ESI) calc for 
C27H28NO3 (M+H+) 414.20637, found  414.20600; IR(film): ν [cm-1] = 3045 (s), 2972 (s), 
2929 (s), 1920 (w), 1830 (w), 1733 (vs), 1620 (vs), 1510 (vs), 1444 (s),  1220 (s), 1060 (s), 
1030 (s), 918 (s), 695 (m). 
N CO2Et
Ph
Ph
MeO
 
(2S,3R)-ethyl 2-(diphenylmethyleneamino)-3-(2-furyl)pent-4-enoate, (83d) 
(2R,3R)-ethyl 2-(diphenylmethyleneamino)-3-(2-furyl)pent-4-enoate, (84d) 
(Table 6, Entry 4) The general procedure A was followed with (E)- 3-furan-2-yl-prop-2-en-
1-ol methyl carbonate  (91 mg, 0.5 mmol), N-(diphenylmethylene)glycin ethyl ester (150 
mg, 0.55 mmol), [Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol) and 
DABCO (12 mg, 0.1 mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 48 
hours. The crude reaction mixture was purified by flash column chromatography on silica 
gel (cyclohexane/Ethylacetate =20/1) to give (76 mg, 41 % yield) of the 83d and (52 mg, 28 
% yield) of the 84d. 
83d: [ ]20Dα = -128.5 (c = 0.92, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 95 % [Diacel Chiralcel AD 
(0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 
mL/min; detection wavelength = 254 nm; TR = 5.9 (-), 7.0 min (+)]; 1H-
O
N CO2Et
Ph
Ph
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NMR (CDCl3, 400 MHz) δ 7.59 (d, 2H, J = 7.3 Hz), 7.41-7.34 (m, 4H), 7.32-7.26 (m, 2H), 
7.22 (s, 1H), 6.96 (d, 1H, J = 3.6 Hz), 6.27-6.17 (m, 2H), 6.01 (d, 1H, J = 3.0 Hz), 5.27-5.20 
(m, 2H), 4.45 (d, 1H, J = 5.4 Hz), 4.22 (dd, 1H, J = 5.6 Hz, J = 8.7 Hz), 4.19-4.07 (m, 2H), 
1.19 (t, 3H, J = 7.1 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 171.5, 170.6, 154.1, 141.1, 
139.6, 136.2, 134.7, 130.3, 128.9, 128.6, 128.3, 127.9, 127.8, 118.3, 110.2, 106.5, 68.5, 60.9, 
47.5, 14.1; HRMS: m/z (ESI) calc for C24H24NO3 (M+H+) 374.17507, found  374.17511; 
IR(film): ν [cm-1] = 3385 (w), 3080 (w), 3054 (w), 2981 (m), 2922 (w), 2340 (m), 1738 (vs), 
1659 (s), 1444 8s9, 1254 (s), 1180 (m), 1142 (m), 932 (s), 702 (vs);  
84d: [ ]20Dα = +34.4 (c = 0.742, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 94 % [Diacel Chiralcel AD 
(0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 95/5; flow rate = 1 
mL/min; detection wavelength = 254 nm; TR = 5.1 (-), 7.3 min (+)]; 1H-
NMR (CDCl3, 400 MHz) δ ppm 7.52 (d, 1H, J = 7.4 Hz), 7.41-7.22 (m, 4H), 7.29-7.22 (m, 
3H), 6.93 (d, 2H, J = 4.4 Hz), 6.25 (s, 1H), 6.17 (d, 1H, J = 2.7 Hz), 5.88 (td, 1H, J = 9.4 Hz, 
J = 18.3 Hz), 5.14 (d, 1H, J = 17.1 Hz), 5.09 (d, 1H, J = 10.2 Hz), 4.35 (d, 1H, J = 8.1 Hz), 
4.24 (t, 1H, J = 8.3 Hz), 4.16 (q, 2H, J = 7.1 Hz), 1.23 (t, 3H, J = 7.1 Hz); 13C-NMR (CDCl3, 
100 MHz) δ ppm 171.4, 170.6, 153.4, 141.2, 139.6, 135.9, 134.9, 130.3, 128.9, 128.6, 128.4, 
128.0, 127.9, 117.8, 110.2, 107.3, 69.1, 60.9, 47.6, 14.2; HRMS: m/z (ESI) calc for 
C24H24NO3 (M+H+) 374.17507, found  374.17516; IR(film): ν [cm-1] = 3380 (w), 3050 (w), 
2952 (s), 2916 (w), 2352 (m), 1730 (vs), 1650 (s), 1645 (s), 1451 (m), 1319 (m), 1265 (vs), 
1037 (m), 918 (s), 715 (s). 
N CO2Et
O
Ph
Ph
 
(2S,3R)-ethyl 2-(diphenylmethyleneamino)-3-(3-purydyl)pent-4-enoate, (83e) 
(2R,3R)-ethyl 2-(diphenylmethyleneamino)-3-(3-purydyl)pent-4-enoate, (84e) 
(Table 6, Entry 5) The general procedure A was followed with (E)- 3-pyridin-3-yl-prop-2-
en-1-ol methyl carbonate  (100 mg, 0.5 mmol), N-(diphenylmethylene)glycin ethyl ester 
(150 mg, 0.55 mmol), [Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol) and 
DABCO (12 mg, 0.1 mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 48 
hours. The crude reaction mixture was purified by flash column chromatography on silica 
gel (cyclohexane/Ethylacetate =20/1) to give (90 mg, 47 % yield) of the 83e and (48 mg, 25 
% yield) of the 84e. 
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83e: [ ]20Dα = +45.4 (c = 0.84, CHCl3); HPLC analysis indicated that the 
enantiomeric excess of the product was 92 % [Diacel Chiralcel AD (0.46 
cm x 25 cm, 5 µm); heptane/2-propanol = 90/10; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 7.9 (major), 10.1 (minor) min]. 1H-NMR (CDCl3, 400 
MHz) δ ppm 8.43-8.35 (m, 2H), 7.61 (d, 2H, J = 7.3 Hz), 7.44 (d, 2H, J = 7.9 Hz), 7.40-7.22 
(m, 7H), 7.12 (dd, 1H, J = 4.8 Hz, J = 7.7 Hz), 6.78 (d, 2H, J = 6.1 Hz), 6.30 (ddd, 1H, J = 
8.7 Hz, J = 10.1 Hz, J = 17.3 Hz), 5.23-5.13 (m, 2H), 4.30 (d, 1H, J = 5.8 Hz), 4.17-4.01 (m, 
3H), 1.12 (t, 3H, J = 7.1 Hz); 13C-NMR (CDCl3, 100 MHz) δ171.9, 170.8, 150.9, 148.2, 
139.6, 136.6, 136.2, 136.0, 135.5, 130.9, 128.8, 128.5, 128.3, 128.0, 127.5, 123.5, 118.8, 
70.9, 61.6, 50.8, 14.7;  HRMS: m/z (ESI) calc for C25H25N2O2 (M+H+) 385.19105, found  
385.19128; IR(film): ν [cm-1] = 3375 (w), 3080 (w), 3047 (m), 2981 (m), 2922 (m), 2850 
(m), 2370 (m), 1740 (vs), 1661 (s), 1575 (s), 1444 (s), 1273 (s), 1175 (m), 1017 (m), 925 (s), 
695 (vs). 
N CO2Et
Ph
Ph
N
84e: [ ]20Dα = +34.4 (c = 0.98, CHCl3);ee not determined; 1H-NMR 
(CDCl3, 400 MHz) δ ppm 8.48-8.39 (m, 2H), 7.55 (d, 1H, J = 7.7 Hz), 
7.47 (d, 2H, J = 7.4 Hz), 7.38 (m, 3H), 7.28-7.22 (m, 3H), 6.82 (d, 2H, J 
= 5.2 Hz), 5.99-5.88 (m, 1H), 5.13-5.04 (m, 2H), 4.36 (d, 1H, J = 8.0 Hz), 4.18-4.07 (m, 
3H), 1.20 (t, 1H, J = 7.1 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 171.7, 170.4, 149.9, 
147.9, 139.1, 136.6, 136.3, 136.1, 135.9, 130.5, 128.9, 128.6, 128.4, 128.0, 127.5, 123.1, 
118.2, 70.0, 61.0, 50.9, 14.1; HRMS: m/z (ESI) calc for C25H25N2O2 (M+H+) 385.19105, 
found  385.19150; IR(film): ν [cm-1] = 3375 (w), 3080 (w), 2988 (m), 2922 (m), 2850 (m), 
2352 (m), 1745 (vs), 1660 (s), 1576 (s), 1477 (m), 1444 (s), 1260 (s), 1175 (m), 1017 (m), 
925 (s), 695 (vs). 
Ph
N
N CO2Et
Ph
 
(2S,3R)-ethyl 2-(diphenylmethyleneamino)-3-(ethyl)pent-4-enoate, (83f) 
(2R,3R)-ethyl 2-(diphenylmethyleneamino)-3-(ethyl)pent-4-enoate, (84f) 
(Table 6, Entry 6) The general procedure A was followed with  methyl (E)-pent-2-enyl 
carbonate (77 mg, 0.5 mmol), N-(Diphenylmethylene)glycin ethyl ester (150 mg, 0.55 
mmol), [Ir(cod)Cl]2 (7 mg, 0.01 mmol), ligand L3 (11 mg, 0.02 mmol) and DABCO (12 mg, 
0.1 mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 48 hours. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate =20/1) to give (79 mg, 47 % yield) of the 83f and (30 mg, 18 % 
yield) of the 84f. 
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83f: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.63 (d, 2H, J = 7.2 Hz), 7.45-
7.34 (m, 4H), 7.30 (t, 2H, J = 7.3 Hz), 7.12 (dd, 2H, J = 2.6 Hz, J = 6.4 
Hz), 5.91 (dt, 1H, J = 9.9 Hz, J = 17.1 Hz), 5.14-5.08 (m, 2H), 4.15 (ddt, 
 7.2 Hz, J = 10.6 Hz), 4.04 (d, 1H, J = 4.6 Hz), 2.63-2.59 (m, 1H), 1.34-
1.20 (m, 5H), 0.77 (t, 3H, J = 7.4 Hz); 13C-NMR (CDCl
2H, J = 3.6 Hz, J =
3, 100 MHz) δ ppm 171.7, 170.5, 
139.7, 138.7, 136.6, 130.2, 128.9, 128.5, 128.4, 127.9, 127.9, 116.9, 69.2, 60.6, 50.1, 24.5, 
14.3, 11.8; HRMS: m/z (ESI) calc for C22H26NO2 (M+H+) 336.19581, found  336.19591; 
IR(film): ν [cm-1] = 3054 (m), 2968 (s), 2929 (s), 2863 (s), 2364 (w), 1976 (w), 1904 (w), 
1733 (vs), 1621 (s), 1528 (m), 1451 (s), 1372 (m), 1319 (w), 1260 (m), 1030 (m), 912 (s), 
695 (s). 
N CO2Et
Ph
Ph
84f: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.63 (d, 2H, J = 7.3 Hz), 7.44-
7.34 (m, 4H), 7.31 (t, 2H, J = 7.3 Hz), 7.11 (dd, 2H, J = 2.7 Hz, J = 6.4 
Hz), 5.45 (dt, 1H, J = 9.8 Hz, J = 17.3 Hz), 5.07-4.98 (m, 2H), 4.12 (q, 
2H, J = 7.1 Hz), 3.94 (d, 1H, J = 7.4 Hz), 2.72-2.62 (m, 1H), 1.66-1.46 (m, 2H), 1.22 (t, 3H, 
J = 7.1 Hz), 0.80 (t, 3H, J = 7.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 171.5, 170.9, 
139.6, 138.4, 136.4, 130.3, 128.9, 128.6, 128.4, 127.9, 127.9, 117.2, 70.1, 60.6, 49.9, 23.3, 
14.3, 11.7; HRMS: m/z (ESI) calc for C22H26NO2 (M+H+) 336.19581, found  336.19595; 
IR(film): ν [cm-1] = 2965 (s), 2931 (s), 2863 (s), 2320 (w), 1976 (w), 1904 (w), 1825 (w),  
1730 (vs), 1625 (s), 1515 (m), 1451 (s), 1312 (w), 1260 (m), 1030 (m), 925 (s), 695 (s). 
N CO2Et
Ph
Ph
 
ethyl 2-(diphenylmethyleneamino)pent-4-enoate, 83h), (Table 6, Entry 7). 
The general procedure A was followed with allyl methylcarbonate (60 mg, 
0.5 mmol), N-(Diphenylmethylene)glycin ethyl ester (150 mg, 0.55 mmol), 
[Ir(cod)Cl]2 (7 mg, 0.01 mmol), racemic ligand L3 (11 mg, 0.02 mmol) and 
DABCO (12 mg, 0.1 mmol) in dry THF (3 mL). The reaction was conducted at 50 °C for 48 
hours. The crude reaction mixture was purified by flash column chromatography on silica 
gel (cyclohexane/Ethylacetate =15/1) to give the title compound (43 mg, 28%) as colourless 
oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 7.62 (d, 2H, J = 7.2 Hz), 7.45-7.28 (m, 6H),  7.18-
7.11 (m, 2H), 5.67 (tdd, 1H, J = 7.2 Hz, J = 10.0 Hz, J = 17.2 Hz), 5.05 (d, 1H, J = 17.1 Hz), 
5.00 (d, 1H, J = 10.1 Hz), 4.20-4.08 (m, 3H), 2.64 (tq, 2H, J = 6.9 Hz, J = 14.0 Hz), 1.24 (t, 
3H, J = 7.1 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 171.8, 170.58, 139.5, 136.4, 134.3, 
N
Ph
Ph
CO2Et
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130.3, 128.8, 128.6, 128.4, 127.9, 127.9, 117.6, 65.3, 60.9, 38.19, 14.2. Analytical data fits 
with literature.105
 
(2S,3R)-methyl 2-(diphenylmethyleneamino)-3-phenylpent-4-enoate (86a) 
To a 20 ml of 1% K2CO3 solution in methanol was added (2S,3S)-ethyl 
2-(diphenylmethyleneamino)-3-phenylpent-4-enoate (83a), 50 mg (0.13 
mmol), and after 1h of stiring at room temperature, methanol was 
removed and the crude rest was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate =15/1) to give the title compound (40 mg, 89%) as colourless oil. 
N
Ph
CO2Me
Ph
Ph
(R)
(S)
[ ]20Dα = - 175 (c = 1.12, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.45-7.09 (m, 13H), 
6.70 (s, 2H), 5.98 (ddd, 2H, J = 8.9, J = 10.4, J = 17.4 Hz), 5.13 (d, 1H, J = 17.4 Hz), 5.07 
(d, 1H, J = 10.4 Hz), 4.39 (d, 1H, J = 8.9 Hz), 4.13 (dd, 1H, J = 8.9, 8.9 Hz), 3.72 (s, 3H); 
13C-NMR (CDCl3, 100 MHz) δ ppm 171.8, 171.3, 140.3, 139.7, 137.4, 135.9, 130.5, 128.9, 
128.8 (2C), 128.3, 128.2, 128.1, 127.9, 126.8, 116.9, 71.4, 54.4, 52.3. Analytical data fits 
with literature.70 
 
2-Amino-4-(1H-indol-3-yl)-3-phenyl-butyric acid ethyl ester (85a) 
The general procedure A was followed with ethyl 2-
(diphenylmethyleneamino)-3-phenylpent-4-enoate (83a+84a) (655 
mg, 1.7 mmol), phenylhydrazine (186 mg, 1.7 mmol), 
Rh(acac)(CO)2 (4.4 mg, 0.017 mmol) and XANTPHOS (65 mg, 0.17 mmol). The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/ethylacetate/triethylamine = 1/2/0.1) to give (334 mg, 61 % yield) of the title 
compound as yellow oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 8.22, 8.12 (2s, 1H), 7.65, 7.61 
(2d, 1H, J = 7.7 Hz), 7.30-7.14 (m, 8H), 6.78, 6.67 (2s, 1H), 4.16-4.06, 4.02-3.92,3.88-3.80 
(3m, 2H), 3.73 (d, 1H, J = 4.9 Hz), 3.57, 3.50-3.34 (dd, m 2H, J = 7.3 Hz, J = 12.8 Hz). 3.17 
(td, 1H, J = 7.7 Hz, J = 14.6 Hz), 1.81 (bs, 2H), 1.22, 1.06 (2t, 1H, J = 7.1 Hz). 13C-NMR 
(CDCl3, 100 MHz) δ ppm 175.2, 174.5 (2xC), 141.5, 140.2 (2xC), 136.0, 135.9 (2xC), 128.5, 
128.4 (2xCH), 128.2, 128.1 (2xCH), 127.5, 127.4 (2xC), 126.9, 126.7 (2xCH), 122.6, 122.4 
(2xCH), 121.6, 121.5 (2xCH), 119.0, 118.9 (2xCH), 118.7, 118.6 (2xCH), 113.5, 113.3 
(2xC), 111.0, 110.9 (2xCH), 60.8, 60.7(2xCH2), 59.2, 57.7 (2xCH), 50.0, 49.3 (2xCH), 27.9, 
N
H
H2N
CO2Et
Ph
                                                 
105 Palacios, F., Aparicio, D., Santos, J. M. de los., Baceiredo, A., Bertrand, G. Tetrahedron, 56, 2000, 663 - 
670. 
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26.0 (2xCH2), 14.1, 13.8 (2xCH3). HRMS: m/z (ESI) calc for C20H23N2O2 (M+H+) 
323.17540, found  323.17553; 
 
2-Amino-3-(1H-indol-3-ylmethyl)-pentanoic acid ethyl ester (85b) 
The general procedure A was followed with ethyl 2-
(diphenylmethyleneamino)-3-(ethyl)pent-4-enoate (83f+84f) (735 
mg, 2.2 mmol), phenylhydrazine (239 mg, 2.2 mmol), 
Rh(acac)(CO)2 (5.7 mg, 0.022 mmol) and XANTPHOS (85 mg, 
0.17 mmol). The crude reaction mixture was purified by flash column chromatography on 
silica gel (cyclohexane/ethylacetate/triethylamine = 1/2/0.1) to give (278 mg, 46 % yield) of 
the title compound as yellow oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 8.35, 8.29 (2s, 1H), 
7.65, 7.58 (2d, 1H, J = 7.8 Hz), 7.31 (d, 1H, J = 7.8 Hz), 7.12 (dt, 2H, J = 7.2 Hz, J = 27.7 
Hz), 7.00, 6.93 (2s, 1H), 4.05  (dq, 1H, J = 7.2 Hz, J = 10.9 Hz), 3.86 (dq, 1H, J = 7.2 Hz, J 
= 10.9 Hz), 3.60, 3.48 (2d, 1H, J = 2.7 Hz), 2.84, 2.73 (2t, 1H, J = 8.1 Hz), 2.27-2.19 (m, 
1H), 1.59 (bs, 2H), 1.54-1.35 (m, 2H), 1.17 (t, 3H, J = 7.1 Hz), 0.97 (t, 3H, J = 7.5 Hz); 13C-
NMR (CDCl3, 100 MHz) δ ppm 175.9, 136.3, 127.6, 122.7, 121.6, 118.9, 118.9, 113.8, 
111.0, 60.7, 55.3, 44.0, 25.1, 23.7, 14.0, 11.9; HRMS: m/z (ESI) calc for C20H23N2O2 
(M+H+) 275.17540, found  275.17548; IR(film): ν [cm-1] = 3389 (bs), 3251 (bs),  2948 (s), 
2863 (s), 1733 (vs), 1477 (s), 1227 (s), 1188 (s), 1024 (m). 
N
H
H2N
CO2Et
 
tert-butyl 2-cyano-3-phenylpent-4-enoate, (91a),  
(Table 8, Entry 1) The general procedure C was followed with [Ir(cod)Cl]2 (13 mg, 0.02 
mmol), ligand L3 (23 mg, 0.04 mmol), cinnamyl methylcarbonate (192 mg, 1 mmol),  t-
butyl cyanoacetate (155 mg, 1.1 mmol, 0.16 mL) and LiHMDS (184 mg, 1.1 mmol, 1.1 mL, 
1.1 equiv.). The reaction was conducted at room temperature for 3h. 1H-NMR of the crude 
reaction mixture indicated the ratio of diastereoisomers (syn/anti) to be 65/35. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/MTBE = 18/1) to give the title compound (168 mg, 65 %) as yellow oil. 
(Table 8, Entry 2) The general procedure D was followed with [Ir(cod)Cl]2 (13 mg, 0.02 
mmol), ligand L3 (23 mg, 0.04 mmol), cinnamyl methylcarbonate (192 mg, 1 mmol),  t-
butyl cyanoacetate (155 mg, 1.1 mmol, 0.16 mL 1.1 equiv.), KOH (62 mg, 1.1 mmol) and 
Bu4NHSO4 (16 mg, 0.2 mmol). The reaction was conducted at r.t. for 16 h. 1H-NMR of the 
crude reaction mixture indicated the ratio of diastereoisomers (syn/anti) to be 43/57. The 
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crude reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/MTBE = 18/1) to give the title compound (160 mg, 62 %) as yellow oil. 
(Table 8, Entry 3) The general procedure D was followed with [Ir(cod)Cl]2 (13 mg, 0.02 
mmol), ligand L3 (23 mg, 0.04 mmol), cinnamyl methyl carbonate (192 mg, 1 mmol),  t-
butyl cyanoacetate (155 mg, 1.1 mmol, 0.16 mL), NaOH (44mg, 1.1 mmol) and Bu4NHSO4 
(16 mg, 0.2 mmol). The reaction was conducted at r.t. for 12 h. 1H-NMR of the crude 
reaction mixture indicated the ratio of diastereoisomers (syn/anti) to be 45/55. The crude 
reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/MTBE = 18/1) to give the title compound (155 mg, 60 %) as yellow oil. 
(Table 8, Entry 4) The general procedure C was followed with [Ir(cod)Cl]2 (13 mg, 0.02 
mmol), ligand L3 (23 mg, 0.04 mmol), cinnamyl methylcarbonate (192 mg, 1 mmol),  t-
butyl cyanoacetate (155 mg, 1.1 mmol, 0.16 mL) and DABCO (23 mg, 0.2 mmol). The 
reaction was conducted at 50 °C for 18h. 1H-NMR of the crude reaction mixture indicated 
the ratio of diastereoisomers (syn/anti) to be 57/43. The crude reaction mixture was purified 
by flash column chromatography on silica gel (cyclohexane/MTBE = 18/1) to give the title 
compound (196 mg, 76 %) as yellow oil. 
(Table 8, Entry 5) The general procedure B for allylic alkylations was followed with 
[Ir(cod)Cl]2 (15 mg, 0.02 mmol), ligand L3 (19 mg, 0.04 mmol), cinnamyl methylcarbonate 
(192 mg, 1 mmol), and t-butyl cyanoacetate (155 mg, 1.1 mmol, 0.16 mL). The reaction 
mixture was stirred at r.t. for 5 days. 1H-NMR of the crude reaction mixture indicated the 
ratio of diastereoisomers (syn/anti) to be 52/48.The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexan/MTBE=9/1) to give to give the title 
compound (108 mg, 42 %) as yellow oil. 
1H NMR (400 MHz, CDCl3 ) δ ppm 7.39-7.26 (m, 10H), 6.21-6.04 (m, 
2H), 5.27 (td, 4H, J = 16.72 Hz, J = 11.22 Hz, J = 11.22 Hz), 4.00 (dt, 
2H, J = 7.60, J = 7.53, J = 2.79 Hz), 3.77 (d, 1H, J = 7.52 Hz), 3.71 (d, 
1H, J = 7.16 Hz), 1.37 (s, 9H), 1.36 (s, 9H); 13C NMR (101 MHz, 
CDCl3) δ ppm 163.7 (C), 163.6 (C), 138.4 (C), 137.8 (C), 136.2 (CH), 
135.0 (CH), 128.8 (CH), 128.7 (CH), 128.6 (CH), 128.5 (CH), 128.1 (CH), 127.9 (CH), 
127.7 (CH), 119.0 (CH2), 118.0 (CH2), 115.7 (C), 115.7 (C), 84.2 (C), 84.1 (C), 49.9 (CH), 
49.6 (CH), 27.6 (CH3), 27.6 (CH3); HRMS: m/z (HPLC-ESI) calc for C16H20 NO2 (M+H+) 
258.1489, found 258.1490; IR(film): ν [cm-1] =3080 (m), 3021 (m), 2956 (s), 2240 (m), 1750 
(vs), 1640 (m), 1615 (m), 1491 (m), 1435 (s), 1260 (s), 1124  (w), 1029 (m), 918 (s), 843 
(w), 726 (m), 702 (m). 
NC
OtBu
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Methyl 2-cyano-3-phenylpent-4-enoate, (91b) (Table 8, Entry 1), 
The general procedure A was followed with cinnamyl methylcarbonate 
(300 mg, 1.56 mmol, 1 equiv.), methylcyanoacetate (185 mg, 1.87 mmol, 
1.2 equiv.), [Ir(cod)Cl]2 (21 mg, 0.03 mmol, 0.02 equiv.), ligand L3 (35 
mg, 0.06 mmol, 0.04 equiv.) and DABCO (35 mg, 0.31 mmol, 0.2 
equiv.) in dry THF (4 mL). The reaction was conducted at 50 °C for 16 hours. 1H-NMR of 
the crude reaction mixture indicated the ratio of diastereoisomers (syn/anti) to be 50/50. The 
crude reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/MTBE = 5/1) to give the title compound (219 mg, 65 %) as colourless oil. 1H 
NMR (400 MHz, CDCl3 ) δ ppm 7.38-7.28 (m, 5 H), 6.23-6.07 (m, 1 H), 5.34-5.24 (m, 2 H), 
4.06 (dd, 1H, J = 8.0 Hz, J = 16.8 Hz), 3.89, 3.83 (2 d, 1H, J = 6.3 Hz, J = 7.4 Hz), 3.73 (s, 
3H), 3.71 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ ppm 165.5 (2xC), 138.5, 137.7 (C), 
136.0, 134.6 (CH), 129.1 (2xCH), 128.3, 128.1 (CH), 128.1, 127.7 (CH), 119.5,118.3 (CH2), 
115.3 (2xC), 53.6, 53.5 (CH), 49.7 (2xCH3), 44.5, 44.0 (CH); HRMS: m/z (FAB) calc for 
C13H14NO2 (M+) 216.1025, found 216.1024; IR(film): ν [cm-1] = 3086 (m), 3032 (s), 2956 
(s), 2249 (m), 1755 (s), 1640 (m), 1602 (m), 1495 (m), 1435 (s), 1259 (s), 1124  (w), 1029 
(m), 929 (s), 843 (w), 726 (m), 702 (m), 671 (w). 
NC
OMe
O
 
Methyl 2-cyano-3-(4-methoxyphenyl)pent-4-enoate (91c), ( Table 8, Entry 2),  
The general procedure A was followed with (E)-3-(4-
methoxyphenyl)allyl methyl carbonate (300 mg, 1.35 mmol, 1 
equiv.), cyanoacetate (160 mg, 1.62 mmol, 0.14 mL 1.2 equiv.), 
[Ir(cod)Cl]2 (24 mg, 0.027 mmol, 0.02 equiv.), ligand L3 (31 mg, 
0.054 mmol, 0.04 equiv.) and DABCO (30 mg, 0.27 mmol, 0.2 
equiv) in 4 mL dry THF. The reaction was conducted at 50 °C for 12 hours. 1H-NMR of the 
crude reaction mixture indicated the ratio of diastereoisomers (syn/anti) to be 50/50. The 
crude reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/MTBE = 5/1) to give the title compound (232 mg, 70 %) as yellow oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 7.24-7.20 (m, 1H), 6.90-6.86 (m, 1H), 6.12 (dddd, 1H, J = 
17.75 Hz, J = 17.16 Hz, J = 10.32 Hz, J = 7.88 Hz), 5.27 (td, 1H, J = 24.60 Hz, J = 12.53 
Hz), 4.02 (dd, 1H, J = 14.22 Hz, J = 6.90 Hz), 3.87-3.84 (m, 1H), 3.79 (s, 1H), 3.78 (d, 1H 
,J = 6.46 Hz), 3.72 (s, 1H), 3.71 (s, 1H); 13C NMR (125 MHz, CDCl3)  δ ppm 165.4, 164.3 
(C), 159.3, 159.2 (C), 136.1, 134.8 (CH), 130.3, 129.5 (C), 129.1, 128.7 (CH), 118.9, 117.7 
Me
O
NC
OMe
O
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(CH2), 115.3, 115.2 (C), 114.3, 114.2 (CH), 55.2, 55.2 (CH3), 53.3, 53.3 (CH3), 48.9, 48.7 
(CH), 45.0, 44.0 (CH). HRMS: m/z (EI) calc for C14H15NO3 (M+) 245.1046, found  
245.1029; IR(film): ν [cm-1] = 3461 (w), 3008 (m), 2955 (s), 2830 (s), 2364 (m), 2252 (m), 
2068 (w), 1766 (vs), 1608 (vs), 1516 (s), 1431 (s), 1306 (m), 1273 (m), 1030 (s), 833 (s). 
 
Methyl 2-cyano-3-(furan-2-yl)pent-4-enoate (91d), ( Table 8, Entry 3) 
The general procedure A was followed with (E)-3-(furan-2-yl)allyl 
methyl carbonate (300 mg, 1.65 mmol, 1 equiv.), methylcyanoacetate 
(195 mg, 1.98 mmol, 1.2 equiv.), [Ir(cod)Cl]2 (30 mg, 0.033 mmol, 0.02 
equiv.), ligand L3 (38 mg, 0.066 mmol, 0.04 equiv.) and DABCO (37 
mg, 0.33 mmol, 0.2 equiv.) in dry THF (4 mL). The reaction was conducted at 50 °C for 3 
hours. 1H-NMR of the crude reaction mixture indicated the ratio of diastereoisomers 
(syn/anti) to be 55/45. The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/MTBE = 5/1) to give the title compound (158 
mg, 47 %) as light yellow oil. 1H NMR (400 MHz, CDCl3)  δ ppm 7.38-7.40 (m, 2H), 6.36-
6.33 (m, 2H), 6.28 (d, 1H, J = 3.21 Hz), 6.24 (d, 1H, J = 3.18 Hz), 6.11-5.97 (m, 2H), 5.35 
(ddd, 4H, J = 14.26 Hz, J = 8.53 Hz, J = 4.96 Hz), 4.22-4.14 (m, 2H), 4.06 (d, 1H, J = 5.36 
Hz), 3.88 (d, 1H, J = 6.35 Hz,), 3.80 (s, 3H), 3.79 (s, 3H); 13C NMR (101 MHz, CDCl3 ) δ 
ppm 165.0 (2xC), 151.0, 150.6 (C), 142.6, 142.5 (CH), 132.9, 131.6 (CH), 120.9, 119.7 
(CH2), 114.7, 114.6 (C), 110.6, 110.5 (CH), 107.9, 107.7 (CH), 53.5 (2xCH3), 43.7, 43.6 
(CH), 42.4, 42.3 (CH). HRMS: m/z (FAB) calc for C11H11NO3 (M+) 205.0739, found 
205.0762; IR(film): ν [cm-1] = 2962 (w), 2909 (m), 2850 (w), 2357 (w), 2245 (w), 1753 (vs), 
1648 (w), 1503 (w), 1434 (m), 1267 (s), 1004 (m)938 (m). 
NC
OMe
O
O
 
Methyl 2-cyano-3-(pyridin-3-yl)pent-4-enoate (mixture of diastereomers), (91e), ( Table 
8, Entry 4) 
The general procedure A was followed with (E)-methyl 3-(pyridin-3-
yl)allyl carbonate (200 mg, 1.04 mmol, 1 equiv.), cyanoacetate (112 mg, 
1.14 mmol, 0.1 mL 1.1 equiv.), [Ir(cod)Cl]2 (14 mg, 0.020 mmol, 0.02 
equiv.), ligand L3 (24 mg, 0.042 mmol, 0.04 equiv.) and DABCO (23 
mg, 0.207 mmol, 0.2 equiv.) in 2 mL dry THF. The reaction was conducted at 50 °C for 45 
hours. 1H-NMR of the crude reaction mixture indicated the ratio of diastereoisomers 
(syn/anti) to be 50/50.  The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/MTBE = 1/2) to give the title compound (108 
N
NC
OMe
O
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mg, 45 %) as yellow oil. 1H NMR (500 MHz, CDCl3)  δ ppm 8.58-8.54 (m, 3H), 8.52 (d, 1H, 
J = 1.61 Hz), 7.75-7.70 (m, 1H), 7.70-7.67 (m, 1H), 7.35-7.28 (m, 2H), 6.20-6.04 (m, 2H), 
5.33 (ddd, 4H, J = 31.21 Hz, J = 16.46 Hz, J = 9.99 Hz), 4.14-4.09 (m, 2H), 3.93 (d, 1H, J 
= 6.62 Hz), 3.82 (d, 1H, J = 6.18 Hz), 3.75 (s, 3H), 3.72 (s, 3H); 13C NMR (101 MHz, 
CDCl3)  δ ppm 164.8 (2xC), 149.6 (2xCH), 149.4, 149.2 (CH), 135.4, 135.0 (CH), 134.7 
(CH), 134.0 (C), 133.4 (CH), 133.2 (C), 123.7 (2xCH), 120.4, 119.2 (CH2), 114.7 (2xC), 
53.7, 53.6 (CH3), 46.9, 46.6 (CH), 43.9, 43.4 (CH); HRMS: m/z (EI) calc for C12H12 N2O2 
(M+) 216.0893, found 216.0897; IR(film): ν [cm-1] = 3474 (w), 3072 (m), 2962 (m), 2922 
(w), 2259 (m), 1753 (vs), 1628 (m), 1582 (m), 1431 (s), 1247 (vs), 1194 (m), 1024 (m), 925 
(s). 
 
Methyl 2-cyanopent-4-enoate (Table 8, Entry 5), (91f) 
The general procedure A for allylic alkylations was followed with  
[Ir(cod)Cl]2 (17 mg, 0.019 mmol), ligand L3 (19 mg, 0.033 mmol), DABCO 
(21 mg, 0.187 mmol), allyl methylcarbonate (85 mg, 0.723 mmol) and 
methylcyanoacetate (135 mg, 1.36 mmol). The reaction mixture was stirred 
at 50°C for 3 days The crude reaction mixture was purified by flash column chromatography 
on silica gel  (cyclohexan/MTBE=9/1) to give 27 mg (0.194 mmol, 27% yield) of the title 
compound as colourless oil. 1H NMR (400 MHz, CDCl3 ) δ ppm 5.81 (tdd, 1H, J = 17.1 Hz, 
J = 10.1 Hz, J = 7.01 Hz), 5.30-5.20 (m, 2H), 3.81 (s, 3H), 3.58 (dd, 1H J = 7.16 Hz, J 
=6.38 Hz), 2.74-2.63 (m, 2H); 13C NMR (101 MHz, CDCl3) δ ppm 166.0 (C), 131.2 (CH), 
120.1 (CH2), 116.0 (C), 53.5 (CH3), 37.3 (CH), 33.8 (CH2); HRMS: m/z (EI) calc for C7H9 
NO2 (M+) 139.0633, found 139.0615; IR(film): ν [cm-1] = 3474 (w), 3072 (m), 2962 (m), 
2922 (w), 2259 (m), 1753 (vs), 1635 (m), 1574 (m), 1432 m), 1242 (vs), 1194 (m), 1010 
(m), 925 (s). 
NC
OMe
O
 
tert-butyl 2-cyanopent-4-enoate, (91g), (Table 8, Entry 6) 
The general procedure A was followed with [Ir(cod)Cl]2 (25 mg, 0.037), 
ligand L3 (39 mg, 0.068 mmol,), DABCO (38 mg, 0.344 mmol) 
allylcarbonate (186 mg, 1.6 mmol) and t-butyl cyanoacetate (260 mg, 1.85 
mmol), in dry THF (3 mL). The reaction was stirred at 50 °C for 48h. After 
standard workup crude reaction mixture was purified by flash column chromatography on 
silica gel (cyclohexane/MTBE = 16:1) to give the title compound (138 mg, 47 %) as 
NC
OtBu
O
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colourless oil. [ ]20Dα = +0.9 (c = 0.937, CHCl3);1H NMR (400 MHz, CDCl3)  δ ppm 5.87-
5.75 (m, 1H), 5.24 (t, 2H, J = 12.17 Hz), 3.46 (t, 1H, J = 6.72 Hz), 2.65 (t, 2H, J = 6.74Hz), 
1.49 (s, 9H); 13C NMR (101 MHz, CDCl3 ) δ ppm 164.4 (C), 131.5 (CH), 119.8 (CH2), 116.4 
(C), 84.2 (C), 38.4 (CH), 33.9 (CH2), 27.8 (3xCH3).Analytical data fits with literature106
 
Tert-butyl 2-cyano-3-(2-methoxyphenyl)pent-4-enoate, (91h),  
(Table 8, Entry 7) The general procedure A was followed with [Ir(cod)Cl]2 (30 mg, 0.045 
mmol, 0.02 equiv.), ligand L3 (49 mg, 0.09 mmol, 0.04 equiv.), DABCO (114 mg, 1.02 
mmol, 0.45 equiv.), (E)-3-(2-methoxyphenyl)allyl methyl carbonate (500 mg, 2.25 mmol, 1 
equiv.) and t-butyl cyanoacetate (349 mg, 2.47 mmol, 1.1 equiv.). The mixture was stirred at 
50 °C for 20 hours. 1H-NMR of the crude reaction mixture indicated the ratio of 
diastereoisomers (syn/anti) to be 70/30. The crude reaction mixture was purified by flash 
column chromatography using cyclohexane/MTBE (10:1) as eluent to afford title compound 
(407 mg, 70% yield) as yellow oil.  
(Table 8, Entry 8) The general procedure B was followed with [Ir(cod)Cl]2 (30 mg, 0.045 
mmol, 0.02 equiv), ligand L3 (49 mg, 0.09 mmol, 0.04 equiv), (E)-3-(2-methoxyphenyl)allyl 
methyl carbonate (445 mg, 2.0 mmol, 1 equiv) and t-butyl cyanoacetate (300 mg, 2.0 mmol, 
1.1 equiv.). The mixture was stirred at 50 °C for 6 days. 1H-NMR of the crude reaction 
mixture indicated the ratio of diastereoisomers (syn/anti) to be 68/32. The crude reaction 
mixture was purified by flash column chromatography using cyclohexane/MTBE (10:1) as 
eluent to afford title compound (180 mg, 35% yield) as yellow oil.  
1H NMR (400 MHz, CDCl3)  δ ppm 7.30-7.21 (m, 4H), 6.98-6.84 (m, 
2H), 6.29-6.07 (m, 2H), 5.30 (dd, 1H, J = 13.61 Hz, J =  7.31 Hz), 5.20 
(dd, 1H, J = 13.49 Hz, J =  9.31 Hz), 4.32-4.22 (m, 1H), 4.05 (dd, 1H, J 
= 14.97 Hz, J = 8.10 Hz), 3.86 (s,3H), 3.85 (s,3H), 1.40 (s, 9H),1.35 (s, 
9H); 13C NMR (100 MHz, CDCl3)  δ ppm 164.2, 164.1 (C), 156.8, 156.5 (C), 135.3, 134.2 
(CH), 129.2 (2xCH), 129.0, 128.9 (2xCH), 120.8 (2xCH), 118.9, 118.1 (2xCH2), 116.2, 
116.1 (C), 110.9, 110.6 (2xCH), 83.7, 83.6 (C), 55.3 (2xCH3), 45.8, 45.5 (2xCH), 42.8, 42.7 
(2xCH), 27.6 (6xCH3). HRMS: m/z (ESI) calc for C17H21 NO3 (M+H+) 287.15214, found 
287.15221; IR(film): ν [cm-1] = 3474 (w), 3073 (m), 2981 (s), 2935 (m), 2239 (m), 1740 
(vs), 1589 (s), 1490 (s), 1450 (s), 1234 /s), 1135 (vs), 1017 (s), 938 (s), 835 (s). 
NC
OtBu
O
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106 Wang, X. S.; Kitamura, M.; Maruoka, K., J. Am. Chem. Soc. 2007, 129, 1038-1039. 
 
 
                                                                                                               6 EXPERIMENTAL SECTION 
 
                                                                                                           
 
                                                                                                                                            
 
tert-butyl 2-cyano-3-(pyridin-3-yl)pent-4-enoate, (91i),  (Table 8, Entry 9) 
The general procedure A was followed with (E)-methyl 3-(pyridin-3-
yl)allyl carbonate (200 mg, 1.04 mmol, 1 equiv.), t-butyl cyanoacetate 
(175 mg, 1.24 mmol, 0.18 mL 1.2 equiv.), [Ir(cod)Cl]2 (14 mg, 0.020 
mmol, 0.02 equiv.), ligand L3 (23 mg, 0.04 mmol, 0.04 equiv.) and 
DABCO (23 mg, 0.207 mmol, 0.2 equiv.) in 1 mL dry THF. The reaction was conducted at 
50 °C for 48 hours. 1H-NMR of the crude reaction mixture indicated the ratio of 
diastereoisomers (syn/anti) to be 52/48. The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE = 3/2) to give the title compound 
(133 mg, 60 %) as yellow oil. 1H NMR (500 MHz, CDCl3 ) δ ppm 8.58-8.53 (m, 1H), 7.78-
7.74 (m, 1H), 7.68-7.65 (m, 1H), 7.31 (td, 1H, J = 7.95 Hz, J =5.05 Hz, J =5.05 Hz), 6.17-
6.05 (m, 1H), 5.37 (d, 1H, J = 10.30 Hz), 5.35-5.24 (m, 1H), 4.06 (dt, 1H, J = 7.51 Hz, J = 
7.21 Hz, J = 3.73 Hz), 3.81 (d, 1H, J = 6.73 Hz), 3.70 (d, 1H, J = 6.97 Hz), 1.38 (s, 9H), 
1.36 (s, 9H); 13C NMR (100 MHz, CDCl3 ) δ ppm 163.2 (2xC), 149.8 (CH), 149.4 (2xCH), 
149.2 (CH), 135.4, 135.1 (CH), 135.1 (CH), 134.1 (C), 133.8 (CH), 133.4 (C), 123.5 
(2xCH), 119.9, 118.9 (CH2), 115.2 (2xC), 84.7, 84,6 (C), 47.1, 46.6 (CH), 44.6, 44.2 (CH), 
27.5 (6x CH3); HRMS: m/z (HPLC-ESI) calc for C15H19 N2O2 (M+H+) 259.1441, found 
259.1441; IR(film): ν [cm-1] = 3435 (w), 2988 (s), 2929 (m), 2252 (m), 2200 (m), 1864 (w), 
1740 (vs), 1648 (w), 1569 (m), 1483 (s), 1424 (s), 1378 (s), 1268 (s), 1142 (s), 918 (s).  
N
NC
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methyl 2-cyano-4-(1H-indol-3-yl)-3-phenylbutanoate, (92a), (Table 9, Entry 1) 
The general procedure was followed with methyl-2-cyano-3-
phenylpent-4-enoat (300 mg, 1.4 mmol), phenylhydrazine (151 mg, 
1.4 mmol), Rh(acac)(CO)2 (3.2 mg, 0.014 mmol) and XANTPHOS 
(73 mg, 0.14 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/MTBE = 2/1) to 
give (174 mg, 39 % yield) of the title compound as yellow oil; 1H 
NMR (500 MHz, CDCl3) δ ppm 8.18, 8.03 (2 bs, 1 H), 7.68, 7.59 (2d, 1H, J = 7.9 Hz, J = 
8.0 Hz), 7.44 (dd, 1H, J = 1.4 Hz, J = 6.7 Hz), 7.40-7.13 (m, 6H), 7.03, 6.91 (2 d, 1H, J = 7.3 
Hz, J = 7.6 Hz), 7.12, 6.89 (2d, 1H, J = 2.3 Hz, J = 1.7 Hz), 4.01 (dd, 1H, J = 5.9 Hz, J = 
12.5 Hz),  3.78-3.72 (m, 1H), 3.91, 3.82, 3.55,3.37 (4 s, 3H), 3.52-3.31 (m, 1H), 2.80-2.38 
(m, 1H); 13C NMR (125 MHz, CDCl3) δ ppm 166.3 (s, C), 144.3 (s, C), 139.1, 129.3, 128.9, 
128.6, 128.2, 128.1, 128.0, 127.8 (s, C), 127.1,123.8 , 123.3, 122.5 (s, C), 122.2, 121.1, 
N
H
CNO
O
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119.7, 119.3 (2 d, CH), 118.9, 118.8 (2 d, CH), 115.7, 115.6, 113.3 (2 s, C), 112.1, 111.7 (2 
s, C), 111.5, 111.3 (2 d, CH), 54.1, 53.2, 53.1, 52.4 (4 q, CH3), 46.0, 44.4 (2 d, CH), 
46.1,43.3 (2 d, CH), 29.7, 28.5, 27.6, 25.9 (4 t, CH2); HRMS: m/z (FAB) calc for 
C20H19N2O2 (M+H+)  319.1447, found 319.1490; IR(film): ν [cm-1] = 3415 (m), 3060 (m), 
2922 (m), 2863 (m), 2245 (w), 1746 (vs), 1503 (m), 1457 (s), 1267 (m), 1017 (m), 741 (vs). 
 
methyl 2-cyano-4-(1H-indol-3-yl)-3-(4-methoxyphenyl)butanoate, (92b), (Table 9, 
Entry 2) 
The general procedure A was followed with methyl 2-cyano-3-(4-
methoxyphenyl)pent-4-enoate (200 mg, 0.8 mmol), 
phenylhydrazine (86 mg, 0.8 mmol), Rh(acac)(CO)2 (2,16 mg, 
0.008 mmol) and XANTPHOS (47 mg, 0.08 mmol).The crude 
reaction mixture was purified by flash column chromatography 
on silica gel (cyclohexane/MTBE = 2/1) to give (189 mg, 66 % yield) of the title compound 
as yellow oil. 1H NMR (500 MHz, CDCl3 ) δ ppm 8.15 (s, 1H), 8.01 (s, 1H), 7.68 (d, 1H, J = 
7.88 Hz), 7.60 (d, 1H, J = 7.84 Hz), 7.41-7.31 (m, 4H), 7.29-7.08 (m, 8H), 6.94-6.83 (m, 
6H), 3.81 (s, 3H), 3.81-3.74 (m, 4H), 3.79 (s, 3H), 3.57 (s, 3H), 3.47 (dd, 1H, J = 14.70 Hz, 
J = 7.56 Hz), 3.43-3.36 (m, 2H), 3.40 (s, 3H), 3.30 (dd, 1H, J = 14.71 Hz, J = 5.96 Hz); 13C 
NMR (125 MHz, CDCl3) δ ppm 166.2, 165.6 (2xC), 159.3, 159.1 (2xC), 136.4, 136.1 (2xC), 
131.9, 130.9 (2xC), 129.9, 128.7 (2xCH), 127.2, 127.0 (2xC), 123.0, 123.5 (2xCH), 122.3, 
122.0 (2xCH), 119.7, 119.5 (2xCH), 118.7, 118.6 (2xCH), 116.0, 115.5 (2xC), 114.1, 114.1 
(2xCH), 112.1, 111.7 (2xC), 111.3, 111.1 (2xCH), 55.2 (2xCH3), 53.1, 52.9 (2xCH3), 45.2, 
45.2 (2xCH), 44.4, 43.3 (2xCH), 29.7, 28.4 (2xCH2); HRMS: m/z (HPLC-ESI) calc for 
C21H21N2O3 (M+H+) 349.15467, found 349.15465; IR(film): ν [cm-1] =3446 (m), 2910 (s), 
2835 (s) , 2215 (m), 1733 (vs), 1502 (m), 1455 (s), 1255 (vs), 1010(m), 740 (vs). 
N
H
CNO
O
OMe
 
tert-butyl 2-cyano-4-(1H-indol-3-yl)-3-phenylbutanoate, (92c), (Table 9, Entry 3),  
The general procedure was followed with tert-butyl 2-cyano-3-
phenylpent-4-enoate (53b) (106 mg, 0.41 mmol), phenylhydrazine (55 
mg, 0.8 mmol), Rh(acac)(CO)2 (1,07 mg, 0.004 mmol) and 
XANTPHOS (23 mg, 0.04 mmol). The crude reaction mixture was 
purified by flash column chromatography on silica gel 
(cyclohexane/MTBE = 2/1) to give (88 mg, 60 % yield) of the title 
compound as yellow oil. 1H NMR (400 MHz, CDCl3 ) δ ppm 8.07 (bs, 1H), 7.90 (bs, 1H), 
N
H
CNO
O
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7.68 (d, 1H, J = 7.76 Hz), 7.56 (d, 1H, J = 7.82 Hz), 7.47 (d, 2H, J = 7.25 Hz), 7.40-7.05 
(m, 16H), 3.79-3.67 (m, 4H), 3.51-3.25 (m, 4H), 1.27 (s, 9H), 1.23 (s, 9H); 13C NMR (101 
MHz, CDCl3) δ ppm 164.7 (C), 164.5 (C), 128.5 (CH), 128.5 (CH), 128.2 (2xCH), 128.0 
(CH), 127.9 (CH), 127.6 (CH), 122.3 (CH), 122.0 (CH), 119.4 (CH), 119.7 (CH), 118.7 
(2xCH), 116.6 (C), 116.1 (C), 112.1 (2xC), 111.3 (CH), 111.1 (CH), 83.8 (C), 46.3 (CH), 
46.0 (CH), 45.0 (CH), 43.7 (CH), 30.1 (CH2), 28.8 (CH2), 27.5 (6xCH3). IR(film): ν [cm-1] = 
3420 (m), 3070 (s), 2922 (s), 2860 (m), 2233 (w), 1737 (vs), 1602 (w), 1508 (m), 1455 (s), 
1261 (s), 1017 (m), 741 (vs). 
 
tert-butyl 2-cyano-4-(1H-indol-3-yl)-3-(2-methoxyphenyl)butanoate, (92d), (Table 9, 
Entry 4),  
The general procedure was followed with tert-butyl 2-cyano-3-(2-
methoxyphenyl)pent-4-enoate (200 mg, 0.69 mmol), 
phenylhydrazine (75 mg, 0.69 mmol), Rh(acac)(CO)2 (1,96 mg, 
0.007 mmol) and XANTPHOS (41 mg, 0.069 mmol). The crude 
reaction mixture was purified by flash column chromatography on 
MTBE = 2/1) to give (101 mg, 37 % yield) of the title compound as 
brown oil; 1H NMR (400 MHz, CDCl
silica gel (cyclohexane/
3) δ ppm 8.11 (s, 1H), 7.95 (s, 1H), 7.74 (d, 1H, J = 
7.71 Hz), 7.60 (d, 7H, J = 7.74 Hz), 7.52 (d, 7H, J = 7.52 Hz), 7.37 (d, 1H, J = 7.68 Hz), 
7.32-7.04 (m, 1H), 6.98-6.76 (m, 1H), 4.30 (td, 1H, J = 9.59 Hz, J =  6.41 Hz), 4.21-4.11 
(m, 1H), 3.89 (s, 3H), 3.81 (s, 3H), 3.31-3.18 (m, 2H), 3.47-3.33 (m, 2H), 1.24 (s, 18H); 13C 
NMR (100 MHz, CDCl3)  δ ppm 164.8, 164.5 (2xC), 157.1, 157.0 (2xC), 136.3, 136.0 
(2xC), 129.2 (CH), 128.5, 128.42 (2xCH), 128.2 (C), 128.0 (CH), 127.5, 127.4 (2xC), 127.2 
(C), 123.0, 122.9 (2xCH), 122.0, 121.8 (2xCH), 120.6, 120.4 (2xCH), 119.4, 119.2 (2xCH), 
118.8, 118.7 (2xCH), 116.8 (2xC), 112.4, 112.4 (2xC), 111.2, 111.0 (2xCH), 110.6, 110.5 
(2xCH), 83.4, 83.4 (2xC), 55.4, 55.3 (2xCH3), 43.6, 42.3 (2xCH), 40.9 (CH), 38.9 (CH), 
29.5 (CH2), 27.4 (6xCH3), 26.8(CH2). IR(film): ν [cm-1] = 3440 (m), 3080 (s), 2922 (s), , 
2233 (m), 1733 (vs), 1605 (w), 1510 (m), 1455 (s), 1245 (vs), 1012(m), 741 (vs). 
N
H
CNO
O
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tert-butyl 2-cyano-4-(1H-indol-3-yl)butanoate, ( Table 9, Entry 5), (92e) 
The general procedure was followed with tert-butyl 2-cyanohex-5-
enoate (300 mg, 1.54 mmol), phenylhydrazine (166 mg, 1.54 mmol), 
Rh(acac)(CO)2 (3.52 mg, 0.015 mmol) and XANTPHOS (80 mg, 0.154 
mmol). The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/ethylacetate = 3/1) to give 
(251 mg, 57 % yield) of the title compound as yellow oil; 1H-NMR 
(CDCl3, 400 MHz) δ ppm 8.22 (s, 1H), 7.63 (d, 1H, J = 7.8 Hz), 7.37 (d, 1H, J = 8.0 Hz), 
7.19 (dt, 2H, J = 7.2 Hz, J = 14.9 Hz), 7.03 (s, 1H), 3.43 (dd, 1H, J = 6.1 Hz, J = 8.4 Hz), 
3.02 (tq, 1H, J = 7.4 Hz, J = 14.9 Hz), 2.40-2.34 (m, 1H), 1.50 (s, 9H); 13C-NMR (CDCl3, 
100 MHz) δ ppm 165.1, 136.3, 126.9, 122.2, 122.0, 119.3, 118.4, 116.9, 112.9, 111.2, 83.9, 
37.8, 30.1, 27.6, 22.2; HRMS: m/z (FAB) calc for C17H20N2O2 (M+)  284.1520, found 
284.1515; IR(film): ν [cm-1] = 3415 (s), 2975 (m), 2935 (m), 2252 (w), 1733 (vs), 1457 (s), 
1365 (s), 1155 (vs), 748 (s). 
N
H
CNO
O
 
General procedure for reduction of  α-cyanoacetate indoles 
In a reaction vial containing PTFE septum cyano indole (40-50 mg, 1 equivalent) and 
Raney-Co (100-200 mg, qualitative superstoichiometric amount), were dissolved in 3 ml of 
MeOH and subsequently 4 ml of water was added. Reaction mixture was placed in an 
autoclave and pressurized with 40 bar of H2. The reaction was vigorously stirred at 90 °C for 
5h. After autoclave is cooled down to room temperature reaction mixture is filtered through 
sintered glass filter, filer was washed with 50 ml of MeOH and volatiles were removed under 
reduced pressure to give desired compound without further purification. 
 
methyl 2-(aminomethyl)-4-(1H-indol-3-yl)-3-phenylbutanoate, (93a) 
The general procedure was followed with methyl 2-cyano-4-(1H-
indol-3-yl)-3-phenylbutanoate (40 mg, 0.13mmol) and 100 mg of 
Raney-Co. The crude reaction mixture was filtered through sintered 
glass filter to yield title compound (42 mg, 100 % yield) without 
further purification. 1H NMR (500 MHz, CDCl3) δ ppm 8.93, 8.03 (2 
bs,1 H, NH), 7.60-7.47 (m, 1H), 7.40-7.08 (m, 6H), 7.04 (d, 1H, J = 
7.7 Hz), 6.90 (t, 1H, J = 7.3 Hz), 6.71, 6.49 (2d, 1H, J = 2.1 Hz, J = 1.9 Hz), 4.00, 3.81 (2m, 
1 H), 3.90, 3.78, 3.63, 3.46 (4 s, 3 H), 3.38-2.95 (m, 2H), 3.28-3.25, 2.93-2.91 (2 m, 1 H),  
2.76-2.32- (m, 2 H); 13C NMR (125 MHz, CDCl3) δ ppm 167.4 (d, C),145.2 (d, C), 135.9, 
N
H
O
O
NH2
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129.3, 128.9, 128.8, 128.7, 128.5, 128.4, 128.1, 127.8 (d, C) ,127.6, 126.7  (d, C) , 122.8, 
122.5, 121.9, 121.7  (2 d, CH) , 121.0, 119.3, 118.8 (d, CH) , 113.3(d, CH) , 112.6, 112.4, 
111.6, 111.2 (2 s, C) , 54.0, 53.5, 53.1, 52.3 (4 q, CH3) , 48.7 , 47.4 (2t, CH2) , 45.9 (d, CH) 
, 46.4, 43.1 (2 d, CH) , 30.2, 27.6, 26.9,25.9 (4 t, CH2); HRMS: m/z (FAB) calc for 
C20H23N2O2 (M+H+)  323.1760, found 323.1800; IR(film): ν [cm-1] =3440-2955 (vs), 2063 
(w), 1731 (vs), 1645 (s), 1440 (s), 1241 (s), 1142 (s), 1010 (vs).  
 
2-aminomethyl-4-(1H-indol-3-yl)-butyric acid tert-butyl ester, (93b) 
The general procedure was followed with tert-butyl 2-cyano-4-(1H-
indol-3-yl)butanoate (50 mg, 0.18 mmol) and 150 mg of Raney-Co 
(3 wt. equiv.). The crude reaction mixture was filtered through 
sintered glass filter to yield title compound (46 mg, 90 % yield) 
without further purification; 1H-NMR (CDCl3, 400 MHz) δ ppm 8.41 
(s, 1H), 7.53 (d, 1H, J = 7.6 Hz), 7.30 (d, 1H, J = 7.8 Hz), 7.10 (dt, 
2H, J = 6.9 Hz, J = 27.9 Hz), 6.99 (s, 1H), 5.22 (bs, 2H), 2.98 (d, 2H, J = 40.3 Hz), 2.80-
2.56 (m, 3H), 2.06-1.80 (m, 2H), 1.43 (s, 9H); 13C-NMR (CDCl3, 100 MHz) δ ppm 173.9, 
136.2, 127.2, 121.9, 121.7, 118.9, 118.6, 114.8, 111.3, 81.5, 46.1, 42.0, 30.1, 28.0, 22.3; 
HRMS: m/z (ESI) calc for C17H25N2O2 (M+H+)  289.19105, found 289.19062; IR(film): ν 
[cm-1] = 3395-2988 (vs), 2055 (w), 1720 (vs), 1641 (s), 1444 (s), 1273 (m), 1142 (s), 741 
(vs).  
N
H
O
O
NH2
 
methyl 2-allyl-2-cyanopent-4-enoate (94a) 
During the synthesis of 91f following the general procedure A for allylic 
alkylations with [Ir(cod)Cl]2 (17 mg, 0.019 mmol), ligand L3 (19 mg, 0.033 
mmol), DABCO (21 mg, 0.187 mmol), allyl methylcarbonate (85 mg, 0.723 
mmol) and methylcyanoacetate (135 mg, 1.36 mmol) 94a was isolated as a 
byproduct. The crude reaction mixture was purified by flash column chromatography on 
silica gel (cyclohexan/MTBE=9/1) to give (21 mg, 21% yield) of the title compound as 
colourless oil. 1H NMR (400 MHz, CDCl3)  δ ppm 5.80 (ddd, 2H J = 17.01 Hz, J = 14.85 
Hz, J =7.31 Hz), 5.28-5.20 (m, 4H), 3.79 (s, 3H), 2.65 (dd, 2H, J = 13.83, J = 7.40 Hz), 
2.55 (dd, 2H, J = 13.80 Hz, J =7.23 Hz); 13C NMR (100 MHz, CDCl3)  δ ppm 168.5 (C), 
130.4 (2xCH), 121.0 (2xCH2), 118.3 (C), 53.3 (CH3), 49.3 (C), 40.6 (CH2); HRMS: m/z 
(ESI) calc for C10H13NO2 (M+H+) 179.09463, found 179.09450; IR(film): ν [cm-1] =3075 
NC
OMe
O
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(w), 2975 (m), 2921 (m), 2235 (w), 1723 (vs), 1655 (m), 1365 (s), 1254 (s), 1151 (vs), 918 
(m).  
 
tert-butyl 2-allyl-2-cyanopent-4-enoate, (94b) 
During the synthesis of 91g following the general procedure A with 
[Ir(cod)Cl]2 (25 mg, 0.037), ligand L3 (39 mg, 0.068 mmol), DABCO (38 
mg, 0.344 mmol), allylcarbonate (186 mg, 1.6 mmol) and t-butyl 
cyanoacetate (225 mg, 1.60 mmol), in dry THF (3 mL). 94b was isolated 
as a byproduct. Crude reaction mixture was purified by flash column chromatography on 
silica gel (cyclohexane/MTBE = 16/1) to give the title compound (71 mg, 20 %) as 
colourless oil. 1H NMR (400 MHz, CDCl3)  δ ppm 5.76 (tdd, 1H J = 14.71 Hz, J = 9.59 Hz, 
J =7.28 Hz), 5.24-5.11 (m, 1H), 2.55 (dd, 1H, J = 13.87 Hz, J = 7.47 Hz), 2.44 (dd, 1H, J = 
13.83 Hz, J = 7.11 Hz), 1.42 (s, 1H); 13C NMR (100 MHz, CDCl3)  δ ppm 166.5 (C), 130.5 
(2xCH), 120.4 (2xCH2), 118.5 (C), 49.5 (C), 40.5 (2xCH2), 33.7 (C), 27.6 (CH3); HRMS: 
m/z (ESI) calc for C13H19NO2 (M+H+) 222.14886, found 222.14890; IR(film): ν [cm-1] = 
3080 (w), 2968 (m), 2922 (m), 2239 (w), 1727 (vs), 1641 (m), 1365 (s), 1254 (s), 1148 (vs), 
918 (m).  
NC
O
O
 
2-Cyano-4-(1H-indol-3-yl)-2-[2-(1H-indol-3-yl)-ethyl]-butyric acid tert-butyl ester, (95) 
The general procedure was followed with tert-butyl 2-allyl-
2-cyanopent-4-enoate (280 mg, 1.26 mmol), 
phenylhydrazine (276 mg, 2.52 mmol), Rh(acac)(CO)2 (3.3 
mg, 0.013 mmol) and XANTPHOS (50 mg, 0.13 mmol). 
The crude reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/Ethylacetate = 3/1) to give (368 mg, 68 % yield) of the title compound as 
yellow oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 8.01 (s, 2H), 7.61 (d, 2H, J = 7.8 Hz), 7.34 
(d, 2H, J = 8.0 Hz), 7.16 (dt, 4H, J = 7.2 Hz, J = 26.4 Hz), 6.99 (s, 2H), 3.08  (td, 2H, J = 4.7 
Hz, J = 13.4 Hz), 2.85 (td, 2H, J = 4.8 Hz, J = 13.4 Hz), 2.38 (td, 2H, J = 4.9 Hz, J = 12.9 
Hz), 2.13 (td, 2H, J = 4.6 Hz, J = 13.0 Hz), 1.54 (s, 9H); 13C-NMR (CDCl3, 100 MHz) δ ppm 
168.0, 136.3, 127.0, 122.1, 121.5, 119.6, 119.4, 118.6, 114.2, 111.2, 84.2, 50.7, 38.2, 27.8, 
21.4; HRMS: m/z (ESI) calc for C27H29N3O2 (M+H+)  428.23325, found 428.23328; 
IR(film): ν [cm-1] = 3415 (s), 3060 (w), 2975 (s), 2742 (s), 2856 (m), 2245 (w), 1727 (vs), 
1464 (s), 1267 (s), 1148 (s), 735 (vs). 
N
H
NC CO2
tBu
NH
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General procedure for deprotection of benzophenone imines 
 
To a stirred solution of imine (1 equiv.) in 1:1 THF/water solution (6 mL/mmol) 
hydroxylamine hydrochloride (3 equiv.) was added. The mixture was stirred for three hours 
at room temperature and the solvent was removed under reduced pressure. The crude 
material was then treated with 1 N HCl and washed with ethylacetate. The aqueous phase 
was neutralized using 1 N NaOH and extracted with DCM. Collected organic extracts were 
dried over MgSO4 and the solvent was removed under reduced pressure to give desired 
product. 
 
Ethyl 2-aminopent-4-enoat, (96a) 
The general procedure was followed with ethyl 2-
(diphenylmethyleneamino)pent-4-enoate  (160 mg, 0.52 mmol) and 
hydroxylaminehydrochloricacid (108 mg, 1.56 mmol) to give the title 
compound 47 mg (63%) as yellowish oil 1H NMR (500 MHz, CDCl3) δ ppm 5.74 (tdd, J = 
17.22, 10.16, 7.20, 7.20 Hz, 1H), 5.13 (dd, J = 13.14, 6.15 Hz, 2H), 4.17 (ttd, J = 10.73, 
7.26, 7.26, 3.61, 3.61 Hz, 2H), 3.52 (dd, J = 7.00, 5.23 Hz, 1H), 2.54-2.44 (m, 1H), 2.37 (td, 
J = 14.03, 7.18, 7.18 Hz, 1H), 1.86 (d, J = 6.44 Hz, 1H), 1.27 (t, J = 7.14, 7.14 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ ppm 169.6 (C), 134.9 (CH), 120.1 (CH2), 62.4 (CH2), 55.3 
(CH), 40.6 (CH2), 15.7 (CH3). Analytical data fits with literature.107
H2N CO2Et
 
2-Amino-3-phenyl-pent-4-enoic acid ethyl ester, (96b) 
The general procedure was followed with ethyl 2-
(diphenylmethyleneamino)-3- phenylpent-4-enoate (355 mg, 0.93 mmol) 
and hydroxylaminehydrochloricacid (195 mg, 2.78 mmol) to give ethyl 2-
amino-3-phenylpent-4-enoate  (113 mg, 56 %) as yellowish oil. 1H-NMR 
(CDCl3, 400 MHz) δ ppm 7.36-7.28 (m, 4H), 7.24 (dd, J = 7.1 Hz, J = 12.3 Hz, 6H), 6.12 
(dddd, J = 8.7 Hz, J = 17.3 Hz, J = 17.5 Hz, J = 17.5 Hz, 2H), 5.24-5.18 (m, 2H), 5.14 (dd, J 
= 6.2 Hz, J = 13.0 Hz, 2H), 4.15 (q, J = 7.1 Hz, 2H), 4.00 (q, J = 7.1 Hz, 2H), 3.76-3.70 (m, 
2H), 3.62-3.58 (m, 2H), 1.50 (s, 4H), 1.25 (t, J = 7.1 Hz, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C-
H2N CO2Et
                                                 
107 Lopez, A., Moreno-Manas, M., Pleixats, R., Roglans, A., Ezquerra, J., Pedregal, C., Tetrahedron, 52, 1996, 
8365-8374. 
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NMR (CDCl3, 400 MHz) δ ppm 174.1, 174.0, 140.5, 139.7, 137.7, 136.6, 128.6, 128.4, 
128.2, 128.0, 127.1, 126.8, 118.1, 116.7, 60.7 (2C), 59.3 (2C), 55.1 (2C), 14.2, 13.9; HRMS: 
m/z (FAB) calc for C13H19NO2 (M+H+) 220.1338, found  220.1331;  
 
2-Amino-3-(4-methoxy-phenyl)-pent-4-enoic acid ethylester, (96c)  
The general procedure was followed with ethyl 2-
(diphenylmethyleneamino)-3-(4- methoxyphenyl)pent-4-enoate  
(422 mg, 1.02 mmol) and hydroxylaminehydrochloricacid (651 mg, 
3.06 mmol) to give ethyl 2-amino-3-(4-  methoxyphenyl)pent-4-
enoate (175 mg, 69 %) as yellow oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 7.15 (dd, J = 8.6 
Hz, J = 12.8 Hz, 4H), 6.85 (dd, J = 8.2 Hz, J = 8.2 Hz, 4H), 6.10-6.06 (m, 2H), 5.23-5.18 (m, 
2H), 5.13-5.10 (m, 2H), 4.15 (q, J = 7.1 Hz, 2H), 4.01 (q, J = 7.1 Hz, 2H), 3.78 (s, 3H), 3.70 
(dd, J = 7.8 Hz, J = 7.8 Hz), 3.56 (td, J = 5.5 Hz, J = 10.9 Hz, 2H), 1.77 (s, 4H), 1.25 (t, J = 
7.1 Hz, 3H), 1.08 (t, J = 7.1 Hz, 3H); 13C-NMR (CDCl3, 400 MHz) δ ppm 174.0 (2C), 158.4, 
138.0, 136.9, 132.5, 131.6, 129.3, 129.0, 117.9, 116.5, 114.1, 113.9, 60.8, 60.7, 59.3, 55.2 
(2C), 54.1 (2C), 14.2, 14.0; HRMS: m/z (FAB) calc for C14H20NO3 (M+H+) 250.1443, found 
250.1438;  
H2N CO2Et
MeO
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6.4 Experiments in Chapter 3 
 
General procedure for tandem hydroformylation / Pictet-Spengler reaction under 
aprotic conditions 
In a thick walled sample vial containing PTFE septum (S)-Triptophanmethylester (1 equiv.), 
olefin (1 equiv.) and Rh(acac)(CO)2 (0.01 equiv.) were dissolved in dry solvent (8 mL). The 
vial was placed in a pressure vessel, flushed with argon and pressurized with 50 bar CO and 
10 bar H2. The reaction mixture was stirred for 3 days at designated temperature. Volatiles 
were removed under reduced pressure and the crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexan/ethylacetat) to give the desired product. 
 
a: (1S,3S)-methyl 1-cyclopentyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate. (Table 10, Entry 7) 
The general procedure was followed with (S)-tryptophane methylester (218 mg, 1 mmol), 
cyclopenten (68 mg, 1 mmol) and Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) in 8 ml of DCM  
under 50 bar CO and 10 bar H2 at 80 °C for 72 h (Table 1, entry 7). The crude reaction 
mixture was purified by flash column chromatography on silica gel (Cyclohexan/Ethylacetat 
= 6/1) to give 113 mg (38 %) of a, 119 mg (40 %) of b, 9 mg, (2.5 %) of c; 3 mg (  1 %) of d 
and 19  mg (5 %) of  e. 
a: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.97 (s, 1H), 7.48 (d, 1H, J = 
7.6Hz), 7.30 (d, 1H, J = 7.9 Hz), 7.12 (dt, 2H, J = 7.0 Hz, J = 20.1 
Hz), 4.10 (d, 1H, J = 6.4 Hz), 3.81 (s, 3H), 3.74 (dd, 1H, J = 4.1Hz, J 
= 11.2 Hz), 3.12 (ddd, 1H, J = 1.5 Hz, J = 4.0 Hz, J = 14.9 Hz), 2.86-
 1H, J = 8.0 Hz), 2.02-1.93 (m, 1H), 1.80-1.36 (m, 8H); 13C-NMR 
(CDCl
2.76 (m, 1H), 2.28 (q,
3, 100 MHz) δ ppm 173.7, 135.8, 135.6, 126.9, 121.5, 119.4, 117.8, 110.7, 108.4, 56.7, 
56.4, 52.1, 44.3, 29.2, 28.5, 25.9, 25.4; HRMS: m/z (ESI) calc for C18H23N2O2 (M+H+) 
299.17540, found 299.17489; IR(film): ν [cm-1] =  3402 (s), 3060 (w), 2955 (s), 2863 (s), 
1740 (vs), 1457 (s), 1359 (m), 1181 (m), 741 (m).   
N
H
NH
CO2Me
b: (1R,3S)-methyl 1-cyclopentyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate.  
N
H
NH
CO2Me
1H-NMR (CDCl3, 400 MHz) δ ppm 7.86 (s, 1H), 7.48 (d, 1H, J = 7.6 
Hz), 7.28 (d, 1H, J = 7.8 Hz), 7.12 (dt, 2H, J = 6.7 Hz, J = 14.7 Hz), 
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4.06-3.98 (m, 2H), 3.73 (s, 3H), 3.11 (dd, 1H, J = 5.1 Hz, J = 15.3 Hz), 2.99 (dd, 1H, J = 7.3 
Hz, J = 15.2 Hz), 2.36 (bs, 1H), 2.21 (dd, 1H, J = 9.1 Hz, J = 17.2 Hz), 1.94-1.80 (m, 2H), 
1.78-1.36 (m, 6H); 13C-NMR (CDCl3, 100 MHz) δ ppm 174.3, 135.7, 135.4, 126.9, 121.5, 
119.2, 117.9, 110.6, 107.1, 55.1, 52.7, 52.0, 45.2, 30.2, 29.9, 25.6, 24.9, 24.7; HRMS: m/z 
(ESI) calc for C18H23N2O2 (M+H+) 299.17540, found 299.17489; IR(film): ν [cm-1] =  3395 
(m), 3054 (w), 2995 (s), 1727 (vs), 1444 (s), 1319 (m), 1260 (m), 1221 (m), 741 (s). 
c: (1R,3S)-methyl 1-cyclopentyl-2-(cyclopentylmethyl)-2,3,4,9-tetrahydro-1H-
pyrido[3,4-b]indole-3-carboxylate.  
1H-NMR (CDCl3, 400 MHz) δ ppm 7.82 (s, 1H), 7.54 (d, 1H, J = 
7.7 Hz), 7.32 (d, 1H, J = 8.0 Hz), 7.15 (dt, 2H, J = 7.0 Hz, J = 
14.9 Hz), 4.05 (dd, 1H, J = 4.6 Hz, J = 11.5 Hz), 3.80 (s, 3H), 3.50 
(d, 1H, J = 9.5 Hz), 3.11 (dd, 1H, J = 11.6 Hz, J = 15.8 Hz), 2.82 
(dd, 1H, J = 4.6 Hz, J = 15.9 Hz), 2.44 (dd, 1H, J = 4.0 Hz, J = 
12.7 Hz), 2.25-2.02 (m, 4H), 1.96-1.20 (m, 14H), 1.01-0.84(m, 1H). 13C-NMR (CDCl3, 100 
MHz) δ ppm 173.8, 135.8, 135.3, 126.9, 121.5, 119.4, 118.1, 110.6, 107.5, 62.0, 57.1, 53.8, 
51.7, 45.5, 38.1, 31.7, 31.1, 30.7, 30.4, 25.5, 25.3, 24.9, 24.3, 19.5; HRMS: m/z (ESI) calc 
for C24H32N2O2 (M+H+) 381.25366, found 381.25362; IR(film): ν [cm-1] =  3395 (m), 2935 
(s), 2870 (s), 1740 (vs), 1575 (m), 1451 (s), 1260 (w), 1083 (w), 748 (s).  
N
H
N
CO2Me
d: (S)-methyl 2-(cyclopentylmethylamino)-3-(1H-indol-3-yl)propanoate. 
 1H-NMR (CDCl3, 400 MHz) δ ppm 8.71 (s, 1H), 7.62 (d, 1H, J = 
7.8 Hz), 7.29 (d, 1H, J = 8.0 Hz), 7.14 (dt, 2H, J = 7.1 Hz, J = 14.7 
Hz), 6.96 (s, 1H), 3.67 (t, 1H, J = 6.8 Hz), 3.64 (s, 3H), 3.17 (qd, 
2H, J = 6.7 Hz, J = 14.3 Hz), 2.50 (ddd, 2H, J = 7.3 Hz, J = 10.9 
Hz, J = 17.8 Hz), 1.96 (dt, 1H, J = 7.6 Hz, J = 15.1 Hz), 1.76 (bs, 1H), 1.74-1.62 (m, 2H), 
1.58-1.42 (m, 4H), 1.14-1.00 (m, 2H). 13C-NMR (CDCl3, 100 MHz) δ ppm 175.4, 136.1, 
127.2, 122.9, 121.7, 119.1, 118.4, 111.1, 110.6, 62.3, 53.9, 51.5, 39.8, 30.6, 30.5, 29.1, 25.1; 
HRMS: m/z (ESI) calc for C18H24N2O2 (M+H+) 301.19105, found 301.19067. IR (film): ν 
[cm-1] =  3152 (m), 2942 (m), 2916 (m), 2863 (m), 2364 (w), 1740 (vs)1457 (s), 1431 (s), 
1325 (s), 1221 (m), 1135 (m), 735 (s). 
N
H
HN
CO2Me
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e: (S)-methyl 2-(bis(cyclopentylmethyl)amino)-3-(1H-indol-3-yl)propanoate. 
 1H-NMR (CDCl3, 400 MHz) δ ppm 8.00 (s, 1H), 7.57 (d, 1H, J = 
7.7 Hz), 7.32 (d, 1H, J = 7.9 Hz), 7.13 (dt, 2H, J = 7.1 Hz, J = 
23.4 Hz), 7.00 (s, 1H), 3.74 (dd, 1H, J = 4.4 Hz, J = 9.7 Hz), 3.57 
(s, 3H), 3.26 (dd, 1H, J = 10.0 Hz, J = 14.1 Hz), 2.92 (dd, 1H, J = 
3.8 Hz, J = 14.1 Hz), 2.52-2.34 (m, 4H), 2.09-1.97 (m, 2H), 1.72-
1.42 (m, 12 H), 1.36-1.18 (m, 2H), 1.15-1.04 (m, 2H). 13C-NMR (CDCl3, 100 MHz) δ ppm 
173.2, 136.1, 127.5, 122.7, 121.8, 119.2, 118.5, 112.7, 111.1, 63.3, 56.7, 50.7, 38.2, 30.8, 
30.7, 25.5, 25.1, 25.1; HRMS: m/z (ESI) calc for C24H35N2O2 (M+H+) 383.26931, found 
383.26895.   IR(film): ν [cm-1] =  3415 (m), 2948 (s), 2856 (s), 1733 (vs), 1457 (s), 1339 
(w), 1162 (m), 735 (s). 
N
H
N
CO2Me
 
a: (1S,3S)-methyl 1-cyclohexyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate. (Table 10, Entry 9)  
The general procedure was followed with (S)-tryptophane methylester (218 mg, 1 mmol), 
cyclohexen (82 mg, 1 mmol) and Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) in 10 ml of DCM 
under 50 bar CO and 10 bar H2 at 100 °C for 72 h (Table 1, entry 9). The crude reaction 
mixture was purified by flash column chromatography on silica gel (cyclohexan/ethylacetat 
= 6/1) to give 87 mg (28 %) of a, 109 mg (35 %) of b, 21 mg (5.1 %) of c, 3 mg (1 %) of d,  
45 mg (11 %) of e and 15 mg (4.8 %) of f. 
a: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.92 (s, 1H), 7.47 (d, 1H, J = 
7.6 Hz), 7.31 (d, 1H, J = 7.9 Hz), 7.12 (dt, 2H, J = 7.1 Hz, J = 14.6 
Hz), 4.14 (d, 1H, J = 1.6 Hz), 3.81 (s, 1H), 3.73 (dd, 1H, J = 4.0 Hz, 
J = 11.1 Hz), 3.10 (ddd, 1H, J = 1.3 Hz, J = 3.6 Hz, J = 14.6 Hz), 
2.82-2.73 (m, 1H), 2.42 (bs, 1H), 1.88-1.64 (m, 6H), 1.50-1.10 (m, 
5H); 13C-NMR (CDCl3, 100 MHz) δ ppm 173.8, 135.9, 134.7, 127.1, 121.5, 119.4, 117.8, 
110.7, 108.9, 57.6, 56.4, 52.1, 42.3, 29.7, 26.8, 26.5, 26.3, 25.9; Analytical data fits with 
literature108
N
H
NH
CO2Me
 
 
 
                                                 
108  Ungemach, F; Soerens, D.; Weber, R.; DiPierro, M.;Campos, O.; Mokry, P.; Cook, J. M. J. Am. Chem. Soc, 
1980, 102, 6976. 
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b: (1R,3S)-methyl 1-cyclohexyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate.  
1H-NMR (CDCl3, 400 MHz) δ ppm 7.81 (s, 1H), 7.50 (d, 1H, J = 7.6 
Hz), 7.31 (d, 1H, J = 7.9 Hz), 7.13 (dt, 2H, J = 6.7 Hz, J = 14.9 Hz), 
4.06 (d, 1H, J = 5.0 Hz), 4.02 (dd, 1H, J = 5.6 Hz, J = 6.6 Hz), 3.73 
(s, 3H), 3.05 (qd, 2H, J = 6.5 Hz, J = 15.7 Hz, J = 44.4 Hz), 2.21 (bs, 
1H), 1.85-1.62 (m, 6H), 1.36-1.12 (m, 5H); 13C-NMR (CDCl3, 100 
MHz) δ ppm 174.5, 135.7, 134.5, 127.0, 121.5, 119.3, 117.9, 110.6, 107.7, 55.2, 53.3, 52.0, 
43.1, 30.2, 28.4, 26.5, 26.4, 26.3, 24.9. Analytical data fits with literature.108 
N
H
NH
CO2Me
c: (1R,3S)-methyl 1-cyclohexyl-2-(cyclohexylmethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-
b]indole-3-carboxylate.  
1H-NMR (CDCl3, 400 MHz) δ ppm 7.73 (s, 1H), 7.52 (d, 1H, J = 
7.6 Hz), 7.30 (d, 1H, J = 7.9 Hz), 7.12 (td, 2H, J = 7.1 Hz, J = 
22.1 Hz), 4.00 (dd, 1H, J = 4.8 Hz, J = 10.5 Hz), 3.74 (s, 3H), 
3.39 (d, 1H, J = 8.5 Hz), 3.09 (dd, 1H, J = 10.6 Hz, J = 15.8 Hz), 
2.82 (dd, 1H, J = 4.8 Hz, J = 15.9 Hz), 2.36 (d, 1H, J = 12.8Hz), 
2.26-2.12 (m, 3H), 1.94-1.60 (m, 9H), 1.40-1.00 (m, 9H), 0.83-0.70 (m, 2H); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 173.8, 135.7, 134.5, 126.9, 121.4, 119.3, 118.0, 110.5, 107.8, 63.2, 
57.2, 55.9, 51.7, 42.0, 36.6, 31.6, 31.4, 30.9, 30.7, 26.9, 26.8, 26.5, 26.4, 26.3, 26.2, 26.1, 
20.1. HRMS: m/z (ESI) calc for C26H37N2O2 (M+H+) 409.28496, found 409.28483. IR(film): 
ν [cm-1] =  3454 (w), 2916 (s), 2850 (s), 1740 (vs), 1451 (s), 1260 (m), 1076 (m), 741 (vs).  
N
H
N
CO2Me
d: (S)-methyl 2-(cyclohexylmethylamino)-3-(1H-indol-3-yl)propanoate.  
1H-NMR (CDCl3, 400 MHz) δ ppm 1H-NMR (400 MHz), 8.80 (s, 
1H), 7.62 (d, 1H, J = 7.8 Hz), 7.28 (d, 1H, J = 8.0 Hz), 7.15 (dt, 
2H, J = 7.1 Hz, J = 22.7 Hz), 6.95 (d, 1H, J = 1.2 Hz), 3.67 (t, 
1H, J = 6.7 Hz), 3.64 (s, 3H), 3.19 (qd, 2H, J = 6.7 Hz, J = 14.4 
Hz), 2.41 (ddd, 2H, J = 6.8 Hz, J = 11.3 Hz, J = 17.7 Hz), 1.85 (bs, 1H), 1.72-1.59 (m, 5H, J 
= 8.9Hz), 1.47-1.34 (m, 1H),1.24-1.04 (m, 3H), 0.89-0.76 (m, 2H). 13C-NMR (CDCl3, 100 
MHz) 175.4, 136.0, 127.1, 122.9, 121.6, 118.9, 118.4, 111.1, 110.4, 62.1, 54.7, 51.5, 37.7, 
31.01, 30.9, 29.0, 26.3, 25.7, 25.6; HRMS: m/z (ESI) calc for C19H27N2O2 (M+H+) 
315.20670, found 315.20630. IR(film): ν [cm-1] =  3421 (s), 2843 (s), 2843 (s), 1746 (vs), 
1444 (vs), 1354 (m), 1267 (m), 1214 (m), 1010 (m), 748 (s). 
N
H
HN
CO2Me
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e: (S)-methyl 2-(bis(cyclohexylmethyl)amino)-3-(1H-indol-3-yl)propanoate. 
 1H-NMR (CDCl3, 400 MHz) δ ppm 8.01 (s, 1H), 7.57 (d, 1H, J 
= 7.7 Hz), 7.32 (d, 1H, J = 8.0 Hz), 7.14 (dt, 2H, J = 7.0 Hz, J = 
22.0 Hz), 6.97 (d, 1H, J = 1.9 Hz), 3.69 (dd, 1H, J = 4.2 Hz, J = 
10.1 Hz), 3.57 (s, 3H), 3.26 (dd, 1H, J = 10.1 Hz, J = 14.1 Hz), 
2.92 (dd, 1H, J = 4.0 Hz, J = 14.1 Hz), 2.40 (dd, 2H, J = 9.1 Hz, 
J = 12.9 Hz), 2.28 (dd, 2H, J = 5.2 Hz, J = 12.9 Hz), 1.92 (d, 2H, J = 12.7 Hz), 1.75-1.61 (m, 
8H), 1.43-1.33(m, 2H), 1.28-1.09 (m, 6H), 0.90-0.75 (m, 4H); 13C-NMR (CDCl3, 100 MHz) 
δ ppm 173.2, 136.2, 127.4, 122.6, 121.7, 119.2, 118.4, 112.7, 111.1, 63.4, 58.5, 50.7, 36.2, 
31.6, 26.9, 26.2, 26.1, 25.6. HRMS: m/z (ESI) calc for C26H39N2O2 (M+H+) 411.30061, 
found 411.30012. IR (film): ν [cm-1] = 3415 (m), 2935 (vs), 2850 (vs), 1740 (vs), 1451 (s), 
1352 (w), 1221 (w), 741 (s). 
N
H
N
CO2Me
f: (S)-methyl 2-(cyclohexylmethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate. 
 1H-NMR (CDCl3, 400 MHz) δ ppm 7.76 (s, 1H), 7.45 (d, 1H, J = 
7.4 Hz), 7.26 (d, 1H, J = 7.8 Hz), 7.09 (tt, 2H, J = 6.7 Hz, J = 
13.6 Hz), 4.13 (d, 1H, J = 15.1 Hz), 3.90 (d, 1H, J = 15.1 Hz), 
3.84 (dd, 1H, J = 4.1 Hz, J = 5.9 Hz), 3.62 (s, 3H), 3.12 (qd, 2H, J 
= 4.9 Hz, J = 15.5 Hz), 2.57 (ddd, 2H, J = 7.1 Hz, J = 12.8 Hz, J = 20.7 Hz), 1.87 (d, 1H, J = 
12.7 Hz), 1.76-1.60 (m, 4H), 1.59-1.47 (m, 1H), 1.30-1.11 (m, 3H), 0.94-0.80 (m, 2H); 13C-
NMR (CDCl3, 100 MHz) δ ppm 173.5, 136.0, 131.9, 127.1, 121.3, 119.2, 117.8, 110.6, 
106.2, 61.3, 60.3, 51.4, 46.8, 36.2, 31.6, 26.8, 26.1, 26.0, 23.7; HRMS: m/z (ESI) calc for 
C20H27N2O2 (M+H+) 327.20670, found 327.20631; IR (film): ν [cm-1] =  3395 (s), 2935 (s),  
2837 (s), 1733 (vs), 1628 (w), 1451 (s), 1155 (m), 1010 (m), 741 (s).  
N
H
N
CO2Me
 
a: (1S,3S)-methyl 1-cycloheptyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate (Table 10, Entry 10)  
The general procedure was followed with (S)-tryptophane methylester (218 mg, 1 mmol), 
cycloheptene (97 mg, 1 mmol) and Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) in 10 ml of DCM 
under 50 bar CO and 10 bar H2 at 80 °C for 72 h. The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexan/ethylacetat = 10/1) to give 101 mg 
(31 %) of a, 130 mg (40 %) of b and 72 mg (22 %) of c 
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a: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.88 (s, 1H) ppm 7.47 (d, 1H, 
J = 7.6 Hz), 7.32 (d, 1H, J = 7.8 Hz), 7.12 (dt, 2H, J = 7.2 Hz, J = 
21.0 Hz), 4.19 (s, 1H), 3.81 (s, 3H), 3.72 (dd, 1H, J = 4.0 Hz, J = 
11.1 Hz), 3.10 (dd, 1H, J = 2.5 Hz, J = 14.8 Hz), 2.82-2.72 (m, 1H), 
2.05-1.96 (m, 2H), 1.83-1.71 (m, 2H), 1.70-1.28 (m, 12H); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 173.8, 135.9, 135.1, 127.2, 121.6, 119.4, 117.8, 1.7, 109.3, 59.2, 
56.4, 52.1, 43.3, 31.6, 28.7, 28.1, 27.8, 27.5, 27.5, 25.9; HRMS: m/z (ESI) calc for 
C20H27N2O2 (M+H+) 327.20670, found 327.20607; IR(film): ν [cm-1] = 3375 (m), 3054 (w), 
2922 (s), 1733 (vs), 1464 (s), 1325 (m), 1260 (m), 1214 (m), 754 (m).  
N
H
NH
CO2Me
b: (1R,3S)-methyl 1-cycloheptyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-
carboxylate. 
 1H-NMR (CDCl3, 400 MHz) δ ppm 7.76 (s, 1H), 7.48 (d, 1H, J = 7.5 
Hz), 7.29 (d, 1H, J = 7.8 Hz), 7.11 (dt, 2H, J = 7.1 Hz, J = 20.0 Hz), 
4.28 (s, 1H), 4.02 (t, 1H, J = 5.0 Hz), 3.65 (s, 3H), 3.15-3.06 (m, 2H), 
2.01-1.92 (m, 2H), 1.91-1.71 (m, 2H), 1.70-1.23 (m, 12H); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 174.7, 135.8, 134.4, 127.1, 121.6, 121.5, 
119.5, 119.3, 117.9, 117.9, 110.7, 110.6, 108.0, 55.6, 53.9, 51.9, 44.7, 31.8, 29.2, 28.2, 27.8, 
27.6, 27.3, 24.2; HRMS: m/z (ESI) calc for C20H27N2O2 (M+H+) 327.20670, found 
327.20618; IR(film): ν [cm-1] = 3389 (m), 2929 (s), 2850 (s), 1733 (vs9, 1621 (w), 1451 (s), 
1339 (m), 1267 (s), 1214 (s), 1017 (w), 735 (s). 
N
H
NH
CO2Me
c: (S)-methyl 2-(cycloheptylmethylamino)-3-(1H-indol-3-yl)propanoate. 
 1H-NMR (CDCl3, 400 MHz) δ ppm 8.27 (s, 1H), 7.60 (d, 1H, J = 
7.8 Hz), 7.31 (d, 1H, J = 8.0 Hz), 7.13 (dt, 1H, J = 7.2 Hz, J = 
25.8 Hz), 7.00 (d, 1H, J = 1.5 Hz), 3.61 (s, 3H), 3.59 (t, 1H, J = 
6.7 Hz), 3.13 (qd, 2H, J = 6.7 Hz, J = 14.4 Hz), 2.36 (ddd, 2H, J 
= 6.8 Hz, J = 11.2 Hz, J = 43.8 Hz), 1.75-1.20 (m, 12H), 1.07 (dd, 2H, J = 10.2 Hz, J = 21.4 
Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 175.6, 136.1, 127.4, 122.7, 121.9, 119.3, 118.7, 
111.2, 111.1, 62.3, 55.2, 51.6, 39.5, 32.5, 32.3, 29.2, 28.4, 28.4, 26.4, 26.4; HRMS: m/z 
(ESI) calc for C20H29N2O2 (M+H+) 329.22235, found 329.22250; IR(film): ν [cm-1] = 3408 
(m), 2922 (s), 2843 (s), 1733 (vs), 1457 (s), 1352 (m), 1267 (m), 1241 (m), 741 (s).  
N
H
N
H
CO2Me
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(S)-methyl 2-(cyclooctylmethylamino)-3-(1H-indol-3-yl)propanoate (Table 10, Entry 
11).  
The general procedure was followed with (S)-tryptophane 
methylester (218 mg, 1 mmol), cyclooctene (110 mg, 1 mmol) 
and Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) in 10 ml of DCM under 
50 bar CO and 10 bar H2 at 80 °C for 72 h (Table 1, entry 11). 
The crude reaction mixture was purified by flash column chromatography on silica gel 
(Cyclohexan/Ethylacetat = 10/1) to give 147 mg (43 %) of title compound as brownish oil. 
N
H
N
H
CO2Me
1H-NMR (CDCl3, 400 MHz) δ ppm  8.29 (s, 1H), 7.60 (d, 1H, J=7.8Hz), 7.31 (d, 1H, 
J=8.0Hz), 7.13 (dt, 2H, J=7.1Hz, J=26.3Hz), 7.01 (d, 1H, J=1.8Hz), 3.61 (s, 3H), 3.58 (d, 
1H, J=6.7Hz), 3.13 (qd, 2H, J=6.7Hz, J=14.4Hz), 2.40 (dd, 1H, J=7.1Hz, J=11.2Hz), 2.27 
(dd, 1H, J=6.4Hz, J=11.1Hz), 2.05-1.80 (m, 2H), 1.65-1.27 (m, 12H), 1.22-1.09 (m, 2H); 
13C-NMR (CDCl3, 100 MHz) δ ppm 175.5, 136.1, 127.3, 122.8, 121.9, 119.3, 118.7, 111.2, 
111.1, 62.3, 55.6, 51.6, 37.5, 30.8, 30.5, 29.2, 26.9, 26.3, 25.5, 25.3; HRMS: m/z (ESI) calc 
for C21H31N2O2 (M+H+) 343.23801, found 343. 23755; IR(film): ν [cm-1] =  3402 (m), 2922 
(s), 2850 (s), 2364 (w), 1733 (vs), 1451 (s), 1345 (m), 1194 (m), 1010 (w), 748 (s). 
 
(1S,3S)-methyl 2,3,4,9-tetrahydro-1-((S)-1,2-diphenylethyl)-1H-pyrido[3,4-b]indole-3-
carboxylate, (113)  
The general procedure was followed with (S)-tryptophane methylester (218 mg, 1 mmol), 
trans-stilbene (180 mg, 1 mmol) and Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) in 8 ml of DCM. 
The crude reaction mixture was purified by flash column chromatography on silica gel 
(Cyclohexan/Ethylacetat = 10/1) to give 138 mg (34 %) of a and 136 mg (33 %) b, and 169 
mg (41 %) of c. 
a: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.66 (bs, 1H), 7.46 (d, 1H, J = 
6.5 Hz), 7.35-6.95 (m, 11H), 6.88 (d, 2H, J = 6.7 Hz), 4.54 (d, 1H, J 
= 7.3 Hz), 3.83 (s, 3H), 3.76 (dd, 1H, J = 3.9 Hz, J = 11.2 Hz), 3.35 
(dd, 1H, J = 3.3 Hz, J = 13.5 Hz), 3.25-3.05 (m, 3H), 2.92-2.82 (m, 
2H); 13C-NMR (CDCl3, 100 MHz) δ ppm 173.6, 141.3, 139.8, 135.5, 134.3, 129.0, 128.9, 
128.8, 127.9, 127.4, 126.6, 125.7, 121.8, 119.4, 117.9, 110.8, 109.4, 57.7, 56.5, 53.0, 52.2, 
37.6, 25.9; HRMS: m/z (ESI) calc for C27H27N2O2 (M+H+) 411.20670, found 411.20665; 
IR(film): ν [cm-1] =  3415 (m), 2922 (s), 2843 (s), 1700 (vs), 1654 (vs), 1457 (s), 1352 (m), 
1260 (vs), 1037 (m), 754 (s). 
N
H
NH
CO2Me
Ph
Ph
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(1R,3S)-methyl 2,3,4,9-tetrahydro-1-((R)-1,2-diphenylethyl)-1H-pyrido[3,4-b]indole-3-
carboxylate, (113)  
b: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.55 (s, 1H), 7.43 (d, 1H, 
J=8.0Hz), 7.40-7.0 (m, 11H), 6.93 (d, 2H, J=6.8Hz), 4.47 (d, 1H, 
J=9.2Hz), 4.02 (dd, 1H, J=5.1Hz, J=8.3Hz), 3.76 (s, 3H), 3.54 (dd, 
1H, J=3.5Hz, J=13.6Hz), 3.19 (td, 1H, J=3.7Hz, J=10.2Hz), 3.13 (dd, 
1H, J=4.9Hz, J=15.4Hz), 3.04-2.90 (m, 2H), 2.11 (bs, 1H); 13C-NMR (CDCl3, 100 MHz) δ 
ppm 174.3, 142.1, 140.3, 135.6, 134.5, 129.2, 129.0, 128.9, 128.1, 127.3, 126.6, 125.8, 
121.8, 119.3, 118.0, 110.7, 108.1, 55.9, 53.1, 52.5, 52.3, 39.1, 25.7; HRMS: m/z (ESI) calc 
for C27H27N2O2 (M+H+) 411.20670, found 411.20676; IR(film): ν [cm-1] =  3435 (m), 2922 
(s), 2847 (s), 1720 (vs), 1624 (vs), 1457 (s), 1352 (m), 1267 (vs), 1024 (w), 728 (s). 
(S)-methyl 2-(2,3-diphenylpropylamino)-3-(1H-indol-3-yl)propanoate, (113) . 
 c: 1H-NMR (CDCl3, 400 MHz) δ ppm 8.04, 7.97 (2s, 1H), 7.54 (t, 
1H, J = 6.9 Hz), 7.28 (dd, 1H, J = 4.2 Hz, J = 8.0 Hz), 7.22-7.06 
(m, 8H), 7.03 (d, 1H, J = 6.9 Hz), 6.98 (t, 1H, J = 6.7 Hz), 6.89 (d, 
1H, J = 6.5 Hz), 6.82, 6.72 (2d, 1H, J = 1.7 Hz), 3.62-3.50 (m, 
4H), 3.13 (dd, 0.5H, J = 5.4 Hz, J = 14.4 Hz), 3.08-2.70 (m, 6H), 2.64 (dd, 0.5H, J = 7.9 Hz, 
J = 10.9 Hz). 13C-NMR (CDCl3, 100 MHz) δ ppm 175.0, 174.9, 142.8, 142.5, 140.0, 139.9, 
136.1, 136.0, 129.0, 128.9, 128.3, 128.2, 128.0, 127.9, 127.7, 127.7, 127.3, 127.1, 126.4, 
126.3, 125.8, 125.7, 122.8, 122.6, 122.0, 121.9, 119.3, 118.6, 118.6, 111.1, 111.1, 111.0, 
110.9, 77.3, 77.0, 76.7, 62.1, 62.0, 52.9, 52.3, 51.7, 51.6, 47.7, 47.6, 41.2, 40.6, 29.2, 28.7; 
HRMS: m/z (ESI) calc for C27H29N2O2 (M+H+) 413.22235, found 413.22195; IR(film): ν 
[cm-1] =  3428 (m), 3034 (m), 2922 (m), 2850 (m), 2370 (w), 1937 (w), 1733 (vs9, 1464 (s9, 
1208 (m), 741 (s) , 659 (s). 
 
(S)-methyl 2,3,4,9-tetrahydro-1-(2,2-diphenylethyl)-1H-pyrido[3,4-b]indole-3-
carboxylate, (115) 
The general procedure was followed with (S)-tryptophane methylester (218 mg, 1 mmol), 
1,1´diphenylethylene (180 mg, 1 mmol) and Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) in 8 ml of 
DCM. The crude reaction mixture was purified by flash column 
chromatography on silica gel (Cyclohexan/Ethylacetat = 10/1) to 
give 275 mg (67 %) of 115 and 72 mg (17 %) of 116. 1H-NMR 
(CDCl3, 400 MHz) δ ppm 7.56 (s, 1H), 7.46 (s, 1H), 7.44 (d, 2H, J = 
7.7 Hz), 7.38-7.04 (m, 26H), 4.42-4.34 (m, 2H), 4.10-4.00 (m, 2H), 
N
H
NH
CO2Me
Ph
Ph
N
H
N
H
CO2Me
Ph
Ph
N
H
NH
CO2Me
Ph
Ph
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3.91 (dd, 1H, J = 4.9 Hz, J = 9.1 Hz), 3.78 (s, 3H), 3.73 (s, 3H), 3.63 (dd, 1H, J = 4.2 Hz, J = 
11.1 Hz), 3.06 (dd, 2H, J = 4.5 Hz, J = 15.3 Hz), 2.80 (dd, 2H, J = 10.2 Hz, J = 14.6 Hz), 
2.74-2.66 (m, 1H), 2.48-2.41 (m, 2H), 2.35 (ddd, 1H, J = 4.7 Hz, J = 9.0 Hz, J = 13.7 Hz), 
1.82 (bs, 2H); 13C-NMR (CDCl3, 100 MHz) δ ppm 174.1, 173.6, 144.6, 144.5, 144.3, 143.6, 
135.9, 135.7, 135.5, 135.3, 128.7, 128.8, 128.6, 128.5, 128.2, 127.7, 127.6, 127.1, 126.9, 
126.7, 126.6, 126.3, 121.8, 119.6, 119.5, 117.9, 110.7, 110.7, 108., 107.2, 56.4, 52.1, 52.0, 
51.9, 51.1, 48.6, 47.8, 47.4, 41.4, 41.3, 25.9, 25.6; HRMS: m/z (ESI) calc for C27H27N2O2 
(M+H+) 411.20670, found 411.20654;IR(film): ν [cm-1] =  3054 (m), 2916 (m), 2850 (m), 
1950 (w), 1815 (w), 1733 (vs), 1680 (s) 1490 (s), 1425 (s), 1345 (m), 1260 (vs), 1010 (m), 
754 (s), 708 (s). 
 
 (S)-methyl 2-(3,3-diphenylpropylamino)-3-(1H-indol-3-yl)propanoate, (116) 
1H-NMR (CDCl3, 400 MHz) δ ppm 8.31 (s, 1H), 7.64 (d, 1H, J = 
7.8 Hz), 7.33 (d, 1H, J = 8.0 Hz), 7.27-7.12 (m, 10H), 7.09 (d, 2H, J 
= 7.1 Hz), 6.96 (d, 1H, J = 1.9 Hz), 3.91 (t, 1H, J = 7.8 Hz), 3.61 (s, 
3H), 3.59 (d, 1H, J = 7.4 Hz), 3.15 (qd, 2H, J = 6.6Hz, J = 14.3 Hz, 
J = 21.6 Hz), 2.63 (dt, 1H, J = 7.0 Hz, J = 11.5 Hz), 2.42 (dt, 1H, J = 7.1 Hz, J = 11.5 Hz), 
2.18 (qd, 2H, J = 2.8 Hz, J = 7.5 Hz, J = 14.2 Hz), 1.77 (bs, 1H); 13C-NMR (CDCl3, 100 
MHz) δ ppm 175.2, 144.5, 144.4, 136.1, 128.3, 127.7, 127.6, 127.3, 126.0, 125.9, 122.8, 
121.9, 119.3, 118.6, 111.2, 110.9, 61.9, 51.6, 48.4, 46.2, 35.5, 29.2; HRMS: m/z (ESI) calc 
for C27H29N2O2 (M+H+)  413.22235, found 413.22155; IR(film): ν [cm-1] = 3421 (s), 3054 
(w), 2916 (m), 2850 (m), 1950 (w), 1884 (w), 1800 (w), 1733 (vs), 1490 (s), 1451 (s), 1345 
(m), 1260 (m), 1010 (m), 754 (s), 702 (s). 
N
H
N
H
CO2Me
Ph Ph
 
General procedure for tandem hydroformylation / Pictet-Spengler reaction under 
protic conditions 
 
In a thick walled sample vial containing PTFE septum tryptamine (1 equiv.), olefin (1 
equiv.), Rh(acac)(CO)2 (0.01 equiv.), and BrØnsted acid (1 equiv.) were dissolved in dry 
solvent (8 mL). The vial was placed in a pressure vessel, flushed with argon and pressurized 
with 50 bar CO and 10 bar H2. The reaction mixture was stirred for 3 days at 80 °C or 110 
°C. Reaction was quenched with ammonia solution (30% in water) and the aqueous phase 
was extracted with 4x10 mL DCM. The combined organic layers were washed with brine, 
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dried over MgSO4, filtered and volatiles were removed in vacuo. The crude reaction mixture 
was purified by column chromatography on silica gel (DCM/MeOH) to give the desired 
product. 
 
1-Cyclopentyl-2, 3, 4, 9-tetrahydro-1H-b-carboline, (101a), (Table 12, Entry 1) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), cyclopenten (68 mg, 1 mmol), Rh(acac)(CO)2 (3.6 mg, 0.01 
mmol) and camphor sulphonicacid  (218 mg, 1 mmol) in 8 ml of DCM. 
The crude reaction mixture was purified by flash column 
chromatography on silica gel (DCM/MeOH/triethylamine = 20/1/0.1) to give (156 mg, 65 % 
yield) of the title compound as yellowish oil; 1H-NMR (CDCl3, 500 MHz) δ ppm 7.99 (s, 
1H), 7.50 (d, 1H, J = 7.7 Hz), 7.32 (d, 1H, J = 7.9 Hz), 7.14 (dt, 2H, J = 7.3 Hz, J = 26.4 
Hz), 3.93 (d, 1H, J = 7.4 Hz), 3.37 (dt, 1H, J = 4.7 Hz, J = 12.5 Hz), 3.06-3.00 (m, 1H), 
2.82-2.72 (m, 2H), 2.41 (bs, 1H), 2.27 (q, 1H,  J = 7.4 Hz ), 2.00-1.92 (m, 1H), 1.84 (dtd, 
1H, J = 3.7 Hz, J = 7.6 Hz, J = 11.5 Hz), 1.79-1.50 (m, 6H), 1.38 (ddd, 1H, J = 8.6 Hz, J = 
12.4 Hz, J = 17.7 Hz); 13C-NMR (CDCl3, 125 MHz) δ ppm 135.9, 135.5, 127.2, 121.4, 
119.2, 117.9, 110.6, 109.1, 56.9, 44.4, 42.3, 29.8, 29.3, 25.8, 25.2, 22.5; HRMS: m/z (FAB) 
calc for C16H21N2 (M+H+) 241.1699, found 241.1686; IR(film): ν [cm-1] =  3421 (m), 3224 
(m), 3047 (m), 2955 (m), 2581 (w), 2475 (w), 1667 (m), 1464 (s), 1418 (s), 1300 (s), 1254 
(s), 1004 (m), 741 (vs). 
N
H
NH
 
1-Cyclohexyl-2,3,4,9-tetrahydro-1H-b-carboline, (101b), (Table 12, Entry 2) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), cyclohexen (82 mg, 1 mmol), Rh(acac)(CO)2 (3.6 mg, 0.01 
mmol) and camphorsulphonicacid  (218 mg, 1 mmol) in 8 ml of DCM 
at 110 °C for 72 h. The crude reaction mixture was purified by flash 
column chromatography on silica gel (DCM/MeOH/triethylamine = 20/1/0.1) to give (117 
mg, 46 % yield) of the title compound as brown oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 7.81 
(s, 1H), 7.39 (d, 1H, J = 7.6 Hz), 7.22 (d, 1H, J = 7.8 Hz), 7.02 (dt, 2H, J = 7.1 Hz, J = 14.9 
Hz), 3.89 (s, 1H), 3.27 (dt, 1H, J = 4.3 Hz, J = 12.5 Hz), 2.92-2.83 (m, 1H), 2.70-2.56 (m, 
2H), 1.80-1.00 (m, 11H); 13C-NMR (CDCl3, 100 MHz) δ ppm 135.5, 135.2, 127.5, 121.3, 
N
H
NH
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119.2, 117.9, 110.6, 109.9, 57.7, 43.0, 42.2, 30.2, 27.5, 26.9, 26.8, 26.5, 26.4, 22.7. 
Analytical data fits with literature.109
 
1-Cycloheptyl-2,3,4,9-tetrahydro-1H-b-carboline, (101c), (Table 12, Entry 3) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), cyclohepten (96 mg, 1 mmol), Rh(acac)(CO)2 (3.6 mg, 0.01 
mmol) and camphorsulphonicacid  (218 mg, 1 mmol) in 8 ml of DCM. 
The crude reaction mixture was purified by flash column 
chromatography on silica gel (DCM/MeOH/triethylamine = 20/1/0.1) to give (182 mg, 68 % 
yield) of the title compound as brown oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 7.89 (s, 1H), 
7.48 (d, 1H, J = 7.6 Hz), 7.31 (d, 1H, J = 7.9 Hz), 7.12 (dt, 2H, J = 7.3 Hz, J = 25.2 Hz), 
4.10 (s, 1H), 3.40 (ddd, 1H, J = 1.8 Hz, J = 4.5 Hz, J = 12.0 Hz), 2.94 (ddd, 1H, J = 5.0 Hz, 
J = 10.1 Hz, J = 12.5 Hz), 2.80-2.64 (m, 2H), 2.16 (bs, 1H), 2.02-1.93 (m, 1H), 1.84-1.28 
(m, 12H); 13C-NMR (CDCl3, 100 MHz) δ ppm 135.6, 135.3, 127.5, 121.3, 119.2, 117.9, 
110.6, 110.3, 59.3, 43.6, 43.3, 32.0, 28.7, 28.2, 27.7, 27.5, 22.6; HRMS: m/z (FAB) calc for 
C18H25N2 (M+H+) 269.2012, found 269.1997; IR(film): ν [cm-1] =  3415 (m), 3283(m), 2935 
(m), 2364 (w), 1917 (w), 1674 (s), 1608 (s), 1464 (s), 1319 (m), 1201 (m), 991 (m), 748 (s).  
N
H
NH
 
1-Cyclooctyl-2,3,4,9-tetrahydro-1H-b-carboline, (101d), (Table 12, Entry 4) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), cycloocten (110 mg, 1 mmol), Rh(acac)(CO)2 (3.6 mg, 0.01 
mmol) and camphorsulphonicacid  (218 mg, 1 mmol) in 8 ml of 
DCM. The crude reaction mixture was purified by flash column 
chromatography on silica gel (DCM/MeOH/triethylamine = 20/1/0.1) to give (166 mg, 59 % 
yield) of the title compound as brown oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 8.04 (s, 1H) 
ppm 7.51 (d, 1H, J = 7.6 Hz), 7.33 (d, 1H, J = 7.8 Hz), 7.15 (dt, 2H, J = 6.9 Hz, J = 20.2 
Hz), 4.08 (s, 1H), 3.42 (ddd, 1H, J = 2.0 Hz, J = 4.5 Hz, J = 12.0 Hz), 2.95 (ddd, 1H, J = 5.0 
Hz, J = 10.0 Hz, J = 12.5 Hz), 2.83-2.68 (m, 2H), 2.24-2.02 (m, 1H), 1.86-1.30 (m, 14H); 
13C-NMR (CDCl3, 100 MHz) δ ppm 135.6, 135.3, 127.4, 121.2, 119.1, 117.8, 110.6, 110.4, 
60.1, 43.5, 41.2, 31.7, 27.9, 27.4, 26.6, 25.6, 25.5, 22.6; HRMS: m/z (FAB) calc for 
C19H25N2 (M-H+) 281.2023, found 281.1996; IR(film): ν [cm-1] = 3408 (m), 3237 (m), 3040 
N
H
NH
                                                 
109 Gremmen, C.; Willemse, B.; Wanner, M. J.; Koomen, G. J.; Org. Lett.  2000; 1955 - 1958. 
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(m), 2916 (s), 2856 (s), 2686 (w), 2357 (w), 1924 (w), 1621 (s), 1464 (s), 1326 (m), 1260 
(m), 741 (s). 
 
1-(2,2-Diphenyl-ethyl)-2,3,4,9-tetrahydro-1H-b-carboline, (101e), (Table 12, Entry 5) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), 1,1´diphenylethen  (180 mg, 1 mmol), Rh(acac)(CO)2 (3.6 
mg, 0.01 mmol) and camphorsulphonicacid  (218 mg, 1 mmol) in 8 
 reaction mixture was purified by flash column chromatography on 
silica gel (DCM/MeOH/triethylamine = 10/1/0.1) to give (229 mg, 64 % yield) of the title 
compound as white solid; 1H-NMR (DMSO D6
ml of DCM. The crude
, 400 MHz) δ ppm 10.78 (s, 1H), 7.53 (d, 2H, 
J = 7.3 Hz), 7.37-7.30 (m, 6H), 7.26 (t, 2H, J = 7.7 Hz), 7.19 (t, 1H, J = 7.4 Hz), 7.13 (t, 1H, 
J = 7.3 Hz), 7.02 (t, 1H, J = 8.0 Hz), 6.93 (t, 1H, J = 7.4 Hz), 4.51 (dd, 1H, J = 3.3 Hz, J = 
12.0 Hz), 3.68 (d, 1H, J = 10.7 Hz), 3.41 (bs, 1H), 3.12 (dt, 1H, J = 4.8 Hz, J = 12.6 Hz), 
3.00-2.93 (m, 1H), 2.76 (ddd, 1H, J = 5.0 Hz, J = 7.4 Hz, J = 12.6 Hz), 2.62-2.49 (m, 2H), 
2.03-1.94 (m, 1H); 13C-NMR (DMSO D6, 100 MHz) δ ppm 146.1, 143.7, 137.3, 135.5, 
128.3, 128.2, 128.1, 127.3, 127.1, 126.0, 125.7, 120.2, 118.0, 117.2, 110.7, 107.2, 49.7, 46.4, 
41.4, 39.5, 22.4; HRMS: m/z (FAB) calc for C25H25N2 (M+H+) 353.2012, found 353.2032; 
IR(film): ν [cm-1] =  3375 (m), 2929 (m), 2909 (m), 1602 (w), 1490 (s), 1464 (m), 1345 (m), 
1313 (w), 1120 (s), 1010 (m), 741 (vs). 
N
H
NH
Ph
Ph
 
2,3,4,9-tetrahydro-1-(1,2-diphenylethyl)-1H-pyrido[3,4-b]indole, (101f), (Table 12, 
Entry 6) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), trans-1,2 diphenylethylen (180 mg, 1 mmol), Rh(acac)(CO)2 
(3.6 mg, 0.01 mmol) and camphorsulphonicacid  (218 mg, 1 mmol) 
in 8 ml of DCM. The crude reaction mixture was purified by flash column chromatography 
on silica gel (DCM/MeOH/triethylamine = 20/1/0.1) to give (173 mg, 49 % yield) of the title 
compound as white solid; 1H-NMR (DMSO D6, 400 MHz) δ ppm 10.87 (s, 1H), 7.28-7.15 
(m, 8H), 7.08 (t, 1H, J = 7.0 Hz), 7.01 (t, 2H, J = 7.4 Hz), 6.98-6.90 (m, 2H), 6.83 (t, 1H, J = 
7.3 Hz), 4.16 (s, 1H), 3.75 (dt, 1H, J = 3.1 Hz, J = 7. 8Hz), 3.30-3.22 (m, 1H), 3.15 (dd, 1H, 
J = 8.5 Hz, J = 13.7 Hz), 2.86 (dt, 1H, J = 4.5 Hz, J = 11.8 Hz), 2.68 (ddd, 1H, J = 4.6 Hz, J 
= 7.9 Hz, J = 12.3Hz), 2.41-2.33 (m, 1H), 2.30-2.20 (m, 1H); 13C-NMR (DMSO D6, 100 
MHz) δ ppm 140.8, 140.7, 135.6, 135.5, 129.1, 128.9, 127.9, 127.3, 126.9, 125.8, 125.7, 
120.1, 117.9, 117.2, 110.7, 108.4, 55.3, 48.7, 42.1, 38.1, 22.3; HRMS: m/z (FAB) calc for 
N
H
NH
Ph
Ph
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C25H25N2  (M+H+) 353.2012, found 353.2011; IR(film): ν [cm-1] =  3421 (m), 3290 (w), 
3054 (m), 2962 (s), 2922 (s), 2344 (w9, 1871 (w), 1700 (m), 1602 (m), 1541 (vs), 1267 (m), 
1102 (m), 1004 (m), 740 (vs).  
 
N-Ethyl-4-methyl-N-[2-methyl-3-(2,3,4,9-tetrahydro-1H-b-carbolin-1-yl)-propyl]-
benzene sulfonamide, (101g), (Table 12, Entry 7) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), N-Ethyl-4-methyl-N-(2-methyl-allyl)-benzenesulfonamide 
(253 mg, 1 mmol), Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) and camphor 
sulphonicacid  (218 mg, 1 mmol) in 8 ml of DCM. The crude 
reaction mixture was purified by flash column chromatography on 
silica gel (DCM/MeOH/triethylamine = 9/1/0.1) to give (315 mg, 74 % yield) of the title 
compound as yellowish oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 8.37 (s, 1H), 7.66 (d, 2H, J = 
8.1 Hz), 7.45 (d, 1H, J = 7.6 Hz), 7.32 (d, 1H, J = 7.9 Hz), 7.24 (d, 2H, J = 8.0 Hz), 7.09 (dt, 
2H, J = 7.1 Hz, J = 14.6 Hz), 4.16 (d, 1H, J = 5.2 Hz), 3.31-3.12 (m, 4H), 3.00 (td, 1H,  J = 
6.3 Hz, J = 12.9 Hz), 2.83 (dd, 1H, J = 7.2 Hz, J = 13.7 Hz), 2.73-2.67 (m, 2H), 2.37 (s, 3H), 
2.24-2.15 (m, 1H), 1.94 (bs, 1H), 1.81 (ddd, 1H, J = 4.4 Hz, J = 9.3 Hz, J = 13.8 Hz), 1.64-
1.59 (m, 1H), 1.01 (dd, 6H, J = 6.9 Hz, J = 16.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 
143.2, 136.9, 136.3, 135.7, 129.6, 127.4, 127.1, 121.4, 119.2, 117.9, 110.9, 108.8, 53.8, 49.9, 
43.3, 42.1, 39.1, 28.8, 22.8, 21.4, 18.0, 13.4; HRMS: m/z (FAB) calc for C24H32N3O2S 
(M+H+) 426.2215, found 426.2224; IR(film): ν [cm-1] =  3380 (s), 2925 (s),1610 (w), 1448 
(vs), 1132 (vs), 1080 (m), 745 (s). 
N
H
NH
N
Ts
Et
 
2-[2-Methyl-3-(2,3,4,9-tetrahydro-1H-b-carbolin-1-yl)-propyl]-isoindole-1,3-dione, 
(101h), (Table 12, Entry 8) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), 2-(2-Methyl-allyl)-isoindole-1,3-dione (201 mg, 1 mmol), 
Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) and camphor sulphonicacid  
(218 mg, 1 mmol) in 8 ml of DCM. The crude reaction mixture was 
purified by flash column chromatography on silica gel (DCM/MeOH/triethylamine = 
9/1/0.1) to give (307 mg, 82 % yield) of the title compound as yellow solid. 1H-NMR 
(CDCl3, 500 MHz) δ ppm 8.99, 8.64 (2s, 1H), 7.86 (dq, 2H, J = 3.0 Hz, J = 5.4 Hz, J = 13.0 
Hz), 7.71 (ddd, 2H, J = 3.0 Hz, J = 5.5 Hz, J = 8.4 Hz), 7.47 (d, 1H, J = 7.7 Hz), 7.39 (dd, 
N
H
NH
NPht
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1H, J = 8.0 Hz, J = 12.6 Hz), 7.15 (ddd, 1H, J = 1.5 Hz, J = 3.2 Hz, J = 9.2 Hz), 7.08 (t, 1H, 
J = 7.4 Hz), 4.25, 4.20 (dd, J = 3.0 Hz, J = 9.0 Hz; t, J = 7.4 Hz, 1H), 3.77 (d, 1H, J = 5.2 
Hz), 3.71 (dd, 1H, J = 5.6 Hz, J = 13.7 Hz), 3.58 (dd, 1H, J = 8.8 Hz, J = 13.7 Hz), 3.30-3.26 
(m, 1H), 3.09-3.01 (m, 1H), 2.72 (t, 2H, J = 5.7 Hz), 2.40-2.31 (m, 1H), 2.12 (bs, 1H), 1.85-
1.70, 1.60-1.54 (2m, 1H), 1.01 (d, 3H, J = 6.8 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 
169.3, 168.7, 136.4, 135.8, 135.7, 133.9, 131.8, 127.2, 123.2, 121.3, 121.2, 119.0, 117.8, 
110.9, 110.8, 108.6, 50.3, 49.4, 43.6, 42.4, 41.4, 41.254, 40.2, 40.1, 30.5, 29.6, 22.7, 19.3, 
18.2; HRMS: m/z (ESI) calc for C23H24N2O3 (M+H+) 374.18630, found 374.18575; 
IR(film): ν [cm-1] =  3395(s), 3054 (m), 2942 (s), 1772 (vs), 1713 (vs), 1621 (w), 1470 (s), 
1267 (m), 1043 (vs), 748 (vs). 
 
1-(3-Benzyloxy-2-methyl-propyl)-2,3,4,9-tetrahydro-1H-b-carboline, (101i), (Table 12, 
Entry 9) 
The general procedure was followed with tryptamine (160 mg, 1 
mmol), (2-Methyl-allyloxymethyl)-benzene (162 mg, 1 mmol), 
Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) and camphor sulphonicacid  
(218 mg, 1 mmol) in 8 ml of DCM. The crude reaction mixture was 
purified by flash column chromatography on silica gel (DCM/MeOH/triethylamine = 
10/1/0.1) to give (171 mg, 51 % yield) of the title compound as yellow oil; 1H-NMR (CDCl3, 
400 MHz) δ ppm 8.64 (s, 1H), 7.45 (d, 1H, J = 7.4 Hz), 7.37-7.26 (m, 5H), 7.12-7.02 (m, 
1H), 4.53 (d, 1H, J = 1.1 Hz) ppm 4.25 (t, 1H, J = 6.9 Hz), 3.48 (dd, 1H, J = 4.1 Hz, J = 9.0 
Hz), 3.39 (t, 1H, J = 8.7 Hz), 3.32-3.25 (m, 1H), 3.09-3.01 (m, 1H), 2.75-2.60 (m, 3H), 2.17-
2.08 (m, 1H), 1.82 (td, 2H, J = 3.1 Hz, J = 6.8 Hz), 0.97 (d, 3H, J = 6.8 Hz); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 137.8, 136.2, 135.4, 128.5, 127.8, 127.3, 121.2, 118.9, 117.8, 
110.7, 108.1, 76.8, 73.4, 50.1, 41.2, 40.6, 30.3, 22.5, 17.9; HRMS: m/z (FAB) calc for 
C22H27N2O (M+H+) 335.2118, found 335.2095; IR(film): ν [cm-1] =  3336 (m), 3054 (w), 
2870 (m),1713 (m), 1621 (m), 1451 (m), 1109 (s), 735 (s). 
OBn
N
H
NH
 
2,3,4,9-tetrahydro-1-isobutyl-1H-pyrido[3,4-b]indole, (117) 
This compound was obtained as a byproduct in the syntheses of the 101 
g-i, in the yields of 10-15%.1H-NMR (CDCl3, 400 MHz) δ ppm 7.89 (s, 
1H), 7.49 (d, 1H, J = 7.5 Hz), 7.27 (d, 1H, J = 7.8 Hz), 7.12 (ddd, 2H, J = 
7.1 Hz, J = 14.2 Hz, J = 14.8 Hz), 4.10 (dd, 1H, J = 6.1 Hz, J = 7.7 Hz), 
3.34 (dt, 1H, J = 4.6 Hz, J = 12.7 Hz), 3.02 (ddd, 1H, J = 4.5 Hz, J = 7.9 Hz, J = 14.8 Hz ), 
N
H
NH
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2.80-2.68 (m, 2H), 2.05-1.90 (m, 1H), 1.73 (bs, 1H), 1.64-1.54 (m, 2H), 1.01 (dd, 6H, J = 
6.6 Hz, J = 12.1 Hz), 13C-NMR (CDCl3, 100 MHz) δ ppm 136.7, 135.5, 127.5, 121.3, 119.2, 
117.9, 110.6, 108.6, 50.4, 44.3, 42.4, 24.5, 23.8, 22.7, 21.6.Analytical data fits with 
literature.110
 
2-Benzyl-1-cyclopentyl-2, 3, 4, 9-tetrahydro-1H-b-carboline, (118) 
1-Cyclopentyl-2,3,4,9-tetrahydro-1H-b-carboline (480 mg, 2 mmol), 
Et3N (202 mg, 0.26 mL, 2 mmol) and benzylbromid (342 mg, 0.24 mL, 
2 mmol) were dissolved in  dry DMF (4 ml)  and the mixture was 
stirred under argon stream at room temperature for 1h. After this time 
reaction mixture was diluted with water and extracted with 4x10 ml DCM. Collected organic 
extracts were washed with brine, dried over MgSO4, filtered and evaporated. The crude 
reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate= 9/1) to give the title compound (562 mg,  85 % yield) as yellow 
oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 7.68 (s, 1H), 7.55 (d, 1H, J = 7.6 Hz), 7.40-7.22 (m, 
6H), 7.16 (dt, 2H, J = 7.3 Hz, J = 26.4 Hz), 3.81 (d, 1H, J = 13.4 Hz), 3.64 (d, 1H, J = 13.4 
Hz), 3.35 (ddd, 1H, J = 5.2 Hz, J = 11.6 Hz, J = 13.6 Hz), 3.27 (d, 1H, J = 9.7 Hz), 3.07 (dd, 
1H, J = 5.8 Hz, J = 13.9 Hz),3.03-2.93 (m, 1H), 2.54 (dd, 1H, J = 5.0 Hz, J = 15.8 Hz), 2.29-
2.18 (m, 1H), 2.24 (q, 1H,  J = 7.4 Hz ), 1.83-1.42 (m, 4H), 1.39-1.22 (m, 2H), 0.92-0.8 (m, 
2H);13C-NMR (CDCl3, 100 MHz) δ ppm 140.0, 135.5, 135.4, 129.0, 128.0, 127.2, 126.8, 
121.3, 119.2, 118.0, 110.6, 107.2, 61.6, 57.1, 45.8, 43.6, 31.4, 31.1, 25.4, 24.3, 16.9; HRMS: 
m/z (FAB) calc for C23H27N2 (M+H+) 331.2169, found 331.2189; IR(film): ν [cm-1] =  
3419(m), 2917(m), 1539(vs), 1452(s), 1321(s), 1142(s), 808 (s). 
N
H
NBn
 
2-Benzyl-3-cyclopentyl-1,2,3,4-tetrahydro-pyrrolo[3,4-b]quinolin-9-one, (119) 
2-benzyl-1-cyclopentyl-2, 3, 4, 9-tetrahydro-1H-b-carboline (120 mg, 
0.34 mmol) and KOtBu (76 mg, 0.68 mmol) were dissolved in 12 ml of 
DMF. Oxygen was bubbled through reaction mixture for 5h at room 
temperature. After this time reaction mixture was diluted with water 
and extracted with 4x10 ml DCM. Collected organic extracts were 
washed with brine, dried over MgSO4, filtered and evaporated. The crude reaction mixture 
N
H
NBn
O
                                                 
110  Yamada, H.; Kawate, T.; Matsumizu, M.; Nishida, A.; Yamaguchi, K.; Nakagawa, M. J. Org. Chem. 1998, 
6348 
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was purified by column chromatography on silica gel (cyclohexane/ethylacetate= 9/1) to 
give the title compound (63 mg,  54 % yield) as yellowish solid ; 1H-NMR (DMSO D6, 400 
MHz) δ ppm 11.80 (s, 1H), 8.07 (d, 1H, J = 8.0 Hz), 7.63-7.56 (m, 2H), 7.40-7.31 (m, 4H), 
7.29-7.20 (m, 2H), 4.34 (s, 1H), 3.99 (d, 1H, J = 13.8 Hz), 3.94 (dd, 1H, J = 2.4 Hz, J = 13.5 
Hz), 3.75 (d, 1H, J = 13.8 Hz), 3.49 (d, 1H, J = 13.4 Hz), 2.45-2.37 (m, 1H), 1.70-1.22 (m, 
8H); 13C-NMR (DMSO D6, 100 MHz) δ ppm 173.1, 152.5, 140.5, 139.7, 130.9, 128.2, 
128.1, 126.8, 125.0, 124.6, 122.6, 118.2, 115.8, 70.2, 61.9, 56.6, 43.9, 28.42, 25.9, 25.2, 
24.4; HRMS: m/z (FAB) calc for C23H25N2 O (M+H+) 345.1961, found 345.1941; IR(film): 
ν [cm-1] =  3441 (m), 3067 (w), 2942 (m), 2870 (w), 2784 (w), 1621 (s), 1562 (s), 1503 (vs), 
1365 (m), 754 (m), 721 (m). 
 
2-Benzyl-1-(2,2-diphenyl-ethyl)-2,3,4,9-tetrahydro-1H-b-carboline, (120) 
1-(2,2-Diphenyl-ethyl)-2,3,4,9-tetrahydro-1H-b-carboline (250 mg, 
0.71 mmol), Et3N (79 mg, 104 µL, 0.78 mmol) and benzylbromid 
(133 mg, 93 µL, 0.78 mmol) were dissolved in  dry DMF (4 ml)  and 
the mixture was stirred under argon stream at room temperature for 2h. After this time 
reaction mixture was diluted with water and extracted with 4x10 ml DCM. Collected organic 
extracts were washed with brine, dried over MgSO4, filtered and evaporated. The crude 
reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate= 9/1) to give the title compound (280 mg, 88 % yield) as yellow 
oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 7.60 (d, 1H, J = 7.3 Hz), 7.50-7.18 (m, 17H), 7.15 
(d, 2H, J = 7.1 Hz), 4.44 (dd, 1H, J = 4.4 Hz, J = 10.5 Hz), 3.87 (d, 1H, J = 13.2 Hz), 3.69-
3.62 (m, 2H), 3.35 (ddd, 1H, J = 4.8 Hz, J = 11.7 Hz, J = 13.9 Hz), 3.13 (dd, 1H, J = 5.2 Hz, 
J = 13.9 Hz), 3.06-2.95 (m, 1H), 2.70-2.55 (m, 2H), 2.50-2.42 (m, 1H); 13C-NMR (CDCl3, 
100 MHz) δ ppm 144.9, 144.8, 139.7, 135.6, 134.9, 129.2, 128.6, 128.4, 128.3, 128.2, 127.7, 
127.2, 127.0, 126.2, 126.0, 121.4, 119.2, 117.9, 110.6, 107.4, 57.2, 54.4, 47.8, 42.9, 41.7, 
16.8; HRMS: m/z (FAB) calc for C32H31N2 (M+H+) 443.2482, found 443.2501; IR(film): ν 
[cm-1] =  3248 (m), 3054 (m), 3021 (m), 2935 (m), 2364 (w), 1963 (w), 1864 (w), 1694 (m), 
1503 (s), 1444 (s), 1339 (m), 1116 (m), 1004 (m), 741 (vs), 695 (vs). 
N
H
NBn
Ph
Ph
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2-Benzyl-3-(2, 2-diphenyl-ethyl)-1,2,3,4-tetrahydro-pyrrolo[3,4-b]quinolin-9-one, (121) 
2-Benzyl-1-(2,2-diphenyl-ethyl)-2,3,4,9-tetrahydro-1H-b-carboline 
(110 mg, 0.25 mmol) and KOtBu (56 mg, 0.50 mmol) were dissolved 
in 10 ml of DMF. Oxygen was bubbled through reaction mixture for 
5h at room temperature. After this time reaction mixture was diluted 
with water and extracted with 4x10 ml DCM. Collected organic 
extracts were washed with brine, dried over MgSO4, filtered and evaporated. The crude 
reaction mixture was purified by column chromatography on silica gel (DCM/MeOH = 20/1) 
to give the title compound (55 mg, 48 % yield) as white solid ; 1H-NMR (DMSO D6, 400 
MHz) δ ppm 11.66 (s, 1H), 7.98 (d, 1H, J = 7.8 Hz), 7.60-7.02 (m, 17H), 6.86 (t, 1H, J = 6.8 
Hz), 4.42 (s, 1H), 4.18 (s, 1H), 3.84 (t, 2H, J = 14.8 Hz), 3.51 (d, 1H, J = 13.1 Hz), 3.40 (d, 
1H, J = 13.0 Hz), 2.81-2.72 (m, 1H), 2.45-2.36 (m, 1H); 13C-NMR (DMSO D6, 100 MHz) δ 
ppm 172.9, 152.0, 145.2, 144.6, 140.3, 139.2, 130.8, 128.5, 128.4, 128.2, 127.9, 127.7, 
127.5, 126.9, 126.0, 125.6, 125.02, 124.5, 122.5, 118.1, 115.5, 66.6, 59.3, 54.9, 46.7, 38.2; 
HRMS: m/z (FAB) calc for C32H29N2 O (M+H+) 457.2274, found 457.2273; IR(film): ν [cm-
1] =  3435 (m), 2364 (vs), 2331 (s), 1621 (m), 1569 (m), 1490 (m), 761 (w), 659 (m). 
N
H
NBn
O
Ph
Ph
 
N-(cyclopentylmethyl)-2-phenylethanamine, (124) 
The general procedure was followed with phenethylamine (120 mg, 1 
mmol), cyclopentene (70 mg, 1 mmol), Rh(acac)(CO)2 (3.6 mg, 0.01 
mmol) and camphor sulphonicacid  (218 mg, 1 mmol) in 8 ml of DCM. The crude reaction 
mixture was purified by flash column chromatography on silica gel 
(cyclohexane/ethylacetate = 10/1) to give (109 mg, 54 % yield) of the title compound as 
yellow oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 7.30-7.23 (m, 2H), 7.21-7.15 (m, 3H), 2.85 
(qd, 4H, J = 2.0 Hz, J = 8.7 Hz), 2.56 (d, 2H, J = 7.2 Hz), 2.25 (bs, 1H), 1.99 ( pd, 1H, J = 
7.7 Hz, J = 15.3 Hz), 1.77-1.68 (m, 2H), 1.60-1.44 (m, 4H), 1.15-1.05 (m, 2H); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 139.8, 128.6, 128.4, 126.1, 55.4, 51.3, 39.8, 36.0, 30.8, 25.2. 
HN
 
N-phenethyl-3,3-diphenylpropan-1-amine, (125) 
The general procedure was followed with phenethylamine (120 
mg, 1 mmol), 1,1’-diphenylethylene (180 mg, 1 mmol), 
Rh(acac)(CO)2 (3.6 mg, 0.01 mmol) and camphor sulphonicacid  
H
N
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(218 mg, 1 mmol) in 8 ml of DCM. The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/ethylacetate = 10/1) to give (179 mg, 57 % yield) 
of the title compound as yellow oil; 1H-NMR (CDCl3, 400 MHz) δ ppm 7.29-7.12 (m, 15H), 
3.93 (t, 1H, J = 7.8Hz), 2.86-2.73 (m, 4H), 2.59 (t, 1H ,J = 7.7Hz), 2.24 (q, 1H, J = 7.7Hz); 
13C-NMR (CDCl3, 100 MHz) δ ppm 144.5, 139.6, 128.7, 128.4, 127.7, 126.2, 50.8, 48.9, 
47.9, 35.9, 35.3. 
 
6.5 Experiments in Chapter 4 
 
General Procedure for the Enantioselective Iridium Catalysed Allylic Amination. 
 [Ir(cod)Cl]2 (0.01 equiv.), phosphoramidite ligand L3 (0.02 equiv.) and DABCO (0.1 
equiv.) were dissolved in  dry THF (1 ml)  and the mixture was stirred under argon stream at 
50 °C for 2h. After this time carbonate (1 equiv.) was added to reaction mixture and allowed 
to stir for 15 min. Then amine (1.5-2.0 equiv.) was added and the reaction was stirred at 50 
°C until the carbonate was fully converted as determined by TLC analysis. The volatile 
materials were evaporated and the ratio of regioisomers (branched to linear, b/l) was 
determined by 1H – NMR of the crude mixture. The crude reaction mixture was purified by 
column chromatography on silica gel (cyclohexane/ethylacetate) to give the desired product. 
 
(R)-N-allyl-1-phenylprop-2-en-1-amine, (137a), (Table 13, Entry 1). 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol), ligand L2 (22 mg, 0.04 mmol), 
DABCO (23 mg, 0.2 mmol), cinnamyl  methyl carbonate (385 mg, 2.0 
mmol) and allylamine (171 mg, 225µl, 3.0 mmol). The reaction was conducted at 50 °C for 
20 h. 1H NMR analysis of the crude reaction mixture indicated the ratio of regioisomers (b/l) 
to be 96/4. The mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 9/1) to give the title compound (263 mg, 76 %) as colourless oil. 
HPLC analysis indicated that the enantiomeric excess of the product was 96 % [Diacel 
Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 99.6/0.4; flow rate = 1 
mL/min; detection wavelength = 254 nm; TR = 7.4 (-), 8.3 (+) min]. [ ]20Dα = -13.6 (c 
=0.1050, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.33 (4, 1H), 7.24 (ddd, 1H, J = 2.8 
Hz, J = 5.8 Hz, J = 8.5 Hz). 5.91 (dt, 2H, J = 7.2 Hz, J = 17.1 Hz), 5.21 (d, 1H, J = 17.3 Hz), 
5.11 (m, 3H), 4.22 (d, 1H, J = 7.1 Hz), 3.18 (m, 2H), 1.46 (s, 1H); 13C-NMR (CDCl3, 100 
HN
(R)
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MHz) δ ppm 142.9, 141.0, 136.9, 128.7, 127.4, 127.3, 116.1, 115.2, 65.3, 50.0. Analytical 
data fits with literature.111
 
N-allyl-1-(2-methoxyphenyl)prop-2-en-1-amine, (137b), (Table 13, Entry 2). 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol) ligand L3 (22 mg, 0.040 mmol), 
DABCO (23 mg, 0.2 mmol), (E)-2-methoxycynnamyl methyl carbonate 
l) and allylamine (171 mg, 225µl, 3.0 mmol). The reaction was conducted 
at 50 °C for 24 h. 1H NMR analysis of the crude reaction mixture indicated the ratio of 
regioisomers (b/l) to be 96/4. The mixture was purified by column chromatography on silica 
gel (cyclohexane/ethylacetate = 3/1) to give the title compound (195 mg, 48 %) as yellowish 
oil. [
(445 mg, 2.0 mmo
]20Dα = +14.1 (c = 0.780, CHC H-NMR (CDCll3); 1
                                                
3, 400 MHz) δ ppm 7.27 (d, 1H, J = 
7.5 Hz), 7.21 (t, 1H, J = 7.4 Hz), 6.92 (t, 1H, J = 7.4 Hz), 6.85 (d, 1H, J = 8.2 Hz), 6.03-5.86 
(m, 2H), 5.15 (dd, 2H, J = 9.9 Hz, J = 17.2 Hz), 5.10-5.02 (m, 2H), 4.53 (d, 1H, J = 6.9 Hz), 
3.81 (s, 3H), 3.16 (qd, 2H, J = 6.0 Hz, J = 13.9 Hz), 1.90 (bs, 1H); 13C-NMR (CDCl3, 100 
MHz) δ ppm 157.0, 139.8, 136.9, 130.6, 128.1, 128.0, 120.8, 115.7, 114.9, 110.7, 59.6, 55.3, 
50.0; HRMS: m/z (FAB) calc. for C13H18NO (M+H+) 204.1383, found 204.1395; IR(film): ν 
[cm-1] = 3343 (w), 2929(m), 2830(s), 1602(s), 1490(s), 1460(s), 1247(s), 925(s), 748(s), 
735(s). 
HN
OMe
 
N-allyl-1-(4-methoxyphenyl)prop-2-en-1-amine, (137c), (Table 13, Entry 3). 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol) ligand L3 (22 mg, 0.040 mmol), 
DABCO (23 mg, 0.2 mmol), (E)-4-methoxycynnamyl methyl 
carbonate (445 mg, 2.0 mmol) and allylamine (171 mg, 225µl, 3.0 
mmol). The reaction was conducted at 50 °C for 20 h. 1H NMR analysis of the crude 
reaction mixture indicated the ratio of regioisomers (b/l) to be 96/4. The mixture was 
purified by column chromatography on silica gel (cyclohexane/ethylacetate = 3/1) to give 
the title compound (299 mg, 74 %) as yellowish oil. HPLC analysis of the Eoc protected 
derivative of amine indicated that the enantiomeric excess of the product was 92 % [Diacel 
HN
MeO
 
111 Polet, D.; Alexakis, A.; Tissot-Croset, K.; Corminboeuf, C.; Ditrich, K.; Chem. Europ. J. 2006; 3596 - 3609. 
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Chiralcel AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 98/2; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 9.9 (-), 10.8 (+) min]. [ ]20Dα = -7.2 (c = 1.12, CHCl3); 
1H-NMR (CDCl3, 400 MHz) δ ppm 7.23 (d, 2H, J = 8.6 Hz), 6.85 (d, 2H, J = 8.6 Hz), 5.89 
(ddd, 2H,  J = 3.3 Hz, J = 7.0 Hz, J = 10.2 Hz), 5.15 (dd, 2H,), 5.07 (d, 2H, J = 10.2 Hz), 
4.16 (d, 1H, J = 7.1 Hz), 3.77 (s, 3H), 3.16 (m, 2H), 1.41 (bs, 1H); 13C-NMR (CDCl3, 100 
MHz) δ ppm 158.7, 141.0, 136.8, 134.8, 128.3, 115.9, 114.8, 113.9, 64.5, 55.2, 49.9,; 
HRMS: m/z (FAB) calc. for C13H18NO (M+H+) 204.1383, found 204.1366; IR(film): ν [cm-
1] = 3316 (w), 2935(m), 2830(s), 1602(s), 1503(s), 1444(s), 1240(s), 1030(s), 965(s). 
 
N-allyl-1-(4-chlorophenyl)prop-2-en-1-amine, (137d), (Table 13, Entry 4). 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (27 mg, 0.04 mmol) ligand L3 (44 mg, 0.08 mmol), 
DABCO (46 mg, 0.4 mmol), (E)-4-chlorocynnamyl methyl carbonate 
d allylamine (342 mg, 450 µl, 6.0 mmol). The reaction was conducted 
at 50 °C for 20 h. 1H NMR analysis of the crude reaction mixture indicated the ratio of 
regioisomers (b/l) to be 93/7. The mixture was purified by column chromatography on silica 
gel (cyclohexane/ethylacetate = 9/1) to give the title compound (650 mg, 78 %) as yellowish 
oil. HPLC analysis indicated that the enantiomeric excess of the product was 91% [Diacel 
Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 99/1; flow rate = 1 mL/min; 
detection wavelength = 254 nm; TR = 3.7 (+), 5.6 (-) min]. 
(907 mg, 4.0 mmol) an
[ ]20Dα = -20.3 (c = 2.2, CHCl3); 
MR (CDCl1H-N 3, 400 MHz) δ ppm 7.27 (s, 4H), 5.86 (ddd, 2H, J=6.0Hz, J=10.0Hz, 
J=17.0Hz), 5.22-5.12 (m, 2H), 5.09 (dd, 2H, J=5.6Hz, J=15.7Hz), 4.19 (d, 1H, J=7.1Hz), 
3.21-3.09 (m, 2H), 1.33 (bs, 1H); 13C-NMR (CDCl3, 100 MHz) δ ppm 141.1, 140.4, 136.5, 
132.6, 128.5, 128.5, 115.9, 115.3, 64.4, 49.7; HRMS: m/z (ESI) calc for C12H15N37Cl 
(M+H+) 210.08580, found 210.08553; IR(film): ν [cm-1] = 3080 (m), 2968 (m), 2817 (m), 
1897 (w), 1838 (w), 1635 (s), 1477 (vs), 1457 (s), 1405 (m), 1286 (w), 1095 (vs). 
HN
Cl
 
N-allyl-1-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine, (137e), (Table 13, Entry 5).The 
general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (27 mg, 0.04 mmol) ligand L3 (44 mg, 0.08 mmol), 
DABCO (46 mg, 0.4 mmol), (E)-4-trifluoromethyl cynnamyl methyl 
carbonate (1.04 g, 4.0 mmol) and allylamine (342 mg, 450 µl, 6.0 
mmol). The reaction was conducted at 50 °C for 24 h. 1H NMR analysis of the crude 
HN
F3C
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reaction mixture indicated the ratio of regioisomers (b/l) to be 92/8. The mixture was 
purified by column chromatography on silica gel (cyclohexane/ethylacetate = 7/1) to give 
the title compound (723 mg, 75%) as colourless oil. [ ]20Dα = -18.4 (c = 1.10, CHCl3); 
Enantiomeric excess not determined. 1H-NMR (CDCl3, 400 MHz) δ ppm 7.57 (d, 2H, 
J=8.1Hz), 7.46 (d, 2H, J=8.1Hz), 5.94-5.81 (m, 2H), 5.25-5.05 (m, 4H), 4.28 (d, 1H, 
J=7.2Hz), 3.22-3.10 (m, 2H), 1.44 (bs, 1H); 13C-NMR (CDCl3, 100 MHz) δ ppm 146.8, 
140.1, 136.4, 129.5, 127.6, 125.4, 122.8, 116.1, 115.8, 64.8, 49.8; HRMS: m/z (ESI) calc for 
C13H15NF3 (M+H+) 242.11511, found 242.11499; IR(film): ν [cm-1] = 3420 (w), 3073 (m), 
2975 (m), 2824 (m), 1640 (s), 1615 (vs), 1444 (s), 1411 (s), 1326 (vs), 1168 (vs), 1122 (vs), 
1050 (s), 918 (vs), 846 (vs).  
 
General Procedure for Protection of Secondary Amines: 
 
To a stirred solution of amine (1 mmol) in 10 ml of dry DCM was added dry triethylamine 
(1.5 mmol) under the argon atmosphere. Reaction mixture was cooled down to 0 °C and 
stirred next 30 min at this temperature, then TsCl, or ClCO2Et (1.5 mmol) was added in one 
portion. The mixture was allowed to stir at room temperature until the amine was fully 
converted as determined by TLC. After completion of the reaction, volatiles were removed 
in vacuo and the crude reaction mixture was purified by column chromatography on silica 
gel (cyclohexane/ethylacetate) to give the desired product. 
 
Ethyl allyl1-phenylallylcarbamate, (139a), (Table 13, Entry 1) 
To a stirred solution of N-allyl-1-phenylprop-2-en-1-amine (346 mg, 2.0 
mmol) in 10 ml of dry THF was added dry triethylamine (303 mg, 0.40 
ml, 3.0 mmol) under the argon atmosphere. Reaction mixture was cooled 
down to 0 °C and stirred next 30 min at this temperature, then chloroethyl formiate (325 mg, 
0.3 ml, 3.0 mmol) was added dropwise via syringe. The mixture was allowed to stir at room 
temperature over night. After completion of the reaction, mixture was filtered through 
sintered glass filter, and the volatiles removed in vacuo. The crude reaction mixture was 
purified by column chromatography on silica gel (cyclohexane/ethylacetate = 9/1) to give 
the title compound (426 mg, 87 %) as yellowish oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 7.27 
(m, 5H), 6.12 (ddd, 1H, J = 6.6 Hz, J = 10.2 Hz, J = 17.0 Hz), 5.66 (m, 2H), 5.31 (d, 1H, J = 
NEoc
(R)
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10.2 Hz), 5.21 (d, 1H, J = 17.2 Hz), 4.94 (d, 2H, J = 11.1 Hz), 4.14 (q, 2H, J = 7.1 Hz), 3.75 
(m, 2H), 1.21 (t, 3H, J = 6.7 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 139.6, 135.5, 135.0, 
128.5, 128.0, 127.5, 118.1, 116.3, 62.1, 61.5, 14.7; HRMS: m/z (ESI) calc for C15H20NO2 
(M+H+) 246.14886, found 246.14877; IR(film): ν [cm-1] = 3067 (w), 2981 (m), 1694 (vs), 
1451 (s), 1411 (s), 1247 (s), 1142 (m);  
 
 (R)-N-Allyl-4-methyl-N-(1-phenyl-allyl)-benzenesulfonamide, (139b), (Table 13, Entry 
1) 
The general procedure for tosylation was followed with allyl-(1-phenyl-
allyl)-amine ( 420  mg, 2.4 mmol), Et3N (0.48 ml,  3.6 mmol) and TsCl (694 
mg, 3.6 mmol) in 25 ml of DCM. The reaction was conducted at room 
temperature for 30 h. The crude reaction mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 9/1) to give the title compound 
(676 mg, 86 %) as white solid. 1H-NMR (CDCl3, 400 MHz) δ ppm 7.69 (d, 2H, J = 8.1 Hz), 
7.28-7.20 (m, 7H), 6.01 (ddd, 1H, J = 7.1 Hz, J = 10.3 Hz, J = 17.3 Hz), 5.65 (d, 1H, J = 6.9 
Hz), 5.46 (tdd, 1H, J = 6.3 Hz, J = 10.2 Hz, J = 16.6 Hz), 5.24 (d, 1H, J = 10.3 Hz), 5.11 (d, 
1H, J = 17.1 Hz), 4.93-4.82 (m, 2H), 3.75 (ddd, 2H, J = 6.3 Hz, J = 16.2 Hz, J = 38.2 Hz), 
2.38 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 142.9, 138.2, 137.8, 134.8, 134.2, 129.2, 
128.2, 128.0, 127.5, 127.2, 118.9, 116.9, 63.2, 47.6, 21.3; Analytical data fits with 
literature.112
Ph
N
Ts
(R)
 
N-allyl-1-(2-methoxyphenyl)-N-tosylprop-2-en-1-amine, (139c), (Table 13, Entry 3) 
The general procedure for tosylation was followed with N-allyl-1-(2-
methoxyphenyl)prop-2-en-1-amine (385  mg, 1.9 mmol), Et3N (0.37 ml,  
2.8 mmol) and TsCl (542 mg, 2.8 mmol) in 20 ml of DCM. The reaction 
room temperature for 30 h. The crude reaction mixture was purified by 
column chromatography on silica gel (cyclohexane/ethylacetate = 7/1) to give the title 
compound (550 mg, 81 %) as white solid. 1H-NMR (CDCl
was conducted at 
                                                
3, 400 MHz) δ ppm 7.51 (d, 2H, J 
= 8.2 Hz), 7.25-7.17 (m, 2H), 7.12 (d, 2H, J = 8.0 Hz), 6.86 (t, 1H, J = 7.4 Hz), 6.67 (d, 1H, 
J = 8.1 Hz), 6.13 (ddd, 1H, J = 6.2 Hz, J = 10.6 Hz, J = 16.9 Hz), 5.81 (d, 1H, J = 5.7 Hz), 
5.44 (tdd, 1H, J = 6.2 Hz, J = 10.2 Hz, J = 16.6 Hz), 5.26 (d, 1H, J = 10.4 Hz), 5.21 (d, 1H, J 
= 17.2 Hz), 4.86 (d, 1H, J = 11.1 Hz), 4.82 (d, 1H, J = 3.8 Hz), 3.81 (qd, 1H, J = 6.2 Hz, J = 
16.2 Hz, J = 39.9 Hz), 3.58 (s, 3H), 2.35 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 157.3, 
N
Ts
OMe
 
112 Robinson, J. E.; Evans P. A.Org. Lett. 1999, 1, 1929-1931 
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142.3, 138.5, 136.2, 135.0, 130.2, 129.2, 128.8, 127.4, 125.9, 120.0, 117.3, 116.7, 110.1, 
58.4, 54.8, 49.0, 21.4; HRMS: m/z (ESI) calc for C20H24NO3S (M+H+) 358.1477, found 
358.1473;  IR(film): ν [cm-1] = 3040 (w), 2916 (w), 1589 (s), 1490 (vs), 1450 (s), 1340 (vs), 
1240 (vs), 1155 (vs), 1089 (s), 1050 (s), 925 (s).  
 
N-allyl-1-(4-methoxyphenyl)-N-tosylprop-2-en-1-amine, (139d), (Table 13, Entry 4) 
The general procedure for tosylation was followed with N-allyl-1-(4-
methoxyphenyl)prop-2-en-1-amine (460  mg, 2.3 mmol), Et3N (0.48 
ml,  3.6 mmol) and TsCl (694 mg, 3.6 mmol) in 25 ml of DCM. The 
reaction was conducted at room temperature for 24 h. The crude 
reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 6/1) to give the title compound (737 mg, 91 %) as white solid. 
1H-NMR (CDCl3, 400 MHz) δ ppm 7.68 (d, 2H, J = 8.2 Hz), 7.23 (d, 2H, J = 8.0 Hz), 7.12 
(d, 2H, J = 8.6 Hz), 6.78 (d, 2H, J = 8.7 Hz), 5.99 (ddd, 1H, J = 6.8 Hz, J = 10.3 Hz, J = 17.1 
Hz), 5.59 (d, 1H, J = 6.7 Hz), 5.43 (tdd, 1H, J = 6.4 Hz, J = 10.1 Hz, J = 16.7 Hz), 5.22 (d, 
1H, J = 10.3 Hz), 5.10 (d, 1H, J = 17.1 Hz), 4.93-4.83 (m, 2H, J = 12.8 Hz), 3.78 (s, 3H), 
3.74 (qd, 2H, J = 6.8 Hz, J = 15 Hz, J = 39 Hz), 3.67 (dd, 1H, J = 6.7 Hz, J = 16.2 Hz), 2.40 
(s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 159.1, 142.9, 138.1, 135.1, 134.7, 130.4, 129.5, 
129.3, 127.4, 118.7, 117.1, 113.7, 62.8, 55.2, 47.6, 21.5; HRMS: m/z (ESI) calc for 
C20H24NO3S (M+H+) 358.1477, found 358.1473; IR(film): ν [cm-1] = 3080 (m), 2929 (m), 
2820 (w), 1615 (vs), 1525 (vs), 1340 (vs), 1240 (vs), 1162 (vs), 1030 (s), 932 (s), 813 (s). 
N
Ts
MeO
 
N-allyl-1-(4-chlorophenyl)-N-tosylprop-2-en-1-amine, (139e), (Table 13, Entry 4) 
The general procedure for tosylation was followed with N-allyl-1-(4-
chlorophenyl)prop-2-en-1-amine ( 745  mg, 3.6 mmol), Et3N (0.72 
ml,  5.4 mmol) and TsCl (1.04 g, 5.4 mmol) in 25 ml of DCM. The 
reaction was conducted at room temperature for 30 h. The crude 
reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 9/1) to give the title compound (1.2 g, 92 %) as white solid. 1H-
NMR (CDCl3, 500 MHz) δ ppm 7.66 (d, 2H, J = 8.3 Hz), 7.25-7.16 (m, 6H), 5.97 (ddd, 1H, 
J = 7.2 Hz, J = 10.3 Hz, J = 17.3 Hz), 5.57 (d, 1H, J = 7.2 Hz), 5.48 (tdd, 1H, J = 6.3 Hz, J = 
10.2 Hz, J = 16.6 Hz), 5.24 (d, 1H, J = 10.4 Hz), 5.08 (d, 1H, J = 17.1 Hz), 4.94-4.86 (m, 
2H), 3.75 (qd, 2H, J = 6.3 Hz, J = 16.2 Hz), 2.38 (s, 3H); 13C-NMR (CDCl3, 125 MHz) δ 
N
Ts
Cl
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ppm 143.0, 137.6, 137.1, 134.6, 133.7, 133.3, 129.4, 129.2, 128.2, 127.2, 119.6, 117.3, 62.6, 
47.8, 21.3; HRMS: m/z (ESI) calc for C19H21NO235ClS (M+H+) 362.09761, found 
362.09768;  IR(film): ν [cm-1] = 3080 (w), 2915 (w), 1635 (w), 1602 (m), 1480 (s), 1352 
(vs), 1162 (vs), 1096 (s), 925 (s). 
 
N-allyl-1-(4-(trifluoromethyl)phenyl)-N-tosylprop-2-en-1-amine, (139f), (Table 13, 
Entry 5) 
The general procedure for tosylation was followed with N-allyl-1-(4-
(trifluoromethyl)phenyl)prop-2-en-1-amine ( 550  mg, 1.4 mmol), 
Et3N (0.28 ml,  2.1 mmol) and TsCl (405 mg, 2.1 mmol) in 25 ml of 
DCM. The reaction was conducted at room temperature for 30 h. 
The crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 12/1) to give the title compound (487 mg, 88 %) as white solid. 
1H-NMR (CDCl3, 400 MHz) δ ppm 7.67 (d, 2H, J = 8.3 Hz), 7.53 (d, 2H, J = 8.2 Hz), 7.40 
(d, 2H, J = 8.2 Hz), 7.25 (d, 2H, J = 8.1 Hz), 6.03 (ddd, 1H, J = 7.4 Hz, J = 10.3 Hz, J = 17.4 
Hz), 5.65 (d, 1H, J = 7.4 Hz), 5.54 (tdd, 1H, J = 6.4 Hz, J = 10.2 Hz, J = 16.6 Hz), 5.31 (d, 
1H, J = 10.3 Hz), 5.12 (d, 1H, J = 17.1 Hz), 4.94-4.89 (m, 2H), 3.80 (qd, 2H, J = 6.4 Hz, J = 
16.1 Hz, J = 37.9 Hz), 2.40 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.3,142.8, 134.6, 
133.6, 129.9, 129.7, 129.4, 128.4, 127.3, 125.2, 120.3, 117.6, 63.1, 48.2, 21.4; HRMS: m/z 
(ESI) calc for C20H21NO2SF3 (M+H+) 396.12396, found 396.12359; IR(film): ν [cm-1] = 
3080 (w), 2929 (w), 1621 (m), 1602 (w), 1424 (m), 1340 (vs), 1162 (vs), 1024 (s), 932 (s). 
N
Ts
F3C
 
N-allyl-N-tosylpent-1-en-3-amine, (139g), (Table 13, Entry 6) 
The general procedure for allylic aminations was followed with [Ir(cod)Cl]2 
(13.5 mg, 0.02 mmol) ligand L3 (22 mg, 0.040 mmol), DABCO (23 mg, 0.2 
mmol), methyl carbonate derived from (E)-pent-2-en-1-ol (289 mg, 2.0 
mmol) and allylamine (171 mg, 225µl, 3.0 mmol). The reaction was conducted at 50 °C for 
24 h. Reaction mixture was cooled down to 0 ° and triethyl amine (305 mg, 0.4 ml, 3 mmol),  
and tosyl chloride ( 420 mg, 2.2 mmol) were added. The mixture was allowed to stir at room 
temperature over night. After completion of the reaction, mixture was filtered through 
sintered glass filter, and the volatiles removed in vacuo The mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 9/1) to give the title compound 
(391 mg, 68 %) as colourless oil. HPLC analysis indicated that the enantiomeric excess of 
the product was 98 % [Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 
N
Ts
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99.5/0.5; flow rate = 1 ml/min; detection wavelength = 254 nm; TR = 29.7 (-), 34.1 (+) min]. 
[ ]20Dα = -45.4 (c = 0.54, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.68 (d, 2H, J = 8.2 Hz), 
7.24 (d, 2H, J = 8.1 Hz), 5.86-5.75 (m, 1H), 5.54 (ddd, 1H, J = 6.3 Hz, J = 10.6 Hz, J = 17.1 
Hz), 5.16-4.96 (m, 4H), 4.21 (q, 1H, J = 7.1 Hz), 3.78 (ddd, 2H, J = 6.2 Hz, J = 10.6 Hz, J = 
16.1 Hz), 3.62 (dd, 1H, J = 6.9 Hz, J = 16.2 Hz), 2.39 (s, 3H), 1.58 (qd, 2H, J = 7.0 Hz, J = 
14.3 Hz), 0.86 (t, 3H, J = 7.3 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 142.9, 138.2, 136.2, 
136.1, 129.4, 127.2, 117.7, 116.9, 61.8, 46.8, 25.2, 21.5, 11.0. HRMS: m/z (ESI) calc for 
C15H22NO2S (M+H+) 280.13658, found 280.13673; IR(film): ν [cm-1] = 3073 (w), 2962 (s9, 
1917 (w), 1595 (w), 1457 (w), 1339 (vs), 1162 (vs), 918 (s). 
 
N-allyl-N-tosylhex-1-en-3-amine, (139h), (Table 13, Entry 7) 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol), ligand L3 (22 mg, 0.040 mmol), 
.2 mmol), methyl carbonate derived from (E)-hex-2-en-1-ol (316 mg, 2.0 
mmol) and allylamine (171 mg, 225µl, 3.0 mmol). The reaction was conducted at 50 °C for 
20 h. Reaction mixture was cooled down to 0 °C and triethyl amine (305 mg, 0.4 ml, 3 
mmol), and tosyl chloride ( 420 mg, 2.2 mmol) were added. The mixture was allowed to stir 
at room temperature over night. After completion of the reaction, mixture was filtered 
through sintered glass filter, and the volatiles removed in vacuo The mixture was purified by 
column chromatography on silica gel (cyclohexane/ethylacetate = 9/1) to give the title 
compound (411 mg, 70 %) as colourless oil. HPLC analysis indicated that the enantiomeric 
excess of the product was 98 % [Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); heptane/2-
propanol = 99/1; flow rate = 1 ml/min; detection wavelength = 254 nm; TR = 23.3 (-), 28.0 
(+) min]. [
DABCO (23 mg, 0
]20Dα = -28.5 (c = 0.89, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm  7.67 (d, 2H, 
J=8.2Hz), 7.24 (d, 2H, J = 8.1 Hz), 5.80 (m, 1H), 5.53 (ddd, 1H, J = 6.2 Hz, J = 10.5 Hz, J = 
17.0 Hz), 5.08 (m, 4H),  4.31 (q, 1H, J = 7.1 Hz), 3.77 (m, 1H), 3.60 (dd, 1H, J = 7.0 Hz, J = 
16.3 Hz), 2.38 (s, 3H), 1.51 (dd, 1H, J = 7.6 Hz, J = 15.2 Hz), 1.29 (tt, 1H, J = 6.9 Hz, J = 
14.0 Hz), 0.85 (t, 1H, J = 7.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.1, 138.3, 136.5, 
136.3, 129.6, 127.4, 117.8, 116.8, 60.1, 46.9, 34.4, 21.6, 19.5, 13.8; HRMS: m/z (FAB) calc 
for C16H24NO2S (M+H+) 294.1522, found 294.1506; IR(film): ν [cm-1] = 2955 (vs), 2922 
(vs), 2351 (w), 1740 (vs), 1451 (s), 1339 (m), 1260 (s), 1162 (vs), 1089 (m). 
N
Ts
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General procedure for the ring closing metathesis reaction 
 
To a stirred solution of tertiary amine (1 mmol.) in dry DCM (15 ml) under argon 
atmosphere was added Grubbs I catalyst (0.05 mmol.) and the reaction was stirred at reflux 
until the amine was fully converted, as determined by TLC. After the reaction was complete, 
mixture was cooled down, diluted with saturated NaHCO3 solution and organic phase was 
washed with water and brine, dried over MgSO4, filtered and volatiles evaporated under 
reduced pressure. The crude reaction mixture was purified by column chromatography on 
silica gel (cyclohexane/ethylacetate) to give desired product. 
 
Ethyl 2-phenyl-2H-pyrrole-1(5H)-carboxylate, (128a), (Table 13, Entry 1) 
The general procedure for ring closing metathesis was followed with N-allyl-
1-phenyl-N-tosylprop-2-en-1-amine (300 mg, 1.22 mmol) and  Grubbs I 
catalyst (50 mg, 0.061 mmol) in 20 ml of CH2Cl2. The reaction was 
conducted at reflux for 24 h. The mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 9/1) to give the title compound 
(243 mg, 92 %) as colourless oil. [ ]20Dα = +174.4 (c = 0.45, CHCl3); 1H-NMR (CDCl3, 400 
MHz) δ ppm 7.25 (m, 5H, J = 7.2 Hz, J = 14.0 Hz), 5.87 (m, 1H), 5.74 (ddd, 1H, J = 1.9 Hz, 
J = 6.2 Hz, J = 15.1 Hz), 5.49 (dd, 1H, J = 2.2 Hz, J = 39.6 Hz), 4.33 (m, 1H), 4.08 (m, 1H), 
3.97 (q, 1H, J = 7.1 Hz), 1.10 (dt, 1H, J = 7.1Hz, J = 93.4 Hz); 13C-NMR (CDCl3, 100 MHz) 
δ ppm 155.1, 154.8; 141.9, 141.3; 131.2, 131.1; 128.6, 128.4; 127.6, 127.5; 127.0, 126.9; 
124.9, 124.8; 68.3, 67.9; 61.1; 54.2, 53.8, 14.9, 14.5; HRMS: m/z (ESI) calc for C13H16NO2 
(M+H+) 218.11756, found 218.11756; IR(film): ν [cm-1] = 3060 (w), 2929 (w), 2981 (m), 
1705 (vs), 1511 (m), 1451 (s), 1411 (s), 1242 (s), 1140 (m), 925 (s);  
N
EtO
O
(R)
 
 (R)-2,5-dihydro-2-phenyl-1-tosyl-1H-pyrrole, (128b), (Table 13, Entry 1) 
The general procedure for ring closing metathesis was followed with N-allyl-
1-phenyl-N-tosylprop-2-en-1-amine (420 mg, 1.28 mmol) and  Grubbs I 
catalyst (53 mg, 0.064 mmol) in 20 ml of CH2Cl2. The reaction was 
flux for 18 h. The mixture was purified by column chromatography on silica 
gel (cyclohexane/ethylacetate = 6/1) to give the title compound (364 mg, 95 %) as white 
crystals. [
conducted at re
]20Dα = +277.1 (c = 2.05, C 3HCl ); 1H-NMR (CDCl3, 500 MHz) δ ppm 7.52 (d, 2H, J 
= 8.3 Hz), 7.26 (m, 5H), 7.19 (d, 2H,  J = 8.0 Hz), 5.78 (dq, 1H, J = 1.9 Hz, J = 6.1 Hz), 5.65 
N
Ts
(R)
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(dq, 1H, J = 2.2 Hz, J = 6.3 Hz), 5.52 (dt, 1H, J = 2.1 Hz, J = 4.4 Hz), 4.35 (dq, 1H, J = 2.3 
Hz, J = 14.6 Hz), 4.26 (ddt, 1H, J = 2.0 Hz, J = 5.6 Hz, J = 14.6 Hz), 2.38 (s, 3H); 13C-NMR 
(CDCl3, 125 MHz) δ ppm δ 144.6, 141.9, 137.0, 132.1, 130.9, 129.9, 129.3, 128.7, 125.9, 
71.7, 56.9, 22.9; Analytical data fits with literature.112 
 
2,5-dihydro-2-(4-methoxyphenyl)-1-tosyl-1H-pyrrole, (128c), (Table 13, Entry 2) 
The general procedure for ring closing metathesis was followed with N-allyl-
1-(2-methoxyphenyl)-N-tosylprop-2-en-1-amine (736 mg, 2.06 mmol) and  
Grubbs I catalyst (85 mg, 0.103 mmol) in 20 ml of CH2Cl2. The reaction was 
conducted at reflux for 24 h. The mixture was purified by column chromatography on silica 
gel (cyclohexane/ethylacetate = 6/1) to give the title compound (603 mg, 89 %) as white 
crystals. [ ]20Dα = +330.2 (c = 0.927, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.64 (d, 2H, 
J = 8.1 Hz), 7.39 (d, 1H, J = 7.5 Hz), 7.26-7.17 (m, 3H), 6.92 (t, 1H, J = 7.5 Hz), 6.79 (d, 
1H, J = 8.2 Hz), 5.84 (s, 1H), 5.66 (dd, 1H, J = 2.1 Hz, J = 6.1 Hz), 5.60 (dd, 1H, J = 1.6 Hz, 
J = 6.1 Hz), 4.35-4.23 (m, 2H), 3.77 (s, 3H), 2.39 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ 
ppm 155.9, 143.1, 134.9, 130.2, 129.5, 129.2, 128.5, 127.6, 127.4, 123.4, 120.8, 110.2, 65.3, 
55.6, 55.3, 21.5; HRMS: m/z (ESI) calc for C18H20NO3S (M+H+) 330.1166, found 330.1156; 
IR(film): ν [cm-1] = 3415 (m), 2968 (w), 2942 (w), 2863 (w), 1602 (m), 1490 (s), 1457 (m), 
1345 (vs), 1240 (s), 1162 (vs), 1090 (s), 1050 (s), 820 (w), 761 (s). 
TsN
OMe
 
2,5-dihydro-2-(4-methoxyphenyl)-1-tosyl-1H-pyrrole, (128d), (Table 13, Entry 3) 
The general procedure for ring closing metathesis was followed with 
N-allyl-1-(4-methoxyphenyl)-N-tosylprop-2-en-1-amine (845 mg, 2.36 
mmol) and  Grubbs I catalyst (97 mg, 0.12 mmol) in 20 ml of CH2Cl2. 
The reaction was conducted at reflux for 24 h. The mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 6/1) to give the title compound 
(723 mg, 93 %) as white crystals. [ ]20Dα = +260.4 (c = 1.24, CHCl3); 1H-NMR (CDCl3, 400 
MHz) δ ppm 7.48 (d, 2H, J = 8.1 Hz), 7.15 (t, 4H, J = 8.6 Hz), 6.78 (d, 2H, J = 8.6 Hz), 5.75 
(dd, 1H, J = 1.7 Hz, J = 6.1 Hz), 5.60 (dd, 1H, J = 2.1 Hz, J = 6.1 Hz), 5.46 (dd, 1H, J = 2.1 
Hz, J = 4.8 Hz), 4.25 (ddd, 2H, J = 3.8 Hz, J = 14.5 Hz, J = 20.0 Hz), 3.77 (s, 3H), 2.36 (s, 
3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 159.2, 142.9, 135.5, 132.5, 130.6, 129.3, 128.5, 
127.1, 124.3, 113.7, 69.6, 55.2, 55.1, 21.4; HRMS: m/z (ESI) calc for C18H20NO3S (M+H+) 
MeO
TsN
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330.1166, found 330.1155; IR(film): ν [cm-1] = 3432 (w), 2955 (w), 2909 (w), 2850 (w), 
1615 (m), 1510 (s), 1340 (vs), 1286 (m), 1254 (vs), 1155 (s)1083 (s), 1055 (m), 833 (m), 807 
(m); 
 
2-(4-chlorophenyl)-2,5-dihydro-1-tosyl-1H-pyrrole, (128e), (Table 13, Entry 4) 
The general procedure for ring closing metathesis was followed with N-
allyl-1-(4-chlorophenyl)-N-tosylprop-2-en-1-amine (650 mg, 1.8 mmol) 
and  Grubbs I catalyst (74 mg, 0.09 mmol) in 20 ml of CH2Cl2. The 
nducted at reflux for 18 h. The mixture was purified by 
columnchromatography on silica gel (cyclohexane/ethylacetate = 10/1) to give the title 
compound (540 mg, 90 %) as white crystals. 
reaction was co
[ ]20Dα = +215.2 (c = 0.955, CHCl3); 1H-NMR 
(CDCl3, 500 MHz) δ ppm 7.51 (d, 2H, J = 8.1 Hz), 7.19 (q, 6H, J = 8.6 Hz), 5.76 (dd, 1H, J 
= 1.6 Hz, J = 6.0 Hz), 5.57 (dd, 1H, J = 2.0 Hz, J = 6.0 Hz), 5.44 (d, 1H, J = 2.3 Hz), 4.32-
4.19 (m, 2H), 2.36 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.3, 139.0, 135.0, 133.4, 
129.9, 129.4, 128.5, 128.4, 127.1, 124.9, 69.4, 55.3, 21.4; HRMS: m/z (ESI) calc for 
C17H17NO235ClS (M+H+) 334.06631, found 334.06649; IR(film): ν [cm-1] = 3248 (w), 3047 
(w), 2922 (w), 2870 (w), 1595 (m), 1490 (s), 1340 (vs), 1155 (vs), 1090 (s), 1055 (s), 820 
(s).    
TsN
Cl
 
2-(4-(trifluoromethyl)phenyl)-2,5-dihydro-1-tosyl-1H-pyrrole, (128f), (Table 13, Entry 
5) 
The general procedure for ring closing metathesis was followed with N-
allyl-1-phenyl-N-tosylprop-2-en-1-amine (397 mg, 1 mmol) and  
Grubbs I catalyst (41 mg, 0.05 mmol) in 20 ml of CH2Cl2. The reaction 
was conducted at reflux for 24 h. The mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 10/1) to give the title compound 
(334 mg, 91 %) as white crystals. [ ]20Dα = +117.4 (c = 0.910, CHCl3);1H-NMR (CDCl3, 500 
MHz) δ ppm 7.50 (t, 4H, J=7.4Hz), 7.34 (d, 2H, J=8.0Hz), 7.17 (d, 2H, J=8.0Hz), 5.80 (dd, 
1H, J=1.7Hz, J=6.1Hz), 5.60 (dd, 1H, J=2.0Hz, J=6.1Hz), 5.51 (d, 1H, J=2.3Hz), 4.37-4.24 
(m, 1H), 2.35 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 144.4, 143.5, 135.0, 129.9, 129.8, 
129.5, 127.5, 127.1, 125.3, 125.3, 122.6, 69.6, 55.5, 21.3; HRMS: m/z (ESI) calc for 
C18H17NO2F3S (M+H+) 368.09266, found 368.09266; IR(film): ν [cm-1] = 3448 (w), 3021 
TsN
F3C
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(w), 2922 (m), 2863 (m), 1910 (m), 1615 (s), 1589 (s), 1411 (s), 132 (vs), 1162 (s), 1110 (s), 
1063 (s), 833 (vs). 
 
2-ethyl-2,5-dihydro-1-tosyl-1H-pyrrole, (128g), (Table 13, Entry 6) 
The general procedure for ring closing metathesis was followed with N-allyl-N-
tosylpent-1-en-3-amine (334 mg, 1.20 mmol) and Grubbs I catalyst (49 mg, 0.060 
mmol) in 20 ml of CH2Cl2. The reaction was conducted at reflux for 24 h. The 
mixture was purified by column chromatography on silica gel (cyclohexane/ethylacetate = 
6/1) to give the title compound (256 mg, 85 %) as colourless oil. [ ]20Dα = +117.5 (c = 0.876, 
CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm  7.64 (d, 2H, J = 8.2 Hz), 7.23 (d, 2H, J = 8.0 
Hz), 5.58-5.46 (m, 2H), 4.42-4.36 (m, 1H), 4.06-4.01 (m, 1H), 2.34 (s, 3H), 1.78-1.70 (m, 
2H), 0.82 (t, 3H, J = 7.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.1, 134.5, 129.5, 
129.1, 127.1, 124.7, 68.0, 55.6, 28.6, 21.3, 8.3; HRMS: m/z (ESI) calc for C13H18NO2S 
(M+H+) 252.10528, found 252.10528; IR(film): ν [cm-1] = 3067 (w), 2968 (vs), 2922 (vs), 
2856 (vs), 1602 (s), 1451 (s9, 1345 (vs), 1168 (vs), 1085 (s), 827 (vs). 
N
Ts
 
2,5-dihydro-2-propyl-1-tosyl-1H-pyrrole, (128h), (Table 13, Entry 7) 
The general procedure for ring closing metathesis was followed with N-allyl-N-
tosylhex-1-en-3-amine (305 mg, 1.04 mmol) and Grubbs I catalyst (42 mg, 
0.052 mmol) in 20 ml of CH2Cl2. The reaction was conducted at reflux for 20 h. 
was purified by column chromatography on silica gel (cyclohexane/ethylacetate 
= 6/1) to give the title compound (262 mg, 94 %) as colourless oil. [
The mixture 
]20Dα = +166.7 (c = 
4, CHCl1.100 3); 1H-NMR (CDCl3, 400 MHz) δ ppm  7.64 (d, 2H, J = 8.2 Hz), 7.24 (d, 2H, J 
= 8.0 Hz), 5.55-5.50 (m, 2H), 4.44-4.38 (m, 1H), 4.06-4.02 (m, 2H), 2.35 (s, 3H), 1.77-1.60 
(m, 2H), 1.39-1.19 (m, 2H), 0.87 (t, 3H, J = 7.4 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 
143.2, 134.6, 129.6, 129.5, 127.2, 124.4, 67.1, 55.5, 38.2, 21.3, 17.7, 13.9; HRMS: m/z (ESI) 
calc for C14H20NO2S(M+H+) 266.12093, found 266.12098; IR(KBr): ν [cm-1] = 2962 (s), 
2922 (s), 2870 (s), 1602 (s), 1490 (s), 1463 (s), 1352 (s), 1168 (s), 1096 (s), 1043 (s), 820 
(vs), 655 (vs). 
N
Ts
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N-(1-phenylallyl)but-3-en-1-amine, (Table 14, Entry 1), (140a) 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol), ligand L3 (22 mg, 0.040 mmol), 
cinnamyl  methyl carbonate (385 mg, 2.0 mmol) and homoallylamine 
(215 mg, 3.0 mmol). The reaction was conducted at room temperature for 48 h. 1H NMR 
analysis of the crude reaction mixture indicated the ratio of regioisomers (b/l) to be 96/4. The 
mixture was purified by column chromatography on silica gel (cyclohexane/ethylacetate = 
9/1) to give the title compound (277 mg, 74 %) as colourless oil. HPLC analysis indicated 
that the enantiomeric excess of the product was 96% [Diacel Chiralcel OJ (0.46 cm x 25 cm, 
5 µm); heptane/2-propanol =99.9/0.1; flow rate = 1.4 mL/min; detection wavelength = 254 
nm; TR = 5.6 (+), 6.2 (-) min]. [ ]20Dα = - 8.7 (c = 0.995, CHCl3); 1H-NMR (CDCl3, 400 MHz) 
δ ppm δ 7.31 (d, 4H, J = 4.3 Hz), 7.23 (m, 1H), 7.23 (m, 1H), 5.90 (ddd, 1H, J = 7.2 Hz, J = 
10.1 Hz, J=17.2Hz), 5.75 (tdd, 1H, J = 6.9 Hz, J = 10.2 Hz, J = 17.0 Hz), 5.18 (d, 1H, J = 
17.1 Hz), 5.08 (s, 1H), 5.03 (dd, 2H, J = 8.8 Hz, J = 17.0 Hz), 4.16 (d, 1H, J = 7.2 Hz), 2.60 
(dtd, 1H, J = 6.8 Hz, J = 11.5 Hz, J = 18.3 Hz), 2.24 (q, 2H, J = 6.8 Hz), 1.45 (bs, 1H); 13C-
NMR (CDCl3, 100 MHz) δ ppm 141.2, 136.6, 128.6, 127.3, 127.3, 116.5, 115.0, 66.2, 46.6, 
34.4; HRMS: m/z (FAB) calc. for C13H18N (M+H+) 188.1434, found 188.1454. IR(film): ν 
[cm-1] =3448 (w), 2929(m), 2824(s),1832 (w),1641(s), 1541(s), 1116(s), 925(s), 702(s). 
HN
 
N-(1-(4-methoxyphenyl)allyl)but-3-en-1-amine, (Table 14, Entry 2), (140b) 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (20 mg, 0.03 mmol), ligand L3 (33 mg, 0.060 mmol), 
methyl carbonate derived from (E)-4-methoxycynnamyl alcohol 
(665 mg, 3.0 mmol) and homoallylamine (337 mg, 4.5 mmol). The reaction was conducted 
at room temperature for 48 h. 1H NMR analysis of the crude reaction mixture indicated the 
ratio of regioisomers (b/l) to be 95/5. The mixture was purified by column chromatography 
on silica gel (cyclohexane/ethylacetate = 3/1) to give the title compound (508 mg, 78 %) as 
yellowish oil. 1H-NMR (CDCl3, 400 MHz) δ ppm  7.22 (d, 2H, J = 8.6 Hz), 6.84 (d, 2H, J = 
8.6 Hz), 5.88 (ddd, 1H, J = 7.2 Hz, J = 10.2 Hz, J = 17.2 Hz), 5.74 (tdd, 1H, J = 6.8 Hz, J = 
10.1 Hz, J = 17.0 Hz), 5.15 (d, 1H, J = 17.1 Hz), 5.03 (m, 3H), 4.11 (d, 1H, J = 7.1 Hz), 3.77 
(s, 3H), 2.58 (dtd, 2H, J = 6.9 Hz, J = 11.5 Hz, J = 18.3 Hz), 2.23 (q, 2H, J = 6.8 Hz), 1.42 
(s, 1H); 13C-NMR (CDCl3, 100 MHz) δ ppm 158.8, 141.4, 136.6, 135.2, 128.4, 116.5, 114.7, 
113.9, 65.5, 55.4, 46.6, 34.4; HRMS: m/z (FAB) calc for C14H19NO (M+) 217.1467, found 
MeO
HN
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217.1452; IR(film): ν [cm-1] = 3310 (w), 2931(s), 2831(s), 1622(s), 1515(vs), 1440(s), 
1214(s), 1030(s), 919(s). 
 
N-(1-(furan-2-yl)allyl)but-3-en-1-amine, (Table 14, Entry 3), (140c) 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol), ligand L3 (22 mg, 0.040 mmol), 
methyl carbonate derived from (E)-3-(2-furanyl)-2-propen-1-ol (365 
mg, 2.0 mmol) and allylamine (171 mg, 225µl, 3.0 mmol). The reaction was conducted at 
room temperature for 4 h. 1H NMR analysis of the crude reaction mixture indicated the ratio 
of regioisomers (b/l) to be 94/6. The mixture was purified by column chromatography on 
silica gel (cyclohexane/ethylacetate = 9/1) to give the title compound (248 mg, 70 %) as 
yellowish oil. HPLC analysis indicated that the enantiomeric excess of the product was 94 % 
[Diacel Chiralcel OJ (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 99/1; flow rate = 1 
ml/min; detection wavelength = 254 nm; TR = 7.5 (minor), 8.1 (major) min]. 1H-NMR 
(CDCl3, 400 MHz) δ ppm  7.34 (s, 1H), 6.29 (m, 1H), 6.15 (d, 1H, J = 3.1 Hz), 5.92 (ddd, 
1H, J = 7.3 Hz, J = 10.1 Hz, J = 17.3 Hz), 5.75 (tdd, 1H, J = 6.8 Hz, J = 10.1 Hz, J = 17.0 
Hz), 5.20 (dd, 2H, J = 13.8 Hz, J = 16.9 Hz), 5.04 (dd, 2H, J = 13.6 Hz, J = 19.7 Hz), 4.26 
(d, 1H, J = 7.2 Hz), 2.62 (ddt, 2H, J = 6.9 Hz, J = 11.4 Hz, J = 18.2 Hz), 2.24 (q, 2H, J = 6.8 
Hz), 1.52 (s, 1H); 13C-NMR (CDCl3, 100 MHz) δ ppm 155.5, 141.9, 137.7, 136.4, 116.8, 
116.6, 110.2, 106.3, 59.4, 46.3, 34.3; HRMS: m/z (FAB) calc for C11H15NO (M+) 177.1153, 
found 177.1172; IR(film): ν [cm-1] = 3322 (w), 3070 (s), 2975 (s), 2912 (s), 2824 (s), 1840 
(w), 1645 (vs), 1500 (s), 1449 (s), 1298 (m), 1153 (s), 1001 (s), 919 (s). 
HN
O
 
N-(1-(pyridin-3-yl)allyl)but-3-en-1-amine, (Table 14, Entry 4), (140d) 
 
The general procedure for allylic aminations was followed with 
[Ir(cod)Cl]2 (13.5 mg, 0.02 mmol), ligand L3 (22 mg, 0.040 mmol), 
methyl carbonate derived from (E)-3-(pyridin-3-yl)prop-2-en-1-ol (386 
mg, 2.0 mmol) and homoallylamine (215 mg, 3.0 mmol). The reaction 
was conducted at room temperature for 24 h. 1H NMR analysis of the crude reaction mixture 
indicated the ratio of regioisomers (b/l) to be 97/3. The mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 1/1) to give the title compound 
(305 mg, 81 %) as colourless oil. HPLC analysis indicated that the enantiomeric excess of 
N
HN
R
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the product was 97 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 
98/2; flow rate = 1 mL/min; detection wavelength = 254 nm; TR = 16.5 (-), 28.2 (major+) 
min]. [ ]20Dα =+ 2.4 (c = 1.30, CHCl3);  1H-NMR (CDCl3, 400 MHz) δ ppm 8.54 (s, 1H), 8.48 
(d, 1H, J = 4.6 Hz), 7.65 (d, 1H, J = 7.8 Hz), 7.23 (dd, 1H, J = 4.8 Hz, J = 7.8 Hz), 5.86 
(ddd, 1H, J = 7.2 Hz, J = 10.1 Hz, J = 17.3 Hz), 5.75 (m, 1H), 5.12 (tt, 4H, J = 14.5 Hz, J = 
13.8 Hz), 4.20 (d, 1H, J = 7.2 Hz), 2.58 (dtd, 2H, J = 6.8 Hz, J = 11.6 Hz, J = 18.2 Hz), 2.23 
(q, 2H, J = 6.7 Hz), 1.52 (bs,1H); 13C-NMR (CDCl3, 100 MHz) δ ppm 149.4, 148.8, 140.2, 
138.3, 136.3, 134.9, 123.6, 116.7,  116.0, 63.8, 46.6, 34.3;   Analytical data fits with 
literature113
 
ethyl but-3-enyl1-(4-methoxyphenyl)allylcarbamate, (142) 
The general procedure for protection was followed with N-(1-(4-
methoxyphenyl)allyl)but-3-en-1-amine (294 mg, 1.35 mmol), 
triethylamine (205 mg, 0.27 ml, 2.03 mmol) and chloroethyl 
formiate (220 mg, 0.2 ml, 2.03 mmol) in 15 ml of THF. The crude reaction mixture was 
purified by column chromatography on silica gel (cyclohexane/ ethylacetate = 4/1) to give 
the title compound (308 mg, 79 %) as yellowish oil. [ ]20Dα = +26.4 (c = 0.92, CHCl3); 1H-
NMR (CDCl3, 400 MHz) δ 7.19 (d, 2H, J = 8.4 Hz), 6.84 (d, 2H, J = 8.6 Hz), 6.12-6.01 (m, 
1H), 5.80-5.48 (m, 2H), 5.30 (d, 1H, J = 10.3 Hz), 5.18 (d, 1H, J = 17.2 Hz), 4.90-4.80 (m, 
2H), 4.15 (q, 2H, J = 7.0 Hz), 3.78 (s, 3H), 3.25-2.98 (m, 2H), 2.10 (bs, 1H), 1.78 (bs, 1H), 
1.26-1.20 (m, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 159.1, 135.8, 135.6, 131.6, 129.5, 
129.3, 117.4, 116.2, 113.9, 113.9, 113.8, 61.4, 61.3, 61.3, 55.4, 33.9, 30.4, 14.8; HRMS: m/z 
(FAB) calc for C17H23NO3 (M+) 289.1678, found 289.1672; IR(film): ν [cm-1] = 3045 (w), 
2985 (m), 1710 (vs), 1444 (s), 1411 (s), 1245 (s), 1110 (m);  
NEoc
MeO
 
Ethyl 5,6-dihydro-2-(4-methoxyphenyl)pyridine-1(2H)-carboxylate, (143) 
The general procedure for ring closing metathesis was followed with 
ethyl allyl-1-(2-methoxyphenyl)allylcarbamate (365 mg, 1.32 mmol) and  
Grubbs I catalyst (54 mg, 0.066 mmol) in 20 ml of CH2Cl2. The reaction 
was conducted at reflux for 18 h. The mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate = 5/1) to give the title compound 
NEtO
O
MeO
                                                 
113 Welter, C., Moreno, R. M., Streiff, S., Helmchen, G. Org. Biomol. Chem. 18,  2005,  3266 - 3268. 
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(284 mg, 87 %) as yellowish oil. 1H-NMR (CDCl3, 400 MHz) δ ppm 7.31 (bs, 2H), 6.83 (d, 
2H, J = 8.6 Hz), 6.03-5.96 (m, 1H), 5.78 (d, 1H, J = 7.8 Hz), 5.55 (d, 1H, J = 41.4 Hz), 4.21-
3.90 (m, 3H), 3.76 (s, 3H), 2.89 (td, 1H, J = 3.8 Hz, J = 12.9 Hz), 2.29 (bs, 1H), 2.06-1.96 
(m, 1H),1.30-1.18 (m, 1H); 13C-NMR (CDCl3, 100 MHz) δ ppm 159.06, 155.48, 133.07, 
129.37, 127.33, 126.38, 113.74, 61.39, 55.38, 54.28, 36.78, 36.73, 25.15, 14.87; HRMS: m/z 
(FAB) calc for C15H19NO3 (M+) 261.1365, found 261.1325; IR(film): ν [cm-1] = 3045 (w), 
2916 (w), 1712 (vs), 1490 (vs), 1340 (s), 1240 (vs), 1155 (vs), 1089 (s), 1050 (s), 925 (s).  
 
General procedure for tandem hydroformylation / Fischer indolization reactions with 
 a thick walled sample vial containing PTFE septum Rh(acac)(CO)2 (0.01 equiv.), ligand 
eneral procedure for tandem hydroformylation / Fischer indolization reactions with 
 a thick walled sample vial containing PTFE septum olefin (1 equiv.), phenylhydrazine (1 
subsequent addition of bronsted acid, General method A 
 
In
(0.05 equiv.), phenylhydrazine (1 equiv.) and ligand (0.05 equiv.) were dissolved in dry THF 
(5 mL). The vial was placed in a pressure vessel, flushed with argon and pressurized with 10 
bar H2 and 50 bar CO. The reaction mixture was stirred for 5 days at  80 °C. A 4 wt. % 
solution of H2SO4 in THF (5 mL) was slowly added and the resulting mixture was refluxed 
for 3 hours. Reaction was quenched with ammonia solution (30% in water) and the aqueous 
phase was extracted with 4x10 mL  DCM. The combined organic layers were washed with 
brine, dried over MgSO4, filtered and volatiles were removed in vacuo. The crude reaction 
mixture was purified by column chromatography on silica gel (cyclohexane/ethylacetate) to 
give the desired product. 
 
G
subsequent addition of Lewis acid, General method B 
 
In
equiv.), Rh(acac)(CO)2 (0.01 equiv.) and ligand (0.05 equiv.) were dissolved in dry THF (5 
mL). The vial was placed in a pressure vessel, flushed with argon and pressurized with 10 
bar H2 and 50 bar CO. The reaction mixture was stirred for 5 days at 80 °C. After 
completion of the reaction volatiles were removed in vacuo, residue was dissolved in toluol 
(10 mL) and ZnCl2 (4 equiv.) was added and the resulting mixture was refluxed for 12 hours. 
Reaction mixture was diluted with water and the aqueous phase was extracted with 4x10 mL 
DCM. The combined organic layers were washed with brine, dried over MgSO4, filtered and 
 191
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volatiles were removed in vacuo. The crude reaction mixture was purified by column 
chromatography on silica gel (cyclohexane/ethylacetate) to give the desired products.  
 
General procedure for tandem hydroformylation / Fischer indolization reactions in 
 a thick walled sample vial containing PTFE septum Rh(acac)(CO)2 (0.01 equiv.), ligand 
eneral procedure for tandem hydroformylation / Fischer indolization reactions with 
 a thick walled sample vial containing PTFE septum olefin (1 equiv.), phenylhydrazine (1 
,3,4,9-tetrahydro-1-phenyl-2-tosyl-1H-pyrido[3,4-b]indole, (133a). 2,3,4,9-tetrahydro-
ihydro-2-phenyl-1-tosyl-1H-pyrrole (200 
mg, 0.67 mmol), phenylhydrazine (72 mg, 1 mmol), Rh(acac)(CO)2 (1.8 mg, 0.007 mmol) 
presence of bronsted acid, General method C 
 
In
(0.05 equiv.),benzophenone protected phenylhydrazine (1 equiv.), olefin (1 equiv.) and 
PTSA (1 equiv.) were dissolved in dry THF (5 mL). The vial was placed in a pressure vessel, 
flushed with argon and pressurized with 10 bar H2 and 50 bar CO. The reaction mixture was 
stirred for 5 days at 80 °C. Reaction was quenched with ammonia solution (30% in water) 
and the aqueous phase was extracted with 4x10 mL DCM. The combined organic layers 
were washed with brine, dried over MgSO4, filtered and volatiles were removed in vacuo. 
The crude reaction mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate) to give the desired products. 
 
G
subsequent addition of Lewis acid (general method D) 
 
In
equiv.), Rh(CO)2 (0.01 equiv.) and ligand (0.05 equiv.) were dissolved in dry THF (5 mL). 
The vial was placed in a pressure vessel, flushed with argon and pressurized with 10 bar H2 
and 50 bar CO. The reaction mixture was stirred for 5 days at 80 °C. After completion of the 
reaction volatiles were removed in vacuo, residue was dissolved in ethylenglycol (10 mL) 
and resulting mixture was refluxed for 24 h at 180 °C. Reaction mixture was extracted with 
4x10 mL DCM. The combined organic layers were washed with brine, dried over MgSO4, 
filtered and volatiles were removed in vacuo. The crude reaction mixture was purified by 
column chromatography on silica gel (cyclohexane/ethylacetate) to give the desired 
products. 
 
2
3-phenyl-2-tosyl-1H-pyrido[3,4-b]indole, (135a) 
The general procedure A was followed with 2,5-d
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and PPh3 (9 mg, 0.033 mmol). The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/ethylacetate = 6/1) to give (62 mg, 23 % yield) of 
the 133a and  (167 mg, 62 % yield) of the 135a. 
 133a: HPLC analysis indicated that the enantiomeric excess of the 
product was 0 % [Diacel 
N
H
Ph
Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
m
N Ts
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
; TR = 24.0, 27.3 min]. wavelength = 254 n [ ]20Dα = 0 (c = 0.98, CHCl3); 1H-NMR (CDCl3, 
J = 8.2 Hz), 7.41 (d, 1H, J = 7.8 Hz),7.31-7-28 
(m, 6H), 7.17 (t, 1H, J = 7.1 Hz), 7.11-7.07 (m , 6.32 (s, 1H), 4.00 (dd, 1H, J = 5.3 Hz, J 
= 14.4 Hz), 3.30 (ddd, 1H, J = 4.8 Hz, J = 11.7 Hz, J = 14.5 Hz), 2.60 (ddt, 2H, J = 4.7 Hz, J 
= 13.6 Hz, J = 15.8 Hz), 2.28 (s, 3H); 13C-NMR (CDCl
400 MHz) δ ppm  7.70 (s, 1H), 7.59 (d, 2H, 
, 3H)
 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
3, 100 MHz) δ ppm 143.4, 139.5, 
138.2, 130.6, 129.6, 128.9, 128.7, 127.1, 122.6, 119.9, 118.6, 111.2, 56.1, 39.7, 21.6, 20.4; 
Analytical data fits with literature.114
135a: HPLC analysis indicated that the enantiomeric excess of the 
product was 97
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 25.7 (-), 29.2 (+) min]. [ ]20Dα = -185.1 (c = 
MR (CDCl  400 MHz) δ ppm 7.82 (s, 1H), 7.64 (d, 2H, J = 8.2 Hz), 
Hz), 7.27-7.23 (m, 3H), 7.15-7.06 (m, 7H), 5.55 (d, 1H, J = 6.3 Hz), 
4.81 (d, 1H, J = 17.0 Hz), 3.96 (d, 1H, J = 17.0 Hz), 3.17 (d, 1H, J = 16.2 Hz), 2.88 (dd, 1H, 
J = 6.3 Hz, J = 16.2 Hz), 2.28 (s, 3H); 13C-NMR (CDCl
N
H
N Ts
Ph
R
0.560, CHCl3);  1H-N 3,
7.42 (d, 1H, J = 7.7 
rahydro-1-phenyl-2-tosyl-1H-pyrido[3,4-b]indole (133a). 2,3,4,9-tetrahydro-
-phenyl-2-tosyl-1H-pyrido[3,4-b]indole (135a). 
the 133a and (125 mg, 62 %) of 135a in 
                                                
3, 100 MHz) δ ppm 143.5, 138.6, 
137.7, 136.2, 129.7, 128.8, 128.5, 127.8, 127.7, 126.9, 122.2, 119.7, 118.1, 111.1, 107.3, 
54.1, 39.5, 22.5, 21.6; HRMS: m/z (ESI) calc for C24H23N2O2S (M+H+) 403.14748, found 
403.14711; IR(film): ν [cm-1] = 3395 (m), 2929 (w), 1602 (w), 1464 (s), 1326 (s), 1155 (vs), 
1096 (s); 
 
2,3,4,9-tet
3
(Table 15, Entry 1) By a procedure similar to that of method A, pyrrole 128b (150 mg, 0.5 
mmol) was converted into (46 mg, 23 % yield) of 
 
114 Silveira, C. C.; Felix, L. A.; Braga, A. L.; Kaufman, T. S. Org. Lett. 2005, 17, 3701 - 3704. 
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the presence of PPh3 (6.5 mg, 0.025 mmol). (Table 15, Entry 2) By a procedure similar to 
that of method A, pyrrole 128b (150 mg, 0.5 mmol) in the presence of dppf (14 mg, 0.025 
mmol) gave no products. (Table 15, Entry 3) By a procedure similar to that of method A, 
pyrrole 128b (150 mg, 0.5 mmol) was converted into (20 mg, 10 % yield) of the 133a and 
(24 mg, 12 %) of 135a in the presence of dppb (10.7 mg, 0.025 mmol). (Table 15, Entry 4) 
By a procedure similar to that of method A, pyrrole 128b (150 mg, 0.5 mmol) in the 
presence of BINAP (16 mg, 0.025 mmol)  gave no products. (Table 15, Entry 5) By a 
procedure similar to that of Method A, pyrrole 128b (150 mg, 0.5 mmol) was converted into 
(12 mg, 6 % yield) of the 133a and (64 mg, 31 %) of 135a in the presence of of 
XANTPHOS (14.5 mg, 0.025 mmol). (Table 15, Entry 6) By a procedure similar to that of 
Method A, pyrrole 128b (150 mg, 0.5 mmol) was converted into (56 mg, 28 % yield) of the 
133a and (89 mg, 44 %) of 135a in the presence of POPh3 (7.8 mg, 0.025 mmol).  (Table 
15, Entry 7) By a procedure similar to that of Method A, pyrrole 128b (150 mg, 0.5 mmol) 
was converted into (68 mg, 34 % yield) of the 133a and (94 mg, 47 %) of 135a in the 
presence of BIPHEPHOS (20 mg, 0.025 mmol). 
(Table 16, Entry 2) General procedure B was followed with 2,5-dihydro-2-phenyl-1-tosyl-
1H-pyrrole (150 mg, 0.5 mmol), phenylhydrazine (54 mg, 0.5 mmol) and Rh(acac)(CO)2 
he general procedure A was followed with 1 (346 mg, 1 mmol), and 2 (200 mg, 1 mmol),  
ol), Rh(acac)(CO)2 (5 mg, 0.02 mmol) and PPh3 (25 mg, 0.1 
(1.3 mg, 0.005 mmol) in 8 ml of THF to yield (30 mg, 15 % yield) of the 133a and (40 mg, 
20 %) of 135a.  (Table 16, Entry 3) General procedure C was followed with 2,5-dihydro-2-
phenyl-1-tosyl-1H-pyrrole (150 mg, 0.5 mmol), phenylhydrazine (54 mg, 0.5 mmol) and 
Rh(acac)(CO)2 (1.3 mg, 0.005 mmol) in 8 ml of THF to yield (22 mg, 11 % yield) of the 
133a and (42 mg, 21 %) of 135a.   (Table 16, Entry 4) General procedure C was followed 
with 2,5-dihydro-2-phenyl-1-tosyl-1H-pyrrole (150 mg, 0.5 mmol), phenylhydrazine (54 mg, 
0.5 mmol) and Rh(acac)(CO)2 (1.3 mg, 0.005 mmol) in 8 ml of THF to yield no product. 
 
Crossover experiment 
T
phenylhydrazine (220mg , 2 mm
mmol). NMR of crude mixture and LCMS analysis indicated only two depicted products are 
formed in the ratio 1:1. No crossover product could be observed. 
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NPht
N(Et)2
N
H
NPhth
NPhth
N
H
N(Et)2
N(Et)2
1. Rh(acac)(CO)2 
    1mol%
    PPh3 5 mol%
    CO/H2, 50:10 bar,
    THF 100 °C, 3d
2. 4W% H2SO4
1mmol
1mmol
115
116
1:1 ratio
+
N
H
N(Et)2
NPhth
N
H
NPht
N(Et)2
not observed
+
NPht
N(Et)2
 
 
Ethyl 3,4-dihydro-1-phenyl-1H-pyrido[3,4-b]indole-2(9H)-carboxylate (133b). Ethyl 
,4-dihydro-3-phenyl-1H-pyrido[3,4-b]indole-2(9H)-carboxylate (135b) (Table 17, 
.6 mmol), phenylhydrazine (173 mg, 1.6 mmol), Rh(acac)(CO)2 (4.1 mg, 0.016 
el AD (0.46 cm x 25 cm, 5 µm); 
1H), 7.57 (d, 1H, J = 7
3
Entry 2). 
The general procedure A was followed with ethyl 2-phenyl-2H-pyrrole-1(5H)-carboxylate 
(350 mg, 1
mmol) and PPh3 (21 mg, 0.08 mmol). The crude reaction mixture was purified by flash 
column chromatography on silica gel (cyclohexane/ethylacetate = 6/1) to give (102 mg, 20 
% yield) of the 133b and (220 mg, 43 % yield) of 135b. 
133b: HPLC analysis indicated that the enantiomeric excess of the 
product was 0 % [Diacel Chiralc
N
H
Ph
N Eoc
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
; TR = 17.5, 36.2 min]. 1H-NMR (CDClwavelength = 254 nm 3, 500 MHz) δ ppm 7.91 (s, 
.6 Hz), 7.31-7.27 (m, 6H), 7.17 (dtd, 2H, J = 4.1 Hz, J = 10.4 Hz, J = 
14.9 Hz), 6.51-6.33 (m, 1H), 4.43-4.20 (m, 3H), 3.19 (ddd, 1H, J = 4.2 Hz, J = 12.0 Hz, J = 
13.4 Hz), 2.99-2.91 (m, 1H), 2.83 (dd, 1H, J = 3.2 Hz, J = 15.3 Hz),1.35-1.26 (m, 3H); 13C-
NMR (CDCl3, 100 MHz) δ ppm 140.1, 136.3, 131.5, 128.9, 128.5, 128.1, 126.7, 124.7, 
122.1, 119.6, 118.2, 110.9, 61.6, 54.3, 38.2, 14.7; HRMS: m/z (FAB) calc for C20H20N2O2 
(M+) 320.1525, found 320.1506; IR(film): ν [cm-1] = 3395 (m), 3310 (s), 3060 (m), 2922 (s), 
1681 (vs), 1464 (s), 1109 (s), 1010 (m), 735 (vs). 
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135b: HPLC analysis indicated that the enantiomeric excess of the 
product was 98 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 19.9 (+), 22.1 (-) min].  [ ]20Dα = -135.2 (c 
MR (CDCl  500 MHz) δ ppm 8.01 (bs, 1H), 7.59 (d, 1H, J = 7.4 Hz), 
z, J = 7.0 Hz), 7.25-7.13 (m, 7H), 5.93 (bs, 1H), 5.05 (bs, 1H), 4.30 
(d, 2H, J = 5.6 Hz), 3.89 (d, 1H, J = 16.5 Hz), 3.40-3.27 (m, 2H), 1.36 (bs, 3H); 13C-NMR 
(CDCl
N
H
N Eoc
Ph
R
= 0.722, CHCl3); 1H-N 3,
7.31 (dd, 1H, J = 1.1 H
133c). 2,3,4,9-
tetrahydro-3-(2-methoxyphenyl)-2-tosyl-1H-pyrido[3,4-b]indole (135c) (Table 17, 
0 mg, 0.91 mmol), phenylhydrazine (98 mg, 0.9 mmol), Rh(acac)(CO)2 (2.4 mg, 
D (0.46 cm x 25 cm, 5 µm); 
)
8.3 Hz), 7.14-7.08 (m, 4H
3, 125 MHz) δ ppm156.1, 139.8, 136.3, 129.8, 128.3, 127.2, 126.9, 121.7, 119.4, 
117.9, 110.9, 61.9, 52.1, 38.6, 23.4, 14.7; HRMS: m/z (FAB) calc for C20H20N2O2 (M+) 
320.1525, found 320.1505;  IR(film): ν [cm-1] = 3402 (m), 3323 (s), 2922 (s), 2850 (m), 
1707 (vs), 1451 (s), 1418 (s), 1313 (m), 1234 (m), 1102 (s), 997 (s), 741 (s). 
 
2,3,4,9-tetrahydro-1-(2-methoxyphenyl)-2-tosyl-1H-pyrido[3,4-b]indole (
Entry 3). 
The general procedure A was followed with 2,5-dihydro-2-(2-methoxyphenyl)-1-tosyl-1H-
pyrrole (30
0.009 mmol) and PPh3 (12 mg, 0.045 mmol). The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexane/ethylacetate = 5/1) to give (43 mg, 
11 % yield) of the 133c and (236 mg, 60 % yield) of the 135c. 
133c: HPLC analysis indicated that the enantiomeric excess of the 
product was 0 % [Diacel Chiralcel A
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 31.1, 54.6 min]. 1H-NMR (CDCl3, 500 
, 7.61 (d, 2H, J = 8.1 Hz), 7.38 (d, 1H, J = 7.7 Hz), 7.23 (d, 2H, J = 
), 7.04 (t, 1H, J = 7.4 Hz), 6.93 (d, 1H, J = 8.2 Hz), 6.84 (t, 1H, J = 
7.5 Hz), 6.63 (s, 1H), 4.21 (dd, 1H, J = 3.1 Hz, J = 14.1 Hz), 3.92 (s, 3H), 3.59 (ddd, 1H, J = 
5.0 Hz, J = 9.6 Hz, J = 14 Hz ), 2.72-2.60 (m, 2H), 2.31 (s, 3H); 13C-NMR (CDCl
OMe
N Ts
N
H
MHz) δ ppm 8.29 (s, 1H
3, 100 
MHz) δ ppm 156.0, 143.0, 138.1, 135.7, 132.0, 129.3, 129.1, 128.7, 128.0, 126.8, 126.4, 
121.9, 121.1, 119.3, 118.1, 111.4, 110.9, 108.3, 55.9, 50.8, 41.7, 21.4, 20.6; HRMS: m/z 
(ESI) calc for C25H25N2O3S (M+H+) 433.1586, found 433.1578; IR(film): ν [cm-1] = 3415 
(m), 2909 (w), 2830 (w), 2364 (m), 2324 (m), 1602 (w), 1490 (m),1339 8s), 1247 (m), 1162 
(vs). 
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135c: HPLC analysis indicated that the enantiomeric excess of the 
product was 95 % [Diacel Chiralcel OD-H (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 17.5 (-), 19.9 (+) min]. [ ]20Dα = -37.5 (c 
= 0.431, CHCl ); 1H-NMR (CDCl  400 MHz) δ ppm 7.92 (s, 1H), 
7.38 (d, 1H, J = 7.7 Hz), 7.27 (d, 1H, J = 8.0 Hz), 7.14 (dd, 1H, J = 
8-7.01 (m, 3H), 6.89 (d, 1H, J = 7.6 Hz), 6.81 (d, 1H, J = 8.2 Hz), 
6.57 (t, 1H, J = 7.5 Hz), 5.98 (d, 1H, J = 6.8 Hz), 4.78 (d, 1H, J = 16.9 Hz), 4.08 (d, 1H, J = 
16.9 Hz), 3.77 (s, 3H), 3.17 (dd, 1H, J = 6.9 Hz, J = 16.2 Hz), 2.99 (d, 1H, J = 16.2 Hz), 2.25 
(s, 3H); 13C-NMR (CDCl
3 3,
, 
7.4 Hz, J = 14.9 Hz), 7.0
ido[3,4-b]indole (133d). 2,3,4,9-
trahydro-3-(4-methoxyphenyl)-2-tosyl-1H-pyrido[3,4-b]indole (135d) (Table 17, 
0 mg, 0.91 mmol), phenylhydrazine (98 mg, 0.91 mmol), Rh(acac)(CO)2 (2.4 mg, 
7.63 (d, 2H, J = 8.1 Hz)
3, 100 MHz) δ ppm 157.1, 142.9, 137.5, 136.0, 129.1, 128.9, 128.9, 
127.7, 127.3, 127.0, 126.9, 121.9, 119.9, 119.4, 118.0, 110.9, 110.5, 107.7, 55.3, 48.5, 39.9, 
24.4, 21.3; HRMS: m/z (ESI) calc for C25H25N2O3S (M+H+) 433.1586, found 433.1578;  
IR(film): ν [cm-1] = 3395 (s), 3060 (w), 2922 (m), 2843 (m), 1910 (w), 1595 (s), 1478 (vs), 
1470 (s), 1254 (s), 1148 (vs), 892 (s). 
 
2,3,4,9-tetrahydro-1-(4-methoxyphenyl)-2-tosyl-1H-pyr
te
Entry 4). 
The general procedure A was followed with 2,5-dihydro-2-(4-methoxyphenyl)-1-tosyl-1H-
pyrrole (30
0.009 mmol) and PPh3 (12 mg, 0.045 mmol). The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexane/ethylacetate = 5/1) to give (47 mg, 
12 % yield) of the 133d and (252 mg, 64 % yield) of the 135d. 
133d: [ ]20Dα = 0 (c = 1.124, CHCl3); 1H-NMR (CDCl3, 500 MHz) δ 
ppm 7.79 (s, 1H), 7.57 (d, 2H, J = 8.2 Hz), 7.40 (d, 1H, J = 7.8 
,
J = 4.7 Hz, J = 11.9 Hz,
OMe
N
H
N Ts
N Ts
OMe
N
H Hz), 7.25 (d, 1H, J = 6.7 Hz), 7.19 (d, 2H, J = 8.6 Hz), 7.13 (dt, 
2H, J = 8.0 Hz J = 22.9 Hz), 7.07 (d, 2H, J = 7.9 Hz), 6.80 (d, 2H, 
 3.98 (dd, 1H, J = 5.4 Hz, J = 14.4 Hz), 3.78 (s, 3H), 3.29 (ddd, 1H, 
 J = 14.6 Hz), 2.66-2.51 (m, 2H), 2.28 (s, 3H); 13C-NMR (CDCl
J = 8.7 Hz), 6.27 (s, 1H)
3, 
125 MHz) δ ppm 159.5, 143.1, 137.9, 136.0, 131.4, 130.6, 129.9, 129.4, 126.7, 126.5, 122.2, 
119.5, 118.2, 113.8, 110.9, 109.7, 55.3 (1xCH, 1xCH3), 39.2, 21.4, 20.1; HRMS: m/z (ESI) 
calc for C25H25N2O3S (M+H+) 433.1586, found 433.1577; IR(film): ν [cm-1] = 3395 (m), 
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3047 (m), 2935 (m), 2843 (w), 1603 (s), 1516 (vs), 1451 (s), 1326 (s), 1240 (vs), 1155 (vs), 
1089 (s);  
135d: HPLC analysis indicated that the enantiomeric excess of the 
product was 96 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 37.0 (-), 51.7 (+) min]. 
[ ]20Dα = +19.4 (c = 0.642, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ 
ppm 8.01 (s, 1H), 7.64 (d, 2H, J = 8.1 Hz), 7.43 (d, 1H, J = 7.6 Hz), 
z), 7.1
Hz), 4.82 (d, 1H, J = 1
133e). 3-(4-
chlorophenyl)-2,3,4,9-tetrahydro-2-tosyl-1H-pyrido[3,4-b]indole (135e). (Table 17, 
45 mg, 1.03 mmol), phenylhydrazine (113 mg, 1.03 mmol), Rh(acac)(CO)2 (2.6 
-7.12 (m, 6H), 7.08 (d, 1H, J 
1
111.0, 109.9, 55.1, 39
7.27 (d, 1H, J = 7.9 H 8-7.05 (m, 6H), 6.64 (d, 2H, J = 8.7 Hz), 5.51 (d, 1H, J = 6.2 
7.0 Hz), 3.94 (d, 1H, J = 17.0 Hz), 3.67 (s, 3H), 3.13 (d, 1H, J = 16.2 
Hz), 2.87 (dd, 1H, J = 6.3 Hz, J = 15.9 Hz), 2.28 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ 
ppm 158.7, 143.3, 137.5, 136.0, 130.4, 129.5, 128.9, 128.8, 126.7, 126.6, 121.9, 119.4, 
117.9, 113.6, 111.0, 106.9, 55.1, 53.4, 39.2, 22.5, 21.4; HRMS: m/z (ESI) calc for 
C25H25N2O3S (M+H+) 433.1586, found 433.1579; IR(film): ν [cm-1] = 3389 (m), 2922 (m), 
2850 (m), 1608 (s), 1516 (vs), 1457 (s), 1332 (s), 1245 (s), 1162 (s), 918 (s); 
 
1-(4-chlorophenyl)-2,3,4,9-tetrahydro-2-tosyl-1H-pyrido[3,4-b]indole (
Entry 5) 
The general procedure A was followed with 2-(4-chlorophenyl)-2,5-dihydro-1-tosyl-1H-
pyrrole (3
mg, 0.01 mmol) and PPh3 (14 mg, 0.052 mmol). The crude reaction mixture was purified by 
flash column chromatography on silica gel (cyclohexane/ethylacetate = 5/1) to give (98 mg, 
22 % yield) of the 133e and (234 mg, 52 % yield) of the 135e. 
133e: 1H-NMR (CDCl3, 400 MHz) δ ppm 7.96 (s, 1H), 7.54 (d, 2H, J 
= 8.1 Hz), 7.37 (d, 1H, J = 7.8 Hz), 7.26
Ts
N
H
N
OMe
N
H
Cl
N Ts
= 7.5 Hz), 7.04 (d, 2H, J = 8.0 Hz), 6.27 (s, 1H), 3.97 (dd, 1H, J = 5.4 
Hz, J = 14.5 Hz), 3.26-3.15 (m, 1H), 2.63-2.46 (m, 2H), 2.28 (d, 1H, J 
= 6 9 Hz), 2.25 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.4, 
34.2, 129.9, 129.7, 129.4, 128.6, 126.7, 126.4, 122.4, 119.6, 118.3, 
.3, 21.4, 19.9; HRMS: m/z (ESI) calc for C
137.8, 137.6, 136.1, 
24H22N2O2SCl (M+H+) 
437.10850, found 437.10826; IR(film): ν [cm-1] =3382 (s), 3054 (m), 2916 (s), 2850 (m), 
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2239 (w), 1930 (w), 1590 (s), 1483 (vs), 1444 (s), 1340 (vs), 1300 (s), 1162 (vs), 1096 (vs), 
754 (vs). 
135e: Enantiomeric excess could not be determined.  [ ]20Dα = +45.6 (c 
 2
thyl)phenyl)-2,3,4,9-tetrahydro-2-tosyl-1H-pyrido[3,4-b]indole (133f). 
3-(4-(trifluoromethyl)phenyl)-2,3,4,9-tetrahydro-2-tosyl-1H-pyrido[3,4-b]indole (135f) 
00 mg, 0.82 mmol), phenylhydrazine (89 mg, 0.82 mmol), 
2H, J = 8.1 Hz), 7.50 (d, 2H, J = 8.1 Hz), 7.38 (d, 3H, J = 7.9 Hz), 
 M
128.9, 126.6, 126.4, 125
= 1.24, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 8.07 (s, 1H), 7.65 
(d, 2H, J = 8.2 Hz), 7.44 (d, 1H, J = 7.6 Hz), 7.28 (d, 1H, J = 7.8 Hz), 
7.20-7.06 (m, 8H), 5.53 (d, 1H, J = 6.1 Hz), 4.87 (d, 1H, J = 17.1 Hz), 
3.95 (d, 1H, J = 17.1 Hz), 3.13 (d, 1H, J = 16.2 Hz), 2.88 (dd, 1H, J = 
.28 (s, 3H); 13C-NMR (CDCl6.2 Hz, J = 16.1 Hz), 3, 100 MHz) δ ppm 143.5, 137.2, 136.9, 
136.1, 133.3, 129.6, 129.1, 128.5, 128.4, 126.6, 126.5, 122.0, 119.5, 117.8, 111.0, 106.4, 
53.4, 39.3, 22.3, 21.4; HRMS: m/z (ESI) calc for C24H22N2O2SCl (M+H+) 437.10850, found 
437.10824; IR(film): ν [cm-1] = 3389 (vs), 3060 (m), 2909 (s), 2581 (w), 2305 (w), 1924 (w), 
1707 (m), 1602 (s), 1490 (vs), 1332 (s), 1247 (s), 1175 (vs), 1024 (s), 932 (s), 761 (vs). 
 
1-(4-(trifluorome
(Table 17, Entry 6) 
The general procedure A was followed with 2-(4-(trifluoromethyl)phenyl)-2,5-dihydro-1-
tosyl-1H-pyrrole (3
Rh(acac)(CO)2 (2.2 mg, 0.008 mmol) and PPh3 (11 mg, 0.041 mmol). The crude reaction 
mixture was purified by flash column chromatography on silica gel 
(cyclohexane/ethylacetate = 5/1) to give (92 mg, 24 % yield) of the 133f and (131 mg, 34 % 
yield) of the 135f. 
133f: 1H-NMR (CDCl3, 400 MHz) δ ppm  7.99 (bs, 1H), 7.53 (d, 
7.25 (d, 1H, J = 8.2 Hz), 7.16 (t, 1H, J = 7.5 Hz), 7.08 (t, 1H, J = 7.4 
Hz), 7.03 (d, 2H, J = 8.0 Hz), 6.34 (s, 1H), 4.00 (dd, 1H, J = 5.0 Hz, 
J = 14.5 Hz), 3.27-3.17 (m, 1H), 2.66-2.47 (m, 2H), 2.25 (s, 3H); 
Hz) δ ppm 143.5, 143.1, 137.4, 136.2, 130.6, 130.3, 129.4, 129.3, 
.4, 122.5, 119.7, 118.3, 111.1, 109.9, 55.3, 39.6, 21.3, 19.9; HRMS: 
m/z (ESI) calc for C
N
H
N Ts
Cl
N
H
CF3
N Ts
13C-NMR (CDCl3, 100
25H22N2F3S (M+H+) 471.13486, found 471.13430; IR(film): ν [cm-1] = 
3382 (s), 3054 (m), 2929 (s), 2850 (m), 252 (w), 1917 (w), 1615 (s), 1602 (s), 1451(s), 1326 
(vs), 1162 (vs), 1129 (vs), 1063 (s), 905 (vs). 
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135f:  Enantiomeric excess could not be determined. [ ]20Dα = +36.1 
(c = 0.750, CHCl ); 1H-NMR (CDCl3 3, 400 MHz) δ ppm 8.00 (s, 
9
100 MHz) δ ppm 143.7,
,3,4,9-tetrahydro-2-tosyl-1H-pyrido[3,4-b]indole (133g). 1-ethyl-2,3,4,9-
trahydro-2-tosyl-1H-pyrido[3,4-b]indole (135g) (Table 17, Entry 7). 
 mg, 0.008 mmol) 
 Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
s
7.12 (t, 1H, J = 7.6 H
5 cm, 5 µm); 
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
N
H
N Ts
CF3
1H), 7.65 (d, 2H, J = 8.2 Hz), 7.44 (d, 1H, J = 7.6 Hz), 7.41-7.34 
(m, 4H), 7.28 (d, 1H, J = 7.9 Hz), 7.18-7.07 (m, 4H), 5.60 (d, 1H, J 
= 6.0 Hz), 4.88 (d, 1H, J = 17.1 Hz), 3.96 (d, 1H, J = 17.1 Hz), 3.18 
3 (dd, 1H, J = 5.9 Hz, J = 16.4 Hz), 2.29 (s, 3H); 13C-NMR (CDCl(d, 1H, J = 16.3 Hz), 2. 3, 
 142.5, 137.2, 136.1, 129.9, 129.7, 129.5, 128.4, 128.0, 126.7, 126.5, 
125.3, 122.2, 119.6, 117.9, 111.1, 106.4, 53.6, 39.5, 22.4, 21.4; HRMS: m/z (ESI) calc for 
C25H22N2F3S (M+H+) 471.13486, found 471.13429; IR(film): ν [cm-1] = 3389 (s), 3054 (w), 
2916 (m), 2843 (m), 1937 (w), 1713 (m), 1621 (vs), 1451 (s), 1313 (vs), 1175 (vs), 1116 (s), 
932 (s). 
 
1-ethyl-2
te
The general procedure A was followed with 2-ethyl-2,5-dihydro-1-tosyl-1H-pyrrole (200 
mg, 0.8 mmol), phenylhydrazine (87 mg, 0.8 mmol), Rh(acac)(CO)2 (2.1
and PPh3 (10 mg, 0.04 mmol). The crude reaction mixture was purified by flash column 
chromatography on silica gel (cyclohexane/ethylacetate = 8/1) to give (42 mg, 15 % yield) of 
the 133g and (142 mg, 50 % yield) of the 135g. 
133g: HPLC analysis indicated that the enantiomeric excess of the 
product was 0 % [Diacel
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 17.0, 20.6  min]. 1H-NMR (CDCl3, 400 
, 1H), 7.61 (d, 2H, J = 8.1 Hz), 7.28 (dd, 2H, J = 5.1 Hz, J = 7.5 Hz), 
z), 7.07 (d, 2H, J = 8.1 Hz), 7.02 (t, 1H, J = 7.4 Hz), 5.05 (dd, 1H, J = 
5.2 Hz, J = 8.3 Hz), 4.11 (dd, 1H, J = 5.6 Hz, J = 14.7 Hz), 3.39 (ddd, 1H, J =  4.5, J = 12.0, 
J = 14.6), 2.47 (dd, 1H, J = 4.3 Hz, J = 15.7 Hz), 2.41-2.30 (m, 1H), 2.26 (s, 1H), 1.87 (ttd, 
2H, J = 7.3 Hz, J = 14.9 Hz, J = 37.5 Hz), 1.10 (t, 1H, J = 7.4 Hz); 13C-NMR (CDCl
N
H
Et
N Ts
MHz) δ ppm 7.87 (b
3, 100 
MHz) δ ppm 143.1, 138.1, 135.7, 133.0, 129.4, 126.7, 126.6, 121.9, 119.4, 118.1, 110.8, 
107.7, 54.5, 39.7, 28.9, 21.4, 19.7, 10.9; Analytical data fits with literature.114 
135g: HPLC analysis indicated that the enantiomeric excess of the 
product was 94 % [Diacel Chiralcel AD (0.46 cm x 2
N
H
N Ts
Et
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wavelength = 254 nm; TR = 18.2 (-), 22.5 (+) min]. [ ]20Dα = -6.8 (c = 0.852, CHCl3); 1H-
Hz) δ ppm 8.05 (bs, 1H), 7.65 (d, 2H, J = 8.1 Hz), 7.35 (d, 1H, J = 7.8 
8.0 Hz), 7.13 (d, 2H, J = 8.4 Hz), 7.05 (t, 1H, J = 7.4 Hz), 4.91 (d, 1H, 
4 (m, 2H), 2.67 (dd, 1H, J = 5.8 Hz, J = 15.7 Hz), 2.57 (d, 1H, J = 15.6 
Hz), 2.30 (s, 3H), 1.56-1.38 (m, 1H), 0.93 (t, 3H, J = 7.4 Hz); 13C-NMR (CDCl
NMR (CDCl3, 500 M
Hz), 7.27 (d, 1H, J = 
J = 16.8 Hz), 4.32-4.2
The general procedure A was followed with 2-ethyl-2,5-dihydro-1-tosyl-1H-pyrrole (200 
as purified by flash 
w rate = 1 mL/min; detection 
0
3.3 Hz, J = 7.8 Hz), 
Hz), 5.12 (t, 1H, J = , 3.39 (ddd, 1H, J = 4.6 
3, 100 MHz) 
δ ppm 143.2, 137.6, 136.1, 129.6, 127.8, 127.3, 126.6, 121.7, 119.3, 117.8, 110.9, 106.5, 
53.9, 38.9, 24.2, 24.0, 21.4, 11.2, HRMS: m/z (ESI) calc for C20H23N2O2S (M+H+) 
355.14748, found 355.14755; IR(film): ν [cm-1] = 3375 (m), 3224 (m), 2962 (m), 2108 (w), 
1654 (m), 1451 (m), 1326 (s), 1155 (vs), 1096 (m); 
 
2,3,4,9-tetrahydro-1-propyl-2-tosyl-1H-pyrido[3,4-b]indole (133h). 2,3,4,9-tetrahydro-
3-propyl-2-tosyl-1H-pyrido[3,4-b]indole (135h) (Table 17, Entry 8). 
mg, 0.75 mmol), phenylhydrazine (82 mg, 0.75 mmol), Rh(acac)(CO)2 (2.0 mg, 0.0075 
mmol) and PPh3 (10 mg, 0.04 mmol). The crude reaction mixture w
column chromatography on silica gel (cyclohexane/ethylacetate = 8/1) to give (41 mg, 15 % 
yield) of the 133g and (149 mg, 54 % yield) of the 135g. 
133h: HPLC analysis indicated that the enantiomeric excess of the 
product was 0 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 90/10; floN
H
N Ts
Pr
wavelength = 254 nm; TR = 18.0, 21.8 min].  
 MHz) δ ppm 7.85 (s, 1H), 7.60 (d, 2H, J = 8.2 Hz), 7.27 (dd, 2H, J = 
7.12 (t, 1H, J = 7.5 Hz), 7.06 (d, 2H, J = 8.1 Hz), 7.02 (t, 1H, J = 7.6 
6.7 Hz), 4.10 (dd, 1H, J = 5.7 Hz, J = 14.7 Hz)
1H-NMR (CDCl3, 50
Hz, J = 12.1 Hz, J = 14.8 Hz), 2.46 (dd, 1H,  J = 4.3 Hz, J = 15.7 Hz), 2.33 (dd, 1H, J = 5.5 
Hz, J = 11.4 Hz), 2.25 (s, 3H), 1.81 (dd, 2H, J = 7.5 Hz, J = 14.9 Hz), 1.64-1.50 (m, 1H), 
0.96 (t, 3H, J = 7.3 Hz); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.1, 138.1, 135.7, 133.2, 
129.4, 126.7, 126.6, 121.9, 119.4, 118.1, 110.8, 107.6, 53.0, 39.5, 38.1, 21.4, 19.7, 19.5, 
13.9; HRMS: m/z (ESI) calc for C21H25N2O2S (M+H+) 369.16313, found 369.16312; 
IR(film): ν [cm-1] = 3369 (m), 2948 (m), 2922 (s), 1924 (w), 1595 (m), 1444 (m), 1326 (s), 
1162 (vs), 1089 (m).  
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135h: HPLC analysis indicated that the enantiomeric excess of the 
product was 93 % [Diacel Chiralcel AD (0.46 cm x 25 cm, 5 µm); 
heptane/2-propanol = 90/10; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 16.5 (-), 20.9 (+) min].  [ ]20Dα = -14.2 (c = 
MR (CDCl  500 MHz) δ ppm 8.03 (s, 1H), 7.65 (d, 2H, J = 8.2 Hz), 
z), 7.28 (d, 1H, J = 7.9 Hz), 7.13 (d, 2H, J = 8.0 Hz), 7.08 (dt, 2H, J = 
7.3 Hz, J = 15.0 Hz), 4.91 (d, 1H, J = 16.8 Hz), 4.39 (d, 1H, J = 6.4 Hz), 4.29 (d, 1H, J = 
16.9 Hz), 2.67 (dd, 1H, J = 5.8 Hz, J = 15.6 Hz), 2.54 (d, 1H, J = 15.6 Hz), 2.30 (s, 3H), 
1.50-1.30 (m, 4H), 0.85 (t, 3H, J = 6.9 Hz); 13C-NMR (CDCl
N
H
N Ts
Pr
0.608, CHCl3); 1H-N 3,
7.34 (d, 1H, J = 7.8 H
8-methyl-3-phenyl-2-tosyl-1H-pyrido[3,4-b]indole, (135i), (Table 18, 
ntry 1) 
tosyl-1H-pyrrole (300 mg, 1 mmol), 2-(diphenylmethylene)-1-o-
s
of the title compound
3, 100 MHz) δ ppm 143.1, 
137.6, 136.1, 129.5, 127.8, 127.3, 126.7, 121.8, 119.3, 117.8, 110.9, 106.6, 52.0, 39.0, 33.3, 
24.3, 21.4, 19.7; HRMS: m/z (ESI) calc for C21H25N2O2S (M+H+) 369.16313, found 
369.16318; IR(film): ν [cm-1] = 3382 (m), 2955 (m), 2929 (m), 1468 (m), 1457 (s), 1339 (s), 
1148 (vs),1096 (s). 
 
2,3,4,9-tetrahydro-
E
The general procedure C was followed with 2,5-dihydro-2-phenyl-1-
tolylhydrazine (286 mg, 1 mmol), PTSA (190 mg, 1 mmol ), 
Rh(acac)(CO)2 (2.6 mg, 0.01 mmol) and PPh3 (13 mg, 0.05 mmol). 
The crude reaction mixture was purified by flash column 
ilica gel (cyclohexane/ethylacetate = 6/1) to give (187 mg, 45 % yield) 
.  HPLC analysis indicated that the enantiomeric excess of the product 
was 95 % [Diacel Chiralcel OD-H (0.46 cm x 25 cm, 5 µm); heptane/2-propanol = 90/10; 
flow rate = 1 mL/min; detection wavelength = 254 nm; TR = 13.4 (-), 21.9 (+) min]. [
N
H
N Ts
chromatography on 
]20Dα = 
-121.1 (c = 0.339, CHCl ); 1H-NMR (CDCl  500 MHz) δ ppm 7.82 (s, 1H), 7.66 (d, 2H, J = 
8.2 Hz), 7.32-7.24 (m, 3H), 7.18-7.14 (m, 3H), 7.12 (d, 2H, J = 8.1 Hz), 7.02 (t, 1H, J .4 
Hz), 6.96 (d, 1H, J = 7.1 Hz), 5.57 (d, 1H, J = 6.2 Hz), 4.86 (d, 1H, J = 17.0 Hz), 3.99 (d, 
1H, J = 17.0 Hz), 3.18 (d, 1H, J = 16.2 Hz), 2.89 (dd, 1H, J = 6.2 Hz, J = 16.1 Hz), 2.41 (s, 
3H), 2.29 (s, 3H); 13C-NMR (CDCl
3 3,
 = 7
3, 100 MHz) δ ppm 143.3, 138.4, 137.6, 135.6, 129.6, 
128.4, 128.3, 127.7, 127.5, 1.7, 126.2, 122.6, 120.2, 119.7, 115.7, 107.5, 53.9, 39.4, 22.5, 
21.4, 16.6; HRMS: m/z (ESI) calc for C25H25N2O2S (M+H+) 417.1637, found 417.1628;  
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IR(film): ν [cm-1] = 3415 (s), 3060 (w), 3021 (w), 2922 (m), 2850 (m), 1635 (m), 1602 (m), 
1497 (m), 1451 (m), 1340 (s), 1155 (vs), 1089 (s), 925 (m). 
 
6-chloro-2,3,4,9-tetrahydro-1-phenyl-2-tosyl-1H-pyrido[3,4-b]indole (133j).  6-chloro-
0 
133j: 
2,3,4,9-tetrahydro-3-phenyl-2-tosyl-1H-pyrido[3,4-b]indole (135j) (Table 18, Entry 2) 
The general procedure C was followed with 2,5-dihydro-2-phenyl-1-tosyl-1H-pyrrole (30
mg, 1 mmol), 1-(4-chlorophenyl)-2-(diphenylmethylene)hydrazine (307 mg, 1 mmol), PTSA 
(190 mg, 1 mmol ), Rh(acac)(CO)2 (2.6 mg, 0.01 mmol) and PPh3 (13 mg, 0.05 mmol). The 
crude reaction mixture was purified by flash column chromatography on silica gel 
(cyclohexane/ethylacetate = 6/1) to give (35 mg, 8 % yield) of the 133j and (144 mg, 33 % 
yield) of the 135j. 
[ ]20Dα = 0 (c = 1.12, CHCl3), 1H-NMR (CDCl3, 500 MHz) δ 
 
135j: HPLC analysis indicated that the enantiomeric excess of the 
ppm 7.81 (d, 1H, J = 11.0 Hz), 7.54 (d, 2H, J = 8.0 Hz), 7.34-7.20 
(m, 6H), 7.15 (d, 1H, J = 8.6 Hz), 7.09 (d, 1H, J = 8.6 Hz), 7.05 (d, 
2H, J = 7.9 Hz), 6.29 (s, 1H), 3.96 (dd, 1H, J = 4.9 Hz, J = 14.5 
5.2 Hz, J = 11.3 Hz, J = 14.6 Hz), 2.60-2.45 (m, 2H), 2.27 (s, 3H); 
13C-NMR (CDCl
Cl
N
H
N Ts
Hz), 3.27 (ddd, 1H , J =
3, 100 MHz) δ ppm 143.3, 138.9, 134.4, 131.9, 129.4, 128.7, 128.5, 127.6, 
126.8, 125.3, 122.5, 117.9, 111.9, 109.7, 108.2, 55.7, 39.2, 21.4, 19.9; HRMS: m/z (ESI) 
calc for C24H22N2O2SCl (M+H+) 437.1090, found 437.1083; IR(film): ν [cm-1] = 3054 (w), 
2909 (w), 2843 (w), 1628 (m), 1589 (m), 1444 (s), 1326 (s), 1300 (s), 1155 (vs), 1090 (m), 
938 (m).  
product was 95 % [Diacel Chiralcel OJ-H (0.46 cm x 25 cm, 5 
µm); heptane/2-propanol = 95/5; flow rate = 1 mL/min; detection 
wavelength = 254 nm; TR = 11.4 (-), 14.2 (+) min]. [ ]20Dα =-114.2 
(c = 0.895, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ p 7.84 (s, 
Hz), 7.36 (d, 2H, J = 11.2 Hz), 7.24-7.06 (m, 8H), 5.54 (d, 1H, J = 
6.2 Hz), 4.82 (d, 1H, J = 17.2 Hz), 3.94 (d, 1H, J = 17.2 Hz), 3.12 (d, 1H, J = 16.2 Hz), 2.83 
(dd, 1H, J = 6.3 Hz, J = 16.3 Hz), 2.30 (s, 3H); 13C-NMR (CDCl
pm 
1H), 7.65 (d, 2H, J = 8.1 
3, 100 MHz) δ ppm 143.5, 
138.1, 137.4, 134.3, 130.3, 129.6, 128.4, 127.8, 127.6, 127.6, 126.8, 125.3, 122.2, 117.6, 
111.9, 106.9, 53.8, 39.3, 22.1, 21.5; HRMS: m/z (ESI) calc for C24H22N2O2SCl (M+H+) 
N
H
N Ts
Cl
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437.1090, found 437.1083; IR(film): ν [cm-1] = 3054 (w), 3034 (w), 2902 (w), 2850 (w), 
1595 (m), 1497 (m), 1437 (s), 1326 (vs), 1286 (s), 1155 (vs), 1090 (m), 920 (m), 754 (s).  
 
2,3,4,9-tetrahydro-6-methoxy-3-phenyl-2-tosyl-1H-pyrido[3,4-b]indole (135k). (Table 
18, Entry 3) 
The general procedure C was followed with 2,5-dihydro-2-
phenyl-1-tosyl-1H-pyrrole (300 mg, 1 mmol), 1-(4-
methoxyphenyl)-2-(diphenylmethylene)hydrazine (302 mg, 1 
mmol), PTSA (190 mg, 1 mmol ), Rh(acac)(CO)2 (2.6 mg, 0.01 
mmol) and PPh3 (13 mg, 0.05 mmol). The crude reaction 
mixture was purified by flash column chromatography on silica gel 
(cyclohexane/ethylacetate = 6/1) to give (198 mg, 46 % yield) of the title compound. 
N
H
N Ts
MeO
1H-NMR (CDCl3, 400 MHz) δ ppm 8.12 (s, 1H), 7.75 (d, 2H, J = 7.9Hz), 7.59 (d, 2H, J = 
11.2 Hz), 7.44-7.16 (m, 8H), 5.61 (d, 1H, J = 6.9 Hz), 4.93 (d, 1H, J = 16.2 Hz), 3.96 (d, 1H, 
J = 17.2 Hz),3.80 (s, 3H), 3.06 (d, 1H, J = 16.8 Hz), 2.90 (dd, 1H, J = 6.6 Hz, J = 16.2 Hz), 
2.35 (s, 3H); HRMS: m/z (ESI) calc for C25H25N2O3S (M+H+) 432.15076, found 432.15070; 
 
2,3,4,9-tetrahydro-3-phenyl-2-tosyl-6-(4H-1,2,4-triazol-4-yl)-1H-pyrido[3,4-b]indole, 
(157) 
The general procedure C was followed with 2,5-dihydro-2-
phenyl-1-tosyl-1H-pyrrole (x) (250 mg, 0.8 mmol), α-Boc-1-
(4-(4H-1,2,4-triazol-4-yl)phenyl)hydrazine (220 mg, 0.8 
mmol), Rh(acac)(CO)2 (2.79 mg, 0.008 mmol) and PPh3 (12 
mg, 0.04 mmol) The crude reaction mixture was purified by 
flash column chromatography on silica gel (DCM/MeOH = 15/1) to give (150 mg, 45 %) of 
the title compound. 1H-NMR (CDCl3, 400 MHz) δ ppm  8.56 (s, 1H), 8.46 (m, 2H), 7.70 (d, 
2H, J = 8.3 Hz), 7.43 (d, 1H, J = 8.5 Hz), 7.41 (d, 1H, J = 1.8 Hz), 7.22 (m, 5H), 7.18 (d, 2H, 
J = 8.3 Hz), 7.13 (dd, 1H, J = 2.0 Hz, J = 8.5 Hz), 5.59 (d, 1H, J = 6.2 Hz), 4.93 (d, 1H, J = 
17.1 Hz), 4.02 (d, 1H, J = 17.2 Hz), 3.21 (d, 1H, J = 16.1 Hz), 2.97 (dd, 1H, J = 6.4 Hz, J = 
16.2 Hz), 2.33 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.5, 138.0, 137.4, 135.7, 
131.9, 129.6, 128.5, 127.7, 127.5, 127.2, 126.8, 126.5, 116.8, 112.4, 112.3, 107.6, 55.6, 39.2, 
35.7, 22.4, 21.5; HRMS: m/z (ESI) calc for C26H23N5O2S (M+H+) 470.1651, found 
470.1639; IR(film): ν [cm-1] = 3040 (w), 3029 (w), 2906 (w), 2850 (m), 1599 (s), 1488 (m), 
1437 (s), 1321 (vs), 1240 (s), 1151 (vs), 1090 (m), 754 (s).  
N
H
N Ts
N
N
N
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(R)-1-phenylprop-2-en-1-amine, (161) 
To a solution of 2-((R)-1-phenylallyl)isoindoline-1,3-dione (3.45g, 13.1 mmol) 
in 50 ml of ethanol was added 1,2 ethanoldiamine (1.5g, 20 mmol) and resulting 
solution was stirred under reflux over night. After completion of reaction, formed solids 
were filtered of, filtrate was concentrated under reduced pressure and submitted to column 
chromatography on slilica gel (cyclohexane/ethylacetate=1/1.5) to give the title compound 
(1.55 g  , 89 %) as colourless oil. [ ]20Dα = +10.0 (c = 1.25, CHCl3); 1H-NMR (CDCl3, 500 
MHz) δ ppm  7.36-7.29 (m, 4H), 7.26-7.20 (m, 1H), 6.01 (ddd, 1H, J = 6.1 Hz, J = 10.2 Hz, J 
= 16.6 Hz), 5.23 (d, 1H, J = 17.1 Hz), 5.09 (d, 1H, J = 10.3 Hz), 4.51 (d, 1H, J = 6.1 Hz), 
1.53 (bs, 2H); 13C-NMR (CDCl3, 100 MHz) δ ppm 144.4, 142.2, 128.5, 127.1, 126.6, 113.6, 
58.4, 35.7; Analytical data fits with literature.115
Ph
NH2
R
 
(R)-1-phenyl-N-tosylprop-2-en-1-amine, (162) 
The general procedure for tosylation was followed with (R)-1-phenylprop-2-en-
1-amine (1.4 g, 10.5 mmol), Et3N (2 ml, 15 mmol) and TsCl (2.86 g, 15 mmol) 
in 25 ml of DCM. The reaction was conducted at r.t. for 22 h. The crude reaction mixture 
was purified by column chromatography on silica gel (cyclohexane/ethylacetate = 10/1) to 
give the title compound (3.92 g, 91 %) as white solid. [ ]20Dα = +52.8 (c = 1.15, CHCl3); 1H-
NMR (CDCl3, 400 MHz) δ ppm 7.61 (d, 2H, J = 8.2 Hz), 7.24-7.14 (m, 5H), 7.10-7.04 (m, 
2H), 5.84 (ddd, 1H, J = 5.5 Hz, J = 10.5 Hz, J = 16.4 Hz), 5.12 (s, 1H), 5.09 (d, 1H, J = 7.7 
Hz), 4.95-4.83 (m, 2H), 2.37 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 143.2, 139.3, 
137.6, 137.0, 129.4, 128.6, 127.8, 127.2, 127.0, 116.8, 59.8, 35.7, 21.5; 
Ph
NHTs
R
Analytical data fits with literature.116
 
(R)-1-phenyl-N-((R)-1-phenylallyl)-N-tosylprop-2-en-1-amine, (163) 
To a solution of (R)-1-phenyl-N-tosylprop-2-en-1-amine (290 mg, 1 mmol) 
in 1 ml of dry THF at -78 °C under argon atmosphere was added LiHMDS (1 
ml, 1M solution in THF), solution was stirred at this temperature for 30 min. 
After this time anion solution was added to a stirred solution of [Ir(COD)Cl]2 (13.5 mg, 0.02 
Ph
TsN
Ph
R
R
                                                 
115 Atobe, M.; Yamazaki, N.; Kibayashi, C. J. Org. Chem. 2004, 69, 5595 - 5607. 
116 Prasad, B. A.; Bisai, A.; Singh, V. K. Org. Lett. 2004, 6, 4829 - 4832. 
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mmol), ligand 5 (23 mg, 0.04 mmol) and cinnamyl methylcarbonate (190 mg, 1 mmol) at -
40 °C under argon atmosphere and stirred at this temperature for next 2h and then allowed to 
warm to r.t. and stirred  for next 48h. After completion reaction was diluted with 10 ml of 
CH2Cl2, quenched with saturated NH4Cl solution, and extracted with 3x20 ml CH2Cl2. 
Collected organic extracts were washed with brine, dried over MgSO4 and concentrated 
under reduced pressure. 1H NMR analysis of the crude reaction mixture indicated the ratio of 
diastereoisomers to be 90/10. Crude product was purified by column chromatography on 
silica gel (cyclohexane/ethylacetate= 15/1) to give title compound (190 mg, 47 % yield) as 
yellow oil. [ ]20Dα = +41.5 (c = 0.787, CHCl3); 1H-NMR (CDCl3, 500 MHz) δ ppm 7.38 (d, 
2H, J = 8.1 Hz), 7.30-7.06 (m, 8H), 7.00 (d, 4H, J = 6.2 Hz), 6.46 (ddd, 2H, J = 7.6 Hz, J = 
10.2 Hz, J = 17.5 Hz), 5.33-5.25 (m, 4H), 5.18 (d, 2H, J = 17.3 Hz), 2.38 (s, 3H); 13C-NMR 
(CDCl3, 100 MHz) δ ppm 142.7, 139.0, 138.9, 136.3, 129.0, 128.7, 127.9, 127.5, 127.4, 
118.6, 64.1, 21.5; HRMS: m/z (ESI) calc for C25H26NO2S (M+H+) 404.16788, found 
404.167564; IR(film): ν [cm-1] = 3068 (m), 3027 (m), 2981 (m), 2909 (m), 1963 (w), 1884 
(w), 1799 (w), 1595 (vs), 1497 (vs), 1457 (vs), 1424 (s), 1326 (vs), 1162 (s), 918 (vs). 
 
2,5-Diphenyl-1-(toluene-4-sulfonyl)-2,5-dihydro-1H-pyrrole, (164) 
ith 1-phenyl-N-((R)-
 
General procedure for Grubbs metathesis was followed w
1-phenylallyl)-N-tosylprop-2-en-1-amine (180 mg, 0.45 mmol) and Grubbs I 
catalyst (20 mg, 0.023 mmol) in 20 ml of CH2Cl2. The reaction was conducted 
24 h. The mixture was purified by column chromatography on silica gel 
(cyclohexane/ethylacetate = 10/1) to give the title compound (154 mg, 90 %) as white 
crystals. [
Ph
TsN R
R
Ph
at reflux for
]20Dα = +361.2 (c = 0.985, CHCl3); 1H-NMR (CDCl3, 400 MHz) δ ppm 7.25 (bs, 
10H), 6.91 (q, 4H, J=8.3Hz), 5.77 (bs, 2H), 5.71 (bs, 2H), 2.29 (s, 3H); 13C-NMR (CDCl3, 
100 MHz) δ ppm 141.9, 139.3, 137.6, 129.8, 128.6, 128.2, 127.9, 127.9, 126.6, 71.1, 21.3; 
HRMS: m/z (ESI) calc for C23H22N2OS (M+H+) 376.13658, found 376.13652; IR(film): ν 
[cm-1] = 3415 (w), 3021 (w), 2916 (w), 1608 (w), 1497 (m), 1451 (m), 1345 (vs), 1168 (vs), 
1096 (vs), 1070 (m), 820 (m), 708 (s).  
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1,3-Diphenyl-2-(toluene-4-sulfonyl)-2,3,4,9-tetrahydro-1H-b-carboline, (165) 
(toluene-4-
u
The general procedure A was followed with 2,5-diphenyl-1-
sulfonyl)-2,5-dihydro-1H-pyrrolle (50 mg, 0.13 mmol), 
phenylhydrazine (15 mg, 0.13 mmol), Rh(acac)(CO)2 (1.0 mg, 0.0013 
mmol) and PPh3 (3 mg, 0.005 mmol). The crude reaction mixture was 
mn chromatography on silica gel (cyclohexane/Ethylacetate = 15/1) to 
give (44 mg, 71 % yield) of title compound as white solid. 
N
H
N Ts
Ph
R
R
Ph
purified by flash col
[ ]20Dα = +13.4 (c = 0.850, CHCl3); 
1H-NMR (CDCl3, 400 MHz) δ ppm 7.77 (s, 1H), 7.53 (d, 1H, J = 7.6 Hz), 7.30-7.05 (m, 
14H), 6.90 (d, 2H, J = 8.0 Hz), 6.67 (d, 1H, J = 8.1 Hz), 6.42 (s, 1H), 5.06 (dd, 1H, J = 4.1 
Hz, J = 9.5 Hz), 3.68 (dd, 1H, J = 9.7 Hz, J = 15.4 Hz), 3.16 (dd, 1H, J = 4.2 Hz, J = 15.4 
Hz), 2.25 (s, 3H); 13C-NMR (CDCl3, 100 MHz) δ ppm 142.3, 139.4, 139.2, 137.9, 136.4, 
131.6, 129.0, 128.7, 128.5, 128.5, 128.3, 127.8, 127.4, 126.9, 126.7, 122.3, 119.7, 118.4, 
111.0, 110.5, 58.2, 56.4, 24.7, 21.3; HRMS: m/z (ESI) calc for C30H27N2O2S (M+H+) 
479.17878, found 479.17831; IR(film): ν [cm-1] = 3345 (m), 2929 (w), 1612 (w), 1565 
(w),1468 (s), 1320 (s), 1150 (vs), 1096 (vs), 1010 (s), 795 (s).
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7 Zusammenfassung 
 
     Es konnte gezeigt werden, daß die Tandem Hydroformylierung / Fischer-Indol Synthese 
in Kombination mit der Ir-katalysierten enantioselektiven allylischen Substitution eine 
leistungs- fähige Methode für die Herstellung von Tryptaminen, Tryptophanen und deren 
Homologen ist. Ausgehend von geeigneten Substraten war es möglich Seitenketten an 
Position 3 der gewünschten Indolstruktur mit unterschiedlicher Komplexität und Länge 
einzuführen.  
     Einfache chirale allylische Amine wurden in hohen Ausbeuten und exzellenten 
Enantioselektivitäten durch die enantioselektive Ir-katalysierte Aminierungsreaktion 
erhalten, wobei Amine als Nukleophile verwendet wurden. Diese schafften nach 
sequentieller Hydroformylierung / Fischer-Indol Synthese einen Zugang zu verschiedenen 
Tryptaminen und Tryptamiden (s. Schema 85). Durch die Verwendung von chiralen 
allylischen Aminen wurde keine Epimerisierung durch Migration der Doppelbindung weder 
durch den Rh-Katalysator noch durch die Säure beobachtet, so dass volle Retention der 
absoluten Konfiguration resultierte. 
 
Scheme 85. Zugang zu chiralen Tryptaminen und Tryptamiden 
 
NO O
R
R
N
H
N
O
O
67%, 98% ee
[Rh], CO/H2
H+
98% ee  
 
     Wenn N-Benzhydrylidenglycinate als Substrate für die enantioselektive Ir-katalysierte 
allylische Substitution mit Allylcarbonaten verwendet werden, werden Allylglycinderivate 
erhalten. Diese sind geeignete Substrate für die Synthese von Molekülen, die das 
Homotrypthophangerüst enthalten. Durch die Verwendung von Phosphoramiditliganden.
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Mit diesem Nukleophil wurden die Endprodukte zum ersten Mal mit hoher Ausbeute und 
Enantioselektivität erhalten (s. Schema 86). Niedrige Katalysator- und Ligandenbeladungen 
und milde Reaktionsbedingungen werden von annehmbaren Reaktionszeiten, guten 
Ausbeuten und exzellenten Enantioselektivitäten in allen Fällen begleitet. All dies macht die 
Phosphoramiditliganden zu Liganden der Wahl für diese Reaktion. 
 
Scheme 86. Enantioselektive Synthese von Allylglycinaten 
 
Ph OCO2Me
Ph N CO2Et
Ph
N CO2EtPh
Ph
N CO2EtPh
Ph+
87%
62 : 38
97%ee 95%ee
[Ir(cod)Cl]2, L3
DABCO
 
 
     Allylierte N-Benzhydrylidenglycinate wurden als Ausgangsmaterialen für die sequentielle 
Hydroformylierung/ Fischer-Indol Synthese hergestellt. Sie gestatten den Zugang zu 
primären Homotryptophanderivaten in guten Ausbeuten. Die Entschützung der 
Benzophenongruppe findet parallel mit der Indolisierung unter sauren Bedingungen statt (s. 
Schema 87). 
 
Scheme 87. Synthese von primären Homotryptophanderivaten 
 
N
Ph
Ph
OEt
O
N
H
H2N
OEt
O
*
61%
*
[Rh], CO/H2
H+
 
 
     Schließlich wurden Cyanoacetate als Substrate für die Ir-katalysierte allylische 
Substitution verwendet, um weitere Homologisierung der Kohlenstoffkette an Position 3 des 
Indolkerns zu erreichen. Hierbei wird die Nitrilgruppe als maskierte Aminofunktion 
verwendet. Alkylierungen von Allylcarbonaten mit Cyanoacetaten verliefen mit guten 
Ausbeuten (s. Schema 88). 
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Scheme 88. Synthese von allylierten Cyanoacetaten 
 
Ph OCOOMe
NC
OMe
O
CO2MeNC
76%
dr 57 : 43
[Ir(cod)Cl]2, L3
DABCO
 
     Die hergestellen Cyanoacetate wurden der sequentiellen Hydroformylierung / Fischer-
Indol Synthese unterworfen und Indole mit mittleren Ausbeuten erhalten. Nach Reduktion 
der Nitrilgruppe wurde ein primärer Aminorest erhalten, so das Tryptophanhomologe mit 
vier Kohlenstoffatomen in der Seitenkette erhalten wurden (s. Schema 89). 
 
Scheme 89. Synthese von längerkettigen Tryptophananaloga 
 
NC
O
O
H+ N
H
NC
O
O
H2
N
H
H2N
O
O
*
quantitative39%
Raney-Co
[Rh], CO/H2
*
*
* *
*
 
 
     Zusammenfassend konnte gezeigt werden, das die Tandem Hydroformylierung / Fischer-
Indol Synthese ein sehr effizientes Werkzeug für die Synthese verschiedener Arten von 
funktionalisierten Indolen, beginnend mit einfachen Tryptaminen bis komplexen 
Tryptophanhomologa die mehrere Stereozentren tragen, ist. 
     Der Anwendungsbereich des Tandemprozess der unter Hydroformylierungsbedingungen 
ausgeführt werden kann, wurde um die Tandem Hydroformylierung / Pictet-Spengler-
Reaktion erweitert. Die Bedeutung dieses Ansatz liegt in der Tatsache das es den schnellen 
und bequemen Zugang zu pharmakologisch wichtigen annulierten Indolsystemen ,die als 
Tetrahydro-β-carboline bekannt sind, gestattet. Die Tandem Hydroformylierung / Pictet-
Spengler Reaktion wurde zum ersten Mal in Lösung durchgeführt. Reaktionen die unter 
aprotischen Bedingungen laufen und Tryptophanmethylester als nukleophile Komponente 
und carbocyclische Olefine als Aldehydprecursor verwenden, gestatten den Zugang zu cis 
und trans Tetrahydro-β-carbolinen in guten Ausbeuten und annähernd im 1:1 Verhältnis in 
allen Fällen (s. Schema 90). 
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Scheme 90. Tandem Hydroformylierung / Pictet-Spengler Reaction unter aprotischen Bedingungen 
 
N
H
NH2
CO2MeS
N
H
NH
CO2MeS
S
N
H
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CO2MeS
R
[Rh]
+ +
79%
48 : 52
CO/H2
 
 
     Diese Reaktion verläuft unter protischen Bedingungen d. h. in Gegenwart von 
Brønstedsäure und Tryptamin als nukleophile Komponente und verschiedenen 
carbocyclischen, methallylischen Aminen und methallylischen Alkoholen als Precurosor der 
elektrophilen Komponente unter optimierten Bedingungen in guten Ausbeuten, obgleich mit 
nachweisbarer Bildung von Nebenprodukten die die Ausbeute der Reaktion senken und die 
auch nicht ganz unterdrückt werden kann (s. Schema 91). 
 
Scheme 91. Tandem Hydroformylierung / Pictet-Spengler Reaction unter protischen Bedingungen 
 
N
H
NH2
N
H
NH
+
CO/H2, H+
[Rh]
59%
 
 
     Die Tandem Hydroformylierung / Pictet-Spengler Reaktion gestattet die Synthese von 
Tetrahydro-β-carbolinen ausgehend von 1,1´ disubstituierten terminalen Olefinen; sie zeigte 
sich aber ungeeignet wenn empfindlichere Substrate wie terminale Olefine die ein 
Stereozentrum tragen verwendet wurden, so dass die Herstellung von komplexeren 
Carbolinstrukturen verhindert wurde. Wegen dieses Nachteils, wurde eine alternative 
Methode für die Synthese von Tetrahydro-β-carbolinen die, die Tandem Hydroformylierung/ 
Fischer-Indol Synthese einbeziehen, untersucht. Diese leistungsfähige Methode wurde für 
die Synthese von Tetrahydro-β-carbolinen die Substituenten enthalten, die nicht durch die 
Tandem Hydroformylierung / Pictet-Spengler Reaktion zugänglich sind, angewandt. Diese 
Substituenten wurden ziemlich generell in Positionen eingeführt, die durch klassische             
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Methoden unzugänglich sind. Die Verwendung von enantiomerenreineem 2-substituierten 
2,5-Dihydropyrrolen (zuvor hergestellt durch die allylische Aminierung / Ringschluss 
Metathese Methode) in der sequentiellen Hydroformylierung/ Fischer-Indol Synthese lieferte 
die Tetrahydro-β-carbolinstrukturen in guten Ausbeuten und mittleren Selektivitäten (s. 
Schema 92). 
 
Scheme 92. Synthese von Tetrahydro-β-carbolinen via Tandem Hydroformylierung / Fischer-Indole Synthese 
 
TsN
MeO
N
H
NTs
OMe
N
H
NTs
OMe
H
N
NH2 + +
1 : 5.5
76%
0%ee 96%ee95%ee
[Rh]/PPh3
H+
CO/H2
 
 
     Hierbei behalten 3-substituierte Produkte ihre Enantiomerenreinheit der Substrate bei, 
während 1-substitutierte in allen Fällen als Racemat isoliert wurden. Das Verhältnis von 1- 
und 3-substituierten Produkten hängt allein von der Regioselektivität des 
Hydroformylierungsschritt ab , der zu einem gewissen Mass von dem Phospinligand 
modifizierten Rh-Katalysator gesteuert wird. 
     Die Verwendung von Benzophenon geschützten Phenylhydrazonen gestattet die 
Einführung von Substituenten in 5-7 Position des Indolkerns. Hierbei wurden die Reaktionen 
in Gegenwart von BrØnstedsäure in der Reaktionsmischung durchgeführt. Dies erlaubt die 
Entschützung der Benzophenongruppe in situ und die anschließende Kondensation mit dem 
Aldehyd, der im Hydroformylierungsschritt aus dem Olefin gebildet wurde. Hierbei werden 
3-substituierte Tetrahydro-β-carboline im Überschuss erhalten wie im Fall als ungeschützte 
Hydrazine verwendet wurden, obwohl die Ausbeuten mit diesen Hydrazonen geringer ist (s. 
Schema 93).  
     Die Gegenwart der p-MeO Gruppe in 5 Position des Indolkerns hat wichtige 
medizinische Auswirkungen, wobei die Gegenwart von Halogeniden in dieser Position 
weitere Derivatisierung dieser Moleküle durch Kreuzkupplungstechniken erlaubt. 
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Scheme 93. Verwendung von Benzophenon-geschützten Hydrazonen in der Synthese von Tetrahydro-β-
carbolinen 
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     Die Verwendung von α-Boc geschützten Hydrazinen, herstellt durch die Goldberg 
Reaktion, zeigte sich als günstig für die Einführung von komplexeren Resten in Position 5 
des Indolkerns, z. B. heterocyclische Triazoleeinheiten wurden mit Hilfe dieser Hydrazine 
eingeführt (s. Schema 94). Die Verwendung dieser Hydrazine ergaben jedoch niedrigere 
Ausbeuten des Endprodukts. 
 
Scheme 94.  Verwendung von  α-Boc geschützten Hydrazinen in der Synthese von THBCs via Tandem 
Hydroformylierung / Fischer Indole Synthese 
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     Die Verwendung von 2,5-disubstituierten Pyrrolen als Substrate für die Tandem 
Hydroformylierung / Fischer Indolisierung gestattet die Herstellung von 1,3-disubstituierten 
Tetrahydro-β-carbolinen in hohen Enantioselektivitäten (s. Scheme 95). 
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Scheme 95. Synthese von 1,3-disubstitutierten Tetrahydro-β-carbolinen 
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CO/H2
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RR
15
71%, 98%ee98%ee  
     Zusammenfassend wurde eine effiziente modulare Synhese von funktionalisierten 
enantiomerenreinen Tetrahydro-β-carbolinen ausgehend von enantiomerenreinen cyclischen 
Aminoolefinen verwirklicht. Gute Ausbeuten des Endprodukts und mittlere bis gute 
Regioselektivitäten der Hydroformylierung wurden erzielt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
